activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1734318	CHEMBL871588	Inhibition of human PI3Kdelta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	nM	20000.0
	1734318	CHEMBL871588	Inhibition of human PI3Kdelta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	nM	20000.0
	1734331	CHEMBL871588	Inhibition of human PI3Kdelta	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	1734467	CHEMBL871588	Inhibition of human PI3Kdelta	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1330.0	CHEMBL3130	Homo sapiens	IC50	nM	1330.0
	1734920	CHEMBL871588	Inhibition of human PI3Kdelta	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccccc3O)o2)S1		CHEMBL208652	>	IC50	nM	5000.0	CHEMBL3130	Homo sapiens	IC50	nM	5000.0
	1918376	CHEMBL895749	Inhibition of recombinant PI3Kdelta	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	IC50	nM	235.0	CHEMBL3130	Homo sapiens	IC50	nM	235.0
	1988773	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12		CHEMBL393525	=	IC50	nM	910.0	CHEMBL3130	Homo sapiens	IC50	uM	0.91
	1988792	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccccn12		CHEMBL239050	=	IC50	nM	5400.0	CHEMBL3130	Homo sapiens	IC50	uM	5.4
	1988793	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2n1CCCC2		CHEMBL239051	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988794	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2c(Br)cccc12		CHEMBL397780	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988795	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2cc(Br)ccc12		CHEMBL397105	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988796	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2ccc(Br)cc12		CHEMBL240336	=	IC50	nM	9000.0	CHEMBL3130	Homo sapiens	IC50	uM	9.0
	1988797	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncc2ccccc12		CHEMBL240335	=	IC50	nM	3600.0	CHEMBL3130	Homo sapiens	IC50	uM	3.6
	1988798	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccccc2c1		CHEMBL240118	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988799	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ccnc2ccccc12		CHEMBL393747	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988800	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cccc2ccccc12		CHEMBL413803	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988801	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1csc2ccccc12		CHEMBL413802	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988802	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1coc2ccccc12		CHEMBL392071	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988803	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1onc2ccccc12		CHEMBL392070	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988804	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cn(C)c2ccccc12		CHEMBL239475	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988805	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ncn2ccccc12		CHEMBL239052	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988806	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1ncc2ccccn12		CHEMBL393526	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	1988807	CHEMBL899009	Inhibition of human recombinant p110delta	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cncn1C		CHEMBL397796	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	2106312	CHEMBL947157	Inhibition of PI3K p110delta	B	N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1		CHEMBL272265	=	IC50	nM	98.0	CHEMBL3130	Homo sapiens	IC50	nM	98.0
	2106318	CHEMBL947157	Inhibition of PI3K p110delta	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21		CHEMBL255592	=	IC50	nM	201.0	CHEMBL3130	Homo sapiens	IC50	nM	201.0
	2106319	CHEMBL947157	Inhibition of PI3K p110delta	B	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1		CHEMBL270638	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	2110278	CHEMBL950969	Inhibition of PI3Kdelta	B	COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL410643	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	2147345	CHEMBL922030	Activity of human PI 3-kinase delta at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	92.0	CHEMBL3130	Homo sapiens	Activity	%	92.0
	2260534	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL512440	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	2260542	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL469209	=	IC50	nM	139.0	CHEMBL3130	Homo sapiens	IC50	nM	139.0
	2260550	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cn[nH]c5)cc43)sc2C(=O)N1		CHEMBL512092	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	2260558	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1n[nH]c(C)c1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL498184	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	2260566	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC(C)(O)Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL498185	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	nM	54.0
	2260574	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1nn(CC(C)(C)O)c(C)c1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL498383	=	IC50	nM	65.0	CHEMBL3130	Homo sapiens	IC50	nM	65.0
	2260582	CHEMBL1008868	Inhibition of PI3Kdelta	B	CCn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL521721	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	2260590	CHEMBL1008868	Inhibition of PI3Kdelta	B	CCn1nc(C)c(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)c1C		CHEMBL496331	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	2260598	CHEMBL1008868	Inhibition of PI3Kdelta	B	COCC(O)Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL496332	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	2260606	CHEMBL1008868	Inhibition of PI3Kdelta	B	CN(C)CCCn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL498392	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	2260614	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1nn(C)c(C)c1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL525352	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	2260622	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cnn(Cc6ccccc6)c5)cc43)sc2C(=O)N1		CHEMBL522069	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	2260630	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cnn(Cc6cccnc6)c5)cc43)sc2C(=O)N1		CHEMBL496541	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	2260638	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1nn(C)cc1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL496542	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
	2260646	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cnn(CCN)c5)cc43)sc2C(=O)N1		CHEMBL498000	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	2260654	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1nn(CCCN)cc1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL526463	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	2260662	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cn1ncc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)c1N		CHEMBL498001	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	2260670	CHEMBL1008868	Inhibition of PI3Kdelta	B	COC[C@@H](O)Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL498002	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	2260678	CHEMBL1008868	Inhibition of PI3Kdelta	B	COC[C@H](O)Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL489602	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	2260686	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(Nc5ccc(N6CCNCC6)nn5)cc43)sc2C(=O)N1		CHEMBL491440	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	2260694	CHEMBL1008868	Inhibition of PI3Kdelta	B	CN1CCN(c2ccc(Nc3ccc4c(c3)N(c3nc5c(s3)C(=O)NC(C)(C)C5)CCO4)nn2)CC1		CHEMBL491441	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	2260702	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1cc(C)c(Nc2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL491641	=	IC50	nM	245.0	CHEMBL3130	Homo sapiens	IC50	nM	245.0
	2260710	CHEMBL1008868	Inhibition of PI3Kdelta	B	Cc1ccc(Nc2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL490428	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	2260718	CHEMBL1008868	Inhibition of PI3Kdelta	B	CN(C)c1ccc(Nc2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL489596	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	2260726	CHEMBL1008868	Inhibition of PI3Kdelta	B	COc1ccc(Nc2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL522910	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	2260734	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(Nc5ccc(-c6ccccc6)nn5)cc43)sc2C(=O)N1		CHEMBL496940	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	2260742	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccc(N6CCNCC6)nn5)cc43)sc2C(=O)N1		CHEMBL496941	=	IC50	nM	103.0	CHEMBL3130	Homo sapiens	IC50	nM	103.0
	2260750	CHEMBL1008868	Inhibition of PI3Kdelta	B	CN1CCN(c2ccc(-c3ccc4c(c3)N(c3nc5c(s3)C(=O)NC(C)(C)C5)CCO4)nn2)CC1		CHEMBL498379	=	IC50	nM	231.0	CHEMBL3130	Homo sapiens	IC50	nM	231.0
	2260758	CHEMBL1008868	Inhibition of PI3Kdelta	B	CN(C)c1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL498586	=	IC50	nM	103.0	CHEMBL3130	Homo sapiens	IC50	nM	103.0
	2260766	CHEMBL1008868	Inhibition of PI3Kdelta	B	COc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL498587	=	IC50	nM	89.0	CHEMBL3130	Homo sapiens	IC50	nM	89.0
	2260774	CHEMBL1008868	Inhibition of PI3Kdelta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccc(N)nn5)cc43)sc2C(=O)N1		CHEMBL524466	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	nM	72.0
	2273598	CHEMBL960870	Inhibition of human PI3Kdelta	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1615278	=	IC50	nM	530.0	CHEMBL3130	Homo sapiens	IC50	nM	530.0
	2273599	CHEMBL960870	Inhibition of human PI3Kdelta	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	nM	440.0
	2360396	CHEMBL980852	Inhibition of human recombinant PI3K p110delta expressed in Sf9 cells coexpressing p85alpha by radiometric scintillation proximity assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	2470355	CHEMBL981737	Inhibition of PIK3CD at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3130	Homo sapiens	INH	%	10.0
	2564125	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL469099	=	IC50	nM	701.0	CHEMBL3130	Homo sapiens	IC50	nM	701.0
	2564165	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3csc4ccccc34)nc2C1		CHEMBL478633	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
	2564166	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3c[nH]c4ncccc34)nc2C1		CHEMBL478425	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	2564167	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL513924	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	2564168	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL514061	=	IC50	nM	2525.0	CHEMBL3130	Homo sapiens	IC50	nM	2525.0
	2564169	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3ccc4ccccc4c3)nc2C1		CHEMBL476953	=	IC50	nM	1392.0	CHEMBL3130	Homo sapiens	IC50	nM	1392.0
	2564170	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOCC3Cc3cccc4ccccc34)nc2C1		CHEMBL477999	=	IC50	nM	126.0	CHEMBL3130	Homo sapiens	IC50	nM	126.0
	2564171	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3ccccc3)nc2C1		CHEMBL453232	=	IC50	nM	2124.0	CHEMBL3130	Homo sapiens	IC50	nM	2124.0
	2564172	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3Cc3ccccc3)nc2C1		CHEMBL477787	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	2564173	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3c3ccccc3)nc2C1		CHEMBL469059	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	2564174	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCOC[C@H]3c3ccccc3)nc2C1		CHEMBL512470	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	2564175	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(-c3ccncc3)nc2C1		CHEMBL469057	=	IC50	nM	19040.0	CHEMBL3130	Homo sapiens	IC50	nM	19040.0
	2564176	CHEMBL989177	Inhibition of PI3Kdelta	B	COCCNc1nc2c(s1)C(=O)CC(C)(C)C2		CHEMBL463606	>	IC50	nM	40000.0	CHEMBL3130	Homo sapiens	IC50	nM	40000.0
	2564177	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CC(=O)c2sc(N3CCCCC3)nc2C1		CHEMBL469058	>	IC50	nM	40000.0	CHEMBL3130	Homo sapiens	IC50	nM	40000.0
	2564178	CHEMBL989177	Inhibition of PI3Kdelta	B	O=C1CC2(CCCCC2)Cc2nc(N3CCOCC3)sc21		CHEMBL469052	=	IC50	nM	1176.0	CHEMBL3130	Homo sapiens	IC50	nM	1176.0
	2564179	CHEMBL989177	Inhibition of PI3Kdelta	B	O=C1CC2(CCCC2)Cc2nc(N3CCOCC3)sc21		CHEMBL512293	=	IC50	nM	1482.0	CHEMBL3130	Homo sapiens	IC50	nM	1482.0
	2564180	CHEMBL989177	Inhibition of PI3Kdelta	B	O=C1CCCc2nc(N3CCOCC3)sc21		CHEMBL466962	=	IC50	nM	3887.0	CHEMBL3130	Homo sapiens	IC50	nM	3887.0
	2564181	CHEMBL989177	Inhibition of PI3Kdelta	B	O=C1CC(c2ccccc2)Cc2nc(N3CCOCC3)sc21		CHEMBL466957	=	IC50	nM	31710.0	CHEMBL3130	Homo sapiens	IC50	nM	31710.0
	2564182	CHEMBL989177	Inhibition of PI3Kdelta	B	CCCC1CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL466106	=	IC50	nM	26240.0	CHEMBL3130	Homo sapiens	IC50	nM	26240.0
	2564183	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL466956	=	IC50	nM	5973.0	CHEMBL3130	Homo sapiens	IC50	nM	5973.0
	2564205	CHEMBL989177	Inhibition of PI3Kdelta	B	CC1(C)CNC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1		CHEMBL514869	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	2570721	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(Br)cc43)nc2C1		CHEMBL469035	=	IC50	nM	249.0	CHEMBL3130	Homo sapiens	IC50	nM	249.0
	2570722	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccccc5)cc43)nc2C1		CHEMBL469200	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	nM	80.0
	2570723	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1		CHEMBL469099	=	IC50	nM	701.0	CHEMBL3130	Homo sapiens	IC50	nM	701.0
	2570726	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(Br)cc43)sc2C(=O)N1		CHEMBL453240	=	IC50	nM	153.0	CHEMBL3130	Homo sapiens	IC50	nM	153.0
	2570727	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467966	=	IC50	nM	357.0	CHEMBL3130	Homo sapiens	IC50	nM	357.0
	2570728	CHEMBL1001352	Inhibition of PI3K delta	B	COc1ccc2c(c1)OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL512624	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	2570729	CHEMBL1001352	Inhibition of PI3K delta	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)CC(C)(C)C4)CCO3)cn1		CHEMBL504616	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	2570730	CHEMBL1001352	Inhibition of PI3K delta	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL512440	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	2570731	CHEMBL1001352	Inhibition of PI3K delta	B	Cn1ccnc1-c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467561	=	IC50	nM	285.0	CHEMBL3130	Homo sapiens	IC50	nM	285.0
	2570732	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1nc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)c[nH]1		CHEMBL467395	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	2570733	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccn[nH]5)cc43)sc2C(=O)N1		CHEMBL511228	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	nM	90.0
	2570734	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5cn[nH]c5)cc43)nc2C1		CHEMBL467394	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	2570735	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cn[nH]c5)cc43)sc2C(=O)N1		CHEMBL512092	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	2570736	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5cnc[nH]5)cc43)sc2C(=O)N1		CHEMBL467553	=	IC50	nM	81.0	CHEMBL3130	Homo sapiens	IC50	nM	81.0
	2570737	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)nn1		CHEMBL469209	=	IC50	nM	139.0	CHEMBL3130	Homo sapiens	IC50	nM	139.0
	2570738	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ncccn5)cc43)sc2C(=O)N1		CHEMBL469208	=	IC50	nM	123.0	CHEMBL3130	Homo sapiens	IC50	nM	123.0
	2570739	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)CC(C)(C)C4)CCO3)cn1		CHEMBL512834	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	2570740	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1ccc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL469202	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	2570741	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccncc5)cc43)nc2C1		CHEMBL512650	=	IC50	nM	94.0	CHEMBL3130	Homo sapiens	IC50	nM	94.0
	2570742	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5cccnc5)cc43)nc2C1		CHEMBL512648	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	2570743	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccc(-c5ccccn5)cc43)nc2C1		CHEMBL469194	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	2570744	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ncccc43)nc2C1		CHEMBL469193	=	IC50	nM	5731.0	CHEMBL3130	Homo sapiens	IC50	nM	5731.0
	2570745	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ncccc43)sc2C(=O)N1		CHEMBL469029	>	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	nM	20000.0
	2570746	CHEMBL1001352	Inhibition of PI3K delta	B	CN(C)Cc1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL467552	=	IC50	nM	7574.0	CHEMBL3130	Homo sapiens	IC50	nM	7574.0
	2570747	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(C5CC5)cc43)sc2C(=O)N1		CHEMBL512091	=	IC50	nM	155.0	CHEMBL3130	Homo sapiens	IC50	nM	155.0
	2570748	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccc(-c5ccccc5)cc43)sc2C(=O)N1		CHEMBL511605	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	2570749	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4cc(-c5ccccc5)ccc43)nc2C1		CHEMBL469271	=	IC50	nM	1050.0	CHEMBL3130	Homo sapiens	IC50	nM	1050.0
	2570750	CHEMBL1001352	Inhibition of PI3K delta	B	CC(=O)c1ccc2c(c1)N(c1nc3c(s1)C(=O)NC(C)(C)C3)CCO2		CHEMBL469270	=	IC50	nM	366.0	CHEMBL3130	Homo sapiens	IC50	nM	366.0
	2570751	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4cc(Br)ccc43)nc2C1		CHEMBL512815	=	IC50	nM	549.0	CHEMBL3130	Homo sapiens	IC50	nM	549.0
	2570752	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1ccc2c(c1)OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL451883	=	IC50	nM	605.0	CHEMBL3130	Homo sapiens	IC50	nM	605.0
	2570753	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4cc(F)ccc43)sc2C(=O)N1		CHEMBL449786	=	IC50	nM	783.0	CHEMBL3130	Homo sapiens	IC50	nM	783.0
	2570754	CHEMBL1001352	Inhibition of PI3K delta	B	Cc1cccc2c1OCCN2c1nc2c(s1)C(=O)NC(C)(C)C2		CHEMBL469249	=	IC50	nM	15280.0	CHEMBL3130	Homo sapiens	IC50	nM	15280.0
	2570755	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4c(F)cccc43)sc2C(=O)N1		CHEMBL469248	=	IC50	nM	11240.0	CHEMBL3130	Homo sapiens	IC50	nM	11240.0
	2570756	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOc4ccccc43)sc2C(=O)N1		CHEMBL468218	=	IC50	nM	1631.0	CHEMBL3130	Homo sapiens	IC50	nM	1631.0
	2570757	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)CC(=O)c2sc(N3CCOc4ccccc43)nc2C1		CHEMBL469201	=	IC50	nM	614.0	CHEMBL3130	Homo sapiens	IC50	nM	614.0
	2570758	CHEMBL1001352	Inhibition of PI3K delta	B	CC1(C)Cc2nc(N3CCOCC3)sc2C(=O)N1		CHEMBL449049	=	IC50	nM	722.0	CHEMBL3130	Homo sapiens	IC50	nM	722.0
	2721685	CHEMBL1059120	Inhibition of PI3K-delta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	2921214	CHEMBL1057589	Inhibition of PIK3CD assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	2949064	CHEMBL1047617	Inhibition of PI3Kdelta	B	COC(=O)N1CCC(n2ncc3c(N4CC5CCC(C4)O5)nc(-c4ccc(NC(=O)NC5CC5)cc4)nc32)CC1		CHEMBL583874	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	2991199	CHEMBL1039202	Inhibition of PI3Kdelta	B	CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4nc(N5CC6CCC(C5)O6)c5cnn(CC(F)(F)F)c5n4)cc3)cc2)CC1		CHEMBL570833	=	IC50	nM	945.0	CHEMBL3130	Homo sapiens	IC50	nM	945.0
	2993576	CHEMBL1040951	Inhibition of human recombinant PI3Kdelta	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	3014982	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	O=c1oc2cc(O)ccc2cc1-c1nc2ccccc2s1		CHEMBL437770	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	uM	4.0
	3014983	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	COC(=O)c1ccc(CSc2ncnc3sc(C)c(C)c23)o1		CHEMBL579219	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
Not Determined	3014984	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	COc1ccccc1-c1nc(-c2cc3cc(C)ccc3[nH]c2=O)no1		CHEMBL567914		IC50			CHEMBL3130	Homo sapiens	IC50		
	3014985	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	Cc1ccc2cc3c(OC(=O)COc4ccccc4)nn(C)c3nc2c1		CHEMBL568574	=	IC50	nM	47000.0	CHEMBL3130	Homo sapiens	IC50	uM	47.0
	3014986	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	COc1cccc(-c2nc(-c3cc4cc(OC)ccc4[nH]c3=O)no2)c1		CHEMBL566046	=	IC50	nM	900.0	CHEMBL3130	Homo sapiens	IC50	uM	0.9
	3014987	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	O=C(CCn1c(=O)oc2cc(Cl)ccc21)Nc1ccccc1		CHEMBL577499	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3014988	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
Not Determined	3016069	CHEMBL1039899	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells	B	COc1nc(-c2ccccc2)ccc1-c1noc(-c2ccncc2)n1		CHEMBL565432		IC50			CHEMBL3130	Homo sapiens	IC50		
	3016080	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016084	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=C(CCn1c(=O)oc2cc(Cl)ccc21)Nc1ccccc1		CHEMBL577499	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016088	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1cccc(-c2nc(-c3cc4cc(OC)ccc4[nH]c3=O)no2)c1		CHEMBL566046	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016092	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	Cc1ccc2cc3c(OC(=O)COc4ccccc4)nn(C)c3nc2c1		CHEMBL568574	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016096	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1ccccc1-c1nc(-c2cc3cc(C)ccc3[nH]c2=O)no1		CHEMBL567914	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016100	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COC(=O)c1ccc(CSc2ncnc3sc(C)c(C)c23)o1		CHEMBL579219	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016104	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	O=c1oc2cc(O)ccc2cc1-c1nc2ccccc2s1		CHEMBL437770	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3016108	CHEMBL1039893	Inhibition of recombinant PI3Kdelta expressed in baculovirus-infected Sf21 cells at 100 uM	B	COc1nc(-c2ccccc2)ccc1-c1noc(-c2ccncc2)n1		CHEMBL565432	>=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	3121471	CHEMBL1065061	Inhibition of PI3Kdelta	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	3132780	CHEMBL1068077	Inhibition of PI3Kdelta	B	CCn1nnc2c(N3CCOCC3)nc(-c3ccc(NC(=O)Nc4ccc(C(=O)N5CCN(C)CC5)cc4)cc3)nc21		CHEMBL589258	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	3198615	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(C(C)(C)O)cc2n1		CHEMBL1085178	=	IC50	nM	5.2	CHEMBL3130	Homo sapiens	IC50	nM	5.2
	3198621	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3)cc2n1		CHEMBL1085177	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	3198626	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CC(C)(O)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1		CHEMBL1084926	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
Not Determined	3198630	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CC(C)(O)c1cc2nc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2s1		CHEMBL1083508		IC50			CHEMBL3130	Homo sapiens	IC50		
	3198721	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083192	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	3198722	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083810	=	IC50	nM	6.6	CHEMBL3130	Homo sapiens	IC50	nM	6.6
	3198723	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccc(N)cc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1083809	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	3198724	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc(CO)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1085160	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
Not Determined	3198725	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccccc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1085159		IC50			CHEMBL3130	Homo sapiens	IC50		
	3198726	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4ccncc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1077023	=	IC50	nM	310.0	CHEMBL3130	Homo sapiens	IC50	nM	310.0
	3198727	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccnc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1086924	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	3198728	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL1086923	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	3198729	CHEMBL1108627	Inhibition of recombinant PI3Kdelta assessed as PIP3 product formation by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	3227660	CHEMBL1107747	Inhibition PI3K-delta-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay	B	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO		CHEMBL1078983	>	IC50	nM	5300.0	CHEMBL3130	Homo sapiens	IC50	uM	5.3
	3235130	CHEMBL1111663	Inhibition of PI3Kdelta	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1091978	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	3264506	CHEMBL1104686	Inhibition of PI3Kdelta	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(Cc5cccnc5)CC4)c3n2)cc1		CHEMBL551440	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	nM	64.0
	3313721	CHEMBL1119663	Inhibition of PI3delta	B	COc1cc(F)c2[nH]c(-c3c(C)nn(C)c3C)c(/C=C3/Oc4ccc(NC(=O)Nc5ccc(C(=O)N(C)CCN(C)C)cc5)cc4C3=O)c2c1		CHEMBL1082621	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	3332093	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3333508	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3334913	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3336333	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3341875	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3343322	CHEMBL1166804	Inhibition of PIK3CD at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	3358744	CHEMBL1175210	Inhibition of PIK3CD at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	76.0	CHEMBL3130	Homo sapiens	INH	%	76.0
	3359186	CHEMBL1175210	Inhibition of PIK3CD at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	76.0	CHEMBL3130	Homo sapiens	INH	%	76.0
	3389767	CHEMBL1216943	Inhibition of p110delta	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	3389771	CHEMBL1216943	Inhibition of p110delta	B	COc1ccccc1-n1c(CSc2ncnc3[nH]cnc23)nc2cccc(Cl)c2c1=O		CHEMBL1213083	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	3389775	CHEMBL1216943	Inhibition of p110delta	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213084	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	3389779	CHEMBL1216943	Inhibition of p110delta	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc(O)c(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213085	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	3389783	CHEMBL1216943	Inhibition of p110delta	B	Cc1ccccc1-n1c(Cn2nc(C#CCO)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213116	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	3389787	CHEMBL1216943	Inhibition of p110delta	B	CC(=O)Nc1nc2ccc(-c3nn(Cc4cc5ccccc5nc4N4CCN(C)CC4)c4ncnc(N)c34)cc2s1		CHEMBL1213117	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	3389791	CHEMBL1216943	Inhibition of p110delta	B	CN1CCN(c2nc3ccccc3cc2Cn2nc(-c3ccc4nc(N)sc4c3)c3c(N)ncnc32)CC1		CHEMBL1213118	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	3389795	CHEMBL1216943	Inhibition of p110delta	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	nM	4.6
	3389799	CHEMBL1216943	Inhibition of p110delta	B	CC(C)n1nc(C#Cc2cccnc2)c2c(N)ncnc21		CHEMBL1213119	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
	3389803	CHEMBL1216943	Inhibition of p110delta	B	CC(C)n1nc(C#Cc2cccc(O)c2)c2c(N)ncnc21		CHEMBL1213120	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	3389807	CHEMBL1216943	Inhibition of p110delta	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(F)cc2)cc(OC)c1		CHEMBL1213168	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	nM	90.0
	3389811	CHEMBL1216943	Inhibition of p110delta	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	3389815	CHEMBL1216943	Inhibition of p110delta	B	COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2c(c1=O)CCCC2		CHEMBL1213169	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	3440716	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21		CHEMBL1242285	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	uM	0.13
	3440730	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br		CHEMBL1242286	=	IC50	nM	206.0	CHEMBL3130	Homo sapiens	IC50	uM	0.206
	3440744	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241299	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	uM	0.023
	3440758	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1		CHEMBL1242287	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	uM	0.041
	3440772	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1		CHEMBL1242376	=	IC50	nM	112.0	CHEMBL3130	Homo sapiens	IC50	uM	0.112
	3440786	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242377	=	IC50	nM	65.0	CHEMBL3130	Homo sapiens	IC50	uM	0.065
	3440800	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242378	=	IC50	nM	3030.0	CHEMBL3130	Homo sapiens	IC50	uM	3.03
	3440814	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242468	=	IC50	nM	4350.0	CHEMBL3130	Homo sapiens	IC50	uM	4.35
	3440828	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242469	=	IC50	nM	1370.0	CHEMBL3130	Homo sapiens	IC50	uM	1.37
	3440842	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242470	=	IC50	nM	716.0	CHEMBL3130	Homo sapiens	IC50	uM	0.716
	3440856	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1		CHEMBL1242566	=	IC50	nM	777.0	CHEMBL3130	Homo sapiens	IC50	uM	0.777
	3440870	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1		CHEMBL1242567	=	IC50	nM	213.0	CHEMBL3130	Homo sapiens	IC50	uM	0.213
	3440884	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1		CHEMBL1242568	=	IC50	nM	142.0	CHEMBL3130	Homo sapiens	IC50	uM	0.142
	3440898	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1		CHEMBL1242656	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	uM	0.058
	3440912	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1		CHEMBL1242657	=	IC50	nM	193.0	CHEMBL3130	Homo sapiens	IC50	uM	0.193
	3440926	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1242658	=	IC50	nM	514.0	CHEMBL3130	Homo sapiens	IC50	uM	0.514
	3440940	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1242748	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	uM	0.015
	3440954	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1242749	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	3440968	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1		CHEMBL1242750	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	uM	0.074
	3440982	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1		CHEMBL1242844	=	IC50	nM	1985.0	CHEMBL3130	Homo sapiens	IC50	uM	1.985
	3440996	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242845	=	IC50	nM	172.0	CHEMBL3130	Homo sapiens	IC50	uM	0.172
	3441010	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1		CHEMBL1241482	=	IC50	nM	1070.0	CHEMBL3130	Homo sapiens	IC50	uM	1.07
	3441024	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F		CHEMBL1241483	=	IC50	nM	281.0	CHEMBL3130	Homo sapiens	IC50	uM	0.281
	3441038	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241484	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	3441052	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241579	=	IC50	nM	1620.0	CHEMBL3130	Homo sapiens	IC50	uM	1.62
	3441066	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1240544	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	3441080	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1		CHEMBL1241580	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	3441617	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL1241481	=	IC50	nM	10200.0	CHEMBL3130	Homo sapiens	IC50	uM	10.2
	3441631	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	3441645	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	3441659	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	3441673	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	3441687	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	3441701	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1		CHEMBL1241675	=	IC50	nM	2300.0	CHEMBL3130	Homo sapiens	IC50	uM	2.3
	3441715	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	3441857	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	3441871	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	3441885	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL1241104	=	IC50	nM	12500.0	CHEMBL3130	Homo sapiens	IC50	uM	12.5
	3441899	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241142	=	IC50	nM	9600.0	CHEMBL3130	Homo sapiens	IC50	uM	9.6
	3441913	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241143	=	IC50	nM	5700.0	CHEMBL3130	Homo sapiens	IC50	uM	5.7
	3441927	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-c1n[nH]c2ncnc(N)c12		CHEMBL1241144	=	IC50	nM	29000.0	CHEMBL3130	Homo sapiens	IC50	uM	29.0
	3441941	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1C		CHEMBL1241145	=	IC50	nM	11000.0	CHEMBL3130	Homo sapiens	IC50	uM	11.0
	3441955	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)c1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241240	=	IC50	nM	18000.0	CHEMBL3130	Homo sapiens	IC50	uM	18.0
	3441969	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21		CHEMBL1241241	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	uM	0.084
	3441983	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(O)c3)c12		CHEMBL1241242	=	IC50	nM	3100.0	CHEMBL3130	Homo sapiens	IC50	uM	3.1
	3441997	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1241269	=	IC50	nM	2900.0	CHEMBL3130	Homo sapiens	IC50	uM	2.9
	3442011	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNc1ncnc2c1c(-c1cccc(O)c1)nn2C(C)C		CHEMBL1241942	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442025	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12		CHEMBL1242024	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	3442039	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OCc1ccccc1		CHEMBL1242025	=	IC50	nM	3190.0	CHEMBL3130	Homo sapiens	IC50	uM	3.19
	3442053	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241270	=	IC50	nM	660.0	CHEMBL3130	Homo sapiens	IC50	uM	0.66
	3442067	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241271	=	IC50	nM	210.0	CHEMBL3130	Homo sapiens	IC50	uM	0.21
	3442081	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242026	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	uM	0.22
	3442095	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21		CHEMBL1242109	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	3442109	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21		CHEMBL1242110	=	IC50	nM	677.0	CHEMBL3130	Homo sapiens	IC50	uM	0.677
	3442123	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1		CHEMBL1242111	=	IC50	nM	249.0	CHEMBL3130	Homo sapiens	IC50	uM	0.249
	3442137	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL1242198	=	IC50	nM	46.0	CHEMBL3130	Homo sapiens	IC50	uM	0.046
	3442151	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1		CHEMBL1242199	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	uM	0.072
	3442165	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242200	=	IC50	nM	2970.0	CHEMBL3130	Homo sapiens	IC50	uM	2.97
	3442189	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242381	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	uM	0.067
	3442203	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240553	=	IC50	nM	57.0	CHEMBL3130	Homo sapiens	IC50	uM	0.057
	3442217	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC		CHEMBL1242471	=	IC50	nM	473.0	CHEMBL3130	Homo sapiens	IC50	uM	0.473
	3442231	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242472	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	uM	0.042
	3442245	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21		CHEMBL1242569	=	IC50	nM	276.0	CHEMBL3130	Homo sapiens	IC50	uM	0.276
	3442259	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240554	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	uM	0.017
	3442273	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1242659	=	IC50	nM	177.0	CHEMBL3130	Homo sapiens	IC50	uM	0.177
	3442287	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL1242660	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	uM	1.9
	3442301	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC		CHEMBL1242751	=	IC50	nM	37000.0	CHEMBL3130	Homo sapiens	IC50	uM	37.0
	3442315	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC		CHEMBL1242752	=	IC50	nM	103.0	CHEMBL3130	Homo sapiens	IC50	uM	0.103
	3442329	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC		CHEMBL1242753	=	IC50	nM	2400.0	CHEMBL3130	Homo sapiens	IC50	uM	2.4
	3442343	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1		CHEMBL1242846	=	IC50	nM	686.0	CHEMBL3130	Homo sapiens	IC50	uM	0.686
	3442357	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1242847	=	IC50	nM	125.0	CHEMBL3130	Homo sapiens	IC50	uM	0.125
	3442371	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3O)c12		CHEMBL1241355	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442385	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21		CHEMBL1242848	=	IC50	nM	1260.0	CHEMBL3130	Homo sapiens	IC50	uM	1.26
	3442399	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N		CHEMBL1241485	=	IC50	nM	280.0	CHEMBL3130	Homo sapiens	IC50	uM	0.28
	3442413	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO		CHEMBL1241486	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	3442427	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1241487	=	IC50	nM	252.0	CHEMBL3130	Homo sapiens	IC50	uM	0.252
	3442441	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N		CHEMBL1241581	=	IC50	nM	144.0	CHEMBL3130	Homo sapiens	IC50	uM	0.144
	3442455	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241356	=	IC50	nM	11000.0	CHEMBL3130	Homo sapiens	IC50	uM	11.0
	3442469	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241357	=	IC50	nM	82000.0	CHEMBL3130	Homo sapiens	IC50	uM	82.0
	3442483	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1241358	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442497	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1241389	=	IC50	nM	2300.0	CHEMBL3130	Homo sapiens	IC50	uM	2.3
	3442511	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21		CHEMBL1241582	=	IC50	nM	670.0	CHEMBL3130	Homo sapiens	IC50	uM	0.67
	3442525	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21		CHEMBL1241583	=	IC50	nM	900.0	CHEMBL3130	Homo sapiens	IC50	uM	0.9
	3442539	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21		CHEMBL1240545	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	3442552	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21		CHEMBL1241679	=	IC50	nM	640.0	CHEMBL3130	Homo sapiens	IC50	uM	0.64
	3442566	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21		CHEMBL1241680	=	IC50	nM	6300.0	CHEMBL3130	Homo sapiens	IC50	uM	6.3
	3442580	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21		CHEMBL1241771	=	IC50	nM	1400.0	CHEMBL3130	Homo sapiens	IC50	uM	1.4
	3442594	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21		CHEMBL1241772	=	IC50	nM	6900.0	CHEMBL3130	Homo sapiens	IC50	uM	6.9
	3442608	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21		CHEMBL1241390	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	uM	1.9
	3442622	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21		CHEMBL1241391	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442636	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1241773	=	IC50	nM	410.0	CHEMBL3130	Homo sapiens	IC50	uM	0.41
	3442650	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241860	=	IC50	nM	213.0	CHEMBL3130	Homo sapiens	IC50	uM	0.213
	3442664	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241861	=	IC50	nM	3900.0	CHEMBL3130	Homo sapiens	IC50	uM	3.9
	3442678	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL1241862	=	IC50	nM	490.0	CHEMBL3130	Homo sapiens	IC50	uM	0.49
	3442692	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1241946	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	3442706	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21		CHEMBL1241439	=	IC50	nM	690.0	CHEMBL3130	Homo sapiens	IC50	uM	0.69
	3442720	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O		CHEMBL1241947	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	3442733	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(NS(C)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1241948	=	IC50	nM	650.0	CHEMBL3130	Homo sapiens	IC50	uM	0.65
	3442746	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(NS(C)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242030	=	IC50	nM	1400.0	CHEMBL3130	Homo sapiens	IC50	uM	1.4
	3442760	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1242031	=	IC50	nM	210.0	CHEMBL3130	Homo sapiens	IC50	uM	0.21
	3442774	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242032	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	uM	0.24
	3442788	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21		CHEMBL1242115	=	IC50	nM	680.0	CHEMBL3130	Homo sapiens	IC50	uM	0.68
	3442802	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(NC(=O)c4ccc(-c5ccccc5)cc4)cc3)c12		CHEMBL1242116	=	IC50	nM	15000.0	CHEMBL3130	Homo sapiens	IC50	uM	15.0
	3442816	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL1242204	=	IC50	nM	23000.0	CHEMBL3130	Homo sapiens	IC50	uM	23.0
	3442830	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12		CHEMBL1242205	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442844	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL1242206	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442858	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1242291	=	IC50	nM	6300.0	CHEMBL3130	Homo sapiens	IC50	uM	6.3
	3442872	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4c(Cl)cccc4Cl)c3)c12		CHEMBL1242292	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3442886	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CCc1ccccc1		CHEMBL1242382	=	IC50	nM	21000.0	CHEMBL3130	Homo sapiens	IC50	uM	21.0
	3442900	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	NC(=O)Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242383	=	IC50	nM	3000.0	CHEMBL3130	Homo sapiens	IC50	uM	3.0
	3442914	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1		CHEMBL1242473	=	IC50	nM	1800.0	CHEMBL3130	Homo sapiens	IC50	uM	1.8
	3442928	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242474	=	IC50	nM	12000.0	CHEMBL3130	Homo sapiens	IC50	uM	12.0
	3442942	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C/C=C/c1ccccc1		CHEMBL1242570	=	IC50	nM	3600.0	CHEMBL3130	Homo sapiens	IC50	uM	3.6
	3442953	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1		CHEMBL1241676	=	IC50	nM	103.0	CHEMBL3130	Homo sapiens	IC50	uM	0.103
	3442967	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1241677	=	IC50	nM	203.0	CHEMBL3130	Homo sapiens	IC50	uM	0.203
	3442981	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1241678	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	3442995	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1241768	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	3443009	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1		CHEMBL1241769	=	IC50	nM	5470.0	CHEMBL3130	Homo sapiens	IC50	uM	5.47
	3443023	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1		CHEMBL1241770	=	IC50	nM	207.0	CHEMBL3130	Homo sapiens	IC50	uM	0.207
	3443037	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1		CHEMBL1241858	=	IC50	nM	6050.0	CHEMBL3130	Homo sapiens	IC50	uM	6.05
	3443051	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1		CHEMBL1241859	=	IC50	nM	199.0	CHEMBL3130	Homo sapiens	IC50	uM	0.199
	3443065	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1		CHEMBL1241943	=	IC50	nM	156.0	CHEMBL3130	Homo sapiens	IC50	uM	0.156
	3443079	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21		CHEMBL1241944	=	IC50	nM	88.0	CHEMBL3130	Homo sapiens	IC50	uM	0.088
	3443093	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21		CHEMBL1241945	=	IC50	nM	161.0	CHEMBL3130	Homo sapiens	IC50	uM	0.161
Not Determined	3443107	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F		CHEMBL1242027		IC50			CHEMBL3130	Homo sapiens	IC50		
	3443121	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21		CHEMBL1242028	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	3443135	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242029	=	IC50	nM	730.0	CHEMBL3130	Homo sapiens	IC50	uM	0.73
	3443149	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O		CHEMBL1242112	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	uM	0.061
	3443163	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241300	=	IC50	nM	198.0	CHEMBL3130	Homo sapiens	IC50	uM	0.198
	3443177	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241301	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	uM	0.076
	3443191	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21		CHEMBL1242113	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	uM	0.047
	3443205	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242114	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	uM	0.074
	3443219	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242201	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	3443233	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O		CHEMBL1242202	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	3443247	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O		CHEMBL1242203	=	IC50	nM	215.0	CHEMBL3130	Homo sapiens	IC50	uM	0.215
	3443261	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O		CHEMBL1242288	=	IC50	nM	680.0	CHEMBL3130	Homo sapiens	IC50	uM	0.68
	3443275	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242289	=	IC50	nM	255.0	CHEMBL3130	Homo sapiens	IC50	uM	0.255
	3443289	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242290	=	IC50	nM	48.0	CHEMBL3130	Homo sapiens	IC50	uM	0.048
	3443303	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242379	=	IC50	nM	197.0	CHEMBL3130	Homo sapiens	IC50	uM	0.197
	3443317	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242380	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	3443750	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C#CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242571	=	IC50	nM	3000.0	CHEMBL3130	Homo sapiens	IC50	uM	3.0
	3443764	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1		CHEMBL1242661	=	IC50	nM	3700.0	CHEMBL3130	Homo sapiens	IC50	uM	3.7
	3443778	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21		CHEMBL1242662	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	uM	0.059
	3443792	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21		CHEMBL1242663	=	IC50	nM	1800.0	CHEMBL3130	Homo sapiens	IC50	uM	1.8
	3443806	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	uM	0.4
	3443820	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1		CHEMBL1242755	=	IC50	nM	453.0	CHEMBL3130	Homo sapiens	IC50	uM	0.453
	3443834	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1242756	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	3443848	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cccc(-c3ccccc3)c2)c2c(N)ncnc21		CHEMBL1242849	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3443862	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1242850	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3443876	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(C3CCc4ccccc4C3)c12		CHEMBL1241440	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3443890	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4ccccc4c3)c12		CHEMBL1241441	=	IC50	nM	810.0	CHEMBL3130	Homo sapiens	IC50	uM	0.81
	3443904	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242851	=	IC50	nM	750.0	CHEMBL3130	Homo sapiens	IC50	uM	0.75
	3443918	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241488	=	IC50	nM	2900.0	CHEMBL3130	Homo sapiens	IC50	uM	2.9
	3443932	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	3443946	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3443960	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C1CCCC1		CHEMBL1241584	=	IC50	nM	6700.0	CHEMBL3130	Homo sapiens	IC50	uM	6.7
	3443974	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2Cc1ccccc1		CHEMBL1241585	=	IC50	nM	28000.0	CHEMBL3130	Homo sapiens	IC50	uM	28.0
	3443988	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1		CHEMBL1241681	=	IC50	nM	89.0	CHEMBL3130	Homo sapiens	IC50	uM	0.089
	3444002	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1		CHEMBL1241682	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	uM	0.056
	3444016	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21		CHEMBL1241683	=	IC50	nM	123.0	CHEMBL3130	Homo sapiens	IC50	uM	0.123
	3444030	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241774	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	3444044	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241775	=	IC50	nM	409.0	CHEMBL3130	Homo sapiens	IC50	uM	0.409
	3444058	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21		CHEMBL1241776	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	uM	0.066
	3444072	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21		CHEMBL1241863	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3444086	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1		CHEMBL1241864	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	3444100	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21		CHEMBL1241949	=	IC50	nM	375.0	CHEMBL3130	Homo sapiens	IC50	uM	0.375
	3444114	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21		CHEMBL1241950	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	3444128	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21		CHEMBL1242033	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	3444142	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21		CHEMBL1242034	=	IC50	nM	5200.0	CHEMBL3130	Homo sapiens	IC50	uM	5.2
	3444156	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242117	=	IC50	nM	3900.0	CHEMBL3130	Homo sapiens	IC50	uM	3.9
	3444170	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242118	=	IC50	nM	1700.0	CHEMBL3130	Homo sapiens	IC50	uM	1.7
	3444184	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1		CHEMBL1242119	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	3444198	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21		CHEMBL1242207	=	IC50	nM	3400.0	CHEMBL3130	Homo sapiens	IC50	uM	3.4
	3444212	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21		CHEMBL1242208	=	IC50	nM	85.0	CHEMBL3130	Homo sapiens	IC50	uM	0.085
	3444226	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1		CHEMBL1242209	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	3444240	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1240565	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	3444254	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242293	=	IC50	nM	77.0	CHEMBL3130	Homo sapiens	IC50	uM	0.077
	3444268	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242294	=	IC50	nM	173.0	CHEMBL3130	Homo sapiens	IC50	uM	0.173
	3444282	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1242295	=	IC50	nM	228.0	CHEMBL3130	Homo sapiens	IC50	uM	0.228
	3444296	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21		CHEMBL1242384	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	uM	0.037
	3444310	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242385	=	IC50	nM	443.0	CHEMBL3130	Homo sapiens	IC50	uM	0.443
	3444324	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21		CHEMBL1242386	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	3444338	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1		CHEMBL1242475	=	IC50	nM	142.0	CHEMBL3130	Homo sapiens	IC50	uM	0.142
	3444352	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21		CHEMBL1242476	=	IC50	nM	68.0	CHEMBL3130	Homo sapiens	IC50	uM	0.068
	3444366	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242477	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	3444380	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1		CHEMBL1242572	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	uM	0.19
	3444394	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242573	=	IC50	nM	162.0	CHEMBL3130	Homo sapiens	IC50	uM	0.162
	3444408	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1240566	=	IC50	nM	660.0	CHEMBL3130	Homo sapiens	IC50	uM	0.66
	3444422	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1242574	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	uM	0.34
	3444436	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1		CHEMBL1242664	=	IC50	nM	966.0	CHEMBL3130	Homo sapiens	IC50	uM	0.966
	3444450	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21		CHEMBL1242665	=	IC50	nM	72000.0	CHEMBL3130	Homo sapiens	IC50	uM	72.0
	3444464	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21		CHEMBL1242666	=	IC50	nM	125.0	CHEMBL3130	Homo sapiens	IC50	uM	0.125
	3444478	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21		CHEMBL1242757	=	IC50	nM	2020.0	CHEMBL3130	Homo sapiens	IC50	uM	2.02
	3444492	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1		CHEMBL1242758	=	IC50	nM	446.0	CHEMBL3130	Homo sapiens	IC50	uM	0.446
	3444506	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21		CHEMBL1242852	=	IC50	nM	2480.0	CHEMBL3130	Homo sapiens	IC50	uM	2.48
	3444520	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242853	=	IC50	nM	1030.0	CHEMBL3130	Homo sapiens	IC50	uM	1.03
	3444534	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21		CHEMBL1241490	=	IC50	nM	436.0	CHEMBL3130	Homo sapiens	IC50	uM	0.436
	3444548	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1		CHEMBL1241491	=	IC50	nM	429.0	CHEMBL3130	Homo sapiens	IC50	uM	0.429
	3444562	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21		CHEMBL1241492	=	IC50	nM	3700.0	CHEMBL3130	Homo sapiens	IC50	uM	3.7
	3444576	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21		CHEMBL1241586	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	3444590	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21		CHEMBL1241587	=	IC50	nM	643.0	CHEMBL3130	Homo sapiens	IC50	uM	0.643
	3444604	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4c(c3)OCO4)c12		CHEMBL1240567	=	IC50	nM	7400.0	CHEMBL3130	Homo sapiens	IC50	uM	7.4
	3444618	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21		CHEMBL1241588	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	3444632	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cc3ccccc3s2)c2c(N)ncnc21		CHEMBL1240594	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	3444646	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21		CHEMBL1241684	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	uM	1.9
	3444660	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	3444673	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	30000.0	CHEMBL3130	Homo sapiens	IC50	uM	30.0
	3444686	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	12000.0	CHEMBL3130	Homo sapiens	IC50	uM	12.0
	3446163	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	3446164	CHEMBL1243967	Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	3447723	CHEMBL1250025	Inhibition of p110delta	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	Ki	nM	20.0	CHEMBL3130	Homo sapiens	Ki	nM	20.0
	3448566	CHEMBL1244919	Binding affinity to PIK3CD	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3449797	CHEMBL1244919	Binding affinity to PIK3CD	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3449954	CHEMBL1244919	Binding affinity to PIK3CD	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3450192	CHEMBL1244919	Binding affinity to PIK3CD	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3450393	CHEMBL1244919	Binding affinity to PIK3CD	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3450847	CHEMBL1244919	Binding affinity to PIK3CD	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3451113	CHEMBL1244919	Binding affinity to PIK3CD	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	uM	10.0
	3499261	CHEMBL1260068	Inhibition of PI3K-delta	B	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1		CHEMBL1258517	=	IC50	nM	77.0	CHEMBL3130	Homo sapiens	IC50	nM	77.0
	3506980	CHEMBL1260891	Inhibition of PI3Kdelta	B	Cn1ncc2c(Oc3ccc(S(C)(=O)=O)cc3)cc(-c3cccc4[nH]ncc34)nc21		CHEMBL1257653	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	3561327	CHEMBL1287083	Inhibition of PI3Kdelta at 10	B	Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1		CHEMBL1276946	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	3590238	CHEMBL1292109	Inhibition of PI3Kdelta	B	Oc1cccc(-c2cc(Nc3ccc4[nH]ncc4c3)nc(N3CCOCC3)n2)c1		CHEMBL1289975	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	3590239	CHEMBL1292109	Inhibition of PI3Kdelta	B	COc1ccc(Nc2cc(-c3cccc(O)c3)nc(N3CCOCC3)n2)cn1		CHEMBL1290744	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	5089456	CHEMBL1633342	Inhibition of PI3Kdelta	B	Nc1ccc(C#Cc2n[nH]c3ccccc23)cc1		CHEMBL1631888	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	5089620	CHEMBL1633342	Inhibition of PI3Kdelta	B	Nc1cccc(C#Cc2n[nH]c3ccccc23)c1		CHEMBL1631895	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	5089622	CHEMBL1633342	Inhibition of PI3Kdelta	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	=	IC50	nM	39000.0	CHEMBL3130	Homo sapiens	I50	uM	39.0
	5134028	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	5134029	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	c1cc(-c2cnc3[nH]ccc3c2)ccn1		CHEMBL1645094	=	IC50	nM	40800.0	CHEMBL3130	Homo sapiens	IC50	uM	40.8
	5134030	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1ncnc2sc(-c3ccncc3)nc12		CHEMBL1645095	=	IC50	nM	11100.0	CHEMBL3130	Homo sapiens	IC50	uM	11.1
	5134031	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	N#Cc1cc(-c2ccncc2)cnc1O		CHEMBL58782	=	IC50	nM	65700.0	CHEMBL3130	Homo sapiens	IC50	uM	65.7
	5134032	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Oc1ccc2oc(-c3ccncc3)nc2c1		CHEMBL1645096	>	IC50	nM	83300.0	CHEMBL3130	Homo sapiens	IC50	uM	83.3
Not Determined	5134033	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Cc1cc(-c2cnc(N)c(C(N)=O)c2)ccn1		CHEMBL1645097		IC50			CHEMBL3130	Homo sapiens	IC50		
	5134034	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1nc2nc(-c3ccncc3)ccn2n1		CHEMBL1645098	=	IC50	nM	43000.0	CHEMBL3130	Homo sapiens	IC50	uM	43.0
	5134035	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1ccc2oc(-c3ccncc3)nc2c1		CHEMBL1645099	>	IC50	nM	83300.0	CHEMBL3130	Homo sapiens	IC50	uM	83.3
	5134036	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	O=c1[nH]cnc2cc(N3CCOCC3)ccc12		CHEMBL1645100	=	IC50	nM	6400.0	CHEMBL3130	Homo sapiens	IC50	uM	6.4
	5134037	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	c1cc(N2CCOCC2)c2cn[nH]c2n1		CHEMBL1645101	=	IC50	nM	12000.0	CHEMBL3130	Homo sapiens	IC50	uM	12.0
	5134038	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL1645102	=	IC50	nM	18000.0	CHEMBL3130	Homo sapiens	IC50	uM	18.0
	5134039	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1ncnc2nc(N3CCOCC3)ncc12		CHEMBL1645103	=	IC50	nM	36800.0	CHEMBL3130	Homo sapiens	IC50	uM	36.8
Not Determined	5134040	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	CN(C)c1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL1645104		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	5134041	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	COc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL1645105		IC50			CHEMBL3130	Homo sapiens	IC50		
	5134042	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1nc2cc(-c3ccncc3)ccc2s1		CHEMBL1645106	=	IC50	nM	5100.0	CHEMBL3130	Homo sapiens	IC50	uM	5.1
	5134043	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1nc2ccc(-c3ccncc3)cc2s1		CHEMBL1645107	=	IC50	nM	8900.0	CHEMBL3130	Homo sapiens	IC50	uM	8.9
	5134044	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1nc2ccc(-c3cccc(O)c3)cc2s1		CHEMBL1645108	=	IC50	nM	6500.0	CHEMBL3130	Homo sapiens	IC50	uM	6.5
Not Determined	5134045	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Cn1ccc2cc(N)ncc21		CHEMBL1645109		IC50			CHEMBL3130	Homo sapiens	IC50		
	5134046	CHEMBL1646729	Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay	B	Nc1nonc1-c1noc(Cc2cccs2)n1		CHEMBL1645110	=	IC50	nM	6800.0	CHEMBL3130	Homo sapiens	IC50	uM	6.8
	5207836	CHEMBL1680118	Inhibition of PI3Kdelta after 15 mins	B	COc1ccc(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)cn1		CHEMBL1672328	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	5247286	CHEMBL1686446	Inhibition of PI3Kdelta	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	6157552	CHEMBL1763564	Inhibition of PI3Kdelta	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	uM	0.24
	6157710	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762788	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	6157711	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccccc3)nc3ccccc32)n1		CHEMBL1762789	=	IC50	nM	360.0	CHEMBL3130	Homo sapiens	IC50	uM	0.36
	6157712	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cc(O)cc(O)c3)nc3ccccc32)n1		CHEMBL1762790	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0004
	6157713	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cccc(C(N)=O)c3)nc3ccccc32)n1		CHEMBL1760153	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	6157714	CHEMBL1763564	Inhibition of PI3Kdelta	B	CNC(=O)Nc1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)cc1		CHEMBL1760154	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	6157715	CHEMBL1763564	Inhibition of PI3Kdelta	B	CC(=O)Nc1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)cc1		CHEMBL1760155	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	uM	0.071
	6157716	CHEMBL1763564	Inhibition of PI3Kdelta	B	CC(=O)Nc1cccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)c1		CHEMBL1760156	=	IC50	nM	890.0	CHEMBL3130	Homo sapiens	IC50	uM	0.89
	6157717	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccc4cc[nH]c4c3)nc3ccccc32)n1		CHEMBL1760157	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	uM	0.24
	6157718	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccc4cn[nH]c4c3)nc3ccccc32)n1		CHEMBL1760158	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	uM	0.32
	6157719	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1615183	=	IC50	nM	510.0	CHEMBL3130	Homo sapiens	IC50	uM	0.51
	6157720	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccn(C)n3)nc3ccccc32)n1		CHEMBL1760159	=	IC50	nM	4600.0	CHEMBL3130	Homo sapiens	IC50	uM	4.6
	6157721	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccn(C(F)F)n3)nc3ccccc32)n1		CHEMBL1760160	=	IC50	nM	530.0	CHEMBL3130	Homo sapiens	IC50	uM	0.53
	6157722	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccon3)nc3ccccc32)n1		CHEMBL1760161	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	6157723	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3n[nH]c4ccccc34)nc3ccccc32)n1		CHEMBL1760162	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	6157724	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cn[nH]c3)nc3ccccc32)n1		CHEMBL1760163	=	IC50	nM	690.0	CHEMBL3130	Homo sapiens	IC50	uM	0.69
	6157725	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3ccnn3C)nc3ccccc32)n1		CHEMBL1760164	=	IC50	nM	3300.0	CHEMBL3130	Homo sapiens	IC50	uM	3.3
	6157726	CHEMBL1763564	Inhibition of PI3Kdelta	B	CNC(=O)c1ccc(Nc2nc3ccccc3n2-c2nc(C)nc(N)n2)o1		CHEMBL1760165	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
Not Determined	6157727	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3nc[nH]n3)nc3ccccc32)n1		CHEMBL1760166		IC50			CHEMBL3130	Homo sapiens	IC50		
	6157728	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(NC3CCOCC3)nc3ccccc32)n1		CHEMBL1760167	=	IC50	nM	710.0	CHEMBL3130	Homo sapiens	IC50	uM	0.71
	6157729	CHEMBL1763564	Inhibition of PI3Kdelta	B	CNc1nc(C)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760168	=	IC50	nM	890.0	CHEMBL3130	Homo sapiens	IC50	uM	0.89
	6157730	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760169	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	uM	4.0
	6157731	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(NCCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760170	=	IC50	nM	5800.0	CHEMBL3130	Homo sapiens	IC50	uM	5.8
	6157732	CHEMBL1763564	Inhibition of PI3Kdelta	B	C#CCNc1nc(C)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1		CHEMBL1760171	=	IC50	nM	4600.0	CHEMBL3130	Homo sapiens	IC50	uM	4.6
	6157733	CHEMBL1763564	Inhibition of PI3Kdelta	B	Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3cc(F)c(F)cc32)n1		CHEMBL1760172	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	6189357	CHEMBL1775869	Inhibition of human PI3Kdelta expressed in Sf9 cells	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1		CHEMBL1615189	=	Ki	nM	1.2	CHEMBL3130	Homo sapiens	Ki	nM	1.2
	6265767	CHEMBL1798656	Inhibition of PI3Kdelta	B	CNC(=O)c1ccc2c(c1)OCCc1cc(C(=O)N(C)c3ccc(C(=O)N(C)C)cc3Cl)sc1-2		CHEMBL1796761	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	6325325	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	68.0	CHEMBL3130	Homo sapiens	INH	%	68.0
	6325355	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	19.0	CHEMBL3130	Homo sapiens	INH	%	19.0
	6325386	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	22.0	CHEMBL3130	Homo sapiens	INH	%	22.0
	6325419	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	10.0	CHEMBL3130	Homo sapiens	INH	%	10.0
	6325450	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	36.0	CHEMBL3130	Homo sapiens	INH	%	36.0
	6325480	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	19.0	CHEMBL3130	Homo sapiens	INH	%	19.0
	6325508	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	18.0	CHEMBL3130	Homo sapiens	INH	%	18.0
	6325538	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	16.0	CHEMBL3130	Homo sapiens	INH	%	16.0
	6325881	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	90.0	CHEMBL3130	Homo sapiens	INH	%	90.0
	6325911	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	42.0	CHEMBL3130	Homo sapiens	INH	%	42.0
	6325940	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	27.0	CHEMBL3130	Homo sapiens	INH	%	27.0
	6325969	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	41.0	CHEMBL3130	Homo sapiens	INH	%	41.0
	6325998	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	8.0	CHEMBL3130	Homo sapiens	INH	%	8.0
	6326027	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	10.0	CHEMBL3130	Homo sapiens	INH	%	10.0
	6326056	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	11.0	CHEMBL3130	Homo sapiens	INH	%	11.0
	6326085	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	10.0	CHEMBL3130	Homo sapiens	INH	%	10.0
	6326115	CHEMBL1820090	Inhibition of PI3Kdelta expressed in Escherichia coli or baculovirus-infected insect cells using gamma-[33P]ATP at 400 uM by scintillation proximity assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	7.0	CHEMBL3130	Homo sapiens	INH	%	7.0
	6339866	CHEMBL1826067	Inhibition of human N-terminal His-tagged PI3Kdelta expressed in insect Sf9 cells using PI(4,5)P2 as substrate after 20 mins by alphascreen assay in presence of 8 uM ATP	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Ki	nM	0.8	CHEMBL3130	Homo sapiens	Ki	nM	0.8
	6339880	CHEMBL1826079	Activity of PIK3CD kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	0.5	CHEMBL3130	Homo sapiens	Activity	%	0.5
	6386329	CHEMBL1839912	Inhibition of recombinant PI3Kdelta by luminescent kinase assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	9000.0	CHEMBL3130	Homo sapiens	IC50	uM	9.0
	7567372	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7567831	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7567860	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7568328	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7568760	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7569345	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7569835	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7570298	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7570725	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7571336	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7571812	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7572275	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	17.0	CHEMBL3130	Homo sapiens	Kd	nM	17.0
	7572691	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7572860	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	7600.0	CHEMBL3130	Homo sapiens	Kd	nM	7600.0
	7573317	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7573793	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7574262	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7574670	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	250.0	CHEMBL3130	Homo sapiens	Kd	nM	250.0
	7574838	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7575299	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7575770	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7576235	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7576643	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7576812	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7577271	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7577749	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7578219	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	31.0	CHEMBL3130	Homo sapiens	Kd	nM	31.0
	7578820	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7579194	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7579644	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7580118	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7580548	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7581178	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7581563	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7582008	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7582501	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7582901	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7583524	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7583921	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7584395	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7584857	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	4200.0	CHEMBL3130	Homo sapiens	Kd	nM	4200.0
	7585261	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7585854	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7586266	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	5.0	CHEMBL3130	Homo sapiens	Kd	nM	5.0
	7586737	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7587191	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7587792	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7588245	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7588716	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7589167	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7589338	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7589762	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4000.0	CHEMBL3130	Homo sapiens	Kd	nM	4000.0
	7590229	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7590703	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7591154	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7591311	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7591733	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7592205	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	3100.0	CHEMBL3130	Homo sapiens	Kd	nM	3100.0
	7592678	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7593131	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7593278	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7593713	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7594185	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7594658	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7595246	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7595690	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7596164	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7596640	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7597218	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7597671	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7598172	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7598614	CHEMBL1908671	Binding constant for PIK3CD kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL3130	Homo sapiens	Kd	nM	10000.0
	7846948	CHEMBL1914122	Inhibition of human His-tagged PI3K p110delta after 2 hrs by HTRF assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	7846954	CHEMBL1914122	Inhibition of human His-tagged PI3K p110delta after 2 hrs by HTRF assay	B	Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910998	=	IC50	nM	0.65	CHEMBL3130	Homo sapiens	IC50	nM	0.65
	7846960	CHEMBL1914122	Inhibition of human His-tagged PI3K p110delta after 2 hrs by HTRF assay	B	FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911002	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	7846966	CHEMBL1914122	Inhibition of human His-tagged PI3K p110delta after 2 hrs by HTRF assay	B	COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O		CHEMBL1911114	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	7846972	CHEMBL1914122	Inhibition of human His-tagged PI3K p110delta after 2 hrs by HTRF assay	B	COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1911117	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	7922929	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccncc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914724	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	7922930	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(-c4cccnc4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914726	=	IC50	nM	5.9	CHEMBL3130	Homo sapiens	IC50	nM	5.9
	7922931	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccncc4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914727	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	7922932	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914743	=	IC50	nM	4.4	CHEMBL3130	Homo sapiens	IC50	nM	4.4
	7922933	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1914736	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	7922934	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	CC(C)N1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1		CHEMBL1914742	=	IC50	nM	5.6	CHEMBL3130	Homo sapiens	IC50	nM	5.6
	7922935	CHEMBL1919684	Inhibition of N-terminus polyHis-tagged human recombinant PI3Kdelta expressed in baculovirus infected insect Sf9 cells using phosphoinositol-4,5-bisphosphate as substrate after 1.5 hrs by spectrophotometric analysis	B	O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCOCC4)c3c2)cnc1Cl)c1ccc(F)cc1		CHEMBL1738719	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	7947852	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)CN)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922090	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	7947853	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)N)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922091	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	7947854	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)C(C)(C)N)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922092	=	IC50	nM	1.5	CHEMBL3130	Homo sapiens	IC50	nM	1.5
	7947855	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	IC50	nM	6.7	CHEMBL3130	Homo sapiens	IC50	nM	6.7
	7947856	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)[C@@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1921986	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	7947857	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)C(C)(C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922095	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	7948544	CHEMBL1925470	Inhibition of PI3K subunit p110delta assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(C(=O)CO)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922093	=	IC50	nM	5.6	CHEMBL3130	Homo sapiens	IC50	nM	5.6
	7954418	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccccc3)c2)cn1		CHEMBL1922773	=	Activity	%	4.2	CHEMBL3130	Homo sapiens	Activity	%	4.2
	7954419	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922779	=	Activity	%	82.0	CHEMBL3130	Homo sapiens	Activity	%	82.0
	7954420	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	CC(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922780	=	Activity	%	65.0	CHEMBL3130	Homo sapiens	Activity	%	65.0
	7954421	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	CS(=O)(=O)Nc1cncc(-c2cnc(N)nc2)c1		CHEMBL1922781	=	Activity	%	38.0	CHEMBL3130	Homo sapiens	Activity	%	38.0
	7954422	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)c2)cn1		CHEMBL1922782	=	Activity	%	0.9	CHEMBL3130	Homo sapiens	Activity	%	0.9
	7954423	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc(F)cc3F)c2)cn1		CHEMBL1922907	=	Activity	%	4.7	CHEMBL3130	Homo sapiens	Activity	%	4.7
	7954424	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1[N+](=O)[O-]		CHEMBL1922908	=	Activity	%	0.1	CHEMBL3130	Homo sapiens	Activity	%	0.1
	7954425	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Cc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922909	=	Activity	%	3.4	CHEMBL3130	Homo sapiens	Activity	%	3.4
	7954426	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)c2)cn1		CHEMBL1922910	=	Activity	%	9.5	CHEMBL3130	Homo sapiens	Activity	%	9.5
	7954427	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	COc1ccc(S(=O)(=O)Nc2cncc(-c3cnc(N)nc3)c2)cc1		CHEMBL1922911	=	Activity	%	4.3	CHEMBL3130	Homo sapiens	Activity	%	4.3
	7954428	CHEMBL1925532	Inhibition of PI3Kdelta assessed as enzyme activity relative to control	B	Nc1ncc(-c2cncc(NS(=O)(=O)c3ccc4ccccc4c3)c2)cn1		CHEMBL1922912	=	Activity	%	4.2	CHEMBL3130	Homo sapiens	Activity	%	4.2
	7959438	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccccc12		CHEMBL1928522	=	IC50	nM	3400.0	CHEMBL3130	Homo sapiens	IC50	nM	3400.0
	7959439	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cc(Br)ccc12		CHEMBL1928523	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959440	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cccc(Br)c12		CHEMBL1928524	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959441	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Br)cc12		CHEMBL1928525	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	7959442	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2c(C)cccc12		CHEMBL1928526	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959443	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc2c(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)cnn2c1		CHEMBL1928527	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959444	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cccc(C)c12		CHEMBL1928528	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959445	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928529	=	IC50	nM	700.0	CHEMBL3130	Homo sapiens	IC50	nM	700.0
	7959446	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928530	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959447	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(F)(F)F)cc12		CHEMBL1928531	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959448	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(-c3ccccc3)cc12		CHEMBL1928532	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959449	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(I)cc12		CHEMBL1926704	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	7959450	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(Cl)cc12		CHEMBL1928533	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	nM	90.0
	7959451	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C3CC3)cc12		CHEMBL1928534	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959452	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C=Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928535	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959453	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C#Cc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928536	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	7959454	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COC(=O)c1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928537	=	IC50	nM	690.0	CHEMBL3130	Homo sapiens	IC50	nM	690.0
	7959455	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(N)=O)cc12		CHEMBL1928538	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959456	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CNC(=O)c1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928539	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959457	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C(=O)N(C)C)cc12		CHEMBL1928540	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959458	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	7959459	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2cc(F)c(C#N)cc12		CHEMBL1928542	=	IC50	nM	2500.0	CHEMBL3130	Homo sapiens	IC50	nM	2500.0
	7959460	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928543	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959461	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(O)cc12		CHEMBL1928544	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959462	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(=O)Oc1ccn2ncc(/C=N/N(C)S(=O)(=O)c3cc([N+](=O)[O-])ccc3C)c2c1		CHEMBL1928545	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959463	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928546	=	IC50	nM	580.0	CHEMBL3130	Homo sapiens	IC50	nM	580.0
	7959464	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928547	=	IC50	nM	900.0	CHEMBL3130	Homo sapiens	IC50	nM	900.0
	7959465	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928548	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	nM	440.0
	7959466	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCC/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928549	=	IC50	nM	310.0	CHEMBL3130	Homo sapiens	IC50	nM	310.0
	7959467	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(Br)cc12		CHEMBL1928550	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	nM	220.0
	7959468	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928551	=	IC50	nM	510.0	CHEMBL3130	Homo sapiens	IC50	nM	510.0
	7959469	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928552	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959470	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCC/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(C#N)cc12		CHEMBL1928553	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7959471	CHEMBL1932528	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C)c1cnn2ccc(Br)cc12		CHEMBL1928554	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960881	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	7960882	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C		CHEMBL1928555	=	IC50	nM	9.3	CHEMBL3130	Homo sapiens	IC50	nM	9.3
	7960883	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(Cc1ccccc1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928556	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	7960884	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN(C)C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928557	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	7960885	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCN(CC)CCN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1C		CHEMBL1928558	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	7960886	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN1CCOCC1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928559	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	7960887	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCN1CCCCC1)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928560	=	IC50	nM	89.0	CHEMBL3130	Homo sapiens	IC50	nM	89.0
	7960888	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	nM	54.0
	7960889	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928562	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	nM	2000.0
	7960890	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1c([N+](=O)[O-])cccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928563	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960891	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1cc([N+](=O)[O-])ccc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928564	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960892	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1cccc([N+](=O)[O-])c1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928565	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	7960893	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(=O)Nc1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928566	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960894	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(NC(=O)C(F)(F)F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928567	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960895	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928568	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960896	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C(=O)O)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928569	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960897	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COC(=O)c1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928570	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	nM	400.0
	7960898	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928571	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	nM	59.0
	7960899	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(S(C)(=O)=O)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928572	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
	7960900	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C(F)(F)F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928573	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	7960901	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(C)c(S(=O)(=O)N(C)/N=C/c2cnn3ccc(C#N)cc23)c1		CHEMBL1928717	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	7960902	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(F)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928718	=	IC50	nM	310.0	CHEMBL3130	Homo sapiens	IC50	nM	310.0
	7960903	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(Cl)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928719	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	7960904	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc(Br)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928720	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	7960905	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cccc([N+](=O)[O-])c1		CHEMBL1928721	=	IC50	nM	410.0	CHEMBL3130	Homo sapiens	IC50	nM	410.0
	7960906	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CCc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928722	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	7960907	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CC(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928723	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	7960908	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1F		CHEMBL1928724	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	7960909	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1Cl		CHEMBL1928725	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	7960910	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928726	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	7960911	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928727	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	7960912	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928728	=	IC50	nM	8.6	CHEMBL3130	Homo sapiens	IC50	nM	8.6
	7960913	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	CN(/N=C/c1cnn2ccc(C#N)cc12)C(=O)c1cccc([N+](=O)[O-])c1		CHEMBL1928729	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	7960914	CHEMBL1932610	Inhibition of recombinant PI3K p110delta using L-alpha-phosphatidylinositol as substrate and [gamma33P]ATP after 60 mins by thin layer chromatographic technique	B	Cc1ccc([N+](=O)[O-])cc1CN(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928730	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	8003520	CHEMBL1942470	Inhibition of human PIK3CD in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3130	Homo sapiens	INH	%	35.0
	8003521	CHEMBL1942470	Inhibition of human PIK3CD in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3130	Homo sapiens	INH	%	35.0
	8003522	CHEMBL1942470	Inhibition of human PIK3CD in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3130	Homo sapiens	INH	%	35.0
	8003523	CHEMBL1942470	Inhibition of human PIK3CD in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3130	Homo sapiens	INH	%	35.0
	8013122	CHEMBL1948359	Inhibition of PI3Kdelta using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	4700.0	CHEMBL3130	Homo sapiens	IC50	uM	4.7
	8042199	CHEMBL1954964	Inhibition of PI3Kdelta using PIP3 as substrate after 30 mins by fluorescence polarization assay	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1091978	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	8047789	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccccc3F)ccn12		CHEMBL1957844	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	8047790	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(F)c3)ccn12		CHEMBL1957845	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	uM	0.4
	8047791	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(F)cc3)ccn12		CHEMBL1957846	=	IC50	nM	630.0	CHEMBL3130	Homo sapiens	IC50	uM	0.63
	8047792	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3)ccn12		CHEMBL1957848	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	uM	0.2
	8047793	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(Cl)cc3)ccn12		CHEMBL1957849	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	8047794	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1ccccc1Cn1ccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL1957850	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	uM	0.2
	8047795	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1cccc(Cn2ccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL1957851	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	8047796	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(C(F)(F)F)c3)ccn12		CHEMBL1957852	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	8047797	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(Cl)c(Cl)c3)ccn12		CHEMBL1957853	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	uM	0.063
	8047798	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3ccc(F)c(Cl)c3)ccn12		CHEMBL1957854	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	uM	0.13
	8047799	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957840	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	8047800	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc4ccccc34)ccn12		CHEMBL1957841	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	8047801	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957855	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	8047802	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1cn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL1957856	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	8047803	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	uM	0.008
	8047804	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	CCc1cn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL1957858	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	8047805	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c3ccccc3n12		CHEMBL1957859	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	8047806	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(C)n2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL1957860	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	uM	0.08
	8047807	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2c(C)c(C)n3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957861	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	8047808	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc4ccccc34)c3ccccc3n12		CHEMBL1957862	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	8047809	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2c3ccccc3n3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957863	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	uM	0.08
	8047810	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1c(F)c(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957864	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	uM	0.031
	8047811	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1nc(N2CCOCC2)cc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1955886	=	IC50	nM	630.0	CHEMBL3130	Homo sapiens	IC50	uM	0.63
	8047812	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)nc(N4CCOCC4)cc23)cccc1C(F)(F)F		CHEMBL1957865	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	uM	0.4
	8047813	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	8047814	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	8047815	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	CC1CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957866	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	8047816	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	CC1(C)CN(c2cc(=O)n3ccn(Cc4cccc(Cl)c4Cl)c3n2)CCO1		CHEMBL1957867	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	8047817	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957868	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	8047818	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCO[C@@H](C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957869	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	uM	0.16
	8047819	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(N4CCO[C@H](C)C4)nc23)cccc1C(F)(F)F		CHEMBL1957870	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	8047820	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCOC(CO)C2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957871	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	uM	0.16
	8047821	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(C4=CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957872	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	8047822	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	Cc1c(Cn2ccn3c(=O)cc(C4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957873	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	8047823	CHEMBL1958673	Inhibition of PI3Kdelta by time-resolved FRET displacement assay	B	O=c1cc(N2CCSCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12		CHEMBL1957874	=	IC50	nM	630.0	CHEMBL3130	Homo sapiens	IC50	uM	0.63
	8056178	CHEMBL1960285	Inhibition of recombinant PI3Kdelta HTRF assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	8061316	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.9	CHEMBL3130	Homo sapiens	Inhibition	%	0.9
	8061493	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.81	CHEMBL3130	Homo sapiens	Inhibition	%	6.81
	8061824	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.79	CHEMBL3130	Homo sapiens	Inhibition	%	4.79
	8062015	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.38	CHEMBL3130	Homo sapiens	Inhibition	%	1.38
	8062355	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.35	CHEMBL3130	Homo sapiens	Inhibition	%	1.35
	8062517	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.89	CHEMBL3130	Homo sapiens	Inhibition	%	1.89
	8062741	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.81	CHEMBL3130	Homo sapiens	Inhibition	%	1.81
	8062839	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.13	CHEMBL3130	Homo sapiens	Inhibition	%	2.13
	8063195	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.6	CHEMBL3130	Homo sapiens	Inhibition	%	6.6
	8063362	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.59	CHEMBL3130	Homo sapiens	Inhibition	%	-0.59
	8063694	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.37	CHEMBL3130	Homo sapiens	Inhibition	%	0.37
	8063876	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.54	CHEMBL3130	Homo sapiens	Inhibition	%	3.54
	8064100	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.36	CHEMBL3130	Homo sapiens	Inhibition	%	1.36
	8064215	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.72	CHEMBL3130	Homo sapiens	Inhibition	%	1.72
	8064425	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.66	CHEMBL3130	Homo sapiens	Inhibition	%	3.66
	8064649	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	20.75	CHEMBL3130	Homo sapiens	Inhibition	%	20.75
	8064787	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.94	CHEMBL3130	Homo sapiens	Inhibition	%	0.94
	8064953	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.57	CHEMBL3130	Homo sapiens	Inhibition	%	2.57
	8065177	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.49	CHEMBL3130	Homo sapiens	Inhibition	%	-0.49
	8065293	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.45	CHEMBL3130	Homo sapiens	Inhibition	%	2.45
	8065692	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.0	CHEMBL3130	Homo sapiens	Inhibition	%	4.0
	8065807	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.62	CHEMBL3130	Homo sapiens	Inhibition	%	0.62
	8066241	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.47	CHEMBL3130	Homo sapiens	Inhibition	%	1.47
	8066377	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.48	CHEMBL3130	Homo sapiens	Inhibition	%	4.48
	8066767	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.82	CHEMBL3130	Homo sapiens	Inhibition	%	-0.82
	8066891	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.03	CHEMBL3130	Homo sapiens	Inhibition	%	1.03
	8067115	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.1	CHEMBL3130	Homo sapiens	Inhibition	%	7.1
	8067290	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.19	CHEMBL3130	Homo sapiens	Inhibition	%	2.19
	8067411	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.65	CHEMBL3130	Homo sapiens	Inhibition	%	1.65
	8067635	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.32	CHEMBL3130	Homo sapiens	Inhibition	%	0.32
	8067845	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.23	CHEMBL3130	Homo sapiens	Inhibition	%	4.23
	8067980	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.1	CHEMBL3130	Homo sapiens	Inhibition	%	6.1
	8068204	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	35.03	CHEMBL3130	Homo sapiens	Inhibition	%	35.03
	8068368	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.63	CHEMBL3130	Homo sapiens	Inhibition	%	-0.63
	8068717	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.32	CHEMBL3130	Homo sapiens	Inhibition	%	1.32
	8068891	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.98	CHEMBL3130	Homo sapiens	Inhibition	%	2.98
	8069240	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.31	CHEMBL3130	Homo sapiens	Inhibition	%	2.31
	8069535	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	31.93	CHEMBL3130	Homo sapiens	Inhibition	%	31.93
	8069696	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.04	CHEMBL3130	Homo sapiens	Inhibition	%	-0.04
	8070046	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.48	CHEMBL3130	Homo sapiens	Inhibition	%	-1.48
	8070218	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.86	CHEMBL3130	Homo sapiens	Inhibition	%	6.86
	8070442	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.16	CHEMBL3130	Homo sapiens	Inhibition	%	3.16
	8070567	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.89	CHEMBL3130	Homo sapiens	Inhibition	%	0.89
	8070865	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	84.15	CHEMBL3130	Homo sapiens	Inhibition	%	84.15
	8071022	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.72	CHEMBL3130	Homo sapiens	Inhibition	%	0.72
	8071246	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.67	CHEMBL3130	Homo sapiens	Inhibition	%	4.67
	8071372	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.15	CHEMBL3130	Homo sapiens	Inhibition	%	-0.15
	8071769	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.6	CHEMBL3130	Homo sapiens	Inhibition	%	2.6
	8071894	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.14	CHEMBL3130	Homo sapiens	Inhibition	%	4.14
	8072208	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.19	CHEMBL3130	Homo sapiens	Inhibition	%	0.19
	8072589	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.3	CHEMBL3130	Homo sapiens	Inhibition	%	0.3
	8072714	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.53	CHEMBL3130	Homo sapiens	Inhibition	%	0.53
	8073105	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.08	CHEMBL3130	Homo sapiens	Inhibition	%	3.08
	8073230	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.44	CHEMBL3130	Homo sapiens	Inhibition	%	1.44
	8073454	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	6.58	CHEMBL3130	Homo sapiens	Inhibition	%	6.58
	8073573	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.23	CHEMBL3130	Homo sapiens	Inhibition	%	1.23
	8073806	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.17	CHEMBL3130	Homo sapiens	Inhibition	%	0.17
	8074030	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.87	CHEMBL3130	Homo sapiens	Inhibition	%	0.87
	8074182	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.14	CHEMBL3130	Homo sapiens	Inhibition	%	0.14
	8074312	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.51	CHEMBL3130	Homo sapiens	Inhibition	%	0.51
	8074536	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.3	CHEMBL3130	Homo sapiens	Inhibition	%	2.3
	8074693	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.67	CHEMBL3130	Homo sapiens	Inhibition	%	2.67
	8075044	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.65	CHEMBL3130	Homo sapiens	Inhibition	%	-1.65
	8075155	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.01	CHEMBL3130	Homo sapiens	Inhibition	%	2.01
	8075379	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.59	CHEMBL3130	Homo sapiens	Inhibition	%	1.59
	8075616	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.83	CHEMBL3130	Homo sapiens	Inhibition	%	3.83
	8075757	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.72	CHEMBL3130	Homo sapiens	Inhibition	%	1.72
	8076123	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.14	CHEMBL3130	Homo sapiens	Inhibition	%	2.14
	8076271	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.58	CHEMBL3130	Homo sapiens	Inhibition	%	2.58
	8076629	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.18	CHEMBL3130	Homo sapiens	Inhibition	%	4.18
	8076955	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.95	CHEMBL3130	Homo sapiens	Inhibition	%	2.95
	8077202	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.44	CHEMBL3130	Homo sapiens	Inhibition	%	2.44
	8077330	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.43	CHEMBL3130	Homo sapiens	Inhibition	%	-0.43
	8077554	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.98	CHEMBL3130	Homo sapiens	Inhibition	%	1.98
	8077705	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	12.21	CHEMBL3130	Homo sapiens	Inhibition	%	12.21
	8077848	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.55	CHEMBL3130	Homo sapiens	Inhibition	%	2.55
	8078072	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	5.55	CHEMBL3130	Homo sapiens	Inhibition	%	5.55
	8078211	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.68	CHEMBL3130	Homo sapiens	Inhibition	%	-0.68
	8078537	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.31	CHEMBL3130	Homo sapiens	Inhibition	%	0.31
	8078787	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.42	CHEMBL3130	Homo sapiens	Inhibition	%	3.42
	8079127	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.12	CHEMBL3130	Homo sapiens	Inhibition	%	1.12
	8079285	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.99	CHEMBL3130	Homo sapiens	Inhibition	%	1.99
	8079651	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.61	CHEMBL3130	Homo sapiens	Inhibition	%	2.61
	8079790	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.48	CHEMBL3130	Homo sapiens	Inhibition	%	2.48
	8080119	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.08	CHEMBL3130	Homo sapiens	Inhibition	%	3.08
	8080371	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.18	CHEMBL3130	Homo sapiens	Inhibition	%	0.18
	8080710	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.99	CHEMBL3130	Homo sapiens	Inhibition	%	1.99
	8080874	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	34.89	CHEMBL3130	Homo sapiens	Inhibition	%	34.89
	8081233	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.44	CHEMBL3130	Homo sapiens	Inhibition	%	5.44
	8081377	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.18	CHEMBL3130	Homo sapiens	Inhibition	%	2.18
	8081601	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	13.28	CHEMBL3130	Homo sapiens	Inhibition	%	13.28
	8081704	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.8	CHEMBL3130	Homo sapiens	Inhibition	%	0.8
	8081956	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.64	CHEMBL3130	Homo sapiens	Inhibition	%	2.64
	8082180	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.65	CHEMBL3130	Homo sapiens	Inhibition	%	-1.65
	8082293	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.84	CHEMBL3130	Homo sapiens	Inhibition	%	2.84
	8082466	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.68	CHEMBL3130	Homo sapiens	Inhibition	%	-0.68
	8082690	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.51	CHEMBL3130	Homo sapiens	Inhibition	%	6.51
	8082813	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.19	CHEMBL3130	Homo sapiens	Inhibition	%	0.19
	8083193	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.52	CHEMBL3130	Homo sapiens	Inhibition	%	0.52
	8083292	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.17	CHEMBL3130	Homo sapiens	Inhibition	%	4.17
	8083516	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.13	CHEMBL3130	Homo sapiens	Inhibition	%	1.13
	8083770	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.74	CHEMBL3130	Homo sapiens	Inhibition	%	0.74
	8083880	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.38	CHEMBL3130	Homo sapiens	Inhibition	%	4.38
	8084289	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.9	CHEMBL3130	Homo sapiens	Inhibition	%	1.9
	8084407	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.4	CHEMBL3130	Homo sapiens	Inhibition	%	3.4
	8084631	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.82	CHEMBL3130	Homo sapiens	Inhibition	%	0.82
	8084792	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.39	CHEMBL3130	Homo sapiens	Inhibition	%	2.39
	8085114	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.97	CHEMBL3130	Homo sapiens	Inhibition	%	4.97
	8085370	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.47	CHEMBL3130	Homo sapiens	Inhibition	%	3.47
	8085478	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	27.11	CHEMBL3130	Homo sapiens	Inhibition	%	27.11
	8085702	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.07	CHEMBL3130	Homo sapiens	Inhibition	%	-0.07
	8085891	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.23	CHEMBL3130	Homo sapiens	Inhibition	%	8.23
	8086230	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.28	CHEMBL3130	Homo sapiens	Inhibition	%	3.28
	8086392	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.92	CHEMBL3130	Homo sapiens	Inhibition	%	1.92
	8086715	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.2	CHEMBL3130	Homo sapiens	Inhibition	%	2.2
	8086926	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.54	CHEMBL3130	Homo sapiens	Inhibition	%	0.54
	8087308	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.57	CHEMBL3130	Homo sapiens	Inhibition	%	0.57
	8087422	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.75	CHEMBL3130	Homo sapiens	Inhibition	%	2.75
	8087646	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.95	CHEMBL3130	Homo sapiens	Inhibition	%	0.95
	8087784	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.39	CHEMBL3130	Homo sapiens	Inhibition	%	3.39
	8088150	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.58	CHEMBL3130	Homo sapiens	Inhibition	%	2.58
	8088298	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.22	CHEMBL3130	Homo sapiens	Inhibition	%	3.22
	8088650	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.44	CHEMBL3130	Homo sapiens	Inhibition	%	2.44
	8088967	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.25	CHEMBL3130	Homo sapiens	Inhibition	%	3.25
	8089095	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.45	CHEMBL3130	Homo sapiens	Inhibition	%	-0.45
	8089467	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.23	CHEMBL3130	Homo sapiens	Inhibition	%	0.23
	8089587	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.21	CHEMBL3130	Homo sapiens	Inhibition	%	1.21
	8089811	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.13	CHEMBL3130	Homo sapiens	Inhibition	%	2.13
	8089991	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.3	CHEMBL3130	Homo sapiens	Inhibition	%	0.3
	8090156	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.97	CHEMBL3130	Homo sapiens	Inhibition	%	-1.97
	8090380	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.26	CHEMBL3130	Homo sapiens	Inhibition	%	-0.26
	8090547	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.22	CHEMBL3130	Homo sapiens	Inhibition	%	-0.22
	8090686	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.32	CHEMBL3130	Homo sapiens	Inhibition	%	0.32
	8090910	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.08	CHEMBL3130	Homo sapiens	Inhibition	%	1.08
	8091115	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.74	CHEMBL3130	Homo sapiens	Inhibition	%	0.74
	8091252	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.66	CHEMBL3130	Homo sapiens	Inhibition	%	0.66
	8091476	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.79	CHEMBL3130	Homo sapiens	Inhibition	%	1.79
	8091631	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.59	CHEMBL3130	Homo sapiens	Inhibition	%	-0.59
	8091971	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.27	CHEMBL3130	Homo sapiens	Inhibition	%	2.27
	8092108	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.6	CHEMBL3130	Homo sapiens	Inhibition	%	0.6
	8092332	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.12	CHEMBL3130	Homo sapiens	Inhibition	%	1.12
	8092483	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.67	CHEMBL3130	Homo sapiens	Inhibition	%	0.67
	8092631	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.77	CHEMBL3130	Homo sapiens	Inhibition	%	3.77
	8092855	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.78	CHEMBL3130	Homo sapiens	Inhibition	%	-0.78
	8092984	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	10.6	CHEMBL3130	Homo sapiens	Inhibition	%	10.6
	8093296	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.76	CHEMBL3130	Homo sapiens	Inhibition	%	4.76
	8093436	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.08	CHEMBL3130	Homo sapiens	Inhibition	%	0.08
	8093660	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.59	CHEMBL3130	Homo sapiens	Inhibition	%	-2.59
	8093799	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.67	CHEMBL3130	Homo sapiens	Inhibition	%	1.67
	8094143	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.67	CHEMBL3130	Homo sapiens	Inhibition	%	1.67
	8094323	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.16	CHEMBL3130	Homo sapiens	Inhibition	%	0.16
	8094722	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-1.34	CHEMBL3130	Homo sapiens	Inhibition	%	-1.34
	8094878	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.85	CHEMBL3130	Homo sapiens	Inhibition	%	0.85
	8095242	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.29	CHEMBL3130	Homo sapiens	Inhibition	%	3.29
	8095445	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.65	CHEMBL3130	Homo sapiens	Inhibition	%	2.65
	8095810	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	17.84	CHEMBL3130	Homo sapiens	Inhibition	%	17.84
	8095958	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.53	CHEMBL3130	Homo sapiens	Inhibition	%	0.53
	8096299	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.47	CHEMBL3130	Homo sapiens	Inhibition	%	2.47
	8096662	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.92	CHEMBL3130	Homo sapiens	Inhibition	%	0.92
	8096818	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.33	CHEMBL3130	Homo sapiens	Inhibition	%	7.33
	8097189	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.29	CHEMBL3130	Homo sapiens	Inhibition	%	2.29
	8097276	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	17.47	CHEMBL3130	Homo sapiens	Inhibition	%	17.47
	8097496	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.87	CHEMBL3130	Homo sapiens	Inhibition	%	4.87
	8097870	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.08	CHEMBL3130	Homo sapiens	Inhibition	%	-3.08
	8098003	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.33	CHEMBL3130	Homo sapiens	Inhibition	%	-1.33
	8098347	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.62	CHEMBL3130	Homo sapiens	Inhibition	%	1.62
	8098527	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.23	CHEMBL3130	Homo sapiens	Inhibition	%	-1.23
	8098751	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.33	CHEMBL3130	Homo sapiens	Inhibition	%	3.33
	8098936	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.71	CHEMBL3130	Homo sapiens	Inhibition	%	2.71
	8099080	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.39	CHEMBL3130	Homo sapiens	Inhibition	%	0.39
	8099304	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.49	CHEMBL3130	Homo sapiens	Inhibition	%	0.49
	8099446	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.03	CHEMBL3130	Homo sapiens	Inhibition	%	1.03
	8099640	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.45	CHEMBL3130	Homo sapiens	Inhibition	%	-0.45
	8100011	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.43	CHEMBL3130	Homo sapiens	Inhibition	%	1.43
	8100157	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.87	CHEMBL3130	Homo sapiens	Inhibition	%	1.87
	8100381	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.72	CHEMBL3130	Homo sapiens	Inhibition	%	0.72
	8100497	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.26	CHEMBL3130	Homo sapiens	Inhibition	%	8.26
	8100861	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.1	CHEMBL3130	Homo sapiens	Inhibition	%	2.1
	8101021	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.29	CHEMBL3130	Homo sapiens	Inhibition	%	2.29
	8101387	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.6	CHEMBL3130	Homo sapiens	Inhibition	%	2.6
	8101572	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.95	CHEMBL3130	Homo sapiens	Inhibition	%	1.95
	8101825	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.94	CHEMBL3130	Homo sapiens	Inhibition	%	0.94
	8102049	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.3	CHEMBL3130	Homo sapiens	Inhibition	%	3.3
	8102204	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	1.39	CHEMBL3130	Homo sapiens	Inhibition	%	1.39
	8102335	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.97	CHEMBL3130	Homo sapiens	Inhibition	%	-1.97
	8102559	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.81	CHEMBL3130	Homo sapiens	Inhibition	%	-0.81
	8102679	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.63	CHEMBL3130	Homo sapiens	Inhibition	%	3.63
	8103081	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	4.52	CHEMBL3130	Homo sapiens	Inhibition	%	4.52
	8103277	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.44	CHEMBL3130	Homo sapiens	Inhibition	%	0.44
	8103639	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.45	CHEMBL3130	Homo sapiens	Inhibition	%	-1.45
	8103789	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.51	CHEMBL3130	Homo sapiens	Inhibition	%	1.51
	8103974	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.14	CHEMBL3130	Homo sapiens	Inhibition	%	-0.14
	8104198	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.7	CHEMBL3130	Homo sapiens	Inhibition	%	-0.7
	8104346	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.9	CHEMBL3130	Homo sapiens	Inhibition	%	5.9
	8104716	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.54	CHEMBL3130	Homo sapiens	Inhibition	%	-0.54
	8104830	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.8	CHEMBL3130	Homo sapiens	Inhibition	%	2.8
	8105054	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	17.62	CHEMBL3130	Homo sapiens	Inhibition	%	17.62
	8105194	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.92	CHEMBL3130	Homo sapiens	Inhibition	%	-2.92
	8105360	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.83	CHEMBL3130	Homo sapiens	Inhibition	%	3.83
	8105584	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.45	CHEMBL3130	Homo sapiens	Inhibition	%	9.45
	8105722	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	11.44	CHEMBL3130	Homo sapiens	Inhibition	%	11.44
	8106002	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.58	CHEMBL3130	Homo sapiens	Inhibition	%	2.58
	8106391	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.6	CHEMBL3130	Homo sapiens	Inhibition	%	2.6
	8106547	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	10.65	CHEMBL3130	Homo sapiens	Inhibition	%	10.65
	8106900	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-1.28	CHEMBL3130	Homo sapiens	Inhibition	%	-1.28
	8107021	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.3	CHEMBL3130	Homo sapiens	Inhibition	%	-0.3
	8107245	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.17	CHEMBL3130	Homo sapiens	Inhibition	%	1.17
	8107417	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.65	CHEMBL3130	Homo sapiens	Inhibition	%	0.65
	8107618	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.52	CHEMBL3130	Homo sapiens	Inhibition	%	1.52
	8107977	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-4.65	CHEMBL3130	Homo sapiens	Inhibition	%	-4.65
	8108135	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.73	CHEMBL3130	Homo sapiens	Inhibition	%	0.73
	8108359	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.41	CHEMBL3130	Homo sapiens	Inhibition	%	6.41
	8108534	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.93	CHEMBL3130	Homo sapiens	Inhibition	%	3.93
	8108681	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	15.62	CHEMBL3130	Homo sapiens	Inhibition	%	15.62
	8108905	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	74.59	CHEMBL3130	Homo sapiens	Inhibition	%	74.59
	8109047	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.99	CHEMBL3130	Homo sapiens	Inhibition	%	0.99
	8109385	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.65	CHEMBL3130	Homo sapiens	Inhibition	%	2.65
	8109515	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.81	CHEMBL3130	Homo sapiens	Inhibition	%	0.81
	8109910	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	62.52	CHEMBL3130	Homo sapiens	Inhibition	%	62.52
	8110042	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.4	CHEMBL3130	Homo sapiens	Inhibition	%	5.4
	8110266	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.83	CHEMBL3130	Homo sapiens	Inhibition	%	5.83
	8110321	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.8	CHEMBL3130	Homo sapiens	Inhibition	%	0.8
	8110545	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.89	CHEMBL3130	Homo sapiens	Inhibition	%	1.89
	8110711	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.0	CHEMBL3130	Homo sapiens	Inhibition	%	2.0
	8110869	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.56	CHEMBL3130	Homo sapiens	Inhibition	%	-2.56
	8111216	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.28	CHEMBL3130	Homo sapiens	Inhibition	%	0.28
	8111567	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.06	CHEMBL3130	Homo sapiens	Inhibition	%	0.06
	8111733	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.77	CHEMBL3130	Homo sapiens	Inhibition	%	1.77
	8111938	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.73	CHEMBL3130	Homo sapiens	Inhibition	%	0.73
	8112162	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.52	CHEMBL3130	Homo sapiens	Inhibition	%	1.52
	8112299	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.39	CHEMBL3130	Homo sapiens	Inhibition	%	-1.39
	8112691	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.02	CHEMBL3130	Homo sapiens	Inhibition	%	1.02
	8112863	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.63	CHEMBL3130	Homo sapiens	Inhibition	%	0.63
	8113239	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.6	CHEMBL3130	Homo sapiens	Inhibition	%	1.6
	8113375	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	10.09	CHEMBL3130	Homo sapiens	Inhibition	%	10.09
	8113723	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.45	CHEMBL3130	Homo sapiens	Inhibition	%	4.45
	8113839	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.22	CHEMBL3130	Homo sapiens	Inhibition	%	-1.22
	8114063	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.73	CHEMBL3130	Homo sapiens	Inhibition	%	1.73
	8114239	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.9	CHEMBL3130	Homo sapiens	Inhibition	%	0.9
	8114595	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.28	CHEMBL3130	Homo sapiens	Inhibition	%	2.28
	8114871	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.33	CHEMBL3130	Homo sapiens	Inhibition	%	1.33
	8115037	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.09	CHEMBL3130	Homo sapiens	Inhibition	%	1.09
	8115202	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-5.7	CHEMBL3130	Homo sapiens	Inhibition	%	-5.7
	8115426	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.12	CHEMBL3130	Homo sapiens	Inhibition	%	-2.12
	8115546	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.23	CHEMBL3130	Homo sapiens	Inhibition	%	3.23
	8115903	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.22	CHEMBL3130	Homo sapiens	Inhibition	%	0.22
	8116062	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.73	CHEMBL3130	Homo sapiens	Inhibition	%	-0.73
	8116286	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.18	CHEMBL3130	Homo sapiens	Inhibition	%	2.18
	8116489	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-0.02	CHEMBL3130	Homo sapiens	Inhibition	%	-0.02
	8116623	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	6.02	CHEMBL3130	Homo sapiens	Inhibition	%	6.02
	8117019	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.18	CHEMBL3130	Homo sapiens	Inhibition	%	3.18
	8117190	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.62	CHEMBL3130	Homo sapiens	Inhibition	%	4.62
	8117572	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.55	CHEMBL3130	Homo sapiens	Inhibition	%	1.55
	8117702	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-2.16	CHEMBL3130	Homo sapiens	Inhibition	%	-2.16
	8117926	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.17	CHEMBL3130	Homo sapiens	Inhibition	%	-1.17
	8118064	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.7	CHEMBL3130	Homo sapiens	Inhibition	%	1.7
	8118404	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.32	CHEMBL3130	Homo sapiens	Inhibition	%	0.32
	8118576	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.81	CHEMBL3130	Homo sapiens	Inhibition	%	1.81
	8118936	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	12.37	CHEMBL3130	Homo sapiens	Inhibition	%	12.37
	8119207	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.12	CHEMBL3130	Homo sapiens	Inhibition	%	0.12
	8119366	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.46	CHEMBL3130	Homo sapiens	Inhibition	%	2.46
	8119757	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.16	CHEMBL3130	Homo sapiens	Inhibition	%	-0.16
	8119876	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.95	CHEMBL3130	Homo sapiens	Inhibition	%	1.95
	8120100	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.42	CHEMBL3130	Homo sapiens	Inhibition	%	5.42
	8120239	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.68	CHEMBL3130	Homo sapiens	Inhibition	%	0.68
	8120623	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.29	CHEMBL3130	Homo sapiens	Inhibition	%	0.29
	8120824	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.63	CHEMBL3130	Homo sapiens	Inhibition	%	0.63
	8120952	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.64	CHEMBL3130	Homo sapiens	Inhibition	%	0.64
	8121176	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.71	CHEMBL3130	Homo sapiens	Inhibition	%	0.71
	8121348	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.42	CHEMBL3130	Homo sapiens	Inhibition	%	1.42
	8121515	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.97	CHEMBL3130	Homo sapiens	Inhibition	%	0.97
	8121739	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.61	CHEMBL3130	Homo sapiens	Inhibition	%	3.61
	8121902	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.31	CHEMBL3130	Homo sapiens	Inhibition	%	2.31
	8122247	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.88	CHEMBL3130	Homo sapiens	Inhibition	%	-2.88
	8122385	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.53	CHEMBL3130	Homo sapiens	Inhibition	%	3.53
	8122729	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.67	CHEMBL3130	Homo sapiens	Inhibition	%	1.67
	8122896	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-0.09	CHEMBL3130	Homo sapiens	Inhibition	%	-0.09
	8123120	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.59	CHEMBL3130	Homo sapiens	Inhibition	%	2.59
	8123262	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.08	CHEMBL3130	Homo sapiens	Inhibition	%	2.08
	8123540	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.2	CHEMBL3130	Homo sapiens	Inhibition	%	2.2
	8123690	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	8.17	CHEMBL3130	Homo sapiens	Inhibition	%	8.17
	8123914	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	17.98	CHEMBL3130	Homo sapiens	Inhibition	%	17.98
	8124081	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.29	CHEMBL3130	Homo sapiens	Inhibition	%	-1.29
	8124424	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.95	CHEMBL3130	Homo sapiens	Inhibition	%	3.95
	8124563	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.76	CHEMBL3130	Homo sapiens	Inhibition	%	0.76
	8124952	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	9.02	CHEMBL3130	Homo sapiens	Inhibition	%	9.02
	8125153	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.87	CHEMBL3130	Homo sapiens	Inhibition	%	1.87
	8125507	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.05	CHEMBL3130	Homo sapiens	Inhibition	%	1.05
	8125675	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	8.98	CHEMBL3130	Homo sapiens	Inhibition	%	8.98
	8126063	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-3.18	CHEMBL3130	Homo sapiens	Inhibition	%	-3.18
	8126227	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.24	CHEMBL3130	Homo sapiens	Inhibition	%	4.24
	8126566	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.2	CHEMBL3130	Homo sapiens	Inhibition	%	-0.2
	8126702	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.72	CHEMBL3130	Homo sapiens	Inhibition	%	2.72
	8126926	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	12.67	CHEMBL3130	Homo sapiens	Inhibition	%	12.67
	8127048	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.16	CHEMBL3130	Homo sapiens	Inhibition	%	-0.16
	8127439	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.23	CHEMBL3130	Homo sapiens	Inhibition	%	2.23
	8127581	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	15.91	CHEMBL3130	Homo sapiens	Inhibition	%	15.91
	8127869	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.25	CHEMBL3130	Homo sapiens	Inhibition	%	0.25
	8128245	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.59	CHEMBL3130	Homo sapiens	Inhibition	%	1.59
	8128412	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.3	CHEMBL3130	Homo sapiens	Inhibition	%	-2.3
	8128755	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	19.1	CHEMBL3130	Homo sapiens	Inhibition	%	19.1
	8128892	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.25	CHEMBL3130	Homo sapiens	Inhibition	%	-0.25
	8129116	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.09	CHEMBL3130	Homo sapiens	Inhibition	%	-1.09
	8129287	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.02	CHEMBL3130	Homo sapiens	Inhibition	%	2.02
	8129476	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.26	CHEMBL3130	Homo sapiens	Inhibition	%	6.26
	8129700	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.78	CHEMBL3130	Homo sapiens	Inhibition	%	1.78
	8129839	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.67	CHEMBL3130	Homo sapiens	Inhibition	%	1.67
	8130000	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.99	CHEMBL3130	Homo sapiens	Inhibition	%	0.99
	8130224	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.05	CHEMBL3130	Homo sapiens	Inhibition	%	2.05
	8130396	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.47	CHEMBL3130	Homo sapiens	Inhibition	%	-0.47
	8130556	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	6.31	CHEMBL3130	Homo sapiens	Inhibition	%	6.31
	8130780	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	40.24	CHEMBL3130	Homo sapiens	Inhibition	%	40.24
	8130896	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.72	CHEMBL3130	Homo sapiens	Inhibition	%	0.72
	8131259	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.8	CHEMBL3130	Homo sapiens	Inhibition	%	0.8
	8131379	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.82	CHEMBL3130	Homo sapiens	Inhibition	%	2.82
	8131603	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.14	CHEMBL3130	Homo sapiens	Inhibition	%	0.14
	8131770	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.91	CHEMBL3130	Homo sapiens	Inhibition	%	4.91
	8131911	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.25	CHEMBL3130	Homo sapiens	Inhibition	%	1.25
	8132135	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.92	CHEMBL3130	Homo sapiens	Inhibition	%	4.92
	8132197	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.99	CHEMBL3130	Homo sapiens	Inhibition	%	2.99
	8132421	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.21	CHEMBL3130	Homo sapiens	Inhibition	%	0.21
	8132568	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.73	CHEMBL3130	Homo sapiens	Inhibition	%	1.73
	8132736	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.5	CHEMBL3130	Homo sapiens	Inhibition	%	0.5
	8132960	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.38	CHEMBL3130	Homo sapiens	Inhibition	%	0.38
	8133081	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.61	CHEMBL3130	Homo sapiens	Inhibition	%	-0.61
	8133443	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.16	CHEMBL3130	Homo sapiens	Inhibition	%	2.16
	8133615	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	6.39	CHEMBL3130	Homo sapiens	Inhibition	%	6.39
	8134019	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.04	CHEMBL3130	Homo sapiens	Inhibition	%	4.04
	8134167	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.57	CHEMBL3130	Homo sapiens	Inhibition	%	-0.57
	8134551	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.77	CHEMBL3130	Homo sapiens	Inhibition	%	1.77
	8134735	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.26	CHEMBL3130	Homo sapiens	Inhibition	%	-1.26
	8135119	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.41	CHEMBL3130	Homo sapiens	Inhibition	%	0.41
	8135234	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	6.19	CHEMBL3130	Homo sapiens	Inhibition	%	6.19
	8135599	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.11	CHEMBL3130	Homo sapiens	Inhibition	%	2.11
	8135944	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.22	CHEMBL3130	Homo sapiens	Inhibition	%	0.22
	8136112	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.9	CHEMBL3130	Homo sapiens	Inhibition	%	0.9
	8136480	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.82	CHEMBL3130	Homo sapiens	Inhibition	%	0.82
	8136770	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.56	CHEMBL3130	Homo sapiens	Inhibition	%	1.56
	8136905	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.18	CHEMBL3130	Homo sapiens	Inhibition	%	0.18
	8137292	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.31	CHEMBL3130	Homo sapiens	Inhibition	%	3.31
	8137412	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.79	CHEMBL3130	Homo sapiens	Inhibition	%	1.79
	8137636	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.64	CHEMBL3130	Homo sapiens	Inhibition	%	-1.64
	8137784	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.94	CHEMBL3130	Homo sapiens	Inhibition	%	1.94
	8137950	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.85	CHEMBL3130	Homo sapiens	Inhibition	%	1.85
	8138174	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.06	CHEMBL3130	Homo sapiens	Inhibition	%	2.06
	8138353	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.76	CHEMBL3130	Homo sapiens	Inhibition	%	0.76
	8138501	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.07	CHEMBL3130	Homo sapiens	Inhibition	%	0.07
	8138725	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.08	CHEMBL3130	Homo sapiens	Inhibition	%	-1.08
	8138883	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.51	CHEMBL3130	Homo sapiens	Inhibition	%	2.51
	8139068	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.45	CHEMBL3130	Homo sapiens	Inhibition	%	-0.45
	8139451	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-0.48	CHEMBL3130	Homo sapiens	Inhibition	%	-0.48
	8139565	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.55	CHEMBL3130	Homo sapiens	Inhibition	%	0.55
	8139789	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.2	CHEMBL3130	Homo sapiens	Inhibition	%	2.2
	8139930	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.17	CHEMBL3130	Homo sapiens	Inhibition	%	2.17
	8140277	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.85	CHEMBL3130	Homo sapiens	Inhibition	%	0.85
	8140436	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.58	CHEMBL3130	Homo sapiens	Inhibition	%	1.58
	8140660	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.79	CHEMBL3130	Homo sapiens	Inhibition	%	0.79
	8140803	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.24	CHEMBL3130	Homo sapiens	Inhibition	%	3.24
	8141105	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.22	CHEMBL3130	Homo sapiens	Inhibition	%	1.22
	8141235	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.04	CHEMBL3130	Homo sapiens	Inhibition	%	1.04
	8141459	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.99	CHEMBL3130	Homo sapiens	Inhibition	%	-0.99
	8141619	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	14.7	CHEMBL3130	Homo sapiens	Inhibition	%	14.7
	8141962	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.98	CHEMBL3130	Homo sapiens	Inhibition	%	-1.98
	8142123	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.13	CHEMBL3130	Homo sapiens	Inhibition	%	2.13
	8142515	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.19	CHEMBL3130	Homo sapiens	Inhibition	%	2.19
	8142691	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.63	CHEMBL3130	Homo sapiens	Inhibition	%	3.63
	8143064	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.45	CHEMBL3130	Homo sapiens	Inhibition	%	-1.45
	8143219	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.98	CHEMBL3130	Homo sapiens	Inhibition	%	0.98
	8143406	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1	Outside typical range	CHEMBL1880739	=	Inhibition	%	-31.04	CHEMBL3130	Homo sapiens	Inhibition	%	-31.04
	8143630	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1	Outside typical range	CHEMBL1880739	=	Inhibition	%	-38.03	CHEMBL3130	Homo sapiens	Inhibition	%	-38.03
	8143789	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.26	CHEMBL3130	Homo sapiens	Inhibition	%	0.26
	8144127	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.72	CHEMBL3130	Homo sapiens	Inhibition	%	0.72
	8144266	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.89	CHEMBL3130	Homo sapiens	Inhibition	%	6.89
	8144490	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.14	CHEMBL3130	Homo sapiens	Inhibition	%	1.14
	8144620	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.96	CHEMBL3130	Homo sapiens	Inhibition	%	0.96
	8144997	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.11	CHEMBL3130	Homo sapiens	Inhibition	%	1.11
	8145134	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.47	CHEMBL3130	Homo sapiens	Inhibition	%	0.47
	8145447	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.33	CHEMBL3130	Homo sapiens	Inhibition	%	3.33
	8145795	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.03	CHEMBL3130	Homo sapiens	Inhibition	%	1.03
	8145956	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.12	CHEMBL3130	Homo sapiens	Inhibition	%	0.12
	8146300	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.7	CHEMBL3130	Homo sapiens	Inhibition	%	0.7
	8146460	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	5.91	CHEMBL3130	Homo sapiens	Inhibition	%	5.91
	8146684	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.01	CHEMBL3130	Homo sapiens	Inhibition	%	0.01
	8146851	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	55.85	CHEMBL3130	Homo sapiens	Inhibition	%	55.85
	8147020	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.51	CHEMBL3130	Homo sapiens	Inhibition	%	0.51
	8147386	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.34	CHEMBL3130	Homo sapiens	Inhibition	%	-0.34
	8147539	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.62	CHEMBL3130	Homo sapiens	Inhibition	%	1.62
	8147763	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.05	CHEMBL3130	Homo sapiens	Inhibition	%	-0.05
	8147950	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-9.64	CHEMBL3130	Homo sapiens	Inhibition	%	-9.64
	8148108	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.0	CHEMBL3130	Homo sapiens	Inhibition	%	2.0
	8148446	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.81	CHEMBL3130	Homo sapiens	Inhibition	%	2.81
	8148809	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.35	CHEMBL3130	Homo sapiens	Inhibition	%	5.35
	8148947	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.53	CHEMBL3130	Homo sapiens	Inhibition	%	0.53
	8149330	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.1	CHEMBL3130	Homo sapiens	Inhibition	%	1.1
	8149464	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.33	CHEMBL3130	Homo sapiens	Inhibition	%	6.33
	8149688	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.31	CHEMBL3130	Homo sapiens	Inhibition	%	0.31
	8149786	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.65	CHEMBL3130	Homo sapiens	Inhibition	%	1.65
	8150135	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.36	CHEMBL3130	Homo sapiens	Inhibition	%	0.36
	8150295	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-1.62	CHEMBL3130	Homo sapiens	Inhibition	%	-1.62
	8150519	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.74	CHEMBL3130	Homo sapiens	Inhibition	%	0.74
	8150639	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	10.22	CHEMBL3130	Homo sapiens	Inhibition	%	10.22
	8151028	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.22	CHEMBL3130	Homo sapiens	Inhibition	%	-0.22
	8151191	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.94	CHEMBL3130	Homo sapiens	Inhibition	%	-1.94
	8151368	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.99	CHEMBL3130	Homo sapiens	Inhibition	%	0.99
	8151592	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.07	CHEMBL3130	Homo sapiens	Inhibition	%	0.07
	8151730	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.75	CHEMBL3130	Homo sapiens	Inhibition	%	8.75
	8152108	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.34	CHEMBL3130	Homo sapiens	Inhibition	%	2.34
	8152296	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-7.81	CHEMBL3130	Homo sapiens	Inhibition	%	-7.81
	8152454	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.87	CHEMBL3130	Homo sapiens	Inhibition	%	1.87
	8152678	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.99	CHEMBL3130	Homo sapiens	Inhibition	%	4.99
	8152792	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.01	CHEMBL3130	Homo sapiens	Inhibition	%	2.01
	8153155	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.29	CHEMBL3130	Homo sapiens	Inhibition	%	1.29
	8153292	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.87	CHEMBL3130	Homo sapiens	Inhibition	%	5.87
	8153516	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.16	CHEMBL3130	Homo sapiens	Inhibition	%	1.16
	8153673	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.27	CHEMBL3130	Homo sapiens	Inhibition	%	4.27
	8154030	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.82	CHEMBL3130	Homo sapiens	Inhibition	%	1.82
	8154127	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.21	CHEMBL3130	Homo sapiens	Inhibition	%	0.21
	8154351	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.37	CHEMBL3130	Homo sapiens	Inhibition	%	3.37
	8154477	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.96	CHEMBL3130	Homo sapiens	Inhibition	%	2.96
	8154860	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.1	CHEMBL3130	Homo sapiens	Inhibition	%	-1.1
	8154980	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.07	CHEMBL3130	Homo sapiens	Inhibition	%	2.07
	8155380	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.55	CHEMBL3130	Homo sapiens	Inhibition	%	0.55
	8155541	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.26	CHEMBL3130	Homo sapiens	Inhibition	%	-0.26
	8155943	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.87	CHEMBL3130	Homo sapiens	Inhibition	%	0.87
	8156081	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.36	CHEMBL3130	Homo sapiens	Inhibition	%	-0.36
	8156517	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.48	CHEMBL3130	Homo sapiens	Inhibition	%	2.48
	8156667	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-1.96	CHEMBL3130	Homo sapiens	Inhibition	%	-1.96
	8157034	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.33	CHEMBL3130	Homo sapiens	Inhibition	%	3.33
	8157154	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.89	CHEMBL3130	Homo sapiens	Inhibition	%	2.89
	8157378	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.84	CHEMBL3130	Homo sapiens	Inhibition	%	3.84
	8157519	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.18	CHEMBL3130	Homo sapiens	Inhibition	%	1.18
	8157873	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.58	CHEMBL3130	Homo sapiens	Inhibition	%	0.58
	8158034	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.68	CHEMBL3130	Homo sapiens	Inhibition	%	0.68
	8158284	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.59	CHEMBL3130	Homo sapiens	Inhibition	%	1.59
	8158666	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	14.45	CHEMBL3130	Homo sapiens	Inhibition	%	14.45
	8158835	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.22	CHEMBL3130	Homo sapiens	Inhibition	%	2.22
	8159194	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.37	CHEMBL3130	Homo sapiens	Inhibition	%	3.37
	8159538	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.37	CHEMBL3130	Homo sapiens	Inhibition	%	2.37
	8159669	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.98	CHEMBL3130	Homo sapiens	Inhibition	%	4.98
	8160034	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	8.16	CHEMBL3130	Homo sapiens	Inhibition	%	8.16
	8160171	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.47	CHEMBL3130	Homo sapiens	Inhibition	%	0.47
	8160395	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.45	CHEMBL3130	Homo sapiens	Inhibition	%	0.45
	8160545	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.72	CHEMBL3130	Homo sapiens	Inhibition	%	3.72
	8160839	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.33	CHEMBL3130	Homo sapiens	Inhibition	%	3.33
	8160989	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.08	CHEMBL3130	Homo sapiens	Inhibition	%	-0.08
	8161213	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.81	CHEMBL3130	Homo sapiens	Inhibition	%	0.81
	8161356	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.69	CHEMBL3130	Homo sapiens	Inhibition	%	4.69
	8161705	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.66	CHEMBL3130	Homo sapiens	Inhibition	%	2.66
	8161843	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-1.04	CHEMBL3130	Homo sapiens	Inhibition	%	-1.04
	8162197	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-0.52	CHEMBL3130	Homo sapiens	Inhibition	%	-0.52
	8162357	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.3	CHEMBL3130	Homo sapiens	Inhibition	%	1.3
	8162581	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	7.49	CHEMBL3130	Homo sapiens	Inhibition	%	7.49
	8162610	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.17	CHEMBL3130	Homo sapiens	Inhibition	%	3.17
	8162834	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.95	CHEMBL3130	Homo sapiens	Inhibition	%	3.95
	8162982	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.31	CHEMBL3130	Homo sapiens	Inhibition	%	5.31
	8163151	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.33	CHEMBL3130	Homo sapiens	Inhibition	%	4.33
	8163375	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.32	CHEMBL3130	Homo sapiens	Inhibition	%	2.32
	8163509	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	15.85	CHEMBL3130	Homo sapiens	Inhibition	%	15.85
	8163856	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.22	CHEMBL3130	Homo sapiens	Inhibition	%	3.22
	8163990	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.18	CHEMBL3130	Homo sapiens	Inhibition	%	2.18
	8164214	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.74	CHEMBL3130	Homo sapiens	Inhibition	%	9.74
	8164354	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.71	CHEMBL3130	Homo sapiens	Inhibition	%	5.71
	8164733	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.45	CHEMBL3130	Homo sapiens	Inhibition	%	3.45
	8164877	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	7.23	CHEMBL3130	Homo sapiens	Inhibition	%	7.23
	8165171	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.46	CHEMBL3130	Homo sapiens	Inhibition	%	1.46
	8165536	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.68	CHEMBL3130	Homo sapiens	Inhibition	%	0.68
	8165679	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	26.11	CHEMBL3130	Homo sapiens	Inhibition	%	26.11
	8166029	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.71	CHEMBL3130	Homo sapiens	Inhibition	%	3.71
	8166167	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.13	CHEMBL3130	Homo sapiens	Inhibition	%	-0.13
	8166391	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.5	CHEMBL3130	Homo sapiens	Inhibition	%	0.5
	8166521	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.01	CHEMBL3130	Homo sapiens	Inhibition	%	2.01
	8166846	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	21.28	CHEMBL3130	Homo sapiens	Inhibition	%	21.28
	8167158	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.26	CHEMBL3130	Homo sapiens	Inhibition	%	1.26
	8167299	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	27.27	CHEMBL3130	Homo sapiens	Inhibition	%	27.27
	8167687	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.96	CHEMBL3130	Homo sapiens	Inhibition	%	4.96
	8167820	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.09	CHEMBL3130	Homo sapiens	Inhibition	%	3.09
	8168044	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.96	CHEMBL3130	Homo sapiens	Inhibition	%	2.96
	8168168	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.41	CHEMBL3130	Homo sapiens	Inhibition	%	2.41
	8168533	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.78	CHEMBL3130	Homo sapiens	Inhibition	%	2.78
	8168669	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	6.91	CHEMBL3130	Homo sapiens	Inhibition	%	6.91
	8169057	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	21.22	CHEMBL3130	Homo sapiens	Inhibition	%	21.22
	8169199	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.92	CHEMBL3130	Homo sapiens	Inhibition	%	0.92
	8169423	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.63	CHEMBL3130	Homo sapiens	Inhibition	%	1.63
	8169503	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.15	CHEMBL3130	Homo sapiens	Inhibition	%	4.15
	8169861	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.51	CHEMBL3130	Homo sapiens	Inhibition	%	0.51
	8170006	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.62	CHEMBL3130	Homo sapiens	Inhibition	%	2.62
	8170230	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.45	CHEMBL3130	Homo sapiens	Inhibition	%	3.45
	8170355	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.83	CHEMBL3130	Homo sapiens	Inhibition	%	1.83
	8170719	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.08	CHEMBL3130	Homo sapiens	Inhibition	%	-0.08
	8170854	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.67	CHEMBL3130	Homo sapiens	Inhibition	%	1.67
	8171275	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.45	CHEMBL3130	Homo sapiens	Inhibition	%	2.45
	8171492	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.06	CHEMBL3130	Homo sapiens	Inhibition	%	3.06
	8171633	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.82	CHEMBL3130	Homo sapiens	Inhibition	%	2.82
	8171857	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.94	CHEMBL3130	Homo sapiens	Inhibition	%	13.94
	8172010	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.15	CHEMBL3130	Homo sapiens	Inhibition	%	2.15
	8172366	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.87	CHEMBL3130	Homo sapiens	Inhibition	%	1.87
	8172494	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.62	CHEMBL3130	Homo sapiens	Inhibition	%	3.62
	8172860	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.2	CHEMBL3130	Homo sapiens	Inhibition	%	6.2
	8172996	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	7.35	CHEMBL3130	Homo sapiens	Inhibition	%	7.35
	8173220	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	8.71	CHEMBL3130	Homo sapiens	Inhibition	%	8.71
	8173385	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.66	CHEMBL3130	Homo sapiens	Inhibition	%	2.66
	8173750	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-8.03	CHEMBL3130	Homo sapiens	Inhibition	%	-8.03
	8173837	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.71	CHEMBL3130	Homo sapiens	Inhibition	%	1.71
	8174061	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.03	CHEMBL3130	Homo sapiens	Inhibition	%	2.03
	8174193	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.23	CHEMBL3130	Homo sapiens	Inhibition	%	3.23
	8174565	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.94	CHEMBL3130	Homo sapiens	Inhibition	%	1.94
	8174687	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.28	CHEMBL3130	Homo sapiens	Inhibition	%	3.28
	8174911	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.96	CHEMBL3130	Homo sapiens	Inhibition	%	2.96
	8175054	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.9	CHEMBL3130	Homo sapiens	Inhibition	%	-0.9
	8175190	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.45	CHEMBL3130	Homo sapiens	Inhibition	%	2.45
	8175414	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.78	CHEMBL3130	Homo sapiens	Inhibition	%	6.78
	8175670	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.88	CHEMBL3130	Homo sapiens	Inhibition	%	2.88
	8175833	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	10.52	CHEMBL3130	Homo sapiens	Inhibition	%	10.52
	8176210	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.69	CHEMBL3130	Homo sapiens	Inhibition	%	3.69
	8176359	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.82	CHEMBL3130	Homo sapiens	Inhibition	%	5.82
	8176715	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.83	CHEMBL3130	Homo sapiens	Inhibition	%	2.83
	8176845	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.43	CHEMBL3130	Homo sapiens	Inhibition	%	1.43
	8177069	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.91	CHEMBL3130	Homo sapiens	Inhibition	%	1.91
	8177211	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.19	CHEMBL3130	Homo sapiens	Inhibition	%	2.19
	8177573	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.48	CHEMBL3130	Homo sapiens	Inhibition	%	4.48
	8177737	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	10.02	CHEMBL3130	Homo sapiens	Inhibition	%	10.02
	8178101	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-3.91	CHEMBL3130	Homo sapiens	Inhibition	%	-3.91
	8178413	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.7	CHEMBL3130	Homo sapiens	Inhibition	%	1.7
	8178540	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.23	CHEMBL3130	Homo sapiens	Inhibition	%	2.23
	8178913	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.38	CHEMBL3130	Homo sapiens	Inhibition	%	2.38
	8179260	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	17.24	CHEMBL3130	Homo sapiens	Inhibition	%	17.24
	8179404	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.21	CHEMBL3130	Homo sapiens	Inhibition	%	0.21
	8179765	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.06	CHEMBL3130	Homo sapiens	Inhibition	%	0.06
	8180022	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.61	CHEMBL3130	Homo sapiens	Inhibition	%	1.61
	8180176	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	53.84	CHEMBL3130	Homo sapiens	Inhibition	%	53.84
	8180400	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.77	CHEMBL3130	Homo sapiens	Inhibition	%	2.77
	8180556	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.07	CHEMBL3130	Homo sapiens	Inhibition	%	6.07
	8180704	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.7	CHEMBL3130	Homo sapiens	Inhibition	%	0.7
	8180928	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.54	CHEMBL3130	Homo sapiens	Inhibition	%	4.54
	8181061	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	10.92	CHEMBL3130	Homo sapiens	Inhibition	%	10.92
	8181416	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.42	CHEMBL3130	Homo sapiens	Inhibition	%	2.42
	8181556	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.52	CHEMBL3130	Homo sapiens	Inhibition	%	6.52
	8181780	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.72	CHEMBL3130	Homo sapiens	Inhibition	%	1.72
	8181919	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.05	CHEMBL3130	Homo sapiens	Inhibition	%	10.05
	8182082	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.18	CHEMBL3130	Homo sapiens	Inhibition	%	7.18
	8182306	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	32.77	CHEMBL3130	Homo sapiens	Inhibition	%	32.77
	8182446	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.05	CHEMBL3130	Homo sapiens	Inhibition	%	1.05
	8182762	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	17.35	CHEMBL3130	Homo sapiens	Inhibition	%	17.35
	8182884	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.55	CHEMBL3130	Homo sapiens	Inhibition	%	0.55
	8183108	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	17.26	CHEMBL3130	Homo sapiens	Inhibition	%	17.26
	8183257	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.48	CHEMBL3130	Homo sapiens	Inhibition	%	3.48
	8183610	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.63	CHEMBL3130	Homo sapiens	Inhibition	%	1.63
	8183752	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.37	CHEMBL3130	Homo sapiens	Inhibition	%	0.37
	8183976	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.01	CHEMBL3130	Homo sapiens	Inhibition	%	0.01
	8184112	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.07	CHEMBL3130	Homo sapiens	Inhibition	%	6.07
	8184378	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.12	CHEMBL3130	Homo sapiens	Inhibition	%	1.12
	8184749	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.44	CHEMBL3130	Homo sapiens	Inhibition	%	9.44
	8184906	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.64	CHEMBL3130	Homo sapiens	Inhibition	%	3.64
	8185279	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.34	CHEMBL3130	Homo sapiens	Inhibition	%	-1.34
	8185410	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	50.68	CHEMBL3130	Homo sapiens	Inhibition	%	50.68
	8185765	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.52	CHEMBL3130	Homo sapiens	Inhibition	%	3.52
	8186128	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.03	CHEMBL3130	Homo sapiens	Inhibition	%	4.03
	8186269	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.6	CHEMBL3130	Homo sapiens	Inhibition	%	1.6
	8186657	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.26	CHEMBL3130	Homo sapiens	Inhibition	%	5.26
	8186796	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.86	CHEMBL3130	Homo sapiens	Inhibition	%	2.86
	8187118	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.87	CHEMBL3130	Homo sapiens	Inhibition	%	0.87
	8187466	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.71	CHEMBL3130	Homo sapiens	Inhibition	%	0.71
	8187614	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.98	CHEMBL3130	Homo sapiens	Inhibition	%	3.98
	8187838	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.84	CHEMBL3130	Homo sapiens	Inhibition	%	4.84
	8187967	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.41	CHEMBL3130	Homo sapiens	Inhibition	%	0.41
	8188334	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.13	CHEMBL3130	Homo sapiens	Inhibition	%	0.13
	8188469	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.0	CHEMBL3130	Homo sapiens	Inhibition	%	1.0
	8188743	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.75	CHEMBL3130	Homo sapiens	Inhibition	%	2.75
	8189115	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	20.86	CHEMBL3130	Homo sapiens	Inhibition	%	20.86
	8189271	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	9.87	CHEMBL3130	Homo sapiens	Inhibition	%	9.87
	8189495	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.26	CHEMBL3130	Homo sapiens	Inhibition	%	4.26
	8189644	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.33	CHEMBL3130	Homo sapiens	Inhibition	%	-0.33
	8189776	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.6	CHEMBL3130	Homo sapiens	Inhibition	%	2.6
	8190000	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.7	CHEMBL3130	Homo sapiens	Inhibition	%	5.7
	8190132	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.45	CHEMBL3130	Homo sapiens	Inhibition	%	7.45
	8190496	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.68	CHEMBL3130	Homo sapiens	Inhibition	%	3.68
	8190633	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.61	CHEMBL3130	Homo sapiens	Inhibition	%	1.61
	8190857	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.87	CHEMBL3130	Homo sapiens	Inhibition	%	1.87
	8191021	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.11	CHEMBL3130	Homo sapiens	Inhibition	%	9.11
	8191159	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.63	CHEMBL3130	Homo sapiens	Inhibition	%	2.63
	8191383	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.9	CHEMBL3130	Homo sapiens	Inhibition	%	5.9
	8191479	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.16	CHEMBL3130	Homo sapiens	Inhibition	%	2.16
	8191703	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.9	CHEMBL3130	Homo sapiens	Inhibition	%	2.9
	8191825	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.67	CHEMBL3130	Homo sapiens	Inhibition	%	5.67
	8192198	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.62	CHEMBL3130	Homo sapiens	Inhibition	%	3.62
	8192327	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.28	CHEMBL3130	Homo sapiens	Inhibition	%	-0.28
	8192695	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.24	CHEMBL3130	Homo sapiens	Inhibition	%	1.24
	8192831	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.43	CHEMBL3130	Homo sapiens	Inhibition	%	2.43
	8193055	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.72	CHEMBL3130	Homo sapiens	Inhibition	%	-1.72
	8193103	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.31	CHEMBL3130	Homo sapiens	Inhibition	%	4.31
	8193327	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.48	CHEMBL3130	Homo sapiens	Inhibition	%	2.48
	8193472	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	71.32	CHEMBL3130	Homo sapiens	Inhibition	%	71.32
	8193853	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.6	CHEMBL3130	Homo sapiens	Inhibition	%	7.6
	8194002	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.19	CHEMBL3130	Homo sapiens	Inhibition	%	0.19
	8194357	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.27	CHEMBL3130	Homo sapiens	Inhibition	%	1.27
	8194488	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	13.86	CHEMBL3130	Homo sapiens	Inhibition	%	13.86
	8194712	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.6	CHEMBL3130	Homo sapiens	Inhibition	%	3.6
	8194855	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.3	CHEMBL3130	Homo sapiens	Inhibition	%	5.3
	8195212	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.25	CHEMBL3130	Homo sapiens	Inhibition	%	2.25
	8195376	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.04	CHEMBL3130	Homo sapiens	Inhibition	%	8.04
	8195739	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.52	CHEMBL3130	Homo sapiens	Inhibition	%	1.52
	8196061	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.49	CHEMBL3130	Homo sapiens	Inhibition	%	4.49
	8196178	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.66	CHEMBL3130	Homo sapiens	Inhibition	%	1.66
	8196552	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.44	CHEMBL3130	Homo sapiens	Inhibition	%	2.44
	8196680	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-2.1	CHEMBL3130	Homo sapiens	Inhibition	%	-2.1
	8196904	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.03	CHEMBL3130	Homo sapiens	Inhibition	%	2.03
	8197045	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.42	CHEMBL3130	Homo sapiens	Inhibition	%	0.42
	8197406	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	10.22	CHEMBL3130	Homo sapiens	Inhibition	%	10.22
	8197681	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.83	CHEMBL3130	Homo sapiens	Inhibition	%	4.83
	8197821	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.19	CHEMBL3130	Homo sapiens	Inhibition	%	0.19
	8198202	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.17	CHEMBL3130	Homo sapiens	Inhibition	%	3.17
	8198340	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.29	CHEMBL3130	Homo sapiens	Inhibition	%	0.29
	8198564	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.06	CHEMBL3130	Homo sapiens	Inhibition	%	2.06
	8198694	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.88	CHEMBL3130	Homo sapiens	Inhibition	%	4.88
	8199049	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.56	CHEMBL3130	Homo sapiens	Inhibition	%	5.56
	8199197	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.22	CHEMBL3130	Homo sapiens	Inhibition	%	7.22
	8199555	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.53	CHEMBL3130	Homo sapiens	Inhibition	%	1.53
	8199718	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	24.95	CHEMBL3130	Homo sapiens	Inhibition	%	24.95
	8199942	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.19	CHEMBL3130	Homo sapiens	Inhibition	%	5.19
	8200080	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.07	CHEMBL3130	Homo sapiens	Inhibition	%	3.07
	8200408	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.92	CHEMBL3130	Homo sapiens	Inhibition	%	4.92
	8200523	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.62	CHEMBL3130	Homo sapiens	Inhibition	%	0.62
	8200747	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.6	CHEMBL3130	Homo sapiens	Inhibition	%	3.6
	8200897	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.54	CHEMBL3130	Homo sapiens	Inhibition	%	4.54
	8201251	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.87	CHEMBL3130	Homo sapiens	Inhibition	%	12.87
	8201386	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.97	CHEMBL3130	Homo sapiens	Inhibition	%	1.97
	8201743	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-2.38	CHEMBL3130	Homo sapiens	Inhibition	%	-2.38
	8202022	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.85	CHEMBL3130	Homo sapiens	Inhibition	%	2.85
	8202162	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	18.43	CHEMBL3130	Homo sapiens	Inhibition	%	18.43
	8202386	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1	Outside typical range	CHEMBL1794053	=	Inhibition	%	-14.42	CHEMBL3130	Homo sapiens	Inhibition	%	-14.42
	8202553	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.9	CHEMBL3130	Homo sapiens	Inhibition	%	4.9
	8202902	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.22	CHEMBL3130	Homo sapiens	Inhibition	%	3.22
	8203032	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.58	CHEMBL3130	Homo sapiens	Inhibition	%	1.58
	8203387	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	6.47	CHEMBL3130	Homo sapiens	Inhibition	%	6.47
	8203533	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	8.91	CHEMBL3130	Homo sapiens	Inhibition	%	8.91
	8203757	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	7.14	CHEMBL3130	Homo sapiens	Inhibition	%	7.14
	8203891	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.09	CHEMBL3130	Homo sapiens	Inhibition	%	1.09
	8204281	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.21	CHEMBL3130	Homo sapiens	Inhibition	%	6.21
	8204418	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.39	CHEMBL3130	Homo sapiens	Inhibition	%	2.39
	8204747	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.17	CHEMBL3130	Homo sapiens	Inhibition	%	7.17
	8205086	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	20.28	CHEMBL3130	Homo sapiens	Inhibition	%	20.28
	8205235	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.85	CHEMBL3130	Homo sapiens	Inhibition	%	1.85
	8205595	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.56	CHEMBL3130	Homo sapiens	Inhibition	%	0.56
	8205734	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.98	CHEMBL3130	Homo sapiens	Inhibition	%	2.98
	8205958	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.9	CHEMBL3130	Homo sapiens	Inhibition	%	0.9
	8206090	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.78	CHEMBL3130	Homo sapiens	Inhibition	%	-1.78
	8206366	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	7.89	CHEMBL3130	Homo sapiens	Inhibition	%	7.89
	8206733	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1	Outside typical range	CHEMBL1794053	=	Inhibition	%	-23.17	CHEMBL3130	Homo sapiens	Inhibition	%	-23.17
	8206913	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.95	CHEMBL3130	Homo sapiens	Inhibition	%	1.95
	8207263	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.57	CHEMBL3130	Homo sapiens	Inhibition	%	2.57
	8207393	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.62	CHEMBL3130	Homo sapiens	Inhibition	%	1.62
	8207617	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.58	CHEMBL3130	Homo sapiens	Inhibition	%	3.58
	8207749	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	29.94	CHEMBL3130	Homo sapiens	Inhibition	%	29.94
	8208118	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	7.98	CHEMBL3130	Homo sapiens	Inhibition	%	7.98
	8208250	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-0.37	CHEMBL3130	Homo sapiens	Inhibition	%	-0.37
	8208474	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.72	CHEMBL3130	Homo sapiens	Inhibition	%	0.72
	8208640	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.38	CHEMBL3130	Homo sapiens	Inhibition	%	4.38
	8208773	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	15.84	CHEMBL3130	Homo sapiens	Inhibition	%	15.84
	8208997	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.84	CHEMBL3130	Homo sapiens	Inhibition	%	1.84
	8209102	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.24	CHEMBL3130	Homo sapiens	Inhibition	%	2.24
	8209442	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.87	CHEMBL3130	Homo sapiens	Inhibition	%	2.87
	8209592	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.21	CHEMBL3130	Homo sapiens	Inhibition	%	4.21
	8209816	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.34	CHEMBL3130	Homo sapiens	Inhibition	%	3.34
	8209952	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.99	CHEMBL3130	Homo sapiens	Inhibition	%	0.99
	8210317	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.78	CHEMBL3130	Homo sapiens	Inhibition	%	1.78
	8210453	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.69	CHEMBL3130	Homo sapiens	Inhibition	%	0.69
	8210712	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.02	CHEMBL3130	Homo sapiens	Inhibition	%	2.02
	8210936	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.9	CHEMBL3130	Homo sapiens	Inhibition	%	3.9
	8211080	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.55	CHEMBL3130	Homo sapiens	Inhibition	%	2.55
	8211250	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.09	CHEMBL3130	Homo sapiens	Inhibition	%	4.09
	8211474	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.02	CHEMBL3130	Homo sapiens	Inhibition	%	2.02
	8211597	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.4	CHEMBL3130	Homo sapiens	Inhibition	%	6.4
	8211950	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.8	CHEMBL3130	Homo sapiens	Inhibition	%	6.8
	8212082	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.08	CHEMBL3130	Homo sapiens	Inhibition	%	2.08
	8212306	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.47	CHEMBL3130	Homo sapiens	Inhibition	%	5.47
	8212447	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.39	CHEMBL3130	Homo sapiens	Inhibition	%	7.39
	8212804	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-0.87	CHEMBL3130	Homo sapiens	Inhibition	%	-0.87
	8212974	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.97	CHEMBL3130	Homo sapiens	Inhibition	%	4.97
	8213327	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.3	CHEMBL3130	Homo sapiens	Inhibition	%	2.3
	8213431	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	5.89	CHEMBL3130	Homo sapiens	Inhibition	%	5.89
	8213655	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.38	CHEMBL3130	Homo sapiens	Inhibition	%	3.38
	8213768	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.05	CHEMBL3130	Homo sapiens	Inhibition	%	3.05
	8214139	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.4	CHEMBL3130	Homo sapiens	Inhibition	%	8.4
	8214276	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	13.61	CHEMBL3130	Homo sapiens	Inhibition	%	13.61
	8214500	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	59.91	CHEMBL3130	Homo sapiens	Inhibition	%	59.91
	8214634	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.88	CHEMBL3130	Homo sapiens	Inhibition	%	2.88
	8214786	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.28	CHEMBL3130	Homo sapiens	Inhibition	%	2.28
	8215010	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.7	CHEMBL3130	Homo sapiens	Inhibition	%	2.7
	8215261	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.42	CHEMBL3130	Homo sapiens	Inhibition	%	0.42
	8215414	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.61	CHEMBL3130	Homo sapiens	Inhibition	%	4.61
	8215802	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.62	CHEMBL3130	Homo sapiens	Inhibition	%	7.62
	8215921	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.37	CHEMBL3130	Homo sapiens	Inhibition	%	1.37
	8216264	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.52	CHEMBL3130	Homo sapiens	Inhibition	%	1.52
	8216624	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.68	CHEMBL3130	Homo sapiens	Inhibition	%	2.68
	8216762	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	10.83	CHEMBL3130	Homo sapiens	Inhibition	%	10.83
	8217120	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-2.41	CHEMBL3130	Homo sapiens	Inhibition	%	-2.41
	8217294	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	6.64	CHEMBL3130	Homo sapiens	Inhibition	%	6.64
	8217649	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.67	CHEMBL3130	Homo sapiens	Inhibition	%	2.67
	8217974	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.76	CHEMBL3130	Homo sapiens	Inhibition	%	2.76
	8218089	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.62	CHEMBL3130	Homo sapiens	Inhibition	%	1.62
	8218440	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.52	CHEMBL3130	Homo sapiens	Inhibition	%	4.52
	8218807	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.28	CHEMBL3130	Homo sapiens	Inhibition	%	2.28
	8218938	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	9.7	CHEMBL3130	Homo sapiens	Inhibition	%	9.7
	8219322	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.02	CHEMBL3130	Homo sapiens	Inhibition	%	3.02
	8219572	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.48	CHEMBL3130	Homo sapiens	Inhibition	%	3.48
	8219733	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.89	CHEMBL3130	Homo sapiens	Inhibition	%	2.89
	8219957	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	11.63	CHEMBL3130	Homo sapiens	Inhibition	%	11.63
	8220126	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.14	CHEMBL3130	Homo sapiens	Inhibition	%	3.14
	8220255	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.4	CHEMBL3130	Homo sapiens	Inhibition	%	3.4
	8220479	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.87	CHEMBL3130	Homo sapiens	Inhibition	%	0.87
	8220593	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.21	CHEMBL3130	Homo sapiens	Inhibition	%	4.21
	8220955	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.45	CHEMBL3130	Homo sapiens	Inhibition	%	5.45
	8221091	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.17	CHEMBL3130	Homo sapiens	Inhibition	%	8.17
	8221315	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.78	CHEMBL3130	Homo sapiens	Inhibition	%	9.78
	8221448	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.59	CHEMBL3130	Homo sapiens	Inhibition	%	-0.59
	8221613	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.88	CHEMBL3130	Homo sapiens	Inhibition	%	7.88
	8221837	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.92	CHEMBL3130	Homo sapiens	Inhibition	%	4.92
	8221968	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.41	CHEMBL3130	Homo sapiens	Inhibition	%	3.41
	8222290	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.22	CHEMBL3130	Homo sapiens	Inhibition	%	0.22
	8222424	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.12	CHEMBL3130	Homo sapiens	Inhibition	%	4.12
	8222648	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	0.62	CHEMBL3130	Homo sapiens	Inhibition	%	0.62
	8222766	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	16.31	CHEMBL3130	Homo sapiens	Inhibition	%	16.31
	8223134	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	22.43	CHEMBL3130	Homo sapiens	Inhibition	%	22.43
	8223263	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.81	CHEMBL3130	Homo sapiens	Inhibition	%	-0.81
	8223487	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.31	CHEMBL3130	Homo sapiens	Inhibition	%	8.31
	8223648	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.96	CHEMBL3130	Homo sapiens	Inhibition	%	-0.96
	8223898	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.31	CHEMBL3130	Homo sapiens	Inhibition	%	1.31
	8224284	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.4	CHEMBL3130	Homo sapiens	Inhibition	%	3.4
	8224454	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.17	CHEMBL3130	Homo sapiens	Inhibition	%	4.17
	8224813	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.77	CHEMBL3130	Homo sapiens	Inhibition	%	1.77
	8224927	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.38	CHEMBL3130	Homo sapiens	Inhibition	%	1.38
	8225151	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.61	CHEMBL3130	Homo sapiens	Inhibition	%	4.61
	8225285	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.48	CHEMBL3130	Homo sapiens	Inhibition	%	2.48
	8225647	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	6.67	CHEMBL3130	Homo sapiens	Inhibition	%	6.67
	8225782	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-3.11	CHEMBL3130	Homo sapiens	Inhibition	%	-3.11
	8226164	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.41	CHEMBL3130	Homo sapiens	Inhibition	%	6.41
	8226289	CHEMBL1962070	GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.22	CHEMBL3130	Homo sapiens	Inhibition	%	1.22
	8226513	CHEMBL1962071	GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.71	CHEMBL3130	Homo sapiens	Inhibition	%	4.71
	10849270	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)cn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL1957857	=	IC50	nM	7.9	CHEMBL3130	Homo sapiens	IC50	uM	0.0079
	10849280	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018214	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	10849286	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018215	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	uM	0.031
	10849292	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)c(C3CC3)nn12		CHEMBL2018216	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	uM	0.13
	10849298	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	uM	0.025
	10849302	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(-c3ccncc3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018218	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
	10849306	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018219	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	10849313	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2018220	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	uM	0.025
	10849319	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C3CC3)nn3c(=O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2018221	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	10849325	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	10849331	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	CSc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2018360	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	uM	0.025
	10849339	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	uM	0.063
	10849345	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1c(Cn2c(C)nn3c(=O)cc(N4CCOC(C)C4)nc23)cccc1C(F)(F)F		CHEMBL2018222	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	10849358	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	10849362	CHEMBL2019375	Inhibition of PI3Kdelta by continuous read time resolved fluorescence resonance energy transfer displacement assay	B	Cc1nn2c(=O)cc(N3CCOC(C)C3)nc2n1Cc1cccc(Cl)c1Cl		CHEMBL2018217	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
Active	10851405	CHEMBL2020220	Inhibition of PI3Kdelta	B	N#Cc1c(N2CCOCC2)sc(-c2ncn[nH]2)c1-c1ccc(Cl)cc1Cl		CHEMBL2017653		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	10851406	CHEMBL2020220	Inhibition of PI3Kdelta	B	N#Cc1ccc(-c2c(-c3ncn[nH]3)sc(N3CCOCC3)c2C#N)c(F)c1		CHEMBL2017654		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	10852414	CHEMBL2020174	Inhibition of PI3K p110delta subunit using [gamma33P]ATP by filter binding assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	116.0	CHEMBL3130	Homo sapiens	IC50	uM	0.116
	10860027	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3cccc(Cl)c3)o2)c(O)c1		CHEMBL2018263	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	10860028	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3ccccc3F)o2)c(O)c1		CHEMBL2018265	=	IC50	nM	18970.0	CHEMBL3130	Homo sapiens	IC50	uM	18.97
	10860029	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3ccc(F)cc3)o2)c(O)c1		CHEMBL2018266	=	IC50	nM	11530.0	CHEMBL3130	Homo sapiens	IC50	uM	11.53
	10860030	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1ccc(-c2nnc(SCc3cccc([N+](=O)[O-])c3)o2)c(O)c1		CHEMBL2018271	=	IC50	nM	29730.0	CHEMBL3130	Homo sapiens	IC50	uM	29.73
	10860031	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	COc1cccc(CSc2nnc(-c3ccc(C)cc3O)o2)c1		CHEMBL2018409	>	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	10860032	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	Cc1ccc(-c2nnc(SCc3ccc([N+](=O)[O-])cc3)o2)c(O)c1		CHEMBL2018413	=	IC50	nM	25560.0	CHEMBL3130	Homo sapiens	IC50	uM	25.56
	10860033	CHEMBL2021236	Inhibition of PI3Kdelta expressed in cells co-expressing N-terminal His-tagged human p85a using L-alpha-phosphatidylinositol substrate by TLC based phosphor imaging	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	uM	0.57
	10957572	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2059907	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	10957573	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059908	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10957574	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059909	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	10957575	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2059910	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	10957576	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2059911	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	10957577	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CN(C)CCNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2059912	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	10957578	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)nn3c2)c1		CHEMBL2059913	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	10957579	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)Nc4ccccc4)nn3c2)c1		CHEMBL2057359	<	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	10957580	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCc4ccccc4)nn3c2)c1		CHEMBL2057360	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	10957581	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4ccccc4)nn3c2)c1		CHEMBL2057361	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	10957582	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	Cc1noc(C)c1CCNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057362	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	10957583	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CN(C)C(=O)CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057363	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	10957584	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCn4cccn4)nn3c2)c1		CHEMBL2057364	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	10957585	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	Cc1nc(CCNC(=O)Nc2nc3ccc(-c4cncc(S(=O)(=O)NC(C)(C)C)c4)cn3n2)cs1		CHEMBL2057365	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	10957586	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4cnccn4)nn3c2)c1		CHEMBL2057366	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	10957587	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCc4nnc(C5CC5)o4)nn3c2)c1		CHEMBL2057367	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	10957588	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCn4nnc(C5CC5)n4)nn3c2)c1		CHEMBL2057368	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	10957589	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCCCn4nnc(C5CC5)n4)nn3c2)c1		CHEMBL2057369	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	10957590	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CNC(=O)CNC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NC(C)(C)C)c3)cn2n1		CHEMBL2057370	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	10957591	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2)c1		CHEMBL2057371	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	10957592	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2057372	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	10957593	CHEMBL2062042	Inhibition of PI3Kdelta in human HL60 cell lysate by kinobead assay	B	CN1CCN(C(=O)CNC(=O)Nc2nc3ccc(-c4cncc(S(=O)(=O)NC(C)(C)C)c4)cn3n2)CC1		CHEMBL2057373	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
Active	10957667	CHEMBL2062052	Inhibition of PI3Kdelta at 1 uM	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)c1		CHEMBL2057372		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	10960504	CHEMBL2060304	Inhibition of human PI3Kdelta by HTRF assay	B	COCCNC(=O)c1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn2c1C		CHEMBL2058172	=	Ki	nM	8.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	8.0
	10968534	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1ccccc1-c1ccc2nc(NC(C)=O)nn2c1		CHEMBL2064478	=	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	10968535	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cc(C)c(O)c(C)c3)cn2n1		CHEMBL2064479	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10968536	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1cccc(-c2ccc3nc(NC(C)=O)nn3c2)c1		CHEMBL2064480	<	IC50	nM	79432.82	CHEMBL3130	Homo sapiens	pIC50		4.1
	10968537	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1ccc(-c2ccc3nc(NC(C)=O)nn3c2)cc1		CHEMBL2064481	=	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	10968538	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1ccc(-c2ccc3nc(NC(C)=O)nn3c2)cc1OC		CHEMBL2064482	=	IC50	nM	1995.26	CHEMBL3130	Homo sapiens	pIC50		5.7
	10968539	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cccc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064483	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	10968540	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cccc(NS(C)(=O)=O)c3)cn2n1		CHEMBL2064484	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	10968541	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CNS(=O)(=O)c1cccc(-c2ccc3nc(NC(C)=O)nn3c2)c1		CHEMBL2064485	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	10968542	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CNC(=O)c1cccc(-c2ccc3nc(NC(C)=O)nn3c2)c1		CHEMBL2064486	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968543	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3ccc(S(C)(=O)=O)cc3)cn2n1		CHEMBL2064487	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968544	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CNS(=O)(=O)c1ccc(-c2ccc3nc(NC(C)=O)nn3c2)cc1		CHEMBL2064488	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968545	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CCCCNS(=O)(=O)c1cccc(-c2ccc3nc(NC(C)=O)nn3c2)c1		CHEMBL2064489	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	10968546	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cccc(S(=O)(=O)NCc4ccccc4)c3)cn2n1		CHEMBL2064490	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10968547	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cccc(-c4ccccc4)c3)cn2n1		CHEMBL2064491	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968548	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1ccc(-c2ccc3nc(NC(C)=O)nn3c2)cc1S(=O)(=O)NCc1ccccc1		CHEMBL2062546	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	10968549	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cccnc3)cn2n1		CHEMBL2064492	<	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	10968550	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncnc3)cn2n1		CHEMBL2064493	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968551	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc4ccccc34)cn2n1		CHEMBL2064494	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968552	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3ccncc3)cn2n1		CHEMBL2064495	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968553	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3sc(C)nc3C)cn2n1		CHEMBL2064496	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968554	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cnn(C)c3)cn2n1		CHEMBL2064497	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968555	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3ccsc3)cn2n1		CHEMBL2064498	<	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	10968556	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	COc1cncc(-c2ccc3nc(NC(C)=O)nn3c2)c1		CHEMBL2064499	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	10968557	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2059907	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	10968558	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(=O)(=O)NCc4ccccc4)c3)cn2n1		CHEMBL2064500	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	10968559	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc(CS(N)(=O)=O)c3)cn2n1		CHEMBL2064501	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	10968560	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059908	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10968561	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)Nc1cccc(-c2ccc3nc(NC(=O)C4CCCCC4)nn3c2)c1		CHEMBL2064502	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	10968562	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)N(C)c1nc2ccc(-c3cccc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064503	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968563	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CNc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064504	<	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	10968564	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CN(C)c1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064505	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968565	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064506	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968566	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	Nc1nc2ccc(-c3cncc(S(=O)(=O)Nc4cccc5ccccc45)c3)cn2n1		CHEMBL2064507	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	10968567	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	Nc1nc2ccc(-c3cncc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2n1		CHEMBL2064508	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	10968568	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	Nc1nc2ccc(-c3cncc(S(=O)(=O)Nc4ccc(Cl)cc4)c3)cn2n1		CHEMBL2064509	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10968569	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	Nc1nc2ccc(-c3cncc(S(=O)(=O)NCc4ccccc4)c3)cn2n1		CHEMBL2064510	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	10968570	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2059909	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	10968571	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(C)NS(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2064511	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	10968572	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	Nc1nc2ccc(-c3cncc(S(=O)(=O)NCC4CC4)c3)cn2n1		CHEMBL2064512	<	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	10968573	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(C)(C)S(=O)(=O)c1cncc(-c2ccc3nc(N)nn3c2)c1		CHEMBL2064513	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	10968574	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2c(C)cc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064514	<	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	10968575	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2cc(C)c(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064566	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968576	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2ccc(-c3cncc(S(C)(=O)=O)c3)c(C)n2n1		CHEMBL2064567	<	IC50	nM	39810.72	CHEMBL3130	Homo sapiens	pIC50		4.4
	10968577	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)c1cncc(-c2cc(C(F)(F)F)c3nc(N)nn3c2)c1		CHEMBL2064568	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968578	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CS(=O)(=O)c1cncc(-c2cc(Cl)c3nc(N)nn3c2)c1		CHEMBL2064569	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10968579	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(=O)Nc1nc2c(F)cc(-c3cncc(S(C)(=O)=O)c3)cn2n1		CHEMBL2064570	<	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	10968580	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1		CHEMBL2064571	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	10968581	CHEMBL2065219	Inhibition of PI3Kdelta by high throughput chemoproteomics binding assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cn3nc(N)nc3cc2F)c1		CHEMBL2064572	<	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	10975486	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	851.0	CHEMBL3130	Homo sapiens	IC50	nM	851.0
	10975487	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(F)ccc1Oc1cccc2c(=O)cc(N3CCOCC3)[nH]c12		CHEMBL2064327	=	IC50	nM	166.0	CHEMBL3130	Homo sapiens	IC50	nM	166.0
	10975488	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	658.0	CHEMBL3130	Homo sapiens	IC50	nM	658.0
	10975489	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)c(F)ccc3o2)[nH]1		CHEMBL2064417	=	IC50	nM	151.0	CHEMBL3130	Homo sapiens	IC50	nM	151.0
	10975490	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccncc4)cccc3o2)[nH]1		CHEMBL2064416	=	IC50	nM	995.0	CHEMBL3130	Homo sapiens	IC50	nM	995.0
	10975491	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccnc4)cccc3o2)[nH]1		CHEMBL2064415	=	IC50	nM	335.0	CHEMBL3130	Homo sapiens	IC50	nM	335.0
	10975492	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccn4)cccc3o2)[nH]1		CHEMBL2064414	=	IC50	nM	2170.0	CHEMBL3130	Homo sapiens	IC50	nM	2170.0
	10975493	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4cccs4)cccc3o2)[nH]1		CHEMBL2064413	=	IC50	nM	398.0	CHEMBL3130	Homo sapiens	IC50	nM	398.0
	10975494	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(-c4ccccc4)c3o2)[nH]1		CHEMBL2064412	=	IC50	nM	1181.0	CHEMBL3130	Homo sapiens	IC50	nM	1181.0
	10975495	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3o2)[nH]1		CHEMBL2064411	=	IC50	nM	373.0	CHEMBL3130	Homo sapiens	IC50	nM	373.0
	10975496	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(Br)cccc3o2)[nH]1		CHEMBL2064410	=	IC50	nM	2271.0	CHEMBL3130	Homo sapiens	IC50	nM	2271.0
	10975497	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc12		CHEMBL2064409	=	IC50	nM	2385.0	CHEMBL3130	Homo sapiens	IC50	nM	2385.0
	10975498	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1ccc2nc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)oc2c1		CHEMBL2064408	=	IC50	nM	1137.0	CHEMBL3130	Homo sapiens	IC50	nM	1137.0
	10975499	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1cccc2oc(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc12		CHEMBL2064406	=	IC50	nM	2755.0	CHEMBL3130	Homo sapiens	IC50	nM	2755.0
	10975500	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cccc(F)c3o2)[nH]1		CHEMBL2064354	=	IC50	nM	2555.0	CHEMBL3130	Homo sapiens	IC50	nM	2555.0
	10975501	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccc(F)cc3o2)[nH]1		CHEMBL2064353	=	IC50	nM	9040.0	CHEMBL3130	Homo sapiens	IC50	nM	9040.0
	10975502	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3o2)[nH]1		CHEMBL2064352	=	IC50	nM	854.0	CHEMBL3130	Homo sapiens	IC50	nM	854.0
	10975503	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(F)cccc3o2)[nH]1		CHEMBL2064351	=	IC50	nM	8450.0	CHEMBL3130	Homo sapiens	IC50	nM	8450.0
	10975504	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccc(-c3ccccc3)cc21		CHEMBL2064350	=	IC50	nM	3406.0	CHEMBL3130	Homo sapiens	IC50	nM	3406.0
	10975505	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(-c3ccccc3)ccc21		CHEMBL2064349	=	IC50	nM	6748.0	CHEMBL3130	Homo sapiens	IC50	nM	6748.0
	10975506	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cccc(-c3ccccc3)c21		CHEMBL2064348	=	IC50	nM	181.0	CHEMBL3130	Homo sapiens	IC50	nM	181.0
	10975507	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2c(-c3ccccc3)cccc21		CHEMBL2064347	=	IC50	nM	274.0	CHEMBL3130	Homo sapiens	IC50	nM	274.0
	10975508	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3c(-c4ccccc4)cccc3[nH]2)[nH]1		CHEMBL2064346	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	10975509	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2Cc2ccccc2)[nH]1		CHEMBL2064345	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	nM	84.0
	10975510	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2-c2ccccc2)[nH]1		CHEMBL2064344	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	10975511	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3n2C2CCCCC2)[nH]1		CHEMBL2064343	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	10975512	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	COCCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064342	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	nM	270.0
	10975513	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3n2C2CC2)[nH]1		CHEMBL2064341	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	10975514	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	CCn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064340	=	IC50	nM	225.0	CHEMBL3130	Homo sapiens	IC50	nM	225.0
	10975515	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)[nH]1		CHEMBL2064339	=	IC50	nM	2850.0	CHEMBL3130	Homo sapiens	IC50	nM	2850.0
	10975516	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	COc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064338	=	IC50	nM	397.0	CHEMBL3130	Homo sapiens	IC50	nM	397.0
	10975517	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cc1ccc2[nH]c(Cc3nc(N4CCOCC4)cc(=O)[nH]3)nc2c1		CHEMBL2064337	=	IC50	nM	2210.0	CHEMBL3130	Homo sapiens	IC50	nM	2210.0
	10975518	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Cl)ccc3[nH]2)[nH]1		CHEMBL2064336	=	IC50	nM	247.0	CHEMBL3130	Homo sapiens	IC50	nM	247.0
	10975519	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(Br)ccc3[nH]2)[nH]1		CHEMBL2064335	=	IC50	nM	442.0	CHEMBL3130	Homo sapiens	IC50	nM	442.0
	10975520	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccc(F)cc21		CHEMBL2064334	=	IC50	nM	1060.0	CHEMBL3130	Homo sapiens	IC50	nM	1060.0
	10975521	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2cc(F)ccc21		CHEMBL2064333	=	IC50	nM	855.0	CHEMBL3130	Homo sapiens	IC50	nM	855.0
	10975522	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc3cc(F)ccc3[nH]2)nc(N2CCOCC2)cc1=O		CHEMBL2064332	=	IC50	nM	5715.0	CHEMBL3130	Homo sapiens	IC50	nM	5715.0
	10975523	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3cc(F)ccc3[nH]2)[nH]1		CHEMBL2064331	=	IC50	nM	219.0	CHEMBL3130	Homo sapiens	IC50	nM	219.0
	10975524	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	1395.0	CHEMBL3130	Homo sapiens	IC50	nM	1395.0
	10975525	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3o2)[nH]1		CHEMBL2064418	=	IC50	nM	779.0	CHEMBL3130	Homo sapiens	IC50	nM	779.0
	10975526	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=c1cc(N2CCOCC2)nc(Cc2nc3ccccc3[nH]2)[nH]1		CHEMBL2064329	=	IC50	nM	2870.0	CHEMBL3130	Homo sapiens	IC50	nM	2870.0
	10975527	CHEMBL2067457	Inhibition of poly-His tagged human PI3Kdelta expressed in baculovirus infected insect sf9 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1		CHEMBL2064419	=	IC50	nM	118.0	CHEMBL3130	Homo sapiens	IC50	nM	118.0
	10975620	CHEMBL2067918	Inhibition of human PI3Kdelta-mediated Akt phosphorylation at Ser473 residue expressed in mouse MEF-3T3 cells after 0.5 to 2 hrs by Western blot analysis	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	2655.0	CHEMBL3130	Homo sapiens	IC50	nM	2655.0
	10975621	CHEMBL2067918	Inhibition of human PI3Kdelta-mediated Akt phosphorylation at Ser473 residue expressed in mouse MEF-3T3 cells after 0.5 to 2 hrs by Western blot analysis	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	252.0	CHEMBL3130	Homo sapiens	IC50	nM	252.0
	10996244	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(N)(=O)=O)cc2)s1		CHEMBL2071326	=	Ki	nM	210.0	CHEMBL3130	Homo sapiens	Ki	uM	0.21
	10996245	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)cc2)s1		CHEMBL2071327	=	Ki	nM	190.0	CHEMBL3130	Homo sapiens	Ki	uM	0.19
	10996246	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(Cl)c2)s1		CHEMBL2071328	=	Ki	nM	79.0	CHEMBL3130	Homo sapiens	Ki	uM	0.079
	10996247	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(Br)c2)s1		CHEMBL2071329	=	Ki	nM	61.0	CHEMBL3130	Homo sapiens	Ki	uM	0.061
	10996248	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(F)c2)s1		CHEMBL2071330	=	Ki	nM	247.0	CHEMBL3130	Homo sapiens	Ki	uM	0.247
	10996249	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(C#N)c2)s1		CHEMBL2071331	=	Ki	nM	79.0	CHEMBL3130	Homo sapiens	Ki	uM	0.079
	10996250	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(C(F)(F)F)c2)s1		CHEMBL2071332	=	Ki	nM	74.0	CHEMBL3130	Homo sapiens	Ki	uM	0.074
	10996251	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(-n3cccn3)cc2)s1		CHEMBL2071333	=	Ki	nM	19.0	CHEMBL3130	Homo sapiens	Ki	uM	0.019
	10996252	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)Nc1nc(C)c(-c2ccc(C(C)=O)cc2)s1		CHEMBL2071334	=	Ki	nM	260.0	CHEMBL3130	Homo sapiens	Ki	uM	0.26
	10996253	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL2071335	=	Ki	nM	3620.0	CHEMBL3130	Homo sapiens	Ki	uM	3.62
	10996254	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071336	=	Ki	nM	2900.0	CHEMBL3130	Homo sapiens	Ki	uM	2.9
	10996255	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(C(F)(F)F)c1		CHEMBL2071337	=	Ki	nM	1670.0	CHEMBL3130	Homo sapiens	Ki	uM	1.67
	10996256	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(-n2cccn2)cc1		CHEMBL2071338	=	Ki	nM	220.0	CHEMBL3130	Homo sapiens	Ki	uM	0.22
	10996257	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)no1		CHEMBL2071340	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	uM	0.003
	10996258	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	=	Ki	nM	4.0	CHEMBL3130	Homo sapiens	Ki	uM	0.004
	10996259	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	Cc1nc(NC(=O)NCCC(=O)OC(C)(C)C)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071341	=	Ki	nM	380.0	CHEMBL3130	Homo sapiens	Ki	uM	0.38
	10996260	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CC(=O)c1ccc(-c2sc(NC(=O)NCCC(=O)NC(C)(C)C)nc2C)cc1		CHEMBL2069328	=	Ki	nM	740.0	CHEMBL3130	Homo sapiens	Ki	uM	0.74
	10996261	CHEMBL2072998	Inhibition of recombinant GST-tagged PI3K p110delta using [32P]ATP after 60 mins by scintillation proximity assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	Ki	nM	470.0	CHEMBL3130	Homo sapiens	Ki	uM	0.47
	10996357	CHEMBL2073030	Inhibition of recombinant GST-tagged PI3K p110delta by KinaseGlo assay	B	NC(=O)[C@@H]1CCCN1C(=O)Nc1nc2ccc(-c3cnc(N)c(C(F)(F)F)c3)cc2s1		CHEMBL2071339	=	IC50	nM	540.0	CHEMBL3130	Homo sapiens	IC50	uM	0.54
	11007495	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(N)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089120	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	11007496	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(SCC(=O)O)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089119	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	uM	0.002
	11007497	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	CSc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1C		CHEMBL2089118	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	11007498	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(S)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089117	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	11007499	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	COc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(Cl)c1C		CHEMBL2089116	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	11007500	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(=O)[nH]c(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089115	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	11007501	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(CO)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089114	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	uM	0.002
	11007502	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(CN)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089113	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	uM	0.16
	11007503	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(CO)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089112	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	11007504	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(Cc3ccccc3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089111	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	uM	0.063
	11007505	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(-c3ccccc3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089110	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	11007506	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(C3CC3)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089109	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	11007507	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	CCc1nc(=O)c2sc(N3CCOCC3)nc2n1Cc1cccc(C(F)(F)F)c1C		CHEMBL2089108	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	11007508	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1c(C)nc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089107	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	11007509	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2c(C)nc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089106	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	11007510	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cl)cccc1Cn1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089105	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	11007511	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1c(Cn2cnc(=O)c3sc(N4CCOCC4)nc32)cccc1C(F)(F)F		CHEMBL2089104	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	uM	0.063
	11007512	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(Cc2cccc(Cl)c2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089103	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
	11007513	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(Cc2cccc(Cl)c2)c2nc(N3CCOCC3)sc12		CHEMBL2089102	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	uM	0.32
	11007514	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccsc2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089101	=	IC50	nM	2500.0	CHEMBL3130	Homo sapiens	IC50	uM	2.5
	11007515	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccccc2Cl)c2nc(N3CCOCC3)sc12		CHEMBL2089100	>	IC50	nM	790.0	CHEMBL3130	Homo sapiens	IC50	uM	0.79
	11007516	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(CCc2ccccc2)c2nc(N3CCOCC3)sc12		CHEMBL2089099	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	11007517	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	CC(c1ccccc1)n1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089098	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	11007518	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	Cc1ccccc1Cn1cnc(=O)c2sc(N3CCOCC3)nc21		CHEMBL2089097	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	11007519	CHEMBL2090369	Inhibition of PI3K delta by continuous TR-FRET assay	B	O=c1ncn(Cc2ccccc2)c2nc(N3CCOCC3)sc12		CHEMBL2089096	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	12046191	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	3.8	CHEMBL3130	Homo sapiens	IC50	nM	3.8
	12046192	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152769	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	nM	2.8
	12046193	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152770	=	IC50	nM	6.3	CHEMBL3130	Homo sapiens	IC50	nM	6.3
	12046194	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152771	=	IC50	nM	2.6	CHEMBL3130	Homo sapiens	IC50	nM	2.6
	12046195	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	Fc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)c2nc(CN3CCOCC3)ccc2n1		CHEMBL2152772	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	12046196	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	OCc1ccc2nc(-c3c(F)ccc4[nH]ccc34)nc(N3CCOCC3)c2n1		CHEMBL2152773	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	12046197	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2nc3c(N4CCOCC4)nc(-c4c(F)ccc5[nH]ccc45)nc3s2)CC1		CHEMBL2152774	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	12046198	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2nc3c(N4CCOCC4)nc(-c4c(F)ccc5[nH]ccc45)nc3[nH]2)CC1		CHEMBL2152775	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	12046199	CHEMBL2157248	Inhibition of PI3K p110delta using PIP2 as substrate assessed as PIP3 formation by fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2152776	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	12046227	CHEMBL2157252	Inhibition of PI3Kdelta in human whole blood assessed as upregulation of CD69	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	12046228	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
	12046229	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152769	=	IC50	nM	55.0	CHEMBL3130	Homo sapiens	IC50	nM	55.0
	12046230	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152770	=	IC50	nM	480.0	CHEMBL3130	Homo sapiens	IC50	nM	480.0
	12046231	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152771	=	IC50	nM	145.0	CHEMBL3130	Homo sapiens	IC50	nM	145.0
	12046232	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	Fc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)c2nc(CN3CCOCC3)ccc2n1		CHEMBL2152772	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	nM	67.0
	12046233	CHEMBL2157253	Inhibition of PI3Kdelta-mediated AKT phosphorylation in B cells in presence of human serum	B	OCc1ccc2nc(-c3c(F)ccc4[nH]ccc34)nc(N3CCOCC3)c2n1		CHEMBL2152773	=	IC50	nM	145.0	CHEMBL3130	Homo sapiens	IC50	nM	145.0
	12047302	CHEMBL2157327	Inhibition of PI3Kdelta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	93.4	CHEMBL3130	Homo sapiens	INH	%	93.4
	12059703	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1ccc(-c2cccc(S(=O)(=O)N3CCN(c4nccnc4-c4ccc(OC)cc4)CC3)c2)cc1		CHEMBL2152124	=	IC50	nM	1134.0	CHEMBL3130	Homo sapiens	IC50	nM	1134.0
	12059704	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(-c3nnn[nH]3)c2)cnc1N		CHEMBL2152125	=	IC50	nM	4204.0	CHEMBL3130	Homo sapiens	IC50	nM	4204.0
	12059705	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1ccc(-c2nccnc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2151050	=	IC50	nM	387.0	CHEMBL3130	Homo sapiens	IC50	nM	387.0
	12059706	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CC(C)c1ccc(-c2nccnc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2152126	=	IC50	nM	816.0	CHEMBL3130	Homo sapiens	IC50	nM	816.0
	12059707	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CC(C)c1ccc(-c2ncccc2N2CCN(S(=O)(=O)c3cccc(-c4cnc(N)nc4)c3)CC2)cc1		CHEMBL2152127	=	IC50	nM	456.0	CHEMBL3130	Homo sapiens	IC50	nM	456.0
	12059708	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(C(F)(F)F)c2)cnc1N		CHEMBL2152128	=	IC50	nM	8359.0	CHEMBL3130	Homo sapiens	IC50	nM	8359.0
	12059709	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152129	=	IC50	nM	1095.0	CHEMBL3130	Homo sapiens	IC50	nM	1095.0
	12059710	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152130	=	IC50	nM	352.0	CHEMBL3130	Homo sapiens	IC50	nM	352.0
	12059711	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)NC)c2)cnc1N		CHEMBL2152131	=	IC50	nM	1073.0	CHEMBL3130	Homo sapiens	IC50	nM	1073.0
	12059712	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(N)(=O)=O)c2)cnc1N		CHEMBL2152132	=	IC50	nM	638.0	CHEMBL3130	Homo sapiens	IC50	nM	638.0
	12059713	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)NCC(F)(F)F)c2)cnc1N		CHEMBL2152133	=	IC50	nM	1418.0	CHEMBL3130	Homo sapiens	IC50	nM	1418.0
	12059714	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(OC)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152134	=	IC50	nM	1202.0	CHEMBL3130	Homo sapiens	IC50	nM	1202.0
	12059715	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(F)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152135	=	IC50	nM	1582.0	CHEMBL3130	Homo sapiens	IC50	nM	1582.0
	12059716	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cnc(N)c(S(=O)(=O)Nc3ccccc3)c2)cnc1N		CHEMBL2152136	=	IC50	nM	533.0	CHEMBL3130	Homo sapiens	IC50	nM	533.0
	12059717	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)cnc1N		CHEMBL2152137	=	IC50	nM	3389.0	CHEMBL3130	Homo sapiens	IC50	nM	3389.0
	12059718	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(NS(=O)(=O)c3cccc(Cl)c3)c2)cnc1N		CHEMBL2152138	=	IC50	nM	2964.0	CHEMBL3130	Homo sapiens	IC50	nM	2964.0
	12059719	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(NS(=O)(=O)c3cccc(Cl)c3)c2)cnc1N		CHEMBL2152139	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	12059720	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(C)c3)c2)cnc1N		CHEMBL2152140	=	IC50	nM	568.0	CHEMBL3130	Homo sapiens	IC50	nM	568.0
	12059721	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3)c2)cnc1N		CHEMBL2152141	=	IC50	nM	415.0	CHEMBL3130	Homo sapiens	IC50	nM	415.0
	12059722	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(OC)c3)c2)cnc1N		CHEMBL2152142	=	IC50	nM	546.0	CHEMBL3130	Homo sapiens	IC50	nM	546.0
	12059723	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(C(F)(F)F)c3)c2)cnc1N		CHEMBL2152143	=	IC50	nM	1355.0	CHEMBL3130	Homo sapiens	IC50	nM	1355.0
	12059724	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(Cl)c3)c2)cnc1N		CHEMBL2152144	=	IC50	nM	437.0	CHEMBL3130	Homo sapiens	IC50	nM	437.0
	12059725	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccccc3Cl)c2)cnc1N		CHEMBL2152145	=	IC50	nM	1020.0	CHEMBL3130	Homo sapiens	IC50	nM	1020.0
	12059726	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(Cl)cc3)c2)cnc1N		CHEMBL2152146	=	IC50	nM	539.0	CHEMBL3130	Homo sapiens	IC50	nM	539.0
	12059727	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3cccc(Cl)c3)c2)cnc1N		CHEMBL2152147	=	IC50	nM	1253.0	CHEMBL3130	Homo sapiens	IC50	nM	1253.0
	12059728	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)cc3Cl)c2)cnc1N		CHEMBL2152148	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	nM	340.0
	12059729	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3Cl)c2)cnc1N		CHEMBL2152149	=	IC50	nM	1186.0	CHEMBL3130	Homo sapiens	IC50	nM	1186.0
	12059730	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(Cl)cc3Cl)c2)cnc1N		CHEMBL2152150	=	IC50	nM	1032.0	CHEMBL3130	Homo sapiens	IC50	nM	1032.0
	12059731	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(Cl)c3Cl)c2)cnc1N		CHEMBL2152250	=	IC50	nM	743.0	CHEMBL3130	Homo sapiens	IC50	nM	743.0
	12059732	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2cccc(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152251	=	IC50	nM	2452.0	CHEMBL3130	Homo sapiens	IC50	nM	2452.0
	12059733	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	=	IC50	nM	690.0	CHEMBL3130	Homo sapiens	IC50	nM	690.0
	12059734	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	=	IC50	nM	415.0	CHEMBL3130	Homo sapiens	IC50	nM	415.0
	12059735	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1cnc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cn1		CHEMBL2152254	=	IC50	nM	4389.0	CHEMBL3130	Homo sapiens	IC50	nM	4389.0
	12059736	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1ncc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cn1		CHEMBL2152255	=	IC50	nM	1316.0	CHEMBL3130	Homo sapiens	IC50	nM	1316.0
	12059737	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	COc1nc(N)ncc1-c1ccc(Cl)c(S(=O)(=O)Nc2cccc(F)c2F)c1		CHEMBL2152256	=	IC50	nM	181.0	CHEMBL3130	Homo sapiens	IC50	nM	181.0
	12059738	CHEMBL2157136	Inhibition of human PI3Kdelta expressed in sf9 cells coexpressing p85alpha assessed as amount of ATP consumed by luciferase-luciferin chemiluminescence assay	B	Nc1ncc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)c(OCC(F)(F)F)n1		CHEMBL2152257	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	12062364	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1		CHEMBL2064419	=	IC50	nM	118.0	CHEMBL3130	Homo sapiens	IC50	nM	118.0
	12062365	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccccc1F		CHEMBL2151819	=	IC50	nM	2450.0	CHEMBL3130	Homo sapiens	IC50	nM	2450.0
	12062366	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(F)c1		CHEMBL2151820	=	IC50	nM	1108.0	CHEMBL3130	Homo sapiens	IC50	nM	1108.0
	12062367	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)cc1		CHEMBL2151821	=	IC50	nM	86.0	CHEMBL3130	Homo sapiens	IC50	nM	86.0
	12062368	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cc1ccccc1NC(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL2151822	=	IC50	nM	4270.0	CHEMBL3130	Homo sapiens	IC50	nM	4270.0
	12062369	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1		CHEMBL2151919	=	IC50	nM	164.0	CHEMBL3130	Homo sapiens	IC50	nM	164.0
	12062370	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(Cl)cc1		CHEMBL2151920	=	IC50	nM	2783.0	CHEMBL3130	Homo sapiens	IC50	nM	2783.0
	12062371	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Cl)c1		CHEMBL2151921	=	IC50	nM	278.0	CHEMBL3130	Homo sapiens	IC50	nM	278.0
	12062372	CHEMBL2156790	Inhibition of PI3Kdelta	B	COc1cccc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c1		CHEMBL2151922	=	IC50	nM	611.0	CHEMBL3130	Homo sapiens	IC50	nM	611.0
	12062373	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1cccc(Br)c1		CHEMBL2151923	=	IC50	nM	189.0	CHEMBL3130	Homo sapiens	IC50	nM	189.0
	12062374	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(F)c1		CHEMBL2151924	=	IC50	nM	135.0	CHEMBL3130	Homo sapiens	IC50	nM	135.0
	12062375	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151925	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
	12062376	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Cl)c1		CHEMBL2151926	=	IC50	nM	137.0	CHEMBL3130	Homo sapiens	IC50	nM	137.0
	12062377	CHEMBL2156790	Inhibition of PI3Kdelta	B	COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151927	=	IC50	nM	148.0	CHEMBL3130	Homo sapiens	IC50	nM	148.0
	12062378	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c(Br)c1		CHEMBL2151048	=	IC50	nM	297.0	CHEMBL3130	Homo sapiens	IC50	nM	297.0
	12062379	CHEMBL2156790	Inhibition of PI3Kdelta	B	COC(=O)c1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)ccc1F		CHEMBL2151928	=	IC50	nM	4647.0	CHEMBL3130	Homo sapiens	IC50	nM	4647.0
	12062380	CHEMBL2156790	Inhibition of PI3Kdelta	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)Nc1ccc(F)c([N+](=O)[O-])c1		CHEMBL2151929	=	IC50	nM	3360.0	CHEMBL3130	Homo sapiens	IC50	nM	3360.0
	12062381	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cn1c(CC(=O)Nc2ccccc2)nc(N2CCOCC2)cc1=O		CHEMBL2151930	=	IC50	nM	4290.0	CHEMBL3130	Homo sapiens	IC50	nM	4290.0
	12062382	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cn1c(CC(=O)Nc2ccc(F)cc2)nc(N2CCOCC2)cc1=O		CHEMBL2151931	=	IC50	nM	1470.0	CHEMBL3130	Homo sapiens	IC50	nM	1470.0
	12062383	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cn1c(CC(=O)Nc2ccc(F)c(F)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151932	=	IC50	nM	1770.0	CHEMBL3130	Homo sapiens	IC50	nM	1770.0
	12062384	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cn1c(CC(=O)Nc2ccc(F)c(Br)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151933	=	IC50	nM	2215.0	CHEMBL3130	Homo sapiens	IC50	nM	2215.0
	12062385	CHEMBL2156790	Inhibition of PI3Kdelta	B	COc1cc(NC(=O)Cc2nc(N3CCOCC3)cc(=O)n2C)ccc1F		CHEMBL2151934	=	IC50	nM	2400.0	CHEMBL3130	Homo sapiens	IC50	nM	2400.0
	12062386	CHEMBL2156790	Inhibition of PI3Kdelta	B	Cn1c(CC(=O)Nc2ccc(F)c(Cl)c2)nc(N2CCOCC2)cc1=O		CHEMBL2151935	=	IC50	nM	2210.0	CHEMBL3130	Homo sapiens	IC50	nM	2210.0
	12072332	CHEMBL2161666	Inhibition of PI3K p110delta	B	O=c1cc(N2CCOCC2)nc(NCc2cccc3ccccc23)[nH]1		CHEMBL2158436	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	12092836	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cc3ccc(S(C)(=O)=O)cc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165007	=	Ki	nM	1.0	CHEMBL3130	Homo sapiens	Ki	nM	1.0
	12092837	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cc3ccccc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165006	=	Ki	nM	15.0	CHEMBL3130	Homo sapiens	Ki	nM	15.0
	12092838	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCS(=O)(=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165005	=	Ki	nM	13.0	CHEMBL3130	Homo sapiens	Ki	nM	13.0
	12092839	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)C3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165004	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	nM	3.0
	12092840	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165003	=	Ki	nM	21.0	CHEMBL3130	Homo sapiens	Ki	nM	21.0
	12092841	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CC3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165020	=	Ki	nM	4.0	CHEMBL3130	Homo sapiens	Ki	nM	4.0
	12092842	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165019	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	nM	3.0
	12092843	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(S(=O)(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165018	=	Ki	nM	6.0	CHEMBL3130	Homo sapiens	Ki	nM	6.0
	12092844	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165017	=	Ki	nM	2.0	CHEMBL3130	Homo sapiens	Ki	nM	2.0
	12092845	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(C(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165016	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	nM	3.0
	12092846	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COC(=O)N1CCN(Cc2cnc(Nc3ccc(OC)nc3)c(-c3nc(C)nc(N)n3)c2)CC1		CHEMBL2165015	=	Ki	nM	6.0	CHEMBL3130	Homo sapiens	Ki	nM	6.0
	12092847	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165014	=	Ki	nM	34.0	CHEMBL3130	Homo sapiens	Ki	nM	34.0
	12092848	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCNCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165013	=	Ki	nM	27.0	CHEMBL3130	Homo sapiens	Ki	nM	27.0
	12092849	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CC[C@@H](CO)C3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165012	=	Ki	nM	51.0	CHEMBL3130	Homo sapiens	Ki	nM	51.0
	12092850	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC(O)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165011	=	Ki	nM	63.0	CHEMBL3130	Homo sapiens	Ki	nM	63.0
	12092851	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165010	=	Ki	nM	18.0	CHEMBL3130	Homo sapiens	Ki	nM	18.0
	12092852	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165009	=	Ki	nM	19.0	CHEMBL3130	Homo sapiens	Ki	nM	19.0
	12092853	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165008	=	Ki	nM	60.0	CHEMBL3130	Homo sapiens	Ki	nM	60.0
	12092854	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CN3CCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165034	=	Ki	nM	50.0	CHEMBL3130	Homo sapiens	Ki	nM	50.0
	12092855	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(-c3cnn(C)c3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165033	=	Ki	nM	6.0	CHEMBL3130	Homo sapiens	Ki	nM	6.0
	12092856	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(-c3ccc(C)nc3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165032	=	Ki	nM	7.0	CHEMBL3130	Homo sapiens	Ki	nM	7.0
	12092857	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(N3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165031	=	Ki	nM	16.0	CHEMBL3130	Homo sapiens	Ki	nM	16.0
	12092858	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(C3=CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165030	=	Ki	nM	2.0	CHEMBL3130	Homo sapiens	Ki	nM	2.0
	12092859	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(N3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165029	=	Ki	nM	4.0	CHEMBL3130	Homo sapiens	Ki	nM	4.0
	12092860	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COCCNCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165028	=	Ki	nM	30.0	CHEMBL3130	Homo sapiens	Ki	nM	30.0
	12092861	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165027	=	Ki	nM	10.0	CHEMBL3130	Homo sapiens	Ki	nM	10.0
	12092862	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165026	=	Ki	nM	20.0	CHEMBL3130	Homo sapiens	Ki	nM	20.0
	12092863	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2165025	=	Ki	nM	7.0	CHEMBL3130	Homo sapiens	Ki	nM	7.0
	12092864	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(C)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165024	=	Ki	nM	110.0	CHEMBL3130	Homo sapiens	Ki	nM	110.0
	12092865	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Br)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165023	=	Ki	nM	92.0	CHEMBL3130	Homo sapiens	Ki	nM	92.0
	12092866	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165022	=	Ki	nM	39.0	CHEMBL3130	Homo sapiens	Ki	nM	39.0
	12092867	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2nccnc2-c2cc(N)nc(C)n2)cn1		CHEMBL2165021	=	Ki	nM	130.0	CHEMBL3130	Homo sapiens	Ki	nM	130.0
	12092868	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2nccnc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165050	=	Ki	nM	300.0	CHEMBL3130	Homo sapiens	Ki	nM	300.0
	12092869	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncncc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165049	=	Ki	nM	62.0	CHEMBL3130	Homo sapiens	Ki	nM	62.0
	12092870	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2cccnc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165048	=	Ki	nM	910.0	CHEMBL3130	Homo sapiens	Ki	nM	910.0
	12092871	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2cnccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165047	=	Ki	nM	240.0	CHEMBL3130	Homo sapiens	Ki	nM	240.0
	12092872	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ccccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165046	=	Ki	nM	310.0	CHEMBL3130	Homo sapiens	Ki	nM	310.0
	12092873	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1cc(-c2cccnc2Nc2cccc(O)c2)nc(N)n1		CHEMBL2165045	=	Ki	nM	6000.0	CHEMBL3130	Homo sapiens	Ki	nM	6000.0
	12092874	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(N(C)c2ncccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165044	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	12092875	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1cc(-c2cccnc2Oc2cccc3[nH]ccc23)nc(N)n1		CHEMBL2165043	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	12092876	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2c[nH]nc2n1		CHEMBL2165042	=	Ki	nM	5000.0	CHEMBL3130	Homo sapiens	Ki	nM	5000.0
	12092877	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2ncnc3nc[nH]c23)cn1		CHEMBL2165041	=	Ki	nM	5700.0	CHEMBL3130	Homo sapiens	Ki	nM	5700.0
	12092878	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	c1cnc(Nc2cccc3n[nH]cc23)c(-c2ncnc3nc[nH]c23)c1		CHEMBL2165040	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	12092879	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2nc(C)nc3nc[nH]c23)cn1		CHEMBL2165039	=	Ki	nM	70.0	CHEMBL3130	Homo sapiens	Ki	nM	70.0
	12092880	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3[nH]ccc23)c2[nH]cnc2n1		CHEMBL2165038	=	Ki	nM	360.0	CHEMBL3130	Homo sapiens	Ki	nM	360.0
	12092881	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2[nH]cnc2n1		CHEMBL2165037	=	Ki	nM	350.0	CHEMBL3130	Homo sapiens	Ki	nM	350.0
	12092882	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Nc1cc(-c2cccnc2Nc2cccc3[nH]ncc23)nc(C(F)(F)F)n1		CHEMBL2165036	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	12092883	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)c(F)c(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165035	=	Ki	nM	810.0	CHEMBL3130	Homo sapiens	Ki	nM	810.0
	12092884	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)cc(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165271	=	Ki	nM	370.0	CHEMBL3130	Homo sapiens	Ki	nM	370.0
	12092885	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)cc(-c2cccnc2Nc2cccc(O)c2)n1		CHEMBL2165270	=	Ki	nM	56.0	CHEMBL3130	Homo sapiens	Ki	nM	56.0
	12092886	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	COc1ccc(Nc2ncccc2-c2nc(C)nc(N)n2)cn1		CHEMBL2165269	=	Ki	nM	37.0	CHEMBL3130	Homo sapiens	Ki	nM	37.0
	12092887	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ccc23)n1		CHEMBL2165268	=	Ki	nM	25.0	CHEMBL3130	Homo sapiens	Ki	nM	25.0
	12092888	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ncc23)n1		CHEMBL2165053	=	Ki	nM	130.0	CHEMBL3130	Homo sapiens	Ki	nM	130.0
	12092889	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cccc(O)c2)n1		CHEMBL2165052	=	Ki	nM	9.0	CHEMBL3130	Homo sapiens	Ki	nM	9.0
	12092890	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL2165051	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	nM	3.0
	12092891	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762782	=	Ki	nM	11.0	CHEMBL3130	Homo sapiens	Ki	nM	11.0
	12092892	CHEMBL2166654	Inhibition of human N-terminal poly-His tagged-PI3Kdelta expressed in Sf9 baculovirus system co-expressing p85alpha after 20 mins by AlphaScreen assay	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	Ki	nM	52.0	CHEMBL3130	Homo sapiens	Ki	nM	52.0
	12094226	CHEMBL2167114	Ratio of IC50 for human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells to IC50 for PI3Kdelta	B	CN(C)C1CCN(Cc2cc3nc(-n4cnc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165497	=	Ratio IC50		42.0	CHEMBL3130	Homo sapiens	Ratio IC50		42.0
	12094227	CHEMBL2167114	Ratio of IC50 for human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells to IC50 for PI3Kdelta	B	CN(C)C1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165666	=	Ratio IC50		16.0	CHEMBL3130	Homo sapiens	Ratio IC50		16.0
	12094228	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4COC4)CC3(C)C)cc2n1		CHEMBL2165502	=	IC50	nM	102.0	CHEMBL3130	Homo sapiens	IC50	uM	0.102
	12094229	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)cc2n1		CHEMBL2165501	=	IC50	nM	116.0	CHEMBL3130	Homo sapiens	IC50	uM	0.116
	12094230	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3)cc2n1		CHEMBL2165500	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
Not Determined	12094231	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(C)(C)C(N)=O)CC3)cc2n1		CHEMBL2165499		IC50			CHEMBL3130	Homo sapiens	IC50		
	12094232	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165498	=	IC50	nM	374.0	CHEMBL3130	Homo sapiens	IC50	uM	0.374
	12094233	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-n4cnc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165497	=	IC50	nM	970.0	CHEMBL3130	Homo sapiens	IC50	uM	0.97
	12094234	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-n4ccc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165496	=	IC50	nM	420.0	CHEMBL3130	Homo sapiens	IC50	uM	0.42
Not Determined	12094235	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-c4c[nH]c5ccccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165495		IC50			CHEMBL3130	Homo sapiens	IC50		
	12094236	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-n4ncc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165494	=	IC50	nM	3200.0	CHEMBL3130	Homo sapiens	IC50	uM	3.2
Not Determined	12094237	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-c4n[nH]c5ccccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165493		IC50			CHEMBL3130	Homo sapiens	IC50		
	12094238	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	Cc1sc2ccccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165492	=	IC50	nM	3800.0	CHEMBL3130	Homo sapiens	IC50	uM	3.8
	12094761	CHEMBL2167596	Inhibition of human recombinant His6-tagged PI3K p110delta expressed in baculovirus infected cells using DiC8-PI(4,5)P2 as substrate after 20 mins by AlphaScreen assay	B	C[C@H]1CN(c2cc(N(CCO)Cc3cccc4ccccc34)[nH]c(=O)n2)CCO1		CHEMBL2165189	=	IC50	nM	168.0	CHEMBL3130	Homo sapiens	IC50	uM	0.168
	12095159	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	Cc1ncc2ccccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165670	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	12095160	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5nccn45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165669	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	uM	0.18
	12095161	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	Cc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CCC(N(C)C)CC4)cc3n2)c1		CHEMBL2165668	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	12095162	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5c4CC(=O)N5)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165667	=	IC50	nM	3400.0	CHEMBL3130	Homo sapiens	IC50	uM	3.4
	12095163	CHEMBL2167115	Inhibition of human PI3Kdelta-mediated AKT phosphorylation at S473 in Ri-1 cells after 30 mins by electrochemiluminescence assay in presence of human serum albumin and alpha1 acid glycoprotein	B	CN(C)C1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165666	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	12095260	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4COC4)CC3(C)C)cc2n1		CHEMBL2165502	=	IC50	nM	2.3	CHEMBL3130	Homo sapiens	IC50	nM	2.3
	12095261	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)cc2n1		CHEMBL2165501	=	IC50	nM	5.3	CHEMBL3130	Homo sapiens	IC50	nM	5.3
	12095262	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3)cc2n1		CHEMBL2165500	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	12095263	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(C)(C)C(N)=O)CC3)cc2n1		CHEMBL2165499	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	12095264	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165498	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	12095265	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-n4cnc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165497	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	12095266	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-n4ccc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165496	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	12095267	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-c4c[nH]c5ccccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165495	=	IC50	nM	5.6	CHEMBL3130	Homo sapiens	IC50	nM	5.6
	12095268	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-n4ncc5ccccc54)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165494	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	12095269	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-c4n[nH]c5ccccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165493	=	IC50	nM	9.8	CHEMBL3130	Homo sapiens	IC50	nM	9.8
	12095270	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1sc2ccccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165492	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	12095271	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1ncc2ccccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCC(N(C)C)CC3)cc2n1		CHEMBL2165670	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	12095272	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5nccn45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165669	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	12095273	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CCC(N(C)C)CC4)cc3n2)c1		CHEMBL2165668	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	12095274	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5c4CC(=O)N5)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165667	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	12095275	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CN(C)C1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165666	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	12095276	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4ccnc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165513	=	IC50	nM	2.3	CHEMBL3130	Homo sapiens	IC50	nM	2.3
	12095277	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4cncc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165512	=	IC50	nM	0.67	CHEMBL3130	Homo sapiens	IC50	nM	0.67
	12095278	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4nccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165511	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
	12095279	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cn1ccc2c(-c3nc(N4CCOCC4)c4sc(CN5CCN(C(C)(C)C(N)=O)CC5)cc4n3)cccc21		CHEMBL2165510	=	IC50	nM	134.0	CHEMBL3130	Homo sapiens	IC50	nM	134.0
	12095280	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Cc1cc2c(-c3nc(N4CCOCC4)c4sc(CN5CCN(C(C)(C)C(N)=O)CC5)cc4n3)cccc2[nH]1		CHEMBL2165509	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	12095281	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4c(F)cc(F)c5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165508	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	12095282	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4cc(C#N)cc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165507	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	12095283	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4cc(F)cc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165506	=	IC50	nM	0.48	CHEMBL3130	Homo sapiens	IC50	nM	0.48
	12095284	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	Fc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCN4CCOC[C@H]4C3)cc2n1		CHEMBL2165505	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	12095285	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165504	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12095286	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165503	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	nM	3.1
	12095287	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12095288	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165672	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	12095289	CHEMBL2167812	Binding affinity to PI3Kdelta after 30 mins by competitive fluorescence polarization assay	B	CC(C)(C(N)=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2165671	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	12100987	CHEMBL2173156	Inhibition of PI3Kdelta	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	12104418	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CS(=O)(=O)C2)c2ccc(N3CCOCC3)cc21		CHEMBL2171924	=	Ki	nM	80.0	CHEMBL3130	Homo sapiens	Ki	nM	80.0
	12104419	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(N3CCOCC3)cc21		CHEMBL2171929	=	Ki	nM	7.0	CHEMBL3130	Homo sapiens	Ki	nM	7.0
	12104424	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1cc(-c2ccc3c(c2)N(c2c(C)c(-c4ccccn4)nc4cc(F)ccc24)CC3(C)C)nc(N)n1		CHEMBL2171928	=	Ki	nM	449.0	CHEMBL3130	Homo sapiens	Ki	nM	449.0
	12104425	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(-c3ccnc(N)n3)cc21		CHEMBL2171930	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	nM	3.0
	12104432	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(-c3ccncc3)cc21		CHEMBL2171926	=	IC50	nM	198.0	CHEMBL3130	Homo sapiens	IC50	nM	198.0
	12104435	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(CO)(CO)c2ccc(N3CCOCC3)cc21		CHEMBL2171925	=	Ki	nM	154.0	CHEMBL3130	Homo sapiens	Ki	nM	154.0
	12104437	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ncc(N3CCOCC3)cc21		CHEMBL2171931	=	Ki	nM	11.0	CHEMBL3130	Homo sapiens	Ki	nM	11.0
	12104438	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(-c3ccnc(N)n3)cc21		CHEMBL2171927	=	Ki	nM	10.0	CHEMBL3130	Homo sapiens	Ki	nM	10.0
	12104444	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1nc2ccc(Cl)cc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171933	=	IC50	nM	886.0	CHEMBL3130	Homo sapiens	IC50	nM	886.0
	12104445	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1nc2ccccc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171932	=	IC50	nM	745.0	CHEMBL3130	Homo sapiens	IC50	nM	745.0
	12104447	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccc(Cl)cc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171933	=	IC50	nM	626.0	CHEMBL3130	Homo sapiens	IC50	nM	626.0
	12104449	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccc2F)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171935	=	IC50	nM	509.0	CHEMBL3130	Homo sapiens	IC50	nM	509.0
	12104450	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccccc2c(N2CC3(CCOCC3)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171921	=	IC50	nM	450.0	CHEMBL3130	Homo sapiens	IC50	nM	450.0
	12104451	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1nc2ccccc2c(N2CC(C)(C)c3ccc(N4CCOCC4)cc32)c1C		CHEMBL2171932	=	IC50	nM	362.0	CHEMBL3130	Homo sapiens	IC50	nM	362.0
	12104452	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cccc(F)c2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171919	=	IC50	nM	263.0	CHEMBL3130	Homo sapiens	IC50	nM	263.0
	12104457	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171923	=	IC50	nM	127.0	CHEMBL3130	Homo sapiens	IC50	nM	127.0
	12104464	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171934	=	IC50	nM	91.0	CHEMBL3130	Homo sapiens	IC50	nM	91.0
	12104465	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171922	=	IC50	nM	91.0	CHEMBL3130	Homo sapiens	IC50	nM	91.0
	12104466	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171934	=	IC50	nM	85.0	CHEMBL3130	Homo sapiens	IC50	nM	85.0
	12104470	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171918	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	nM	76.0
	12104472	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2cccnc2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171920	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	12104473	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cccc(F)c2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171919	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	nM	72.0
	12104482	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccc2)nc2ccccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171922	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	nM	64.0
	12104483	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ccc(N3CCOCC3)cc21		CHEMBL2171923	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	nM	64.0
	12104503	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccc2F)nc2ccccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171935	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	12104517	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171918	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	12104528	CHEMBL2174948	Inhibition of PI3Kdelta using phosphatidylinositol-4,5-bisphosphate by ATP bioluminescence assay	B	Cc1c(-c2cccnc2)nc2cc(F)ccc2c1N1CC(C)(C)c2ccc(N3CCOCC3)cc21		CHEMBL2171920	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	12104545	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC2(CCOCC2)c2ncc(N3CCOCC3)cc21		CHEMBL2171931	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	12104553	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(N3CCOCC3)cc21		CHEMBL2171929	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	12104558	CHEMBL2174947	Inhibition of PI3Kdelta in human B cells assessed as inhibition of anti-IgM/CD40L-induced proliferation after 72 hrs by [3H]thymidine incorporation assay	B	Cc1c(-c2ccccn2)nc2cc(F)ccc2c1N1CC(C)(C)c2ncc(-c3ccnc(N)n3)cc21		CHEMBL2171930	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	12104582	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12104607	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2ccc(N3CCC(C(C)(C)O)CC3)nc2n1		CHEMBL2171947	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	12104610	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)cc2n1		CHEMBL2165501	=	IC50	nM	116.0	CHEMBL3130	Homo sapiens	IC50	nM	116.0
	12104611	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)sc2n1		CHEMBL2171946	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	12104612	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	Cn1c(CN2CCC(C(C)(C)O)CC2)nc2c(N3CCOCC3)nc(-n3c(N4CCOCC4)nc4ccccc43)nc21		CHEMBL2171937	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	12104613	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171952	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	12104614	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	Cn1c(CN2CCC(C(C)(C)O)CC2)nc2c(N3CCOCC3)nc(-n3c(C4CC4)nc4ccccc43)nc21		CHEMBL2171950	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	12104615	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CC(O)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171951	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	12104616	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CN(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171936	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	12104617	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171944	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	12104618	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)[nH]c2n1		CHEMBL2171943	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	12104619	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	COC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171949	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	12104620	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)nc2n1		CHEMBL2171945	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	12104621	CHEMBL2174982	Inhibition of human PI3Kdelta in Ri-1 cells assessed as inhibition AKt phosphorylation incubated for 30 mins by sandwich immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)nc2n1		CHEMBL2171945	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	12104622	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCN(S(C)(=O)=O)CC3)n(C)c2n1		CHEMBL2171938	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	12104623	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CN(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171936	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	12104624	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CC(O)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171951	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	12104625	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)cc2n1		CHEMBL2165501	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	12104626	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	Cn1c(CN2CCC(C(C)(C)O)CC2)nc2c(N3CCOCC3)nc(-n3c(C4CCCO4)nc4ccccc43)nc21		CHEMBL2171948	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	12104627	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3C[C@@H]4C[C@H]3CN4C3COC3)n(C)c2n1		CHEMBL2171941	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12104628	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	Cn1c(CN2CCC(C(C)(C)O)CC2)nc2c(N3CCOCC3)nc(-n3c(C4CC4)nc4ccccc43)nc21		CHEMBL2171950	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12104629	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)[nH]c2n1		CHEMBL2171943	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12104630	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CC(C4CCOCC4)C3)n(C)c2n1		CHEMBL2171942	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	12104631	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCN(C(C)(C)C(N)=O)CC3)n(C)c2n1		CHEMBL2171939	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	12104632	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171952	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	12105492	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	COC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171949	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	12105493	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171944	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	12105494	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCN(C(C)(C)C)CC3)n(C)c2n1		CHEMBL2171940	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	12105495	CHEMBL2174981	Inhibition of recombinant PI3Kdelta assessed as inhibition of PIP3 production for 30 mins by fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)sc2n1		CHEMBL2171946	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	12165508	CHEMBL2186368	Inhibition of PI3Kdelta at 1 uM	B	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOCC4)n2)CCN(c2ncccn2)C3)cc1		CHEMBL2181661	=	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	12166161	CHEMBL2211630	Inhibition of human N-terminal polyHis-tagged PI3K p110delta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	COCCOc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2206906	=	Ki	nM	6.1	CHEMBL3130	Homo sapiens	Ki	nM	6.1
	12166162	CHEMBL2211630	Inhibition of human N-terminal polyHis-tagged PI3K p110delta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)c(-c2nc(C)nc(N)n2)c1		CHEMBL2206904	=	Ki	nM	1.1	CHEMBL3130	Homo sapiens	Ki	nM	1.1
	12166163	CHEMBL2211630	Inhibition of human N-terminal polyHis-tagged PI3K p110delta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	=	Ki	nM	0.4	CHEMBL3130	Homo sapiens	Ki	nM	0.4
	12166164	CHEMBL2211630	Inhibition of human N-terminal polyHis-tagged PI3K p110delta expressed in baculovirus infected Hi5 cells using Phosphatidylinositol-4,5-bisphosphate as substrate after 20 mins by AlphaScreen assay	B	Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1		CHEMBL2206913	=	Ki	nM	1.2	CHEMBL3130	Homo sapiens	Ki	nM	1.2
	12172273	CHEMBL2212503	Inhibition of PIK3CD assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	12176877	CHEMBL2214581	Inhibition of PI3Kdelta by HTRF assay in presence of ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0083
	12176909	CHEMBL2214581	Inhibition of PI3Kdelta by HTRF assay in presence of ATP	B	Cc1c(OCc2cccnc2)ccc2c(=O)nc(N3CCOCC3)oc12		CHEMBL1276684	=	IC50	nM	2020.0	CHEMBL3130	Homo sapiens	IC50	uM	2.02
	12176918	CHEMBL2214581	Inhibition of PI3Kdelta by HTRF assay in presence of ATP	B	Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)nc(N3CCOCC3)oc12		CHEMBL244672	>=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	IC50	uM	100.0
	12176925	CHEMBL2214581	Inhibition of PI3Kdelta by HTRF assay in presence of ATP	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL243810	=	IC50	nM	950.0	CHEMBL3130	Homo sapiens	IC50	uM	0.95
	12183787	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CCCNS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205764	>	IC50	nM	19952623.15	CHEMBL3130	Homo sapiens	pIC50		1.7
	12185205	CHEMBL2211982	Inhibition of PIK3Cd	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	=	IC50	nM	707.95	CHEMBL3130	Homo sapiens	pIC50		6.15
	12185219	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1		CHEMBL2064571	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	12185230	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)n3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205763	=	IC50	nM	7943282.35	CHEMBL3130	Homo sapiens	pIC50		2.1
	12185231	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)NCC(F)(F)F)c3)ccn2n1	Outside typical range	CHEMBL2205767	=	IC50	nM	7943282.35	CHEMBL3130	Homo sapiens	pIC50		2.1
	12185236	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CCN(CC)S(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205771	=	IC50	nM	12589254.12	CHEMBL3130	Homo sapiens	pIC50		1.9
	12185243	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)NCc4ccccc4)c3)ccn2n1	Outside typical range	CHEMBL2205770	=	IC50	nM	19952623.15	CHEMBL3130	Homo sapiens	pIC50		1.7
	12185247	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(=O)(=O)Nc4ccccc4)c3)ccn2n1	Outside typical range	CHEMBL2205769	=	IC50	nM	25118864.32	CHEMBL3130	Homo sapiens	pIC50		1.6
	12185248	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CNS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205774	=	IC50	nM	25118864.32	CHEMBL3130	Homo sapiens	pIC50		1.6
	12185251	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC1(C)CCN1S(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205772	=	IC50	nM	31622776.6	CHEMBL3130	Homo sapiens	pIC50		1.5
	12185252	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC(C)(NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1)C(F)(F)F	Outside typical range	CHEMBL2205768	=	IC50	nM	31622776.6	CHEMBL3130	Homo sapiens	pIC50		1.5
	12185253	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205765	=	IC50	nM	31622776.6	CHEMBL3130	Homo sapiens	pIC50		1.5
	12185254	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	Nc1nc2cc(-c3cncc(S(N)(=O)=O)c3)ccn2n1	Outside typical range	CHEMBL2205773	=	IC50	nM	31622776.6	CHEMBL3130	Homo sapiens	pIC50		1.5
	12185259	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2203312	=	IC50	nM	39810717.06	CHEMBL3130	Homo sapiens	pIC50		1.4
	12185265	CHEMBL2215896	Inhibition of PI3Kdelta assessed as change in pIC50 by kinobeads assay	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1	Outside typical range	CHEMBL2205766	=	IC50	nM	50118723.36	CHEMBL3130	Homo sapiens	pIC50		1.3
	12205252	CHEMBL2217284	Inhibition of PI3Kdelta-mediated Akt phosphorylation at 10 uM by cell-based assay	B	CC(C)(Oc1cccc2[nH]c(-c3nccc(-c4cncc(S(N)(=O)=O)c4)n3)cc12)C(=O)O		CHEMBL2216831	>	Inhibition	%	95.0	CHEMBL3130	Homo sapiens	INH	%	95.0
	12205266	CHEMBL2217292	Inhibition of PI3Kdelta by cell-based assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2scc(C)c2c1=O		CHEMBL2216843	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205270	CHEMBL2217293	Inhibition of PI3Kdelta in human PBMC	B	COc1ccccc1S(=O)(=O)Nc1cc(-c2cc(NC(=O)c3csc(CN4C[C@H](C)O[C@H](C)C4)n3)c3cn[nH]c3c2)cnc1OC		CHEMBL2216836	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205271	CHEMBL2217294	Inhibition of PI3Kdelta in neutrophil assessed as inhibition of superoxide production by cell-based assay	B	Cn1cc(-c2ccc3c(c2)N(C2=NC4CC(C)(C)NC(=O)C4S2)CCO3)cn1		CHEMBL2216857	=	IC50	nM	111.0	CHEMBL3130	Homo sapiens	IC50	uM	0.111
	12205275	CHEMBL2217300	Inhibition of PI3Kdelta-mediated AKT phosphorylation in human Ramos cells by ELISA	B	CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2cncn2c1-c1cccc(F)c1		CHEMBL2216865	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205276	CHEMBL2217300	Inhibition of PI3Kdelta-mediated AKT phosphorylation in human Ramos cells by ELISA	B	Cc1cccn2c(C(C)Nc3ncnc4[nH]cnc34)c(-c3cc(F)cc(F)c3)nc12		CHEMBL2216864	<	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	12205277	CHEMBL2217301	Inhibition of PI3Kdelta assessed as inhibition of H2O2-induced AKT phosphorylation by cell-based assay	B	C#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3cccc(OC)c3)c(=O)c12		CHEMBL2216862	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	uM	0.57
	12205278	CHEMBL2217303	Inhibition of PI3Kdelta in human B-cells assessed as inhibition of anti-IgM-induced thymidine incorporation by radiometry	B	CN(C)CC(=O)N[C@H]1CC[C@H](Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2216881	=	IC50	nM	0.62	CHEMBL3130	Homo sapiens	IC50	uM	0.00062
	12205279	CHEMBL2217302	Inhibition of PI3Kdelta in human PBMC assessed as inhibition of anti-IgM-induced AKT phosphorylation by FACS analysis	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(CN(C)C)cc2)cc(OC)c1		CHEMBL2216880	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	12205288	CHEMBL2217312	Inhibition of PI3Kdelta by scintillation counting method	B	CC1=CC(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)=NC1		CHEMBL2216883	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	12205289	CHEMBL2217313	Inhibition of PI3Kdelta by cell-based proliferation assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)cc2cccc(C)c2c1=O		CHEMBL2216876	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	12205290	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	6.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0061
	12205291	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2ccnnc2c1-c1cccc(F)c1		CHEMBL2216867	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205292	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	Cc1csc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL2216863	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205293	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	Cc1cccc2cc(C(C)Nc3ncnc4[nH]cnc34)nc(OC3CCN(C)CC3)c12		CHEMBL2216898	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205294	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2nc1-c1cscn1		CHEMBL2216889	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0005
	12205295	CHEMBL2217314	Inhibition of PI3Kdelta in B-cells by proliferation assay	B	Cc1cccc2nc(-c3ccccc3Cl)c(Cn3nc(C#N)c4c(N)ncnc43)nc12		CHEMBL2216888	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	uM	0.002
	12205296	CHEMBL2217315	Inhibition of PI3Kdelta in neutrophil assessed as elastase release by cell-based assay	B	CC(c1nc2c(c(Br)nn2C)c(=O)n1-c1ccccc1)n1cnc2c(N)ncnc21		CHEMBL2216887	=	IC50	nM	665.0	CHEMBL3130	Homo sapiens	IC50	uM	0.665
	12205297	CHEMBL2217315	Inhibition of PI3Kdelta in neutrophil assessed as elastase release by cell-based assay	B	CC(c1nc2cccnc2c(=O)n1-c1ccccc1)n1cnc2c(N)ncnc21		CHEMBL2216886	=	IC50	nM	665.0	CHEMBL3130	Homo sapiens	IC50	uM	0.665
	12205298	CHEMBL2217316	Inhibition of human PI3Kdelta expressed in Rat-1 cells assessed as inhibition of AKT phosphorylation by ELISA	B	CC1=CC(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)=NC1		CHEMBL2216883	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	uM	0.015
	12205299	CHEMBL2217317	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of CD69 production in B lymphocyte by immunoassay	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2oc(CN3CCN(C(C)(C)C(N)=O)CC3)cc2n1		CHEMBL2216882	=	IC50	nM	17.8	CHEMBL3130	Homo sapiens	IC50	uM	0.0178
	12205300	CHEMBL2217317	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of CD69 production in B lymphocyte by immunoassay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	uM	0.041
	12205301	CHEMBL2217317	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of CD69 production in B lymphocyte by immunoassay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2216903	=	IC50	nM	5.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0052
	12205302	CHEMBL2217317	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of CD69 production in B lymphocyte by immunoassay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2216902	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	12205303	CHEMBL2217317	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of CD69 production in B lymphocyte by immunoassay	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2216901	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	uM	0.017
	12205430	CHEMBL2217274	Inhibition of PI3Kdelta in presence of 200 uM ATP	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	12205443	CHEMBL2217270	Inhibition of PI3Kdelta in presence of 10 uM ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	48.0	CHEMBL3130	Homo sapiens	IC50	uM	0.048
	12205444	CHEMBL2217270	Inhibition of PI3Kdelta in presence of 10 uM ATP	B	COc1ccc2c(c1OC)N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL1241857	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	uM	0.058
	12205445	CHEMBL2217270	Inhibition of PI3Kdelta in presence of 10 uM ATP	B	COc1ccccc1-n1c(CSc2ncnc3[nH]cnc23)nc2cccc(Cl)c2c1=O		CHEMBL1213083	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	uM	0.18
	12205446	CHEMBL2217270	Inhibition of PI3Kdelta in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	uM	0.13
	12205450	CHEMBL2217266	Inhibition of PI3Kdelta using phosphatidylinositol as substrate by gamma33P[ATP] incorporation assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1050.0	CHEMBL3130	Homo sapiens	IC50	uM	1.05
	12205457	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2scc(C)c2c1=O		CHEMBL2216843	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205458	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc(O)c(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213085	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	12205459	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1nc(C(=O)Nc2cc(-c3cnc4[nH]nc(S(C)(=O)=O)c4c3)cc3[nH]ncc23)cs1		CHEMBL2216842	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205460	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C(CN1CCOCC1)Nc1cc(-c2cc(F)cc3[nH]ccc23)cc2[nH]ncc12		CHEMBL2216841	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205461	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1nc(C(=O)Nc2cc(-c3ccnc4[nH]ccc34)cc3[nH]ncc23)cs1		CHEMBL2216840	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205462	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@H]1CN(Cc2nnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)C[C@@H](C)O1		CHEMBL2216839	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205463	CHEMBL2217262	Inhibition of PI3Kdelta	B	CN1CCOC(C(=O)Nc2cc(-c3cccc4[nH]ccc34)cc3[nH]ncc23)C1		CHEMBL2216838	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205464	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C(Nc1cc(-c2cnc3[nH]ncc3c2)cc2[nH]ncc12)c1cccc(CN2CCS(=O)(=O)CC2)n1		CHEMBL2216837	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205465	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccccc1S(=O)(=O)Nc1cc(-c2cc(NC(=O)c3csc(CN4C[C@H](C)O[C@H](C)C4)n3)c3cn[nH]c3c2)cnc1OC		CHEMBL2216836	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	12205466	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC[C@H]1CN(c2sc(-c3nnc[nH]3)c(-c3ccc(Cl)cc3Cl)c2C#N)CCO1		CHEMBL2216835	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205467	CHEMBL2217262	Inhibition of PI3Kdelta	B	Clc1ccc(-c2nc(N3CCOCC3)sc2-c2nnc[nH]2)c(Cl)c1		CHEMBL2216834	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205468	CHEMBL2217262	Inhibition of PI3Kdelta	B	COCC(O)Cn1cc(-c2ccc3c(c2)N(C2=NC4CC(C)(C)NC(=O)C4S2)CCO3)cn1		CHEMBL2216833	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	12205469	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccc(-c2ccc3c(c2)N(C2=NC4CC(C)(C)NC(=O)C4S2)CCO3)nn1		CHEMBL2216832	=	IC50	nM	139.0	CHEMBL3130	Homo sapiens	IC50	uM	0.139
	12205470	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cn1cc(-c2ccc3c(c2)N(C2=NC4CC(C)(C)NC(=O)C4S2)CCO3)cn1		CHEMBL2216857	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	uM	0.032
	12205471	CHEMBL2217262	Inhibition of PI3Kdelta	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	uM	0.034
	12205472	CHEMBL2217262	Inhibition of PI3Kdelta	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	uM	0.018
	12205473	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccc(-c2ccc3c(n2)N(C2=NC(=O)C(C)(C)S2)CCO3)cc1OC		CHEMBL2216856	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	12205474	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C1NC(=O)/C(=C/c2ccc3ncnc(N4CCC(C(F)(F)F)CC4)c3n2)S1		CHEMBL2216855	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	12205475	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1nc2c(s1)-c1c(c(C3CC3)nn1C1CCC(C(=O)N[C@H]3CC[C@H](N4CCCC4)CC3)CC1)CC2		CHEMBL2216854	<	IC50	nM	600.0	CHEMBL3130	Homo sapiens	IC50	uM	0.6
	12205476	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)N[C@@H](C)C(=O)OC3CCCC3)c2)s1		CHEMBL2216853	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205477	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1ccc(C(=O)NC2=Nc3cc(N4CCOCC4)ccc3C3=NCCN23)cn1		CHEMBL2216852	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205478	CHEMBL2217262	Inhibition of PI3Kdelta	B	Nc1ncc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccccc3)c2)nc1C(=O)c1cccnc1		CHEMBL2216756	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	12205479	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1nc(NC(=O)NCCC(=O)OC(C)(C)C)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071341	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	12205480	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccc(-c2nn(C)c3nc(N)nc(NCc4ccccc4)c23)cc1F		CHEMBL2216851	<	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	12205481	CHEMBL2217262	Inhibition of PI3Kdelta	B	CCN(CC)C(=O)c1cccc(Nc2nc3ccc(-c4cncc(OC)c4)cc3s2)n1		CHEMBL2216850	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	uM	0.003
	12205482	CHEMBL2217262	Inhibition of PI3Kdelta	B	CCNC(=O)Nc1nc2ccc(-c3cncc(C(F)(F)F)c3)cc2s1		CHEMBL2216849	=	Ki	nM	10.0	CHEMBL3130	Homo sapiens	Ki	uM	0.01
	12205483	CHEMBL2217262	Inhibition of PI3Kdelta	B	CCOC(=O)CCNC(=O)Nc1nc2c(s1)CN(c1cnc(Cl)c(OC)c1)CC2		CHEMBL2216848	=	Ki	nM	3.0	CHEMBL3130	Homo sapiens	Ki	uM	0.003
	12205484	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)NCCNS(=O)(=O)c1ccc(-c2sc(NC(C)=O)nc2C)o1		CHEMBL2216847	=	Ki	nM	100.0	CHEMBL3130	Homo sapiens	Ki	uM	0.1
	12205485	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C(NCC(=O)N1CCCC1)Nc1nc2ccc(-c3cncc(C(F)(F)F)c3)cn2n1		CHEMBL2216846	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205486	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C(Nc1nn[nH]n1)c1cnc(N2CCOCC2)nc1OC1CCCCCC1		CHEMBL2216845	=	IC50	nM	197.0	CHEMBL3130	Homo sapiens	IC50	uM	0.197
	12205487	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1cc2c(CC3CCCC(C)C3)c(C(=O)Nc3nn[nH]n3)sc2cc1C		CHEMBL2216844	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	12205488	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C1NC(=S)SC1Cc1ccc2c(c1)N(Cc1ccc(F)c(Cl)c1)C(=O)CO2		CHEMBL2216874	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	uM	0.054
	12205489	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)[N-]c1nc(C)c(-c2csc(C(=O)Nc3nnn[nH]3)n2)s1.[K+]		CHEMBL2216873	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	12205490	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccc(NC(=O)c2c(C)oc3ncn(CC(C)C)c(=O)c23)cc1		CHEMBL2216872	=	IC50	nM	5.9	CHEMBL3130	Homo sapiens	IC50	uM	0.0059
	12205491	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1cccc2nc(C(C)n3cnc4c(N)ncnc43)n(-c3ccccc3)c(=O)c12		CHEMBL2216871	=	Ki	nM	7.0	CHEMBL3130	Homo sapiens	Ki	uM	0.007
	12205492	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	12205493	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1cccc2cc(Cn3cnc4c(N)ncnc43)c(N(C)CC3CCCN3C)nc12		CHEMBL2216869	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205494	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cn1c(C(=O)NCC(F)(F)F)nc2c(N3CCC(n4c(=O)[nH]c5ncccc54)CC3)ncnc21		CHEMBL2216868	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205495	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2ccnnc2c1-c1cccc(F)c1		CHEMBL2216867	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205496	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(Nc1ncnc2[nH]cnc12)c1c(C#N)c2ccc(Cl)cc2n1-c1cccc(F)c1		CHEMBL3706626	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205497	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2cncn2c1-c1cccc(F)c1		CHEMBL2216865	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205498	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1cccn2c(C(C)Nc3ncnc4[nH]cnc34)c(-c3cc(F)cc(F)c3)nc12		CHEMBL2216864	<	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	uM	0.2
	12205499	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1csc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL2216863	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205500	CHEMBL2217262	Inhibition of PI3Kdelta	B	C#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3cccc(OC)c3)c(=O)c12		CHEMBL2216862	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	12205501	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(c1oc2ccccc2c(=O)c1-c1cccc(F)c1)n1cnc2c(N)ncnc21		CHEMBL2216861	<	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	12205502	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL2216860	>	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	12205503	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1		CHEMBL2216859	>	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	12205504	CHEMBL2217262	Inhibition of PI3Kdelta	B	c1ccc2c(N3CCOCC3)nc(-c3cccc4[nH]ccc34)cc2c1		CHEMBL2216858	=	IC50	nM	260.0	CHEMBL3130	Homo sapiens	IC50	uM	0.26
	12205505	CHEMBL2217262	Inhibition of PI3Kdelta	B	CN(C)CC(=O)N[C@H]1CC[C@H](Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2216881	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0036
	12205506	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2c(c1=O)CCCC2		CHEMBL1213169	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	uM	0.034
	12205507	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(F)cc2)cc(OC)c1		CHEMBL1213168	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	12205508	CHEMBL2217262	Inhibition of PI3Kdelta	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(CN(C)C)cc2)cc(OC)c1		CHEMBL2216880	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	12205509	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1oc2ncn(CC(C)C)c(=O)c2c1C(=O)NCc1ccccc1		CHEMBL2216879	=	IC50	nM	2100.0	CHEMBL3130	Homo sapiens	IC50	uM	2.1
	12205510	CHEMBL2217262	Inhibition of PI3Kdelta	B	OCCn1cnc2c(-n3c(C(F)F)nc4ccccc43)nc(N3CCOCC3)nc21		CHEMBL2216878	<	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	uM	0.03
	12205511	CHEMBL2217262	Inhibition of PI3Kdelta	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0046
	12205512	CHEMBL2217262	Inhibition of PI3Kdelta	B	CN(C)CCCOc1cccc2c1nc(C(F)F)n2-c1nc(OC2CCN(C(=O)CCl)CC2)nc(N2CCOCC2)n1		CHEMBL2216877	>	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205513	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(C#CCO)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213116	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	12205514	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213084	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	uM	0.0007
	12205515	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	12205516	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)cc2cccc(C)c2c1=O		CHEMBL2216876	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0003
	12205517	CHEMBL2217262	Inhibition of PI3Kdelta	B	CN1CCN(c2nc3ccccc3cc2Cn2nc(-c3ccc4nc(N)sc4c3)c3c(N)ncnc32)CC1		CHEMBL1213118	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0005
	12205518	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1nc2ccc(-c3nn(Cc4cc5ccccc5nc4N4CCN(C)CC4)c4ncnc(N)c34)cc2s1		CHEMBL1213117	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	uM	0.001
	12205519	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(C)n1nc(C#Cc2cccnc2)c2c(N)ncnc21		CHEMBL1213119	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	12205520	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1nc2ccc(-c3nn(C4CCCC4)c4ncnc(N)c34)cc2s1		CHEMBL2216875	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	12205521	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1cccc2cc(C(C)Nc3ncnc4[nH]cnc34)nc(OC3CCN(C)CC3)c12		CHEMBL2216898	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205522	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(=O)Nc1nc2ccc(-c3nn(Cc4cc5cccc(C)c5c(=O)n4-c4ccccc4C)c4ncnc(N)c34)cc2s1		CHEMBL2216897	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205523	CHEMBL2217262	Inhibition of PI3Kdelta	B	CNc1nc(C)c2cc(-c3cc(O)cc(F)c3)ccc2n1		CHEMBL2216896	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205524	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1		CHEMBL2216895	=	Ki	nM	0.2	CHEMBL3130	Homo sapiens	Ki	uM	0.0002
	12205525	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@H](Nc1nc(N)ncc1Cl)c1cc2cccc(Cl)c2nc1-c1ccccn1		CHEMBL2216894	=	IC50	nM	105.9	CHEMBL3130	Homo sapiens	IC50	uM	0.1059
	12205526	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL2216893	=	Ki	nM	5.0	CHEMBL3130	Homo sapiens	Ki	uM	0.005
	12205527	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCS(C)(=O)=O)c1-c1ccccc1		CHEMBL2216892	=	Ki	nM	2.26	CHEMBL3130	Homo sapiens	Ki	uM	0.00226
	12205528	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1ccc(S(C)(=O)=O)c(-c2nc3cc(F)cc(F)c3c(N3CC(C)(C)c4ncc(N5CCOCC5)cc43)c2C)c1		CHEMBL2216891	=	Ki	nM	1.05	CHEMBL3130	Homo sapiens	Ki	uM	0.00105
	12205529	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1c(-c2ccccn2)nc2cc(F)cc(F)c2c1Nc1cc(N2CCOCC2)cnc1-c1ccc(O)cc1		CHEMBL2216890	=	Ki	nM	2.85	CHEMBL3130	Homo sapiens	Ki	uM	0.00285
	12205530	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccsc2c(=O)n1-c1ccccc1		CHEMBL2216885	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	12205531	CHEMBL2217262	Inhibition of PI3Kdelta	B	C[C@@H](c1nc2ccsc2c(=O)n1-c1ccccc1)n1cnc2c(N)ncnc21		CHEMBL2216884	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	uM	0.04
	12205532	CHEMBL2217262	Inhibition of PI3Kdelta	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2oc(CN3CCN(C(C)(C)C(N)=O)CC3)cc2n1		CHEMBL2216882	=	IC50	nM	2.74	CHEMBL3130	Homo sapiens	IC50	uM	0.00274
	12205533	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	3.43	CHEMBL3130	Homo sapiens	IC50	uM	0.00343
	12205534	CHEMBL2217262	Inhibition of PI3Kdelta	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2216903	=	Ki	nM	0.576	CHEMBL3130	Homo sapiens	Ki	uM	0.000576
	12205535	CHEMBL2217262	Inhibition of PI3Kdelta	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2216902	=	Ki	nM	0.46	CHEMBL3130	Homo sapiens	Ki	uM	0.00046
	12205536	CHEMBL2217262	Inhibition of PI3Kdelta	B	CN(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2216901	=	Ki	nM	4.9	CHEMBL3130	Homo sapiens	Ki	uM	0.0049
	12205537	CHEMBL2217262	Inhibition of PI3Kdelta	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2216900	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	12205538	CHEMBL2217262	Inhibition of PI3Kdelta	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	12205539	CHEMBL2217262	Inhibition of PI3Kdelta	B	O=C1NC(=O)/C(=C\c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL2216899	>	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	uM	20.0
	12205540	CHEMBL2217262	Inhibition of PI3Kdelta	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	12625627	CHEMBL2317621	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2316958	=	IC50	nM	3020.0	CHEMBL3130	Homo sapiens	IC50(app)	nM	3020.0
Not Active	12645680	CHEMBL2330456	Binding affinity to PI3Kdelta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(N4CCOCC4)cc3)csc12		CHEMBL2322238		Activity			CHEMBL3130	Homo sapiens	Activity		
Not Active	12645681	CHEMBL2330456	Binding affinity to PI3Kdelta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(N3CCCCC3)csc12		CHEMBL2322237		Activity			CHEMBL3130	Homo sapiens	Activity		
	12645727	CHEMBL2330611	Ratio of LY294002 IC50 to compound IC50 for PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)csc12		CHEMBL2322239	=	Ratio IC50		4.1	CHEMBL3130	Homo sapiens	Ratio IC50		4.1
	12645772	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	12645773	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CN1CCN(c2ncc(-c3csc4c(=O)cc(N5CCOCC5)oc34)cn2)CC1		CHEMBL2326951	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	12645774	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	COC(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326953	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	12645775	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CCOC(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326952	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	12645776	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	S=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL2326965	=	IC50	nM	14940.0	CHEMBL3130	Homo sapiens	IC50	nM	14940.0
	12645777	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	3223.0	CHEMBL3130	Homo sapiens	IC50	nM	3223.0
	12645778	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=C(Nc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1)c1cccnc1		CHEMBL2326955	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	12645779	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CNc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326954	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	12645780	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CC(=O)Nc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322236	=	IC50	nM	125.0	CHEMBL3130	Homo sapiens	IC50	nM	125.0
	12645781	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	COc1ccc(C#Cc2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322235	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	12645782	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(C(F)(F)F)cc3)csc12		CHEMBL2322234	=	IC50	nM	4200.0	CHEMBL3130	Homo sapiens	IC50	nM	4200.0
	12645783	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)c(Cl)c3)csc12		CHEMBL2322233	=	IC50	nM	278.0	CHEMBL3130	Homo sapiens	IC50	nM	278.0
	12645784	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)csc12		CHEMBL2322232	=	IC50	nM	3732.0	CHEMBL3130	Homo sapiens	IC50	nM	3732.0
	12645785	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	N#Cc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322231	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	12645786	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(Cc3ccccc3)csc12		CHEMBL2322230	=	IC50	nM	2420.0	CHEMBL3130	Homo sapiens	IC50	nM	2420.0
	12645787	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	COc1cccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL2322229	=	IC50	nM	7894.0	CHEMBL3130	Homo sapiens	IC50	nM	7894.0
	12645788	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCCO4)csc12		CHEMBL2322228	=	IC50	nM	960.0	CHEMBL3130	Homo sapiens	IC50	nM	960.0
	12645789	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccoc3)csc12		CHEMBL2322227	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	12645790	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccsc3)csc12		CHEMBL2322226	>	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	nM	20000.0
	12645791	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4[nH]ccc4c3)csc12		CHEMBL2322225	=	IC50	nM	649.0	CHEMBL3130	Homo sapiens	IC50	nM	649.0
	12645792	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	Cc1cccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL2326971	=	IC50	nM	3998.0	CHEMBL3130	Homo sapiens	IC50	nM	3998.0
	12645793	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	Cc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326970	=	IC50	nM	1142.0	CHEMBL3130	Homo sapiens	IC50	nM	1142.0
	12645794	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccs3)csc12		CHEMBL2326969	>	IC50	nM	23000.0	CHEMBL3130	Homo sapiens	IC50	nM	23000.0
	12645795	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CS(=O)(=O)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2326968	=	IC50	nM	13830.0	CHEMBL3130	Homo sapiens	IC50	nM	13830.0
	12645796	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cc4ccccc4[nH]3)csc12		CHEMBL2326967	=	IC50	nM	8936.0	CHEMBL3130	Homo sapiens	IC50	nM	8936.0
	12645797	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	Nc1cccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL2322247	=	IC50	nM	9807.0	CHEMBL3130	Homo sapiens	IC50	nM	9807.0
	12645798	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2ccsc12		CHEMBL2322246	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	12645799	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	CN(C)c1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322245	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
	12645800	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	COc1ccc(-c2csc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL2322244	=	IC50	nM	555.0	CHEMBL3130	Homo sapiens	IC50	nM	555.0
	12645801	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL2322243	=	IC50	nM	481.0	CHEMBL3130	Homo sapiens	IC50	nM	481.0
	12645802	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccco3)csc12		CHEMBL2322242	>	IC50	nM	30000.0	CHEMBL3130	Homo sapiens	IC50	nM	30000.0
	12645803	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccncc3)csc12		CHEMBL2322241	>	IC50	nM	23000.0	CHEMBL3130	Homo sapiens	IC50	nM	23000.0
	12645804	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccnc3)csc12		CHEMBL2322240	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	12645805	CHEMBL2330619	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)csc12		CHEMBL2322239	=	IC50	nM	784.0	CHEMBL3130	Homo sapiens	IC50	nM	784.0
	12655422	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(NC(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322356	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655423	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)Nc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)c(C)nn12		CHEMBL2322355	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655424	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(NCCO)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322354	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655425	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(NO)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322353	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	12655426	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	CNc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)c(C)nn12		CHEMBL2321882	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655427	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322352	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	12655428	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(C#N)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322351	<	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	12655429	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(C(N)=O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322350	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655430	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(C(=O)O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322349	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	12655431	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2ccc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322348	<	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	12655432	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(Cc2cnn3c(Cl)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322347	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655433	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	COc1cc(N2CCOCC2)nc2c(Cc3cccc(C(F)(F)F)c3C)cnn12		CHEMBL2322346	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655434	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Nc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322345	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655435	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	COc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322344	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	12655436	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(Cc2c(=O)[nH]n3c(=O)cc(C4CCOCC4)[nH]c23)cccc1C(F)(F)F		CHEMBL3145359	<	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	12655437	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc(C2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322342	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	12655438	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc(-c2ccncc2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322341	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	12655439	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc(N2CCOCC2)nc2c(Cc3cccc(Cl)c3Cl)c(C(F)(F)F)nn12		CHEMBL2322340	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	12655440	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322339	<	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	12655441	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nn2c(O)cc(-c3ccncc3)nc2c1Cc1cccc(Cl)c1Cl		CHEMBL2322338	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	12655442	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(Cc2cnn3c(O)cc(-c4ccncc4)nc23)cccc1C(F)(F)F		CHEMBL2322337	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	12655443	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(Cc2cnn3c(O)cc(N4CCOCC4)nc23)cccc1C(F)(F)F		CHEMBL2322336	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	12655444	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOC(C)C3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322335	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	12655445	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3=O)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322334	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	12655446	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(O)cc(C3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322333	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	12655447	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc2ccccc12		CHEMBL2322332	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	12655448	CHEMBL2328821	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nn2c(O)cc(N3CCOCC3)nc2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL2322331	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	12656697	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CN(C)CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322672	=	IC50	nM	330.0	CHEMBL3130	Homo sapiens	IC50	nM	330.0
	12656698	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CN[C@@H](C)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322671	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	nM	290.0
	12656699	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322670	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	12656700	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCCCC[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322669	=	IC50	nM	670.0	CHEMBL3130	Homo sapiens	IC50	nM	670.0
	12656701	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668	=	IC50	nM	390.0	CHEMBL3130	Homo sapiens	IC50	nM	390.0
	12656702	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322667	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	nM	1200.0
	12656703	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC[C@H](C)[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322666	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	12656704	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322665	=	IC50	nM	3600.0	CHEMBL3130	Homo sapiens	IC50	nM	3600.0
	12656705	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	N[C@@H](Cc1ccccc1)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322664	=	IC50	nM	2200.0	CHEMBL3130	Homo sapiens	IC50	nM	2200.0
	12656706	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322663	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	12656707	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	C[C@H](N)C(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322662	=	IC50	nM	490.0	CHEMBL3130	Homo sapiens	IC50	nM	490.0
	12656708	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	CC(=O)NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322661	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	12656709	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	NCC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322660	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	12656710	CHEMBL2328968	Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphatidylinositol bisphosphate and 10 uM ATP as substrate measured after 60 mins by luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	12662877	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323113	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	12662879	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323115	=	IC50	nM	2770.0	CHEMBL3130	Homo sapiens	IC50	uM	2.77
	12662883	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)nc(C(C)C)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323118	=	IC50	nM	1120.0	CHEMBL3130	Homo sapiens	IC50	uM	1.12
	12662888	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323116	=	IC50	nM	458.0	CHEMBL3130	Homo sapiens	IC50	uM	0.458
	12662890	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C(C)C)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323119	=	IC50	nM	423.0	CHEMBL3130	Homo sapiens	IC50	uM	0.423
	12662895	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	Cc1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL1910989	=	IC50	nM	187.0	CHEMBL3130	Homo sapiens	IC50	uM	0.187
	12662896	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL2323117	=	IC50	nM	128.0	CHEMBL3130	Homo sapiens	IC50	uM	0.128
	12662897	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(C(F)F)n(-c3nc(N4CCOCC4)nc(N4CCOCC4)n3)c2c1		CHEMBL2323114	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	12662901	CHEMBL2328236	Inhibition of PI3Kdelta (unknown origin) expressed in SF21 cells using phosphatidylinositol as substrate after 60 mins by Kinase-Glo assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	12673490	CHEMBL2340892	Inhibition of PI3Kdelta (unknown origin) at 1 uM	B	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)C[C@@H]2CC[C@H]3N2C2COC2)cc1		CHEMBL2334763	=	Inhibition	%	51.0	CHEMBL3130	Homo sapiens	INH	%	51.0
	12679753	CHEMBL2346293	Inhibition of human PI3Kdelta	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Ki	nM	0.122	CHEMBL3130	Homo sapiens	Ki	nM	0.122
	12693274	CHEMBL2341974	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	5000.0	CHEMBL3130	Homo sapiens	IC50	nM	5000.0
	12698990	CHEMBL2338828	Inhibition of PI3Kdelta (unknown origin) using lipid PIP2 as substrate	B	COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@H](C)O[C@H](C)C4)nc3n2)cc1CO		CHEMBL1078983	=	IC50	nM	5300.0	CHEMBL3130	Homo sapiens	IC50	uM	5.3
	13312300	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cnn(CCO)c3)ccc1-2		CHEMBL2381373	=	Ki	nM	0.61	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.61
	13312521	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Ki	nM	31.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	31.0
	13312522	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)(O)Cn1cc(-c2ccc3c(c2)OCCc2sc(-c4ncnn4CC(F)(F)F)nc2-3)cn1		CHEMBL2381379	<	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	13312523	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ccc(N)nc3)ccc1-2		CHEMBL2381273	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	13312524	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ccc[nH]c3=O)ccc1-2		CHEMBL2381272	=	IC50	nM	7.6	CHEMBL3130	Homo sapiens	IC50	nM	7.6
	13312525	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cn(C)cn3)ccc1-2		CHEMBL2381271	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	13312526	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3ncc[nH]3)ccc1-2		CHEMBL2381270	=	IC50	nM	2.6	CHEMBL3130	Homo sapiens	IC50	nM	2.6
	13312527	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(-c3cn[nH]c3)ccc1-2		CHEMBL2381269	<	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	13312528	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCNCC3)ccc1-2		CHEMBL2381268	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	13312529	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCCN3)ccc1-2		CHEMBL2381267	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	13312530	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CCNC3)ccc1-2		CHEMBL2381266	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	13312531	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C3CNC3)ccc1-2		CHEMBL2381265	<	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	13312532	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(CNCCO)ccc1-2		CHEMBL2381264	=	IC50	nM	8.4	CHEMBL3130	Homo sapiens	IC50	nM	8.4
	13312533	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(=O)NCc1ccc2c(c1)OCCc1sc(-c3ncnn3C(C)C)nc1-2		CHEMBL2381263	=	IC50	nM	10.2	CHEMBL3130	Homo sapiens	IC50	nM	10.2
	13312534	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(C(O)CO)ccc1-2		CHEMBL2381262	=	IC50	nM	8.1	CHEMBL3130	Homo sapiens	IC50	nM	8.1
	13312535	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1cc(CO)ccc1-2		CHEMBL2381261	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	13312536	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1nc2c(s1)CCOc1ccccc1-2		CHEMBL2381253	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
	13312537	CHEMBL2383017	Inhibition of GST-fused human recombinant PI3Kdelta expressed in baculovirus infected SF9 cells after 1 hr by scintillation proximity assay in presence of [gamma-33P]-ATP	B	CC(C)n1ncnc1-c1cc2c(s1)-c1ccc(C(N)=O)cc1OCC2		CHEMBL2322764	=	IC50	nM	3.9	CHEMBL3130	Homo sapiens	IC50	nM	3.9
	13313861	CHEMBL2388233	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1		CHEMBL2387080	=	Ki	nM	0.12	CHEMBL3130	Homo sapiens	Ki	nM	0.12
	13313871	CHEMBL2388243	Inhibition of PI3Kdelta (unknown origin) at 1 uM	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1		CHEMBL2387080	=	Inhibition	%	97.9	CHEMBL3130	Homo sapiens	INH	%	97.9
	13350656	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(-n2cccn2)cc1		CHEMBL2071338	=	IC50	nM	620.0	CHEMBL3130	Homo sapiens	IC50	uM	0.62
	13350695	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C)CC2)n1		CHEMBL2397199	=	IC50	nM	3000.0	CHEMBL3130	Homo sapiens	IC50	uM	3.0
	13350696	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CCN(CC)c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1		CHEMBL2397198	=	IC50	nM	2500.0	CHEMBL3130	Homo sapiens	IC50	uM	2.5
	13350697	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CC(C)(c1cc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2Cl)ccn1)C(F)(F)F		CHEMBL2397197	=	IC50	nM	4900.0	CHEMBL3130	Homo sapiens	IC50	uM	4.9
	13350698	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CC(C)(c1cc(-c2cnc(NC(=O)N3CCC[C@H]3C(N)=O)s2)ccn1)C(F)(F)F		CHEMBL2397196	=	IC50	nM	2900.0	CHEMBL3130	Homo sapiens	IC50	uM	2.9
	13350699	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1cc(C(C)C)ncn1		CHEMBL2397195	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	13350700	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2CCC2)n1		CHEMBL2397194	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	13350701	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)C)n1		CHEMBL2397193	=	IC50	nM	1300.0	CHEMBL3130	Homo sapiens	IC50	uM	1.3
	13350702	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C#N)CC2)c1		CHEMBL2397192	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	13350703	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	13350704	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397191	=	IC50	nM	1600.0	CHEMBL3130	Homo sapiens	IC50	uM	1.6
Not Determined	13350705	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397190		IC50			CHEMBL3130	Homo sapiens	IC50		
	13350706	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCCC2)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397189	=	IC50	nM	770.0	CHEMBL3130	Homo sapiens	IC50	uM	0.77
	13350707	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	CNC(=O)[C@@H]1CCCN1C(=O)Nc1nc(C)c(-c2ccnc(C(C)(C)C)c2)s1		CHEMBL2397188	=	IC50	nM	5800.0	CHEMBL3130	Homo sapiens	IC50	uM	5.8
	13350708	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397187	=	IC50	nM	720.0	CHEMBL3130	Homo sapiens	IC50	uM	0.72
	13350709	CHEMBL2400724	Inhibition of N-terminal myristoylated P110delta (unknown origin)-mediated AKT phosphorylation at Ser473 expressed in rat Rat1 cells by ELISA	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	13350780	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C)CC2)n1		CHEMBL2397199	=	IC50	nM	810.0	CHEMBL3130	Homo sapiens	IC50	uM	0.81
	13350781	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	CCN(CC)c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1		CHEMBL2397198	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	uM	0.34
	13350782	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	CC(C)(c1cc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2Cl)ccn1)C(F)(F)F		CHEMBL2397197	=	IC50	nM	430.0	CHEMBL3130	Homo sapiens	IC50	uM	0.43
	13350783	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	CC(C)(c1cc(-c2cnc(NC(=O)N3CCC[C@H]3C(N)=O)s2)ccn1)C(F)(F)F		CHEMBL2397196	=	IC50	nM	1100.0	CHEMBL3130	Homo sapiens	IC50	uM	1.1
Not Determined	13350784	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1cc(C(C)C)ncn1		CHEMBL2397195		IC50			CHEMBL3130	Homo sapiens	IC50		
	13350785	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2CCC2)n1		CHEMBL2397194	=	IC50	nM	690.0	CHEMBL3130	Homo sapiens	IC50	uM	0.69
	13350786	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)C)n1		CHEMBL2397193	=	IC50	nM	960.0	CHEMBL3130	Homo sapiens	IC50	uM	0.96
	13350787	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C2(C#N)CC2)c1		CHEMBL2397192	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	13350788	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	uM	0.29
	13350789	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397191	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	uM	0.29
	13350790	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397190	=	IC50	nM	3300.0	CHEMBL3130	Homo sapiens	IC50	uM	3.3
	13350791	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCCC2)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397189	=	IC50	nM	590.0	CHEMBL3130	Homo sapiens	IC50	uM	0.59
	13350792	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	CNC(=O)[C@@H]1CCCN1C(=O)Nc1nc(C)c(-c2ccnc(C(C)(C)C)c2)s1		CHEMBL2397188	=	IC50	nM	4200.0	CHEMBL3130	Homo sapiens	IC50	uM	4.2
	13350793	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)c1		CHEMBL2397187	=	IC50	nM	330.0	CHEMBL3130	Homo sapiens	IC50	uM	0.33
	13350794	CHEMBL2400731	Inhibition of P110delta (unknown origin) using PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	350.0	CHEMBL3130	Homo sapiens	IC50	uM	0.35
	13352097	CHEMBL2399036	Inhibition of PIK3CD (unknown origin)	B	Cc1nc(NC(=O)[C@@H](C)CC(F)(F)F)sc1-c1ccc(N)nc1		CHEMBL2397315	=	IC50	nM	11000.0	CHEMBL3130	Homo sapiens	IC50	uM	11.0
	13406727	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2414301	=	IC50	nM	9.96	CHEMBL3130	Homo sapiens	IC50	nM	9.96
	13406728	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2216903	=	IC50	nM	11.9	CHEMBL3130	Homo sapiens	IC50	nM	11.9
Not Determined	13406729	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(NC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2414300		IC50			CHEMBL3130	Homo sapiens	IC50		
	13406730	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414299	=	IC50	nM	4.02	CHEMBL3130	Homo sapiens	IC50	nM	4.02
	13406731	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2216902	=	IC50	nM	4.38	CHEMBL3130	Homo sapiens	IC50	nM	4.38
	13406732	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(NC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414298	=	IC50	nM	80.2	CHEMBL3130	Homo sapiens	IC50	nM	80.2
	13406733	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(N(C)C3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414297	=	IC50	nM	1.79	CHEMBL3130	Homo sapiens	IC50	nM	1.79
	13406734	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(C(=O)N3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2414296	=	IC50	nM	52.8	CHEMBL3130	Homo sapiens	IC50	nM	52.8
	13406735	CHEMBL2415716	Inhibition of PI3Kdelta in human whole blood assessed as expression of CD69 in B cell preincubated for 1 hr by flow cytometry	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171944	=	IC50	nM	21.3	CHEMBL3130	Homo sapiens	IC50	nM	21.3
	13406756	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2414301	=	Ki	nM	0.36	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.36
	13406757	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2216903	=	Ki	nM	0.58	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.58
	13406758	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(NC3CN(C(=O)C(C)C)C3)n(C)c2n1		CHEMBL2414300	=	Ki	nM	0.88	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.88
	13406759	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414299	=	Ki	nM	0.23	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.23
	13406760	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(OC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2216902	=	Ki	nM	0.47	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.47
	13406761	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(NC3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414298	=	Ki	nM	0.9	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.9
	13406762	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(N(C)C3CN(C4CCS(=O)(=O)CC4)C3)n(C)c2n1		CHEMBL2414297	=	Ki	nM	0.59	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.59
	13406763	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(C(=O)N3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2414296	=	Ki	nM	3.1	CHEMBL3130	Homo sapiens	Ki(app)	nM	3.1
	13406764	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(C(=O)N3CCN(C(C)(C)C(N)=O)CC3)c(C)c2n1		CHEMBL2414295	=	Ki	nM	12.7	CHEMBL3130	Homo sapiens	Ki(app)	nM	12.7
	13406765	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(C(=O)N3CCN(C(C)(C)C(N)=O)CC3)n(C)c2n1		CHEMBL2414294	=	Ki	nM	0.8	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.8
	13406766	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCN(C(C)(C)C(N)=O)CC3)n(C)c2n1		CHEMBL2171939	=	Ki	nM	1.8	CHEMBL3130	Homo sapiens	Ki(app)	nM	1.8
	13406767	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CC(C)c1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171952	=	Ki	nM	2.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.0
	13406768	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	Cn1c(CN2CCC(C(C)(C)O)CC2)nc2c(N3CCOCC3)nc(-c3cccc4[nH]ncc34)nc21		CHEMBL2414239	=	Ki	nM	2.3	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.3
	13406769	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCC(C(C)(C)O)CC3)cc2n1		CHEMBL2165501	=	Ki	nM	5.5	CHEMBL3130	Homo sapiens	Ki(app)	nM	5.5
	13406770	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CC(C)(O)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2414238	=	Ki	nM	1.1	CHEMBL3130	Homo sapiens	Ki(app)	nM	1.1
	13406771	CHEMBL2415771	Inhibition of PI3Kdelta (unknown origin) assessed as formation of PIP3 by competitive fluorescence polarization assay	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C(C)(C)O)CC3)n(C)c2n1		CHEMBL2171944	=	Ki	nM	2.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.0
	13417310	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3C[C@@H]4C[C@H]3CO4)c3c(cnn3C)n2)cc1		CHEMBL2418351	=	Ki	nM	5147.0	CHEMBL3130	Homo sapiens	Ki	nM	5147.0
	13417311	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3CC)c3c(n2)c(C)nn3C)cc1		CHEMBL2418350	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417312	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3CC)c3c(cnn3C)n2)cc1		CHEMBL2418349	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417313	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(cnn3C)n2)cc1		CHEMBL2418348	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417314	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3CC)c3c(ccn3C)n2)cc1		CHEMBL2418347	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417315	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(ccn3C)n2)cc1		CHEMBL2418346	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417316	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCCOCC3)c3c(ncn3C)n2)cc1		CHEMBL2418345	=	IC50	nM	7300.0	CHEMBL3130	Homo sapiens	IC50	nM	7300.0
	13417317	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3CC)c3c(ncn3C)n2)cc1		CHEMBL2418344	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	13417318	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@H]3C)c3c(ncn3C)n2)cc1		CHEMBL2418343	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	nM	4000.0
	13417319	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(ncn3CC)n2)cc1		CHEMBL2418341	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417320	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3ncn(CC)c3n2)cc1		CHEMBL2418340	=	Ki	nM	630.0	CHEMBL3130	Homo sapiens	Ki	nM	630.0
	13417321	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(ncn3C)n2)cc1		CHEMBL2418339	>	Ki	nM	10000.0	CHEMBL3130	Homo sapiens	Ki	nM	10000.0
	13417322	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3c(n2)nc(C(C)(C)O)n3C)cc1		CHEMBL2418338	=	Ki	nM	7300.0	CHEMBL3130	Homo sapiens	Ki	nM	7300.0
	13417323	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3ncn(C)c3n2)cc1		CHEMBL2418337	=	Ki	nM	890.0	CHEMBL3130	Homo sapiens	Ki	nM	890.0
	13417324	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3nc(C(C)(C)O)n(C)c3n2)cc1		CHEMBL2418354	=	Ki	nM	490.0	CHEMBL3130	Homo sapiens	Ki	nM	490.0
	13417325	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)c3nc(C(C)(C)O)n(CCO)c3n2)cc1		CHEMBL2418353	=	Ki	nM	160.0	CHEMBL3130	Homo sapiens	Ki	nM	160.0
	13417326	CHEMBL2421128	Displacement of TAMRA-PIP3 from PI3Kdelta GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay	B	CC(C)(O)c1nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2n1CCO		CHEMBL2418352	=	Ki	nM	4.0	CHEMBL3130	Homo sapiens	Ki	nM	4.0
	13424287	CHEMBL2423424	Inhibition of PI-3K delta (unknown origin)	B	CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1		CHEMBL1086377	<	IC50	nM	0.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0001
	13425351	CHEMBL2423274	Inhibition of PI3Kdelta (unknown origin) using 1alpha-phosphotidylinositol by luminescence assay	B	CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1		CHEMBL2418954	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	13425352	CHEMBL2423274	Inhibition of PI3Kdelta (unknown origin) using 1alpha-phosphotidylinositol by luminescence assay	B	COC(=O)c1ccc2nc(NC(C)=O)sc2c1		CHEMBL2418960	>	IC50	nM	25000.0	CHEMBL3130	Homo sapiens	IC50	uM	25.0
	13425750	CHEMBL2423424	Inhibition of PI-3K delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	uM	0.22
	13425753	CHEMBL2423424	Inhibition of PI-3K delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	uM	0.03
Not Active	13508486	CHEMBL2447358	Inhibition of PI3Kdelta (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	13863508	CHEMBL3101987	Inhibition of PIK3CD (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	13863509	CHEMBL3101987	Inhibition of PIK3CD (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	13895016	CHEMBL3111948	Inhibition of PIK3CD (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	5.4	CHEMBL3130	Homo sapiens	Activity	%	5.4
	13895067	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(CO)cc1)Nc1cccc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109147	=	IC50	nM	836.0	CHEMBL3130	Homo sapiens	IC50	uM	0.836
	13895068	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1)Nc1cccnc1		CHEMBL3109146	=	IC50	nM	134.0	CHEMBL3130	Homo sapiens	IC50	uM	0.134
	13895069	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109145	=	IC50	nM	565.0	CHEMBL3130	Homo sapiens	IC50	uM	0.565
	13895070	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(O)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109144	=	IC50	nM	449.0	CHEMBL3130	Homo sapiens	IC50	uM	0.449
	13895071	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1)Nc1cccc(O)c1		CHEMBL3109143	=	IC50	nM	770.0	CHEMBL3130	Homo sapiens	IC50	uM	0.77
	13895072	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	13895073	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=C(Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1)Nc1cccc(CO)c1		CHEMBL3109141	=	IC50	nM	104.0	CHEMBL3130	Homo sapiens	IC50	uM	0.104
	13895074	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	CNC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109140	=	IC50	nM	77.0	CHEMBL3130	Homo sapiens	IC50	uM	0.077
	13895075	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3cccnc3n2)cn1		CHEMBL3109139	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	uM	0.018
	13895076	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	OCc1cccc(-c2nc(N3CCOCC3)c3cccnc3n2)c1		CHEMBL3109138	=	IC50	nM	7600.0	CHEMBL3130	Homo sapiens	IC50	uM	7.6
	13895077	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3cccnc3n2)c1		CHEMBL3109137	=	IC50	nM	367.0	CHEMBL3130	Homo sapiens	IC50	uM	0.367
	13895078	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N(C(C)=O)c1ncc(-c2nc(N3CCOCC3)c3ncccc3n2)cn1		CHEMBL3109136	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895079	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)Nc1ncc(-c2nc(N3CCOCC3)c3ncccc3n2)cn1		CHEMBL3109135	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	uM	1.9
	13895080	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ncccc3n2)cn1		CHEMBL3109134	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	13895081	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cn1		CHEMBL3109133	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	uM	0.008
	13895082	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	c1cnc2c(N3CCOCC3)nc(-c3cccc4[nH]ncc34)nc2c1		CHEMBL3109132	=	IC50	nM	5280.0	CHEMBL3130	Homo sapiens	IC50	uM	5.28
	13895083	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	c1cnc2c(N3CCOCC3)nc(-c3ccc4cn[nH]c4c3)nc2c1		CHEMBL3109131	=	IC50	nM	26500.0	CHEMBL3130	Homo sapiens	IC50	uM	26.5
	13895084	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	c1cncc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109130	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895085	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109129	=	IC50	nM	11130.0	CHEMBL3130	Homo sapiens	IC50	uM	11.13
	13895086	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Nc1cccc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109128	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	13895087	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	OCc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109127	=	IC50	nM	1140.0	CHEMBL3130	Homo sapiens	IC50	uM	1.14
	13895088	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	OCc1cccc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109126	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	uM	0.024
	13895089	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109125	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895090	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	COc1cccc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109124	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895091	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109123	=	IC50	nM	1530.0	CHEMBL3130	Homo sapiens	IC50	uM	1.53
	13895092	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1ccccc1-c1nc(N2CCOCC2)c2ncccc2n1		CHEMBL3109122	=	IC50	nM	24030.0	CHEMBL3130	Homo sapiens	IC50	uM	24.03
	13895093	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	C[C@H]1CN(c2nc(-c3cccc(O)c3)nc3cccnc23)C[C@@H](C)O1		CHEMBL3109121	=	IC50	nM	687.0	CHEMBL3130	Homo sapiens	IC50	uM	0.687
	13895094	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1cccc(-c2nc(N3CCC(F)(F)CC3)c3ncccc3n2)c1		CHEMBL3109120	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895095	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	CN1CCN(c2nc(-c3cccc(O)c3)nc3cccnc23)CC1		CHEMBL3109119	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895096	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	O=S1(=O)CCN(c2nc(-c3cccc(O)c3)nc3cccnc23)CC1		CHEMBL3109118	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895097	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1cccc(-c2nc(N3CCSCC3)c3ncccc3n2)c1		CHEMBL3109117	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	13895098	CHEMBL3112127	Inhibition of PI3Kdelta (unknown origin) after 1 hr by TR-FRET assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3ncccc3n2)c1		CHEMBL3109116	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	13917237	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112867	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	13917238	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112866	=	IC50	nM	468.0	CHEMBL3130	Homo sapiens	IC50	nM	468.0
	13917239	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1(C)CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112865	=	IC50	nM	278.0	CHEMBL3130	Homo sapiens	IC50	nM	278.0
	13917240	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)c2ccccc21		CHEMBL3112864	=	IC50	nM	87.0	CHEMBL3130	Homo sapiens	IC50	nM	87.0
	13917241	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1(C)Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112863	=	IC50	nM	580.0	CHEMBL3130	Homo sapiens	IC50	nM	580.0
	13917242	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112862	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	13917423	CHEMBL3117352	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	13917431	CHEMBL3117352	Inhibition of PI3Kdelta (unknown origin)	B	CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL3115681	=	IC50	nM	144.0	CHEMBL3130	Homo sapiens	IC50	nM	144.0
	13918189	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cn1c(CC(=O)N2CCc3ccccc32)nc(N2CCOCC2)cc1=O		CHEMBL3112861	=	IC50	nM	278.0	CHEMBL3130	Homo sapiens	IC50	nM	278.0
	13918190	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CN1CCN(Cc2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112860	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	13918191	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	CN1CCN(c2cccc3c2CCN3C(=O)Cc2nc(N3CCOCC3)cc(=O)[nH]2)CC1		CHEMBL3112859	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	13918192	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccncc3)cccc21		CHEMBL3112858	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	13918193	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3cccnc3)cccc21		CHEMBL3112857	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	13918194	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccn3)cccc21		CHEMBL3112856	=	IC50	nM	106.0	CHEMBL3130	Homo sapiens	IC50	nM	106.0
	13918195	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(-c3ccccc3)cccc21		CHEMBL3112855	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	13918196	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(OC(F)(F)F)cccc21		CHEMBL3112854	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	13918197	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c1cccc2C(F)(F)F		CHEMBL3112853	=	IC50	nM	98.0	CHEMBL3130	Homo sapiens	IC50	nM	98.0
	13918198	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	COc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112852	=	IC50	nM	648.0	CHEMBL3130	Homo sapiens	IC50	nM	648.0
	13918199	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cc1cccc2c1CCN2C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1		CHEMBL3112851	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	13918200	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Br)cccc21		CHEMBL3112850	=	IC50	nM	55.0	CHEMBL3130	Homo sapiens	IC50	nM	55.0
	13918201	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(Cl)cccc21		CHEMBL3112849	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	13918202	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2c(F)cccc21		CHEMBL3112848	=	IC50	nM	122.0	CHEMBL3130	Homo sapiens	IC50	nM	122.0
	13918203	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(Cl)ccc21		CHEMBL3112592	=	IC50	nM	4135.0	CHEMBL3130	Homo sapiens	IC50	nM	4135.0
	13918204	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2cc(F)ccc21		CHEMBL3112847	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	13918205	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	O=C(Cc1nc(N2CCOCC2)cc(=O)[nH]1)N1CCc2ccccc21		CHEMBL3112690	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
	13918206	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cn1c(Cc2nc(N3CCOCC3)cc(=O)[nH]2)nc2ccccc21		CHEMBL2064330	=	IC50	nM	1395.0	CHEMBL3130	Homo sapiens	IC50	nM	1395.0
	13918207	CHEMBL3119745	Inhibition of N-terminal ploy-His-tagged human PI3Kdelta expressed in baculovirus-infected sf9 cells using PI(4,5)P2 as substrate after 15 mins by HTRF assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	851.0	CHEMBL3130	Homo sapiens	IC50	nM	851.0
	13943738	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125375	=	IC50	nM	127.0	CHEMBL3130	Homo sapiens	IC50	nM	127.0
	13943862	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125377	=	IC50	nM	2723.0	CHEMBL3130	Homo sapiens	IC50	nM	2723.0
	13943867	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Cl)ccc21		CHEMBL3125392	=	IC50	nM	1863.0	CHEMBL3130	Homo sapiens	IC50	nM	1863.0
	13943870	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125376	=	IC50	nM	1555.0	CHEMBL3130	Homo sapiens	IC50	nM	1555.0
	13943875	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125382	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	13943877	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	861.0	CHEMBL3130	Homo sapiens	IC50	nM	861.0
	13943879	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1CN(C(=O)Cc2nc(N3CCOCC3)sc2C(N)=O)c2ccccc21		CHEMBL3125387	=	IC50	nM	567.0	CHEMBL3130	Homo sapiens	IC50	nM	567.0
	13943880	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(F)cccc21		CHEMBL3125388	=	IC50	nM	485.0	CHEMBL3130	Homo sapiens	IC50	nM	485.0
	13943881	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(Br)ccc21		CHEMBL3125393	=	IC50	nM	483.0	CHEMBL3130	Homo sapiens	IC50	nM	483.0
	13943882	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125386	=	IC50	nM	435.0	CHEMBL3130	Homo sapiens	IC50	nM	435.0
	13943883	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	430.0	CHEMBL3130	Homo sapiens	IC50	nM	430.0
	13943889	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125389	=	IC50	nM	277.0	CHEMBL3130	Homo sapiens	IC50	nM	277.0
	13943891	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Cl)cccc21		CHEMBL3125378	=	IC50	nM	245.0	CHEMBL3130	Homo sapiens	IC50	nM	245.0
	13943893	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2ccccc21		CHEMBL3125385	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	13943894	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)Nc1ccc(F)c(Cl)c1		CHEMBL3125541	=	IC50	nM	227.0	CHEMBL3130	Homo sapiens	IC50	nM	227.0
	13943895	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2cc(F)ccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125381	=	IC50	nM	219.0	CHEMBL3130	Homo sapiens	IC50	nM	219.0
	13943896	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125390	=	IC50	nM	178.0	CHEMBL3130	Homo sapiens	IC50	nM	178.0
	13943899	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125379	=	IC50	nM	149.0	CHEMBL3130	Homo sapiens	IC50	nM	149.0
	13943902	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	NC(=O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125391	=	IC50	nM	134.0	CHEMBL3130	Homo sapiens	IC50	nM	134.0
	13943903	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2c(Br)cccc21		CHEMBL3125383	=	IC50	nM	133.0	CHEMBL3130	Homo sapiens	IC50	nM	133.0
	13943907	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125395	=	IC50	nM	92.0	CHEMBL3130	Homo sapiens	IC50	nM	92.0
	13943911	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	O=C(O)c1sc(N2CCOCC2)nc1CC(=O)N1CCc2cc(F)ccc21		CHEMBL3125380	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	nM	64.0
	13943912	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Br)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(=O)O		CHEMBL3125384	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
	13943913	CHEMBL3129533	Inhibition of human PI3Kdelta after 15 mins	B	CC1Cc2c(Cl)cccc2N1C(=O)Cc1nc(N2CCOCC2)sc1C(N)=O		CHEMBL3125394	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	13967090	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	N#Cc1cc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)ccc1NCCN1CCOCC1		CHEMBL3134265	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	uM	0.24
	13967091	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	CN(C)CCN(C)c1ccc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)cc1C#N		CHEMBL3134282	=	IC50	nM	640.0	CHEMBL3130	Homo sapiens	IC50	uM	0.64
	13967092	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	CN(C)CCN(C)c1ccc(C#N)cc1S(=O)(=O)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134281	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	uM	2.0
	13967093	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	CN(C)CCN(C)c1ccc(C#N)cc1[S+]([O-])c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134280	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	13967094	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	N#Cc1cc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)ccc1F		CHEMBL3134279	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	13967095	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	N#Cc1ccc(F)c(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134278	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	uM	0.44
	13967096	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	N#Cc1ccc(F)c([S+]([O-])c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134277	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	uM	0.2
	13967097	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccccc1[S+]([O-])c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134276	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967098	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	O=[N+]([O-])c1cccc(S(=O)(=O)c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134275	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	13967099	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	O=[N+]([O-])c1cccc([S+]([O-])c2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134274	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	uM	0.32
	13967100	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	O=[N+]([O-])c1cccc(Sc2nc(-c3cnn4ccc(Br)cc34)cs2)c1		CHEMBL3134273	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967101	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)/N=c1/scc(-c2cnn3ccc(Br)cc23)n1C		CHEMBL3134272	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967102	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134271	=	IC50	nM	1550.0	CHEMBL3130	Homo sapiens	IC50	uM	1.55
	13967103	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1CS(=O)(=O)c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134270	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967104	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1Nc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134269	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967105	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Cc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134268	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	13967106	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134267	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967107	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1CSc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134266	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967108	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1Cc1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134297	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967109	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1-c1nc(-c2cnn3ccc(Br)cc23)cs1		CHEMBL3134296	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967110	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134295	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967111	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)NC1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134294	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967112	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134293	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967113	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134292	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967114	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134291	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967115	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N[C@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134290	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967116	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)NC1CN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134289	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967117	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134288	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967118	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134287	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967119	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CCN(Cc2cnn3ccc(C#N)cc23)CC1		CHEMBL3134286	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967120	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134285	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967121	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CCCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134284	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967122	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134283	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967123	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CCN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134303	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967124	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CN(Cc2cnn3ccc(C#N)cc23)C1		CHEMBL3134302	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967125	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1C(=O)N1CCC(c2cnn3ccc(Br)cc23)CC1		CHEMBL3134301	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967126	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCC(c2cnn3ccc(Br)cc23)CC1		CHEMBL3134300	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967127	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCCC(c2cnn3ccc(Br)cc23)C1		CHEMBL3134299	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967128	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N1CCC(c2cnn3ccc(Br)cc23)C1		CHEMBL3134298	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	13967129	CHEMBL3134980	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)C/C=C/c1cnn2ccc(Br)cc12		CHEMBL3132876	=	IC50	nM	3350.0	CHEMBL3130	Homo sapiens	IC50	uM	3.35
	14553166	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0025
	14553167	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	14553170	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	14553171	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	14553194	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc2c(c1OC)N=C(NC(=O)c1cccnc1)N1CCN=C21		CHEMBL1241857	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	uM	0.058
	14553203	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)/N=c1/[nH]c(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1		CHEMBL1229535	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	14553209	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	14553216	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	14553217	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL2064328	=	IC50	nM	260.0	CHEMBL3130	Homo sapiens	IC50	uM	0.26
	14553221	CHEMBL3223607	Inhibition of PI3Kdelta (unknown origin) by lipid kinase assay	B	O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1		CHEMBL568150	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	uM	0.3
	14553223	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	O=C1NC(=S)S/C1=C/c1ccc2c(c1)N(Cc1ccc(F)c(Cl)c1)C(=O)CO2		CHEMBL3218571	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	uM	0.34
	14553231	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	14553236	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1cc(Oc2ccccc2C)c2[nH]c(N3CCOCC3)cc(=O)c2c1		CHEMBL3218572	=	IC50	nM	630.0	CHEMBL3130	Homo sapiens	IC50	uM	0.63
	14553238	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	14553240	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1cc(NCc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3218574	=	IC50	nM	870.0	CHEMBL3130	Homo sapiens	IC50	uM	0.87
	14553243	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1cc(C(C)Nc2ccccc2)c2oc(-c3ccncc3)cc(=O)c2c1		CHEMBL3218573	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	14553262	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	N=C(N)NCCCC(NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)[O-]		CHEMBL3218580	=	IC50	nM	3225.0	CHEMBL3130	Homo sapiens	IC50	uM	3.225
	14553271	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	14553272	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	O=Cc1ccc(N2CCOCC2)cc1O		CHEMBL2181110	=	IC50	nM	5100.0	CHEMBL3130	Homo sapiens	IC50	uM	5.1
	14553274	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	14553288	CHEMBL3223607	Inhibition of PI3Kdelta (unknown origin) by lipid kinase assay	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	uM	20.0
	14553290	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	IC50	nM	22000.0	CHEMBL3130	Homo sapiens	IC50	uM	22.0
	14553294	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	14553298	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1		CHEMBL3349370	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	14553304	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113	=	IC50	nM	75000.0	CHEMBL3130	Homo sapiens	IC50	uM	75.0
	14553305	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190	=	IC50	nM	75000.0	CHEMBL3130	Homo sapiens	IC50	uM	75.0
	14553338	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	14553342	CHEMBL3223609	Inhibition of PI3Kdelta (unknown origin)	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	14664281	CHEMBL3271253	Inhibition of PIK3CD (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	14664282	CHEMBL3271253	Inhibition of PIK3CD (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	78.0	CHEMBL3130	Homo sapiens	INH	%	78.0
	14664283	CHEMBL3271253	Inhibition of PIK3CD (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	55.0	CHEMBL3130	Homo sapiens	INH	%	55.0
	14743615	CHEMBL3293771	Inhibition of human PI3K-delta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	14743616	CHEMBL3293771	Inhibition of human PI3K-delta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1cc(-c2ccc3ncc4c(c3c2)n(-c2ccc(C(C)(C)C#N)cc2)c(=O)n4C)cn1		CHEMBL3290293	=	IC50	nM	794.0	CHEMBL3130	Homo sapiens	IC50	uM	0.794
	14743617	CHEMBL3293771	Inhibition of human PI3K-delta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3ccccc3ncc21		CHEMBL3290300	=	IC50	nM	15849.0	CHEMBL3130	Homo sapiens	IC50	uM	15.849
	14743618	CHEMBL3293771	Inhibition of human PI3K-delta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	Cc1ccc(-n2c(=O)n(C)c3cnc4ccc(-c5ccncc5)cc4c32)cc1		CHEMBL3290305	=	IC50	nM	2512.0	CHEMBL3130	Homo sapiens	IC50	uM	2.512
	14743619	CHEMBL3293771	Inhibition of human PI3K-delta assessed as inhibition of Ptdlns(3,4,5)P3 phosphorylation after 1 hr by TR-FRET analysis	B	COc1ccc(-n2c(=O)n(C)c3cnc4ccc(-c5ccncc5)cc4c32)cc1		CHEMBL3290307	=	IC50	nM	2512.0	CHEMBL3130	Homo sapiens	IC50	uM	2.512
	14977842	CHEMBL3376675	Inhibition of human PI3KCdelta by non-radiometric ADP-Glo assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	uM	0.006
	14977843	CHEMBL3376675	Inhibition of human PI3KCdelta by non-radiometric ADP-Glo assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	14977844	CHEMBL3376675	Inhibition of human PI3KCdelta by non-radiometric ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	uM	0.025
	14977891	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CSC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3355021	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	14977894	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CSC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3355021	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	14977897	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cc(F)cc(F)c2c(=O)n1-c1ccccc1		CHEMBL3355019	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	uM	0.043
	14977898	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3355018	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	14977899	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1C1CCOCC1		CHEMBL3355017	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	uM	0.008
	14977900	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3355015	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	14977903	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1N1CCOCC1		CHEMBL3355016	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	14977906	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1N1CCOCC1		CHEMBL3355016	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	14977913	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	COc1cccc2nc([C@@H]3CCCN3c3ncnc(N)c3C#N)n(-c3ccccc3)c(=O)c12		CHEMBL3355014	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	uM	0.076
	14977916	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3355015	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	14977922	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	Cn1cnc2c(N3CCC[C@H]3c3nc4cccc(Cl)c4c(=O)n3-c3ccccc3)nc(N)nc21		CHEMBL3355013	=	IC50	nM	52.0	CHEMBL3130	Homo sapiens	IC50	uM	0.052
	14977925	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	Cn1cnc2c(N3CCC[C@H]3c3nc4cccc(Cl)c4c(=O)n3-c3ccccc3)nc(N)nc21		CHEMBL3355013	=	IC50	nM	52.0	CHEMBL3130	Homo sapiens	IC50	uM	0.052
	14977928	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	COc1cccc2nc([C@@H]3CCCN3c3ncnc(N)c3C#N)n(-c3ccccc3)c(=O)c12		CHEMBL3355014	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	uM	0.076
	14977929	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1cnc(N)nc1N1CCC[C@H]1c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3355020	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	uM	0.023
	14977930	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cc(F)cc(F)c2c(=O)n1-c1ccccc1		CHEMBL3355019	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	uM	0.043
	14977931	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3355018	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	14977932	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1C1CCOCC1		CHEMBL3355017	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	uM	0.008
	14977933	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3355012	<	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	14977936	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3355012	<	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	14977944	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	Cc1ccccc1-n1c([C@@H]2CCCN2c2ncnc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3355011	<	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	14977947	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	Cc1ccccc1-n1c([C@@H]2CCCN2c2ncnc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3355011	<	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	14979124	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	N#Cc1cnc(N)nc1N1CCC[C@H]1c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3355020	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	uM	0.023
	14979130	CHEMBL3379043	Inhibition of PI3Kdelta (unknown origin) by TR-FRET assay	B	CO[C@H]1C[C@@H](c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)N(c2ncnc(N)c2C#N)C1		CHEMBL3355022	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	14979133	CHEMBL3379046	Inhibition of PI3Kdelta (unknown origin) assessed as PI3Kalpha-mediated Akt1/2 (S473) phosphorylation rate by cellular assay	B	CO[C@H]1C[C@@H](c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)N(c2ncnc(N)c2C#N)C1		CHEMBL3355022	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
Not Active	14979383	CHEMBL3372414	Inhibition of PI3Kdelta (unknown origin) at <8 uM	B	C[C@@H]1COCCN1c1nc(-c2cncc3[nH]ccc23)cc2c1ncn2[C@@H](C)S(C)(=O)=O		CHEMBL3355474		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	14998944	CHEMBL3368180	Inhibition of human recombinant PI3Kdelta assessed as PIP3 production by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	uM	0.08
	14998945	CHEMBL3368180	Inhibition of human recombinant PI3Kdelta assessed as PIP3 production by AlphaScreen assay	B	C[C@@H](Oc1ccccc1)c1cc(C(=O)N(C)CCO)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318728	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	uM	0.4
	15002506	CHEMBL3366582	Inhibition of PIK3CD (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	4.4	CHEMBL3130	Homo sapiens	Activity	%	4.4
	15063401	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccccc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318711	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	15063402	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccccc1)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3318715	=	IC50	nM	85.0	CHEMBL3130	Homo sapiens	IC50	uM	0.085
	15063403	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1cccc(Cl)c1F)c1cc(C(=O)NCCN(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319485	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	uM	0.051
	15063404	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319486	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	uM	0.23
	15063405	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	CC(Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319489	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	uM	0.045
	15063406	CHEMBL3366870	Inhibition of human recombinant PI3Kdelta assessed as depletion of ATP substrate by Ultra Glo luciferase assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3319490	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	uM	0.032
	15152472	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1600.0	CHEMBL3130	Homo sapiens	IC50	uM	1.6
	15152473	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	Cc1c(CN2CCN(C(=O)[C@@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1921986	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	15152474	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	3.8	CHEMBL3130	Homo sapiens	IC50	nM	3.8
	15152475	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	CCn1nnc2c(N3CCOCC3)nc(-c3ccc(NC(=O)Nc4ccc(C(=O)N5CCN(C)CC5)cc4)cc3)nc21		CHEMBL589258	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	15152476	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	15152477	CHEMBL3395878	Inhibition of PI3K p110delta (unknown origin)	B	Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C		CHEMBL3393066	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	15165879	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(C)ccc3n1CCO2		CHEMBL3403813	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15165880	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(F)ccc3n1CCO2		CHEMBL3401243	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15165881	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Fc1ccc2c(c1)nc1n2CCOc2ccc(Cl)cc2-1		CHEMBL3401244	=	IC50	nM	42618.0	CHEMBL3130	Homo sapiens	IC50	uM	42.618
	15165882	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Fc1ccc2c(c1)nc1n2CCOc2ccc(Br)cc2-1		CHEMBL3401245	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15165883	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Clc1ccc2c(c1)-c1nc3cc(Cl)ccc3n1CCO2		CHEMBL3401248	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15165884	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Clc1ccc2c(c1)nc1n2CCOc2ccc(Br)cc2-1		CHEMBL3401249	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15166407	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(S(C)(=O)=O)c1-c1ccccc1		CHEMBL3403664	=	IC50	nM	0.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0001
	15166408	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	COc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403665	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	uM	0.0008
	15166409	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(O)c1-c1ccccc1		CHEMBL3403666	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	uM	0.0028
	15166410	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccc1		CHEMBL3403668	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	15166411	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCO)c1-c1ccccc1		CHEMBL3403669	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0031
	15166412	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	COCCNc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403670	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0024
	15166413	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCS(C)(=O)=O)c1-c1ccccc1		CHEMBL2216892	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0005
	15166414	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(Cl)c1-c1ccccn1		CHEMBL3403673	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	15166415	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N(C)C)c1-c1ccccn1		CHEMBL3403674	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0036
	15166416	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CC(O)C2)c1-c1ccccn1		CHEMBL3403675	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0014
	15166417	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CCOCC2)c1-c1ccccn1		CHEMBL3403676	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0012
	15166418	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	COCc1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3400185	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0031
	15166419	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccn1		CHEMBL3403677	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	15166420	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(-c2ccccn2)c1-c1ccccn1		CHEMBL3403678	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0046
	15166421	CHEMBL3404165	Inhibition of PI3Kdelta (unknown origin) assessed as inhibition of AKT phosphorylation by cell-based HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	uM	0.0027
	15166581	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(Br)ccc3n1CCO2		CHEMBL3401251	=	IC50	nM	47763.0	CHEMBL3130	Homo sapiens	IC50	uM	47.763
	15166582	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Brc1ccc2c(c1)-c1nc3cc(Br)ccc3n1CCO2		CHEMBL3401253	=	IC50	nM	39842.0	CHEMBL3130	Homo sapiens	IC50	uM	39.842
	15166583	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc([N+](=O)[O-])ccc3n1CCO2		CHEMBL3401255	=	IC50	nM	34624.0	CHEMBL3130	Homo sapiens	IC50	uM	34.624
	15166584	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	Cc1ccc2c(c1)-c1nc3cc(C(F)(F)F)ccc3n1CCO2		CHEMBL3401259	>	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	uM	50.0
	15166585	CHEMBL3405881	Inhibition of recombinant PI3Kdelta (unknown origin) using PI(3,4)P2 as substrate after 3 hrs incubation by competitive fluorescence polarization kinase activity assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1362.0	CHEMBL3130	Homo sapiens	IC50	uM	1.362
	15168808	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(S(C)(=O)=O)c1-c1ccccc1		CHEMBL3403664	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	uM	0.0007
	15168809	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	COc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403665	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0012
	15168810	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(O)c1-c1ccccc1		CHEMBL3403666	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	15168811	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c([S+]([O-])CCO)c1-c1ccccc1		CHEMBL3403667	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0025
	15168812	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccc1		CHEMBL3403668	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0013
	15168813	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCO)c1-c1ccccc1		CHEMBL3403669	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0004
	15168814	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	COCCNc1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403670	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0006
	15168815	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCN(C)C)c1-c1ccccc1		CHEMBL3403671	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	uM	0.0017
	15168816	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(NCCS(C)(=O)=O)c1-c1ccccc1		CHEMBL2216892	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0002
	15168817	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2cc1-c1ccccn1		CHEMBL3403672	=	IC50	nM	8.8	CHEMBL3130	Homo sapiens	IC50	uM	0.0088
	15168818	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(Cl)c1-c1ccccn1		CHEMBL3403673	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	15168819	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N(C)C)c1-c1ccccn1		CHEMBL3403674	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0014
	15168820	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CC(O)C2)c1-c1ccccn1		CHEMBL3403675	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	uM	0.018
	15168821	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(N2CCOCC2)c1-c1ccccn1		CHEMBL3403676	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0012
	15168822	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	COCc1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3400185	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	15168823	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C#N)c1-c1ccccn1		CHEMBL3403677	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0083
	15168824	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(-c2ccccn2)c1-c1ccccn1		CHEMBL3403678	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0024
	15168825	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	Cc1cccnc1-c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL3403679	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	uM	0.015
	15168826	CHEMBL3404161	Inhibition of PI3Kdelta (unknown origin) by biochemical Alphascreen assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	uM	0.024
	15173834	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Fc1cnc2[nH]cc(-c3ncc(F)c(N[C@H]4C5CCC(CC5)[C@@H]4c4nnn[nH]4)n3)c2c1		CHEMBL3401975	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15173835	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	O=P(O)(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401976	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174737	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	O=P(O)(O)CC[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401977	=	Ki	nM	3100.0	CHEMBL3130	Homo sapiens	Ki	uM	3.1
	15174738	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	O=c1[nH]c(=O)n(C[C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401978	=	Ki	nM	180.0	CHEMBL3130	Homo sapiens	Ki	uM	0.18
	15174739	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)no1		CHEMBL3401979	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174740	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401980	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174741	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)on1		CHEMBL3401981	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174742	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	O=c1nc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]o1		CHEMBL3401982	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174743	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	NS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401983	=	Ki	nM	1900.0	CHEMBL3130	Homo sapiens	Ki	uM	1.9
	15174744	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	OCC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401984	=	Ki	nM	1600.0	CHEMBL3130	Homo sapiens	Ki	uM	1.6
	15174745	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)[nH]n1		CHEMBL3401985	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174746	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	CNC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401986	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174747	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	CC(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401987	>	Ki	nM	4000.0	CHEMBL3130	Homo sapiens	Ki	uM	4.0
	15174748	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Cc1noc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)n1		CHEMBL3401988	=	Ki	nM	2500.0	CHEMBL3130	Homo sapiens	Ki	uM	2.5
	15174749	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nnc([C@H]2C3CCC(CC3)[C@@H]2Nc2nc(-c3c[nH]c4ncc(F)cc34)ncc2F)o1		CHEMBL3401989	=	Ki	nM	1200.0	CHEMBL3130	Homo sapiens	Ki	uM	1.2
	15174750	CHEMBL3406125	Inhibition of PI3Kdelta (unknown origin)	B	CS(=O)(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3401990	=	Ki	nM	3300.0	CHEMBL3130	Homo sapiens	Ki	uM	3.3
	15196306	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1ccc(F)cc1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408244	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	15196307	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3407508	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	uM	0.073
	15196308	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408245	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	uM	0.073
	15196309	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cccc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408246	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	uM	0.076
	15196310	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1ccc(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408247	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	uM	0.032
	15196311	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	15196312	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)ccc1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408249	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	15196313	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cccc(Cl)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408250	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	uM	0.022
	15196314	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1ccc(F)c(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408251	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	uM	0.064
	15196315	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408252	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	15196316	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	Cc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408253	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	15196317	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	COc1cc(F)cc(NC(C)c2cc(C(=O)N(C)C)cc3c(=O)cc(N4CCOCC4)oc23)c1		CHEMBL3408254	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	uM	0.061
	15196318	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(Cl)cc(Cl)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408255	=	IC50	nM	52.0	CHEMBL3130	Homo sapiens	IC50	uM	0.052
	15196319	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)c(F)c(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408256	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	uM	0.023
	15196320	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1F)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408257	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	uM	0.041
	15196321	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408258	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	uM	0.059
	15196322	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	COCCN(C)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408259	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	uM	0.16
	15196323	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408260	=	IC50	nM	62.0	CHEMBL3130	Homo sapiens	IC50	uM	0.062
	15196324	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CCN(CC)C(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408261	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	uM	0.071
	15196325	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408262	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	15196326	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408263	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	15196327	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCCCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408264	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	uM	0.059
	15196328	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCOCC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408265	=	IC50	nM	115.0	CHEMBL3130	Homo sapiens	IC50	uM	0.115
	15196329	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408266	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	15196330	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CNC(=O)c1cc([C@@H](C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408267	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	15196331	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408268	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	uM	0.044
	15196332	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	COCCNC(=O)c1cc(C(C)Nc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408269	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	uM	0.054
	15196333	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408270	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	uM	0.012
	15196334	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc([C@H](C)Nc4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3408271	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
	15196335	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CN(C)C(=O)c1cc(CNc2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408272	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	uM	0.08
	15196336	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	15196337	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408274	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	uM	0.073
	15196338	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@@H](Oc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408275	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	uM	0.16
	15196339	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	CC(c1cc(C(=O)N2CCCC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408276	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	15196340	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N(C)CCO)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408277	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	uM	0.053
	15196341	CHEMBL3411218	Inhibition of human recombinant PI3Kdelta using PIP2 by Kinase-Glo Plus assay	B	C[C@H](c1cc(C(=O)N2CCC(O)CC2)cc2c(=O)cc(N3CCOCC3)oc12)N(C)c1cc(F)cc(F)c1		CHEMBL3408278	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	uM	0.082
	15197143	CHEMBL3413524	Inhibition of recombinant PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate	B	C[C@H]1COCCN1c1cc(C2(S(=O)(=O)C3CC3)CC2)nc(-c2ccc(NC(=S)NCCO)cc2)n1		CHEMBL3410672	=	IC50	nM	9332.54	CHEMBL3130	Homo sapiens	pIC50		5.03
	15197705	CHEMBL3411226	Inhibition of PI3Kdelta in human Jeko B cells assessed as inhibition of Akt phosphorylation after 2 hrs	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	uM	0.017
	15245306	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNC(C)=O)cc(C)nc23)cc1OC		CHEMBL3426594	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245307	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNC(=O)C(C)C)cc(C)nc23)cc1OC		CHEMBL3426595	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245308	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCNS(C)(=O)=O)cc(C)nc23)cc1OC		CHEMBL3426596	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245309	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCOC(C)=O)cc(C)nc23)cc1OC		CHEMBL3426597	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245310	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCN4CCOCC4)ccnn23)cc1OC		CHEMBL3426598	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245311	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)cc1OC		CHEMBL3426599	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245312	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)NCCNc1cc(Cl)nn2c(-c3ccc(F)c(C=O)c3)c(C)nc12		CHEMBL3426600	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245313	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)NCCNc1cc(Cl)nn2c(-c3cccc(S(=O)(=O)NC(C)C)c3)c(C)nc12		CHEMBL3426601	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245314	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)ccnn23)cc1OC		CHEMBL3426602	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245315	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nc3c(N)cc(Cl)nn23)cc1OC		CHEMBL3426603	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15245316	CHEMBL3429708	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2c(C)nn3c(NCCN4CCOCC4)cc(C)nc23)cc1OC		CHEMBL2397317	<=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15608382	CHEMBL3579765	Inhibition of PI3Kdelta (unknown origin) using PIP2/PS as substrate after 1 hr by luciferase-based luminescence assay	B	COc1ncc(-c2cc3c(-c4ccncc4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3577921	=	IC50	nM	13.3	CHEMBL3130	Homo sapiens	IC50	nM	13.3
	15608383	CHEMBL3579765	Inhibition of PI3Kdelta (unknown origin) using PIP2/PS as substrate after 1 hr by luciferase-based luminescence assay	B	O=S(=O)(Nc1cc(-c2cc3c(-c4ccncc4)ncnc3s2)cnc1Cl)c1ccc(F)cc1F		CHEMBL3577925	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	nM	3.1
	15615254	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NCCc3ccccc3F)c2)cn1		CHEMBL3582350	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	15615255	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NCCC(C)C)c2)cn1		CHEMBL3582351	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
Not Determined	15615560	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COC(=O)c1cc(I)cc(CNc2ccc(S(=O)(=O)Nc3nnc(C)s3)cc2)c1		CHEMBL3582352		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	15615561	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COC(=O)c1cc(CNc2ccc(S(=O)(=O)Nc3nnc(C)s3)cc2)cc(-c2ccc(OC)nc2)c1		CHEMBL3582353		IC50			CHEMBL3130	Homo sapiens	IC50		
	15615562	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)O)c2)cn1		CHEMBL3582354	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	nM	59.0
	15615563	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cccc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)c2)cn1		CHEMBL3582355	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
	15615564	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nnc(NS(=O)(=O)c2ccc(NCc3cc(C(=O)O)cc(-c4ccc5c(c4)OCCO5)c3)cc2)s1		CHEMBL3582356	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	IC50	nM	63.1
	15615565	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nnc(NS(=O)(=O)c2ccc(NCc3cc(C(=O)O)cc(-c4ccc5c(c4)OCO5)c3)cc2)s1		CHEMBL3582357	=	IC50	nM	199.0	CHEMBL3130	Homo sapiens	IC50	nM	199.0
	15615566	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)N(C)c4nnc(C)s4)cc3)cc(C(=O)NCCc3ccccc3F)c2)cn1		CHEMBL3582358	=	IC50	nM	2000.0	CHEMBL3130	Homo sapiens	IC50	nM	2000.0
	15615567	CHEMBL3584208	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(-c2cc(CNc3ccc(S(=O)(=O)Nc4nnc(C)s4)cc3)cc(C(=O)NC(CO)CO)c2)cn1		CHEMBL3582359	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	15627180	CHEMBL3587146	Inhibition of PI3Kdelta in human THP1 cells assessed as inhibition of CSF1-stimulated chemotaxis pre-incubated for 1 hr before MCP1 stimulation	B	COc1cc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)cnc1Cl		CHEMBL3585362	>	IC50	nM	20000.0	CHEMBL3130	Homo sapiens	IC50	uM	20.0
	15628796	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL1972466	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	15628797	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(C(C)N(C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585581	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	uM	0.22
	15628798	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CNc3ccccc3)cccn12		CHEMBL3585582	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	15628799	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	CN(Cc1cccn2c(=O)cc(N3CCOCC3)nc12)c1ccccc1		CHEMBL3585583	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	15628800	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1NCc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585584	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	15628801	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585585	=	IC50	nM	810.0	CHEMBL3130	Homo sapiens	IC50	uM	0.81
	15628802	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585586	=	IC50	nM	710.0	CHEMBL3130	Homo sapiens	IC50	uM	0.71
	15628803	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CNc3ccc(Cl)cc3)cccn12		CHEMBL3585587	=	IC50	nM	1100.0	CHEMBL3130	Homo sapiens	IC50	uM	1.1
	15628804	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	COc1ccc(NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585588	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	uM	0.24
	15628805	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(S(=O)(=O)NCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585589	=	IC50	nM	600.0	CHEMBL3130	Homo sapiens	IC50	uM	0.6
	15628806	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CS(=O)(=O)c3ccccc3)cccn12		CHEMBL3585351	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15628807	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(CSc3ccccc3)cccn12		CHEMBL3585590	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	uM	0.57
	15628808	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(COc3ccccc3)cccn12		CHEMBL3585591	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	15628809	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585592	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	uM	0.55
	15628810	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	COc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585593	=	IC50	nM	460.0	CHEMBL3130	Homo sapiens	IC50	uM	0.46
	15628811	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	N#Cc1ccc(OCc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585594	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	15628812	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585595	=	IC50	nM	410.0	CHEMBL3130	Homo sapiens	IC50	uM	0.41
	15628813	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N(C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585596	=	IC50	nM	900.0	CHEMBL3130	Homo sapiens	IC50	uM	0.9
	15628814	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585597	=	IC50	nM	310.0	CHEMBL3130	Homo sapiens	IC50	uM	0.31
	15628815	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(Nc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585598	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	15628816	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(Nc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585599	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	15628817	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(Nc2c(C)cccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585600	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	uM	0.5
	15628818	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585601	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	uM	0.23
	15628819	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccc2C)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3218574	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	15628820	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(CNc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585602	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	uM	0.2
	15628821	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(CNc2cc(C)cn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585603	=	IC50	nM	640.0	CHEMBL3130	Homo sapiens	IC50	uM	0.64
	15628822	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccccn2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585604	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	15628823	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2cccnc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585605	=	IC50	nM	450.0	CHEMBL3130	Homo sapiens	IC50	uM	0.45
	15628824	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(NCc2ccncc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585606	=	IC50	nM	710.0	CHEMBL3130	Homo sapiens	IC50	uM	0.71
	15628825	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N[C@@H](C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585607	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	15628826	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cc(N[C@H](C)c2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3585608	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	15628827	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1ccccc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585609	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	uM	0.15
	15628828	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1NC(=O)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585610	=	IC50	nM	530.0	CHEMBL3130	Homo sapiens	IC50	uM	0.53
	15628829	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(NC(=O)c2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585611	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	uM	0.3
	15628830	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(NC(=O)c2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585612	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	uM	0.14
	15628831	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1ccccn1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585613	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15628832	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1cccnc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585614	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15628833	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(NCc1ccncc1)c1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585615	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15628834	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1cccn2c(=O)cc(N3CCOCC3)nc12)c1ccccc1		CHEMBL3585616	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	uM	0.22
	15628835	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccccc1C(=O)Nc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585617	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	15628836	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1cccc(C(=O)Nc2cccn3c(=O)cc(N4CCOCC4)nc23)c1		CHEMBL3585618	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	uM	0.47
	15628837	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	Cc1ccc(C(=O)Nc2cccn3c(=O)cc(N4CCOCC4)nc23)cc1		CHEMBL3585619	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	uM	0.03
	15628838	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=c1cc(N2CCOCC2)nc2c(NS(=O)(=O)c3ccccc3)cccn12		CHEMBL3585620	=	IC50	nM	1700.0	CHEMBL3130	Homo sapiens	IC50	uM	1.7
	15628839	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1ccccc1)Nc1cccn2c(=O)cc(N3CCOCC3)nc12		CHEMBL3585621	=	IC50	nM	480.0	CHEMBL3130	Homo sapiens	IC50	uM	0.48
	15628840	CHEMBL3587455	Inhibition of N-terminal His-tagged human p110delta expressed in Sf9 cells co-expressing p85alpha regulatory subunit using phosphatidylinositol substrate and [gamma-33P]-ATP by basic thin layer chromatography technique based lipid kinase assay	B	O=C(Nc1cccn2c(=O)cc(N3CCOCC3)nc12)Oc1ccccc1		CHEMBL3585622	=	IC50	nM	1800.0	CHEMBL3130	Homo sapiens	IC50	uM	1.8
	15633322	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c(N3CCOCC3)nc(-c3cccc(OC)c3)nc21		CHEMBL3589320	=	IC50	nM	14570.0	CHEMBL3130	Homo sapiens	IC50	uM	14.57
	15633323	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c(N3CCOCC3)nc(-c3ccc(OC)cc3)nc21		CHEMBL3589321	=	IC50	nM	20120.0	CHEMBL3130	Homo sapiens	IC50	uM	20.12
	15633324	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	COc1cccc(-c2nc(N3CCOCC3)c3c(n2)N(c2ccccc2)C(=S)N2CCCC32)c1		CHEMBL3589322	=	IC50	nM	71350.0	CHEMBL3130	Homo sapiens	IC50	uM	71.35
	15633325	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	COc1ccc(-c2nc(N3CCOCC3)c3c(n2)N(c2ccccc2)C(=S)N2CCCC32)cc1		CHEMBL3589323	=	IC50	nM	56890.0	CHEMBL3130	Homo sapiens	IC50	uM	56.89
	15633326	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(CN1CCOCC1)[nH]c2=O		CHEMBL3589324	=	IC50	nM	1020.0	CHEMBL3130	Homo sapiens	IC50	uM	1.02
	15633327	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(C(C)N1CCOCC1)[nH]c2=O		CHEMBL3589370	=	IC50	nM	880.0	CHEMBL3130	Homo sapiens	IC50	uM	0.88
	15633328	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	O=c1[nH]c(CN2CCOCC2)nc2c1C1CCCN1C(=S)N2c1ccccc1		CHEMBL3589371	=	IC50	nM	1680.0	CHEMBL3130	Homo sapiens	IC50	uM	1.68
	15633329	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CC(c1nc2c(c(=O)[nH]1)C1CCCN1C(=S)N2c1ccccc1)N1CCOCC1		CHEMBL3589372	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	uM	0.32
	15633330	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	S=C1N(c2ccccc2)c2nc(CN3CCOCC3)nc(N3CCOCC3)c2C2CCCN12	Outside typical range	CHEMBL3589373	=	IC50	nM	120000.0	CHEMBL3130	Homo sapiens	IC50	uM	120.0
	15633331	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CC(c1nc(N2CCOCC2)c2c(n1)N(c1ccccc1)C(=S)N1CCCC21)N1CCOCC1	Outside typical range	CHEMBL3589374	=	IC50	nM	154780.0	CHEMBL3130	Homo sapiens	IC50	uM	154.78
	15633332	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1cccc(O)c1)c(C#N)c2N1CCOCC1		CHEMBL3589375	=	IC50	nM	3550.0	CHEMBL3130	Homo sapiens	IC50	uM	3.55
	15633333	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1cccc(OC)c1)c(C#N)c2N1CCOCC1		CHEMBL3589376	=	IC50	nM	2740.0	CHEMBL3130	Homo sapiens	IC50	uM	2.74
	15633334	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)cc1)c(C#N)c2N1CCOCC1		CHEMBL3589377	=	IC50	nM	1810.0	CHEMBL3130	Homo sapiens	IC50	uM	1.81
	15633335	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)c(O)c1)c(C#N)c2N1CCOCC1		CHEMBL3589378	=	IC50	nM	3970.0	CHEMBL3130	Homo sapiens	IC50	uM	3.97
	15633336	CHEMBL3592015	Inhibition of GST-tagged p110delta (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay	B	CCN1C(=S)N2CCCC2c2c1nc(-c1ccc(OC)c(OC)c1)c(C#N)c2N1CCOCC1		CHEMBL3589379	=	IC50	nM	2610.0	CHEMBL3130	Homo sapiens	IC50	uM	2.61
	15637799	CHEMBL3591970	Inhibition of recombinant human PI3Kdelta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	15637800	CHEMBL3591970	Inhibition of recombinant human PI3Kdelta using PIP2/ATP as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by Kinase-Glo plus assay	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590222	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	uM	0.017
	15665863	CHEMBL3602859	Inhibition of recombinant PI3Kd (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	67.0	CHEMBL3130	Homo sapiens	INH	%	67.0
	15669869	CHEMBL3602346	Inhibition of PI3Kdelta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1		CHEMBL3601923	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	15669870	CHEMBL3602346	Inhibition of PI3Kdelta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1		CHEMBL3601925	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	15669871	CHEMBL3602346	Inhibition of PI3Kdelta (unknown origin) assessed as reduction of ATP level after 40 mins by luciferase based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	164.0	CHEMBL3130	Homo sapiens	IC50	nM	164.0
	15673147	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCOc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600683	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	15673148	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL1645105	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	15673149	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCSc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600684	=	IC50	nM	1995.26	CHEMBL3130	Homo sapiens	pIC50		5.7
	15673150	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600685	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	15673151	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CNCc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600686	=	IC50	nM	63095.73	CHEMBL3130	Homo sapiens	pIC50		4.2
	15673152	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)Oc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600687	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	15673153	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCNc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600688	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	15673154	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCN(C)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600689	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
Not Determined	15673155	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(CO)nc3)cc2s1		CHEMBL3600690		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	15673156	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600691	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	15673157	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(C(F)(F)F)nc3)cc2s1		CHEMBL3600692	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	15673158	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CS(=O)(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600693	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	15673159	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(OCCO)nc3)cc2s1		CHEMBL3600694	=	IC50	nM	1995.26	CHEMBL3130	Homo sapiens	pIC50		5.7
	15673160	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCCOc1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600695	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
Not Determined	15673161	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CNC(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600696		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	15673162	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CN(C)C(=O)c1ccc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600697	=	IC50	nM	63095.73	CHEMBL3130	Homo sapiens	pIC50		4.2
	15673163	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)Oc1cncc(-c2ccc3nc(N)sc3c2)c1		CHEMBL3600698	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	15673164	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CS(=O)(=O)c1cncc(-c2ccc3nc(N)sc3c2)c1		CHEMBL3600699	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
Not Determined	15673165	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccccc3)cc2s1		CHEMBL97245		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	15673166	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccccn3)cc2s1		CHEMBL3600700	=	IC50	nM	79432.82	CHEMBL3130	Homo sapiens	pIC50		4.1
	15673167	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cccnc3)cc2s1		CHEMBL3600701	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
Not Determined	15673168	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccncc3)cc2s1		CHEMBL1645107		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	15673169	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ncccn3)cc2s1		CHEMBL3600702	=	IC50	nM	50118.72	CHEMBL3130	Homo sapiens	pIC50		4.3
	15673170	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnccn3)cc2s1		CHEMBL3600765	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	15673171	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccc(=O)[nH]c3)cc2s1		CHEMBL3600766	=	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	15673172	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cc[nH]c(=O)c3)cc2s1		CHEMBL3600767	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	15673173	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1ccc(-c2ccc3nc(N)sc3c2)n1		CHEMBL3600768	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	15673174	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1nccc1-c1ccc2nc(N)sc2c1		CHEMBL3600769	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	15673175	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600770	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	15673176	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600771	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	15673177	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCCn1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600772	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	15673178	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CC(C)n1cc(-c2ccc3nc(N)sc3c2)cn1		CHEMBL3600773	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	15673179	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(C4CC4)c3)cc2s1		CHEMBL3600774	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	15673180	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(CC4CC4)c3)cc2s1		CHEMBL3600775	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	15673181	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3cnn(Cc4ccccc4)c3)cc2s1		CHEMBL3600776	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	15673182	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Cn1ccc(-c2ccc3nc(N)sc3c2)cc1=O		CHEMBL3600777	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	15673183	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	CCn1ccc(-c2ccc3nc(N)sc3c2)cc1=O		CHEMBL3600778	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	15673184	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1		CHEMBL3600779	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	15673185	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	COCCOn1ccc(-c2ccc3nc(N)sc3c2)cc1=O	Outside typical range	CHEMBL3600780	<	IC50	nM	199526.23	CHEMBL3130	Homo sapiens	pIC50		3.7
	15673186	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NCC4CCOCC4)sc3c2)ccn1CC1CC1		CHEMBL3600781	=	IC50	nM	100000.0	CHEMBL3130	Homo sapiens	pIC50		4.0
	15673187	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	C[C@@H](Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1)C1CCOCC1	Outside typical range	CHEMBL3600782	<	IC50	nM	199526.23	CHEMBL3130	Homo sapiens	pIC50		3.7
	15673188	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	C[C@H](Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1)C1CCOCC1	Outside typical range	CHEMBL3600783	<	IC50	nM	199526.23	CHEMBL3130	Homo sapiens	pIC50		3.7
	15673189	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NCC4CCS(=O)(=O)CC4)sc3c2)ccn1CC1CC1	Outside typical range	CHEMBL3600784	<	IC50	nM	199526.23	CHEMBL3130	Homo sapiens	pIC50		3.7
	15673190	CHEMBL3603394	Inhibition of PI3Kdelta (unknown origin) pre-incubated for 20 mins before phosphatidylinositol 4, 5-bisphosphate substrate addition by kinase-glo plus luminescence assay	B	O=c1cc(-c2ccc3nc(NC[C@H]4CC[C@H](C(=O)O)CC4)sc3c2)ccn1CC1CC1		CHEMBL3600785	<	IC50	nM	79432.82	CHEMBL3130	Homo sapiens	pIC50		4.1
Active	15679175	CHEMBL3607630	Inhibition of N-terminal poly-His tagged human p110-delta expressed in Sf9 cells incubated for 20 mins by alpha screen assay	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1		CHEMBL1615189		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	15687174	CHEMBL3606201	Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	uM	0.29
	15687175	CHEMBL3606201	Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2cc(C(C)(C)C(F)(F)F)ncc2OC3)[C@@H]1C(N)=O		CHEMBL3605177	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	uM	0.22
	15687176	CHEMBL3606201	Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL3605178	=	IC50	nM	390.0	CHEMBL3130	Homo sapiens	IC50	uM	0.39
	15687188	CHEMBL3606206	Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL3605178	=	IC50	nM	616.0	CHEMBL3130	Homo sapiens	IC50	uM	0.616
	15687189	CHEMBL3606206	Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2cc(C(C)(C)C(F)(F)F)ncc2OC3)[C@@H]1C(N)=O		CHEMBL3605177	=	IC50	nM	540.0	CHEMBL3130	Homo sapiens	IC50	uM	0.54
	15687190	CHEMBL3606206	Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analysis	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	uM	1.2
	15693450	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3218581	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	15693451	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@H]3C(N)=O)sc1-2		CHEMBL3609514	=	IC50	nM	700.0	CHEMBL3130	Homo sapiens	IC50	uM	0.7
	15693452	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	NC(=O)[C@@H]1CCCN1C(=O)Nc1nc2c(s1)-c1nc(CC3CC3)sc1CC2		CHEMBL3609515	=	IC50	nM	1600.0	CHEMBL3130	Homo sapiens	IC50	uM	1.6
Not Determined	15693453	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CCC[C@@]3(C)C(N)=O)sc1-2		CHEMBL3609516		IC50			CHEMBL3130	Homo sapiens	IC50		
	15693454	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1nc2c(s1)CCc1nc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)sc1-2		CHEMBL3609517	=	IC50	nM	5600.0	CHEMBL3130	Homo sapiens	IC50	uM	5.6
	15693455	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	C[C@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609518	=	IC50	nM	910.0	CHEMBL3130	Homo sapiens	IC50	uM	0.91
	15693456	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609519	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	15693457	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609520	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	uM	0.23
	15693458	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)sc2CC3)[C@@H]1C(N)=O		CHEMBL3609521	=	IC50	nM	970.0	CHEMBL3130	Homo sapiens	IC50	uM	0.97
	15693459	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	uM	0.38
	15693460	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@H]3C(N)=O)nc1CC2		CHEMBL3609522	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	uM	0.064
	15693461	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CCC[C@@]3(C)C(N)=O)nc1CC2		CHEMBL3609523	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	uM	0.07
	15693462	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CC(C)(C)c1ncc2c(n1)-c1sc(NC(=O)N3CC[C@@H]4C[C@@]43C(N)=O)nc1CC2		CHEMBL3609524	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	15693463	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609525	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	15693464	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C(F)(F)F)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609526	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	uM	0.021
Not Determined	15693465	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CN(C)C[C@@H]1CCN(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)[C@@H]1C(N)=O		CHEMBL3609527		IC50			CHEMBL3130	Homo sapiens	IC50		
	15693466	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CN(C)C[C@@]1(C(N)=O)CCCN1C(=O)Nc1nc2c(s1)-c1nc(C(C)(C)C)ncc1CC2		CHEMBL3609528	=	IC50	nM	69.0	CHEMBL3130	Homo sapiens	IC50	uM	0.069
	15693467	CHEMBL3610612	Inhibition of PI3Kdelta (unknown origin) using PI or PIP2:PS as substrate by TR-FRET assay	B	CN(C)[C@@H]1C[C@@H](C(N)=O)N(C(=O)Nc2nc3c(s2)-c2nc(C(C)(C)C)ncc2CC3)C1		CHEMBL3609529	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	uM	0.4
	15694999	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)Nc1nc(C)c(-c2ccc(S(C)(=O)=O)c(F)c2)s1		CHEMBL2071330	=	IC50	nM	410.0	CHEMBL3130	Homo sapiens	IC50	uM	0.41
	15695000	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(F)c1		CHEMBL2071336	=	IC50	nM	4700.0	CHEMBL3130	Homo sapiens	IC50	uM	4.7
	15695001	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	uM	0.38
	15695002	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	uM	0.29
	15695003	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)Nc1nc(C)c(-c2csc(C(C)C)n2)s1		CHEMBL3608321	=	IC50	nM	620.0	CHEMBL3130	Homo sapiens	IC50	uM	0.62
Not Determined	15695004	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)C)n1		CHEMBL3609536		IC50			CHEMBL3130	Homo sapiens	IC50		
	15695005	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(CC2CC2)n1		CHEMBL3609537	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	15695006	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2CCC2)n1		CHEMBL3609538	=	IC50	nM	1600.0	CHEMBL3130	Homo sapiens	IC50	uM	1.6
	15695007	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	CCC(CC)c1nc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)cs1		CHEMBL3609539	=	IC50	nM	1800.0	CHEMBL3130	Homo sapiens	IC50	uM	1.8
	15695008	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3218581	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
Not Determined	15695009	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2(C)CC2)n1		CHEMBL3609540		IC50			CHEMBL3130	Homo sapiens	IC50		
	15695010	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(N(C)C)n1		CHEMBL3609541	=	IC50	nM	8100.0	CHEMBL3130	Homo sapiens	IC50	uM	8.1
	15695011	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(-c2cccnc2)n1		CHEMBL3609542	=	IC50	nM	630.0	CHEMBL3130	Homo sapiens	IC50	uM	0.63
	15695012	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(-c2ccccc2F)n1		CHEMBL3609543	=	IC50	nM	7400.0	CHEMBL3130	Homo sapiens	IC50	uM	7.4
Not Determined	15695013	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(CN(C)C)n1		CHEMBL3609544		IC50			CHEMBL3130	Homo sapiens	IC50		
	15695014	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3609545	=	IC50	nM	810.0	CHEMBL3130	Homo sapiens	IC50	uM	0.81
Not Determined	15695015	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@@]2(C)C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608924		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	15695016	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CCC[C@@]2(C)C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608925		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	15695017	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@H](C)[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608926		IC50			CHEMBL3130	Homo sapiens	IC50		
	15695018	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H](C)[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608927	=	IC50	nM	1500.0	CHEMBL3130	Homo sapiens	IC50	uM	1.5
	15695019	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@H](O)[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608928	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	15695020	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H](O)[C@H]2C(N)=O)sc1-c1csc(C2(C(F)(F)F)CC2)n1		CHEMBL3608929	=	IC50	nM	3900.0	CHEMBL3130	Homo sapiens	IC50	uM	3.9
	15695021	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](F)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608930	=	IC50	nM	3800.0	CHEMBL3130	Homo sapiens	IC50	uM	3.8
	15695022	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](O)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608931	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	uM	4.0
	15695023	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@@H](O)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608932	=	IC50	nM	7900.0	CHEMBL3130	Homo sapiens	IC50	uM	7.9
	15695024	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608933	=	IC50	nM	9200.0	CHEMBL3130	Homo sapiens	IC50	uM	9.2
	15695025	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C2(C)CC2)n1		CHEMBL3608934	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	15695026	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2C[C@@H](N(C)C)C[C@H]2C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608935		IC50			CHEMBL3130	Homo sapiens	IC50		
	15695027	CHEMBL3611489	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)N2CC[C@@H]3C[C@@]32C(N)=O)sc1-c1csc(C(C)(C)C)n1		CHEMBL3608936	=	IC50	nM	3300.0	CHEMBL3130	Homo sapiens	IC50	uM	3.3
	15719252	CHEMBL3620388	Inhibition of PI3Kdelta (unknown origin) by alpha screen assay	B	COc1ncc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cc1F		CHEMBL3618245	=	Ki	nM	0.6	CHEMBL3130	Homo sapiens	Ki	nM	0.6
	15743080	CHEMBL3626574	Inhibition of recombinant human PI3Kdelta by TR-FRET analysis	B	C[C@@H]1COCCN1c1cc(=O)n2c(n1)N(Cc1cncc(Cl)c1)[C@H](C(F)(F)F)CC2		CHEMBL3622372	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
244571	16258547	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnco5)C4)c3C2)cnc1OC		CHEMBL3643370	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
244587	16259210	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOC(C)(C)C5)C4)c3C2)cc1C		CHEMBL3643385	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
244615	16259739	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
244576	16260993	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)CC5CCOCC5)C4)c3C2)cc1C#N		CHEMBL3643374	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
244566	16260996	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCN(C(C)=O)CC5)C4)c3C2)cc1C		CHEMBL3643365	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
243217	16261381	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	O=S(=O)(Nc1cncc(-c2ccc3ncnc(Oc4cccnc4)c3n2)c1)c1ccccc1		CHEMBL3652552	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
244606	16262692	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(OC4CN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643404	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
244611	16263549	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
244626	16264233	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)c5cnco5)C4)c3C2)cc1C		CHEMBL3643424	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
244608	16264259	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	O=C(C1CCOCC1)N1CC[C@H](Oc2ncnc3c2CN(c2cnc4ccccc4c2)CC3)C1		CHEMBL3643406	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
244565	16265734	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cocn5)C4)c3C2)cc1C		CHEMBL3643364	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
244604	16266113	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1Cl		CHEMBL3643402	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
243220	16268744	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	CN1CCC(Oc2ncnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5F)c4)nc23)CC1		CHEMBL3652555	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
244623	16268757	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)[C@H]5CC[C@@H](O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643421	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
244621	16269291	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)[C@H]5CC[C@@H](OC)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643419	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
243219	16270436	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	O=S(=O)(Nc1cc(-c2ccc3ncnc(OC4CCOCC4)c3n2)cnc1Cl)c1ccc(F)cc1F		CHEMBL3652554	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
244625	16272308	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)c5cn(C)cn5)C4)c3C2)cc1C		CHEMBL3643423	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
244610	16272500	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)CC(C)(C)C)C4)c3C2)cc1C(F)(F)F		CHEMBL3643408	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
244642	16272653	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnco5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643440	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
244591	16273818	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccnn5C)C4)c3C2)cc1C(F)(F)F		CHEMBL3643389	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
244586	16275314	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	[C-]#[N+]c1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccn(C)n5)C4)c3C2)cnc1OC		CHEMBL3643384	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
244605	16275320	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	Nc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643403	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
244580	16275619	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnoc5C)C4)c3C2)cc1C		CHEMBL3643378	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
244582	16275689	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccon5)C4)c3C2)cc1C		CHEMBL3643380	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
244592	16276167	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CNC(=O)C5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643390	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
244555	16278649	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	N#Cc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cnc1N		CHEMBL3643354	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
244567	16280796	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ocnc5C)C4)c3C2)cc1C		CHEMBL3643366	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
244597	16281229	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cn(C)nc5C)C4)c3C2)cc1C(F)(F)F		CHEMBL3643395	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
244559	16283520	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5oc(C)nc5C)C4)c3C2)cc1C		CHEMBL3643358	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
244570	16284089	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cocn5)C4)c3C2)cnc1OC		CHEMBL3643369	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
244628	16284812	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOC(C)(C)C5)C4)c3C2)cc1C		CHEMBL3643426	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
244574	16284935	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5oc(C)nc5C)C4)c3C2)cnc1OC		CHEMBL3639422	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
244639	16286164	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cocn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643437	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
244599	16286384	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5nnc(C)o5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643397	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
244583	16286685	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccno5)C4)c3C2)cc1C		CHEMBL3643381	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
244641	16288706	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cncn5C)C4)c3C2)cc1C(F)(F)F		CHEMBL3643439	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
244568	16290351	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccc(=O)[nH]c5)C4)c3C2)cc1C		CHEMBL3643367	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
244627	16294375	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)c5cocn5)C4)c3C2)cc1C		CHEMBL3643425	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
244556	16297451	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1F		CHEMBL3643355	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
244590	16297519	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cncs5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643388	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
244561	16298405	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnco5)C4)c3C2)cc1C		CHEMBL3643360	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
244630	16299632	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1Cl		CHEMBL3643428	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
244588	16300191	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCS(=O)(=O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643386	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
244581	16300421	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5conc5C)C4)c3C2)cc1C		CHEMBL3643379	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
244603	16301349	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cscn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643401	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
244564	16301555	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CC(OC)C5)C4)c3C2)cc1C		CHEMBL3643363	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
244637	16304133	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)N5CCN(C(C)=O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643435	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
244593	16306038	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cccnc5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643391	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
244632	16307363	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	O=C(C1CCOCC1)N1CC[C@H](Nc2ncnc3c2CN(c2cncc(C(F)(F)F)c2)CC3)C1		CHEMBL3643430	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
244572	16308242	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5coc(C)n5)C4)c3C2)cnc1OC		CHEMBL3643371	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
244634	16308443	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)N5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643432	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
243222	16308689	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	O=S(=O)(Nc1cc(-c2ccc3ncnc(NC4CCOCC4)c3n2)cnc1Cl)c1ccc(F)cc1F		CHEMBL3652557	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
244589	16310637	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5oc(C)nc5C)C4)c3C2)cc1C(F)(F)F		CHEMBL3643387	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
244562	16312155	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cncn5C)C4)c3C2)cc1C		CHEMBL3643361	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
244578	16313865	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOC(C)(C)C5)C4)c3C2)cc1C#N		CHEMBL3643376	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
244616	16313990	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643414	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
244594	16315344	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnc[nH]5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643392	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
244584	16315495	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	[C-]#[N+]c1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cscn5)C4)c3C2)cnc1OC		CHEMBL3643382	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
244558	16316280	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCCC5)C4)c3C2)cc1C#N		CHEMBL3643357	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
243218	16317028	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	O=S(=O)(Nc1cncc(-c2ccc3ncnc(OC4CCOCC4)c3n2)c1)c1ccccc1		CHEMBL3652553	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
244552	16319767	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C#N		CHEMBL3643351	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
244554	16320075	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cnc1OC		CHEMBL3643353	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
244638	16320655	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C#N)c2)CC3)C1		CHEMBL3643436	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
244614	16320770	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(c5ncccn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643412	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
244596	16322174	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccncc5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643394	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
244600	16323893	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnccn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643398	=	IC50	nM	46.0	CHEMBL3130	Homo sapiens	IC50	nM	46.0
244560	16324141	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ccoc5)C4)c3C2)cc1C		CHEMBL3643359	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
244633	16326201	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)N5CCN(C)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643431	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
244563	16326230	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5coc(C)n5)C4)c3C2)cc1C		CHEMBL3643362	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
244553	16326963	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(OC)c2)CC3)C1		CHEMBL3643352	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
244612	16327410	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C#N)c2)CC3)C1		CHEMBL3643410	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
244624	16328696	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)[C@H]5CC[C@H](O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643422	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
244551	16329402	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)c(OC)n1		CHEMBL3643350	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
244640	16329914	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCN(C(C)=O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643438	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
244622	16330014	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)[C@H]5CC[C@H](OC)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643420	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
244550	16330563	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
244631	16330964	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643429	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
244557	16332505	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C#N)c2)CC3)C1		CHEMBL3643356	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
244643	16334474	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ccc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cn1		CHEMBL3643441	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	nM	53.0
244607	16334860	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cn1		CHEMBL3643405	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
244609	16335304	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643407	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
244575	16337454	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCC(F)(F)CC5)C4)c3C2)cnc1OC		CHEMBL3643373	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
244579	16339955	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5ncoc5C)C4)c3C2)cc1C		CHEMBL3643377	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
244635	16339968	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)N5CCC(O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643433	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
244569	16340264	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cn(C)cn5)C4)c3C2)cc1C		CHEMBL3643368	=	IC50	nM	48.0	CHEMBL3130	Homo sapiens	IC50	nM	48.0
244619	16341260	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOC(C)(C)C5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643417	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
244617	16341571	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C#N		CHEMBL3643415	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
244618	16342587	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCN(C(C)=O)CC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643416	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
244598	16344870	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cn[nH]c5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643396	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
244595	16346810	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCC(=O)N5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643393	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
244577	16347263	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5oc(C)nc5C)C4)c3C2)cc1C#N		CHEMBL3643375	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
244620	16347399	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)c5cnco5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643418	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
244602	16347498	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnn(C)c5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643400	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
243221	16348813	CHEMBL3707814	Competitive Assay: The PI3 Kinase Activity/Inhibitor Assay is a competitive assay used for the fast and sensitive quantitation of activity of the four class I PI3 kinases (p110 α, β, γ, δ). The PI3 Kinase Activity/Inhibitor Assay works on the principle that PI3 Kinase phosphorylates P1(3,4)P2 (PIP2), converting it to PI(3,4,5)P3 (PIP3). The PH domain of the protein GRP-1 binds PIP3 with high affinity and specificity. The kit includes this recombinant protein that is used as the capture protein. This protein binds to the glutathione plate and captures either the PIP3 generated as part of the kinase reaction or the biotinylated-PIP3 tracer included in the kit. The captured biotinylated-PIP3 is detected using streptavidin-HRP conjugate and a colorimetric read out (OD 450). The lower the signal, the higher the PI3 Kinase activity.	B	CN1CCC(Oc2ncnc3ccc(-c4cncc(NS(=O)(=O)c5ccccc5)c4)nc23)CC1		CHEMBL3652556	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
244585	16352003	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	[C-]#[N+]c1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cnn(C)c5)C4)c3C2)cnc1OC		CHEMBL3643383	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
244601	16353123	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)c5cn(C)cn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643399	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
244613	16354302	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(c5ccccn5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643411	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
244629	16355032	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)C1		CHEMBL3643427	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
244636	16355717	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)N(C)CCO)C4)c3C2)cc1C(F)(F)F		CHEMBL3643434	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
244573	16356286	CHEMBL3707605	Enzyme Assay: Test of Lipid Kinase Activity: The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and phosphatidyl inositol in the assay are 5 μM and 6 μg/mL, respectively. The reaction is started by the addition of PI3 kinase, e.g. PI3 kinase δ. Refer to the patent for more info.	B	COc1cc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOC(C)(C)C5)C4)c3C2)cnc1OC		CHEMBL3643372	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	16391026	CHEMBL3738872	Inhibition of PI3Kdelta (unknown origin) at 1 uM after 1 hr by ADP-Glo Luminescent assay	B	CC(C)(C#N)c1ccc(Nc2c(C(N)=O)cnc3ccc(-c4cnc5ccccc5c4)cc23)cc1	Outside typical range	CHEMBL3736298	=	Inhibition	%	-12.8	CHEMBL3130	Homo sapiens	INH	%	-12.8
	16391027	CHEMBL3738872	Inhibition of PI3Kdelta (unknown origin) at 1 uM after 1 hr by ADP-Glo Luminescent assay	B	Cl.NC(=O)c1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCNCC2)c(C(F)(F)F)c1		CHEMBL3735194	=	Inhibition	%	16.7	CHEMBL3130	Homo sapiens	INH	%	16.7
	16391028	CHEMBL3738873	Inhibition of PI3Kdelta (unknown origin) after 1 hr by ADP-Glo Luminescent assay	B	CC(=O)N1CCN(c2ccc(Nc3c(C(N)=O)cnc4ccc(-c5cnc6ccccc6c5)cc34)cc2C(F)(F)F)CC1		CHEMBL3735090	>	IC50	nM	5000.0	CHEMBL3130	Homo sapiens	IC50	nM	5000.0
	16391029	CHEMBL3738873	Inhibition of PI3Kdelta (unknown origin) after 1 hr by ADP-Glo Luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	16421955	CHEMBL3748472	Inhibition of PI3Kdelta (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	9100.0	CHEMBL3130	Homo sapiens	IC50	uM	9.1
	16442717	CHEMBL3756406	Inhibition of PI3Kdelta (unknown origin) using 1 alpha-phosphatidylinositol as substrate assessed as ATP depletion after 5 mins by KinaseGlo assay	B	CC(=O)Nc1cn2cc(-c3cnc(N)c(OC(C)C(F)(F)F)n3)ccc2n1		CHEMBL3753450	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	uM	0.008
	16451560	CHEMBL3760857	Inhibition of PI3KD (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-7.6	CHEMBL3130	Homo sapiens	INH	%	-7.6
	16467820	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)cccc12		CHEMBL3764119	=	IC50	nM	4500.0	CHEMBL3130	Homo sapiens	IC50	uM	4.5
	16467825	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccnc3)cccc12		CHEMBL3765523	=	Inhibition	%	37.0	CHEMBL3130	Homo sapiens	INH	%	37.0
	16467888	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3763707	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16467893	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL3765681	=	Inhibition	%	4.0	CHEMBL3130	Homo sapiens	INH	%	4.0
	16467898	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(CO)cc3)cccc12		CHEMBL3763205	=	IC50	nM	9000.0	CHEMBL3130	Homo sapiens	IC50	uM	9.0
	16467903	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)cccc12		CHEMBL3763897	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16467966	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2cccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3765105	=	IC50	nM	2700.0	CHEMBL3130	Homo sapiens	IC50	uM	2.7
	16468001	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)cccc12		CHEMBL3765574	=	IC50	nM	4800.0	CHEMBL3130	Homo sapiens	IC50	uM	4.8
	16468064	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4ccccc34)cccc12		CHEMBL3765457	=	IC50	nM	640.0	CHEMBL3130	Homo sapiens	IC50	uM	0.64
	16468847	CHEMBL3768548	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	16468848	CHEMBL3768548	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	16468849	CHEMBL3768548	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCN(S(C)(=O)=O)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763244	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	16468850	CHEMBL3768548	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	CCOC(=O)N1CCN(CC#Cc2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)CC1		CHEMBL3765587	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	16468918	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1		CHEMBL3763473	=	Inhibition	%	10.0	CHEMBL3130	Homo sapiens	INH	%	10.0
	16468919	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763397	=	Inhibition	%	6.1	CHEMBL3130	Homo sapiens	INH	%	6.1
	16468920	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	CCN(CC)CC#Cc1ccnc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc12		CHEMBL3765500	=	Inhibition	%	1.2	CHEMBL3130	Homo sapiens	INH	%	1.2
	16468921	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C)CCO)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764095	=	Inhibition	%	16.0	CHEMBL3130	Homo sapiens	INH	%	16.0
	16468922	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN(C4CCCCC4)C4CCCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765013	=	Inhibition	%	3.2	CHEMBL3130	Homo sapiens	INH	%	3.2
	16468923	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764069	=	Inhibition	%	3.0	CHEMBL3130	Homo sapiens	INH	%	3.0
	16468924	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCC(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765065	=	Inhibition	%	7.7	CHEMBL3130	Homo sapiens	INH	%	7.7
	16468925	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCCCC4C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3765031	=	Inhibition	%	4.6	CHEMBL3130	Homo sapiens	INH	%	4.6
	16468926	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCOCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3764625	=	Inhibition	%	35.0	CHEMBL3130	Homo sapiens	INH	%	35.0
	16468927	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	CCOC(=O)N1CCN(CC#Cc2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)CC1		CHEMBL3765587	=	Inhibition	%	20.7	CHEMBL3130	Homo sapiens	INH	%	20.7
	16468928	CHEMBL3768551	Inhibition of PI3K-delta (unknown origin) using PIP2 as substrate at 10 nM incubated for 1 hr by Kinase-Glo luminescent kinase assay	B	COc1ncc(-c2ccc3nccc(C#CCN4CCN(S(C)(=O)=O)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3763244	=	Inhibition	%	25.8	CHEMBL3130	Homo sapiens	INH	%	25.8
	16468983	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3oc3ccccc34)cccc12		CHEMBL3763392	=	IC50	nM	12000.0	CHEMBL3130	Homo sapiens	IC50	uM	12.0
	16468988	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL3764883	=	IC50	nM	8500.0	CHEMBL3130	Homo sapiens	IC50	uM	8.5
	16468994	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)cccc12		CHEMBL3763878	=	IC50	nM	3700.0	CHEMBL3130	Homo sapiens	IC50	uM	3.7
	16468999	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2cc(Cl)cc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL3764880	=	IC50	nM	2600.0	CHEMBL3130	Homo sapiens	IC50	uM	2.6
	16469004	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)cc(Cl)cc12		CHEMBL3763764	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16469009	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)cc(Cl)cc12		CHEMBL3765110	=	Inhibition	%	16.0	CHEMBL3130	Homo sapiens	INH	%	16.0
	16469014	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cc(Cl)cc12		CHEMBL3763722	=	Inhibition	%	36.0	CHEMBL3130	Homo sapiens	INH	%	36.0
	16469019	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccccc3)cc12		CHEMBL3764490	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469024	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	COc1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3765645	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469029	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccc(Cl)cc3)cc12		CHEMBL3763662	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469034	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccc(CO)cc3)cc12		CHEMBL3763655	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
Not Determined	16469039	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)c1		CHEMBL3764800		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16469044	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3763440		IC50			CHEMBL3130	Homo sapiens	IC50		
	16469049	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccnc3)cc12		CHEMBL3764517	=	Inhibition	%	3.0	CHEMBL3130	Homo sapiens	INH	%	3.0
Not Determined	16469054	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccs3)cc12		CHEMBL3763957		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16469059	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccsc3)cc12		CHEMBL3765350		IC50			CHEMBL3130	Homo sapiens	IC50		
	16469064	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4ccccc34)cc12		CHEMBL3765284	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469069	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4c3oc3ccccc34)cc12		CHEMBL3765235	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469074	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc4c3sc3ccccc34)cc12		CHEMBL3763170	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469079	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccc(-c4ccccc4)c3)cc12		CHEMBL3763994	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469084	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(/C=C/c3ccccc3)cc12		CHEMBL3765722	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469089	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cc4ccccc4s3)cc12		CHEMBL3764702	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16469094	CHEMBL3767084	Inhibition of PI3Kdelta (unknown origin) incubated for 60 mins by kinase-glo luminescence assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	950.0	CHEMBL3130	Homo sapiens	IC50	uM	0.95
Not Determined	16469262	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	Nc1cccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)c1		CHEMBL3764800		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16469263	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	NC(=O)c1ccc(-c2ccc3oc(N4CCOCC4)nc(=O)c3c2)cc1		CHEMBL3763440		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16469264	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3cccs3)cc12		CHEMBL3763957		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16469265	CHEMBL3767083	Inhibition of PI3Kdelta (unknown origin) at 10 uM incubated for 60 mins by kinase-glo luminescence assay	B	O=c1nc(N2CCOCC2)oc2ccc(-c3ccsc3)cc12		CHEMBL3765350		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16484069	CHEMBL3772931	Inhibition of human recombinant PI3K delta by scintillation proximity radiometric assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	16484074	CHEMBL3772927	Inhibition of PI3K delta (unknown origin) using PIP2 as substrate after 1 hr by kinase-Glo luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	16484075	CHEMBL3772927	Inhibition of PI3K delta (unknown origin) using PIP2 as substrate after 1 hr by kinase-Glo luminescent assay	B	N#Cc1ncccc1Nc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc2c1		CHEMBL3769902	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	16490965	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	16490966	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4cc(OC)ccc4O)CC3)cc21		CHEMBL3770294	=	IC50	nM	489.0	CHEMBL3130	Homo sapiens	IC50	nM	489.0
	16490967	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4cc(Br)ccc4O)CC3)cc21		CHEMBL3771053	=	IC50	nM	474.0	CHEMBL3130	Homo sapiens	IC50	nM	474.0
	16490968	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4c(C)cccc4O)CC3)cc21		CHEMBL3770650	=	IC50	nM	683.0	CHEMBL3130	Homo sapiens	IC50	nM	683.0
	16490969	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4cc(Cl)ccc4O)CC3)cc21		CHEMBL3770169	=	IC50	nM	311.0	CHEMBL3130	Homo sapiens	IC50	nM	311.0
	16490970	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cc([N+](=O)[O-])ccc4O)CC3)c(F)cc2c1=O		CHEMBL3770035	=	IC50	nM	722.0	CHEMBL3130	Homo sapiens	IC50	nM	722.0
	16490971	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cc(Br)ccc4O)CC3)c(F)cc2c1=O		CHEMBL3770822	=	IC50	nM	674.0	CHEMBL3130	Homo sapiens	IC50	nM	674.0
	16490972	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cc([N+](=O)[O-])cc([N+](=O)[O-])c4O)CC3)c(F)cc2c1=O		CHEMBL3769747	=	IC50	nM	271.0	CHEMBL3130	Homo sapiens	IC50	nM	271.0
	16490973	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	COc1ccc(C(=O)N2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)c(O)c1		CHEMBL3770144	=	IC50	nM	348.0	CHEMBL3130	Homo sapiens	IC50	nM	348.0
	16490974	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cc(Cl)ccc4O)CC3)c(F)cc2c1=O		CHEMBL3769739	=	IC50	nM	553.0	CHEMBL3130	Homo sapiens	IC50	nM	553.0
	16490975	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	O=C(O)c1cn(C2CC2)c2cc(N3CCN(C(=O)c4cccnc4Cl)CC3)c(F)cc2c1=O		CHEMBL3770290	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16490976	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	COc1ccc(C(=O)N2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)cn1		CHEMBL3771254	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16490977	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4cccnc4Cl)CC3)cc21		CHEMBL3770164	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16490978	CHEMBL3772544	Inhibition of human PI3Kdelta by fluorescence-based immunoassay	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C(=O)c4ccc(OC)nc4)CC3)cc21		CHEMBL3769663	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16495173	CHEMBL3777962	Inhibition of PI3Kdelta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-5.0	CHEMBL3130	Homo sapiens	Activity	%	-5.0
	16496092	CHEMBL3777962	Inhibition of PI3Kdelta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL3130	Homo sapiens	Activity	%	-6.0
	16506461	CHEMBL3778434	Inhibition of PI3K p110delta (unknown origin) at 5 uM relative to control	B	CC1C/C(=C\c2ccc3c(c2)CCO3)C(=O)O1		CHEMBL3775111	=	Inhibition	%	73.0	CHEMBL3130	Homo sapiens	INH	%	73.0
	16506462	CHEMBL3778434	Inhibition of PI3K p110delta (unknown origin) at 5 uM relative to control	B	O=C1OCC/C1=C\c1ccc2ncsc2c1		CHEMBL3774704	=	Inhibition	%	77.0	CHEMBL3130	Homo sapiens	INH	%	77.0
	16506463	CHEMBL3778435	Inhibition of PI3K p110delta (unknown origin) at 1 uM relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	Inhibition	%	90.0	CHEMBL3130	Homo sapiens	INH	%	90.0
	16506464	CHEMBL3778435	Inhibition of PI3K p110delta (unknown origin) at 1 uM relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	16506465	CHEMBL3778436	Inhibition of PI3K p110delta (unknown origin)	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	IC50	nM	12.4	CHEMBL3130	Homo sapiens	IC50	nM	12.4
	16506466	CHEMBL3778436	Inhibition of PI3K p110delta (unknown origin)	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	IC50	nM	16.1	CHEMBL3130	Homo sapiens	IC50	nM	16.1
	16508279	CHEMBL3777962	Inhibition of PI3Kdelta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	0.0	CHEMBL3130	Homo sapiens	Activity	%	0.0
	16513123	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3781415	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	nM	1200.0
	16513124	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	c1ccc(CNc2ncc(-c3ccnc(Nc4ccncc4)n3)c(CC3CC3)n2)cc1		CHEMBL3781615	=	IC50	nM	3700.0	CHEMBL3130	Homo sapiens	IC50	nM	3700.0
	16513125	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)(O)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3781466	=	IC50	nM	820.0	CHEMBL3130	Homo sapiens	IC50	nM	820.0
	16513126	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)(C)CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3780339	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	nM	500.0
	16513127	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)(C)Nc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3781926	=	IC50	nM	740.0	CHEMBL3130	Homo sapiens	IC50	nM	740.0
	16513128	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	c1cc(Nc2nccc(-c3cnc(NC4CCOCC4)nc3CC3CC3)n2)ccn1		CHEMBL3780762	=	IC50	nM	4200.0	CHEMBL3130	Homo sapiens	IC50	nM	4200.0
	16513129	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3781634	=	IC50	nM	8500.0	CHEMBL3130	Homo sapiens	IC50	nM	8500.0
	16513130	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	c1cc(Nc2nccc(-c3cncnc3CC3CC3)n2)ccn1		CHEMBL3781020	>	IC50	nM	9100.0	CHEMBL3130	Homo sapiens	IC50	nM	9100.0
	16513131	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	CNc1ncc(-c2ccnc(Nc3ccncc3)n2)c(CC2CC2)n1		CHEMBL3780029	=	IC50	nM	2900.0	CHEMBL3130	Homo sapiens	IC50	nM	2900.0
	16513132	CHEMBL3784756	Inhibition of PI3Kdelta (unknown origin)	B	CNc1ncc(-c2ccnc(N[C@H]3CC[C@H](O)CC3)n2)c(CC2CC2)n1		CHEMBL3781916	=	IC50	nM	7000.0	CHEMBL3130	Homo sapiens	IC50	nM	7000.0
	16517037	CHEMBL3784498	Inhibition of PI3Kdelta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	16517038	CHEMBL3784498	Inhibition of PI3Kdelta (unknown origin) after 1 hr by ADP-Glo luminescent assay	B	CC(=O)Nc1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCN(C(C)=O)CC2)c(C(F)(F)F)c1		CHEMBL3781971	=	IC50	nM	2075.0	CHEMBL3130	Homo sapiens	IC50	nM	2075.0
	16517043	CHEMBL3784502	Inhibition of PI3Kdelta (unknown origin) at 1 uM after 1 hr by ADP-Glo luminescent assay	B	CC(=O)Nc1cnc2ccc(-c3cnc4ccccc4c3)cc2c1Nc1ccc(N2CCNCC2)c(C(F)(F)F)c1.Cl		CHEMBL3781549	=	Inhibition	%	34.9	CHEMBL3130	Homo sapiens	INH	%	34.9
	16525413	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	CC(=O)/N=c1/[nH]c(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1		CHEMBL1229535	=	IC50	nM	77.0	CHEMBL3130	Homo sapiens	IC50	nM	77.0
	16525414	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	CC(=O)Nc1nc(C)c(-c2ccc(Br)c(S(=O)(=O)NCCO)c2)s1		CHEMBL3787634	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	16525415	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	COc1ccc(-c2sc(NC(C)=O)nc2C)cc1S(=O)(=O)NCCO		CHEMBL3786633	=	IC50	nM	223.0	CHEMBL3130	Homo sapiens	IC50	nM	223.0
	16525416	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	Cc1nc(NC(=O)C(C)(C)C)sc1-c1ccc(Cl)c(S(=O)(=O)NCCO)c1		CHEMBL3785630	=	IC50	nM	1570.0	CHEMBL3130	Homo sapiens	IC50	nM	1570.0
	16525417	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	Cc1nc(NC(=O)C2CCCC2)sc1-c1ccc(Cl)c(S(=O)(=O)NCCO)c1		CHEMBL3786159	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	nM	340.0
	16525418	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(O)cc3)c2)s1		CHEMBL3787013	=	IC50	nM	4.9	CHEMBL3130	Homo sapiens	IC50	nM	4.9
	16525419	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)cc3)c2)s1		CHEMBL3787054	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	16525420	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)NCCO		CHEMBL3785694	=	IC50	nM	50000.0	CHEMBL3130	Homo sapiens	IC50	nM	50000.0
	16525421	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	COc1ccc(-c2sc(NC(=O)C3CCCC3)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1		CHEMBL3785311	=	IC50	nM	152.0	CHEMBL3130	Homo sapiens	IC50	nM	152.0
	16525422	CHEMBL3789430	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)Nc1ccc(O)cc1		CHEMBL3786230	=	IC50	nM	720.0	CHEMBL3130	Homo sapiens	IC50	nM	720.0
	16525482	CHEMBL3789708	Inhibition of histidine-tagged recombinant human full length PI3Kdelta expressed in baculovirus at 50 uM preincubated for 15 mins followed by addition of cold ATP/gamma32P-ATP measured after 20 mins in presence of MgCl2	B	COc1ccc(-c2sc(NC(=O)C(C)(C)C)nc2C)cc1S(=O)(=O)NCCO		CHEMBL3785694	<	Inhibition	%	50.0	CHEMBL3130	Homo sapiens	INH	%	50.0
	16525640	CHEMBL3790298	Inhibition of PI3Kdelta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	9100.0	CHEMBL3130	Homo sapiens	IC50	uM	9.1
	16525641	CHEMBL3790298	Inhibition of PI3Kdelta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	6600.0	CHEMBL3130	Homo sapiens	IC50	uM	6.6
	16525642	CHEMBL3790298	Inhibition of PI3Kdelta (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	16525643	CHEMBL3790298	Inhibition of PI3Kdelta (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16564795	CHEMBL3802882	Inhibition of PI3Kdelta in human JeKo1 cells assessed as inhibition of AKT phosphorylation at Ser-473 residue after 1 hr	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	uM	0.047
	16564830	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	16564831	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3ccc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799187	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	uM	0.013
	16564832	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cccc54)c3o2)CCO1		CHEMBL3798914	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	16564833	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5ccc(F)cc54)c3o2)CCO1		CHEMBL3799511	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	16564834	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN4CCOc5c(F)cc(F)cc54)c3o2)CCO1		CHEMBL3797812	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	16564835	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	C[C@@H]1CN(c2cc(=O)c3cc(C(=O)N(C)C)cc(CN(C)c4cc(F)cc(F)c4)c3o2)CCO1		CHEMBL3797698	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	16564836	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cc(F)cc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3797750	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	16564837	CHEMBL3802886	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN(C)c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3408273	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	16566113	CHEMBL3802916	Tight binding affinity to human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins by luminescence assay	B	CN(C)C(=O)c1cc(CN2CCOc3c(F)cccc32)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL3799831	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
Not Determined	16566753	CHEMBL3803002	Inhibition of PI3Kdelta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221		IC50			CHEMBL3130	Homo sapiens	IC50		
	16566770	CHEMBL3803002	Inhibition of PI3Kdelta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	=	IC50	nM	1840.0	CHEMBL3130	Homo sapiens	IC50	nM	1840.0
	16566774	CHEMBL3803006	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by HTRF assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	=	IC50	nM	1840.0	CHEMBL3130	Homo sapiens	IC50	nM	1840.0
	16566820	CHEMBL3803002	Inhibition of PI3Kdelta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797590	=	IC50	nM	271.0	CHEMBL3130	Homo sapiens	IC50	nM	271.0
	16566834	CHEMBL3803002	Inhibition of PI3Kdelta (unknown origin) using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC		CHEMBL3800138	=	IC50	nM	505.0	CHEMBL3130	Homo sapiens	IC50	nM	505.0
	16566840	CHEMBL3803006	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(CC4CCCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3797933	=	IC50	nM	7.3	CHEMBL3130	Homo sapiens	IC50	nM	7.3
	16566853	CHEMBL3803006	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(CC4CCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797834	=	IC50	nM	149.0	CHEMBL3130	Homo sapiens	IC50	nM	149.0
	16566869	CHEMBL3803006	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2cncnc21		CHEMBL3798574	=	IC50	nM	221.0	CHEMBL3130	Homo sapiens	IC50	nM	221.0
	16578329	CHEMBL3804383	Inhibition of partial length wild type human PIK3CD expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	37.0	CHEMBL3130	Homo sapiens	Activity	%	37.0
	16590723	CHEMBL3806632	Inhibition of PI3Kdelta in human whole blood assessed as basophil degranulation by measuring CD63 surface expression on CCR3 positive cells after 60 mins by flow cytometric analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3805738	=	EC50	nM	1.0	CHEMBL3130	Homo sapiens	EC50	nM	1.0
	16612879	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612880	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612881	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccc(N)nc4)cc23)nc(N)n1		CHEMBL3814154	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612882	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccco4)cc23)nc(N)n1		CHEMBL3814317	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612883	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)nc(N)n1		CHEMBL3813865	>	IC50	nM	30000.0	CHEMBL3130	Homo sapiens	IC50	uM	30.0
	16612884	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4ccn[nH]4)cc23)nc(N)n1		CHEMBL3814539	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612885	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3814785	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612886	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CCN(C)C)c4)cc23)nc(N)n1		CHEMBL3814770	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612887	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(C)C)c4)cc23)nc(N)n1		CHEMBL3813933	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16612888	CHEMBL3815760	Inhibition of PI3K delta (unknown origin)	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	uM	4.0
	16612895	CHEMBL3815763	Inhibition of PI3K delta (unknown origin) at 10 uM	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Inhibition	%	77.0	CHEMBL3130	Homo sapiens	INH	%	77.0
	16672502	CHEMBL3855735	Inhibition of PI3Kdelta in IgM-stimulated human Raji cells assessed as reduction in AKT phosphorylation at S473 incubated for 30 mins followed by stimulation with IgM for 30 mins by ELISA	B	C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1		CHEMBL3984425	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	16673470	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	<	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	16673471	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	16673472	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16673473	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1cc(S(N)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL3932938	=	IC50	nM	820.0	CHEMBL3130	Homo sapiens	IC50	nM	820.0
	16673474	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc21		CHEMBL3904942	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	16673475	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	16673476	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(N)(=O)=O)c3)nc1N2C		CHEMBL3913941	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	nM	76.0
	16673477	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3ccc(S(N)(=O)=O)cc3)nc1N2C		CHEMBL3950648	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	16673478	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3ccc(S(=O)(=O)N4CCC(O)CC4)cc3)nc1N2C		CHEMBL3922919	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	16673479	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	16673480	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)nc1N2C		CHEMBL3948672	=	IC50	nM	2600.0	CHEMBL3130	Homo sapiens	IC50	nM	2600.0
	16673481	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCN(C)CC4)c3)nc1N2C		CHEMBL3986648	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	16673482	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	16673483	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1cccc(NS(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)c1		CHEMBL3935895	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	nM	440.0
	16673484	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1cccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)c1		CHEMBL3907932	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	16673485	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3926951	=	IC50	nM	96.0	CHEMBL3130	Homo sapiens	IC50	nM	96.0
	16673486	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)cc1		CHEMBL3898901	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	16673487	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)NC1CCN(S(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)CC1		CHEMBL3918001	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	16673488	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)NC1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3889977	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	16673489	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)CC1		CHEMBL3909068	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	16673490	CHEMBL3855894	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system incubated for 60 mins by ADAPTA assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3979343	=	IC50	nM	1.5	CHEMBL3130	Homo sapiens	IC50	nM	1.5
Active	16673503	CHEMBL3855891	Inhibition of p110delta in HMEC assessed as reduction in S6RP phosphorylation at Ser-235/236 residue at 10 nM after 1 hr by Western blot analysis	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673504	CHEMBL3855891	Inhibition of p110delta in HMEC assessed as reduction in S6RP phosphorylation at Ser-235/236 residue at 10 nM after 1 hr by Western blot analysis	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673505	CHEMBL3855891	Inhibition of p110delta in HMEC assessed as reduction in S6RP phosphorylation at Ser-235/236 residue at 10 nM after 1 hr by Western blot analysis	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673506	CHEMBL3855911	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Thr-308 residue at 10 nM after 1 hr by Western blot analysis	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673507	CHEMBL3855911	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Thr-308 residue at 10 nM after 1 hr by Western blot analysis	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673508	CHEMBL3855911	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Thr-308 residue at 10 nM after 1 hr by Western blot analysis	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673509	CHEMBL3855910	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Ser-473 residue at 10 nM after 1 hr by Western blot analysis	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673510	CHEMBL3855910	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Ser-473 residue at 10 nM after 1 hr by Western blot analysis	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	16673511	CHEMBL3855910	Inhibition of p110delta in HMEC assessed as reduction in Akt phosphorylation at Ser-473 residue at 10 nM after 1 hr by Western blot analysis	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16754177	CHEMBL3860727	Inhibition of PI3Kdelta (unknown origin) up to 10 uM using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])O		CHEMBL3948305		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16754182	CHEMBL3860727	Inhibition of PI3Kdelta (unknown origin) up to 10 uM using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)CO)n1		CHEMBL3939525		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16754183	CHEMBL3860724	Inhibition of PI3Kdelta (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3975097	=	IC50	nM	1530.0	CHEMBL3130	Homo sapiens	IC50	uM	1.53
	16754184	CHEMBL3860724	Inhibition of PI3Kdelta (unknown origin) expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser473 residue	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	1570.0	CHEMBL3130	Homo sapiens	IC50	uM	1.57
	16754189	CHEMBL3860721	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(N)=O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3975097	=	IC50	nM	360.0	CHEMBL3130	Homo sapiens	IC50	uM	0.36
	16754190	CHEMBL3860721	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL2397186	=	IC50	nM	530.0	CHEMBL3130	Homo sapiens	IC50	uM	0.53
	16754249	CHEMBL3860727	Inhibition of PI3Kdelta (unknown origin) up to 10 uM using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(=O)O)sc1-c1ccnc(C(C)(C)C)n1		CHEMBL3911550		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16754252	CHEMBL3860727	Inhibition of PI3Kdelta (unknown origin) up to 10 uM using phosphatidylinositol/PIP2:PS as substrate after 15 to 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])C(c1nccc(-c2sc(NC(=O)N3CCC[C@H]3C(=O)O)nc2C)n1)(C([2H])([2H])[2H])C([2H])([2H])[2H]		CHEMBL3920489		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16756919	CHEMBL3861277	Inhibition of N-terminal 6x-his-tagged human recombinant PIK3Cdelta (431 to 600 residues) expressed in Sdf9 cells using diC8-PIP2 incubated for 1 hr by transcreener ADP Assay	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(F)cc2)cc(OC)c1		CHEMBL1213168	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	16772504	CHEMBL3864078	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	CCc1cc(CNc2cc(Cl)nn3c(-c4ccc(OC)c(S(=O)(=O)NCCO)c4)c(C)nc23)ccn1		CHEMBL3976651	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16776669	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1cc(N2CCOCC2)oc2cc3ccccc3cc12		CHEMBL175883	=	Inhibition	%	-10.0	CHEMBL3130	Homo sapiens	INH	%	-10.0
	16776670	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1cc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c3ccccc3cc12		CHEMBL3950259	=	Inhibition	%	52.0	CHEMBL3130	Homo sapiens	INH	%	52.0
	16776671	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3ccccc3c12		CHEMBL1795742	=	Inhibition	%	8.0	CHEMBL3130	Homo sapiens	INH	%	8.0
	16776672	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4ccccc4)ccc3c12		CHEMBL3943031	=	Inhibition	%	-1.0	CHEMBL3130	Homo sapiens	INH	%	-1.0
	16776673	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3c(ccc4oc(N5CCOCC5)nc(=O)c43)c2)cc1		CHEMBL3945601	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16776674	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4ccc(Cl)cc4)ccc3c12		CHEMBL3951788	=	Inhibition	%	-1.0	CHEMBL3130	Homo sapiens	INH	%	-1.0
	16776675	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL1795743	=	Inhibition	%	12.0	CHEMBL3130	Homo sapiens	INH	%	12.0
	16776676	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccccc1)c1ccccc12		CHEMBL3925185	=	Inhibition	%	3.0	CHEMBL3130	Homo sapiens	INH	%	3.0
	16776677	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)cc1		CHEMBL3897141	=	Inhibition	%	9.0	CHEMBL3130	Homo sapiens	INH	%	9.0
	16776678	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3c1oc1ccccc13)c1ccccc12		CHEMBL3934067	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16776679	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3c1sc1ccccc13)c1ccccc12		CHEMBL3906076	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	16776712	CHEMBL3864786	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption after 60 mins by Kinase-Glo assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)c3ccccc3cc12		CHEMBL3945937	=	IC50	nM	7700.0	CHEMBL3130	Homo sapiens	IC50	uM	7.7
	16776713	CHEMBL3864786	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption after 60 mins by Kinase-Glo assay	B	COc1ccc(-c2c3ccccc3cc3c(=O)cc(N4CCOCC4)oc23)cc1		CHEMBL3915703	=	IC50	nM	5600.0	CHEMBL3130	Homo sapiens	IC50	uM	5.6
Not Determined	16776757	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4cccc5c4oc4ccccc45)ccc3c12		CHEMBL3979696		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776758	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2ccc3cc(-c4cccc5c4sc4ccccc45)ccc3c12		CHEMBL3950725		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776759	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccc(Cl)cc1)c1ccccc12		CHEMBL3910266		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776760	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccc(CO)cc1)c1ccccc12		CHEMBL3972212		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776761	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Nc1cccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)c1		CHEMBL3919181		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776762	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	NC(=O)c1ccc(-c2cc3c(=O)nc(N4CCOCC4)oc3c3ccccc23)cc1		CHEMBL3946978		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776763	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(/C=C/c1ccccc1)c1ccccc12		CHEMBL3892236		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776764	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccs1)c1ccccc12		CHEMBL3920237		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776765	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1ccsc1)c1ccccc12		CHEMBL3901196		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Determined	16776766	CHEMBL3864779	Inhibition of p110delta (unknown origin) assessed as decrease in ATP consumption at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=c1nc(N2CCOCC2)oc2c1cc(-c1cccc3ccccc13)c1ccccc12		CHEMBL3929149		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	16779818	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CN(C)CCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3897548	=	Kd	nM	513.0	CHEMBL3130	Homo sapiens	Kd	nM	513.0
	16779819	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CNCCS(C)(=O)=O)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3916621	=	Kd	nM	178.0	CHEMBL3130	Homo sapiens	Kd	nM	178.0
	16779820	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3986383	=	Kd	nM	316.0	CHEMBL3130	Homo sapiens	Kd	nM	316.0
	16779821	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(C(=O)O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3970860	=	Kd	nM	174.0	CHEMBL3130	Homo sapiens	Kd	nM	174.0
	16779822	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(C(N)=O)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3941289	=	Kd	nM	12589.0	CHEMBL3130	Homo sapiens	Kd	nM	12589.0
	16779823	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CS(=O)(=O)O.Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3894812	=	Kd	nM	225.0	CHEMBL3130	Homo sapiens	Kd	nM	225.0
Not Determined	16779824	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CO)nc3c(N)cc(N4CCOCC4)nn23)cccc1C(F)(F)F.O=S(=O)(O)O		CHEMBL3966155		Kd			CHEMBL3130	Homo sapiens	Kd		
	16779825	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(=O)NCc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3903747	=	Kd	nM	59.0	CHEMBL3130	Homo sapiens	Kd	nM	59.0
	16779826	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Cc2c(CO)nc3c(C(=O)O)cc(N4CCOCC4)nn23)cccc1C(F)(F)F		CHEMBL3974658	=	Kd	nM	48.0	CHEMBL3130	Homo sapiens	Kd	nM	48.0
	16779827	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Cc1cccc(C(F)(F)F)c1C		CHEMBL3975628	=	Kd	nM	171.0	CHEMBL3130	Homo sapiens	Kd	nM	171.0
	16779828	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1C		CHEMBL3946307	=	Kd	nM	49.0	CHEMBL3130	Homo sapiens	Kd	nM	49.0
	16779829	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(-c3cnc[nH]3)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3983623	=	Kd	nM	11.0	CHEMBL3130	Homo sapiens	Kd	nM	11.0
	16779830	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CC(O)C1		CHEMBL3955003	=	Kd	nM	73.0	CHEMBL3130	Homo sapiens	Kd	nM	73.0
	16779831	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(C(F)(F)F)c1CN1CCN(C)CC1		CHEMBL3956037	=	Kd	nM	20.0	CHEMBL3130	Homo sapiens	Kd	nM	20.0
	16779832	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	Kd	nM	138.0	CHEMBL3130	Homo sapiens	Kd	nM	138.0
	16779833	CHEMBL3865234	Binding affinity to human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1c(Nc2c(CO)nc3c(N)cc(N4CCOC(CO)C4)nn23)cccc1C(F)(F)F		CHEMBL3928423	=	Kd	nM	10965.0	CHEMBL3130	Homo sapiens	Kd	nM	10965.0
	16781932	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213084	<	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	16781933	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	COc1cc(F)cc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)c1		CHEMBL3977335	=	IC50	nM	2790.0	CHEMBL3130	Homo sapiens	IC50	nM	2790.0
	16781934	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	COc1cc(F)cc(-c2nn(C3CCc4ccccc43)c3ncnc(N)c23)c1		CHEMBL3920744	=	IC50	nM	1830.0	CHEMBL3130	Homo sapiens	IC50	nM	1830.0
	16781935	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	COc1cc(F)cc(-c2nn(C3CCc4ccccc4C3)c3ncnc(N)c23)c1		CHEMBL3892739	=	IC50	nM	1340.0	CHEMBL3130	Homo sapiens	IC50	nM	1340.0
	16781936	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1Cc2ccccc2C1		CHEMBL3896635	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
	16781937	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCc2ccccc21		CHEMBL3924678	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	16781938	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCc2ccccc2C1		CHEMBL3905578	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
Not Determined	16781939	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3933590		IC50			CHEMBL3130	Homo sapiens	IC50		
	16781940	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)cc(Cl)c1)nn2C1Cc2ccccc2C1		CHEMBL3914552	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	16781941	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3942550	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	nM	61.0
	16781942	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3923573	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	16781943	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3964073	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
	16781944	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Cc1ccc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc1O		CHEMBL3957821	=	IC50	nM	172.0	CHEMBL3130	Homo sapiens	IC50	nM	172.0
	16781945	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	COc1ccc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc1O		CHEMBL3983045	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	16781946	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)c(F)c(F)c1)nn2C1Cc2ccccc2C1		CHEMBL3907591	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	16781947	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1Cc2ccccc2C1		CHEMBL3948373	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
Not Determined	16781948	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1CCc2ccccc2C1		CHEMBL3893661		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16781949	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1Cc2cc(F)ccc2C1=O		CHEMBL3906843		IC50			CHEMBL3130	Homo sapiens	IC50		
	16781950	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)C2		CHEMBL3897842	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	16781951	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)C2		CHEMBL3897842	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	16781952	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)CC2		CHEMBL3925929	=	IC50	nM	55.0	CHEMBL3130	Homo sapiens	IC50	nM	55.0
	16781953	CHEMBL3865686	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate in presence of streptavidin-APC by FRET assay	B	Nc1ccc2c(c1)CC(n1nc(-c3cc(F)c4c(c3)NCCO4)c3c(N)ncnc31)CC2		CHEMBL3925929	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	nM	72.0
	16781966	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3933590	=	Inhibition	%	41.0	CHEMBL3130	Homo sapiens	INH	%	41.0
	16781967	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(O)c(F)c(F)c1)nn2C1Cc2ccccc2C1		CHEMBL3907591	=	Inhibition	%	87.0	CHEMBL3130	Homo sapiens	INH	%	87.0
	16781968	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c(F)c(F)c1)nn2C1Cc2ccccc2C1		CHEMBL3921872	=	Inhibition	%	21.0	CHEMBL3130	Homo sapiens	INH	%	21.0
	16781969	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1cc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)ccc1F		CHEMBL3944020	=	Inhibition	%	8.2	CHEMBL3130	Homo sapiens	INH	%	8.2
	16781970	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1cc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc(F)c1F		CHEMBL3938517	=	Inhibition	%	26.0	CHEMBL3130	Homo sapiens	INH	%	26.0
	16781971	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	COc1ccc(-c2nn(C3Cc4ccccc4C3)c3ncnc(N)c23)cc1N		CHEMBL3939609	=	Inhibition	%	14.0	CHEMBL3130	Homo sapiens	INH	%	14.0
	16781972	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc3c(c1)NCCO3)nn2C1Cc2ccccc2C1		CHEMBL3911636	=	Inhibition	%	40.0	CHEMBL3130	Homo sapiens	INH	%	40.0
	16781973	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1Cc2ccccc2C1		CHEMBL3948373	=	Inhibition	%	53.0	CHEMBL3130	Homo sapiens	INH	%	53.0
	16781974	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1Cc2ccccc2C1		CHEMBL3920574	=	Inhibition	%	24.0	CHEMBL3130	Homo sapiens	INH	%	24.0
	16781975	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1ccc3nc[nH]c3c1)nn2C1Cc2ccccc2C1		CHEMBL3921674	=	Inhibition	%	78.0	CHEMBL3130	Homo sapiens	INH	%	78.0
	16781976	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1CCc2ccccc2C1		CHEMBL3893661	=	Inhibition	%	52.0	CHEMBL3130	Homo sapiens	INH	%	52.0
	16781977	CHEMBL3865688	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate at 100 nM in presence of streptavidin-APC by FRET assay	B	Nc1ncnc2c1c(-c1cc(F)c3c(c1)NCCO3)nn2C1Cc2cc(F)ccc2C1=O		CHEMBL3906843	=	Inhibition	%	26.0	CHEMBL3130	Homo sapiens	INH	%	26.0
	16782069	CHEMBL3865718	Inhibition of PI3Kdelta (unknown origin) in presence of [gamma-32P]ATP by phosphorimaging assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213084	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
Not Determined	16786835	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@@H]1CCCN1)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3908177		IC50			CHEMBL3130	Homo sapiens	IC50		
	16786836	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	C[C@@H](N)C(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3936124	=	IC50	nM	740.0	CHEMBL3130	Homo sapiens	IC50	nM	740.0
	16786837	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	C[C@H](N)C(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3917147	=	IC50	nM	1090.0	CHEMBL3130	Homo sapiens	IC50	nM	1090.0
	16786838	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)N1CCC(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3930788	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
Not Determined	16786839	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)N1CCC(Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3972268		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786840	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(NC2CCNCC2)nc(N2CCOCC2)n1		CHEMBL3900274		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786841	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NC1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL3978019		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786842	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL3948855		IC50			CHEMBL3130	Homo sapiens	IC50		
	16786843	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3949883	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
Not Determined	16786844	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3922132		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786845	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3958556		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786846	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	CC(=O)NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3963433		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786847	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NCC(=O)NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3962354		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16786848	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3893326		IC50			CHEMBL3130	Homo sapiens	IC50		
	16786849	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C(C1CCNCC1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3953591	=	IC50	nM	330.0	CHEMBL3130	Homo sapiens	IC50	nM	330.0
	16786850	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	16786851	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	CC(C)C[C@H](N)CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3944869	=	IC50	nM	9100.0	CHEMBL3130	Homo sapiens	IC50	nM	9100.0
	16786852	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	N[C@@H](CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)c1ccccc1		CHEMBL3974302	=	IC50	nM	17000.0	CHEMBL3130	Homo sapiens	IC50	nM	17000.0
	16786853	CHEMBL3866410	Inhibition of PI3Kdelta (unknown origin) expressed in Escherichia coli-infected fall armyworm sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	N[C@H](CC(=O)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)Cc1ccccc1		CHEMBL3935927	=	IC50	nM	2841.0	CHEMBL3130	Homo sapiens	IC50	nM	2841.0
	16790987	CHEMBL3867037	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by kinase-glo luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(CN(C)C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3963018	=	IC50	nM	3.8	CHEMBL3130	Homo sapiens	IC50	nM	3.8
	16790988	CHEMBL3867037	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by kinase-glo luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(CN(C)CCO)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3905146	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	16790989	CHEMBL3867037	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by kinase-glo luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccc(Cn5cncn5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL3968925	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	nM	2.8
	16790990	CHEMBL3867037	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by kinase-glo luminescence assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	16790991	CHEMBL3867037	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 1 hr in presence of ATP by kinase-glo luminescence assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	9.4	CHEMBL3130	Homo sapiens	IC50	nM	9.4
	16798461	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL3960012	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	16798463	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	16798464	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	16798465	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3896413	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	16798467	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3930000	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	16798469	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3905342	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	16798470	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3966263	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	uM	0.015
	16798471	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3969716	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	16798472	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	16798473	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)nc23)C1		CHEMBL3977135	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	uM	0.022
	16798474	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	16798475	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3896413	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	16798478	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	uM	0.039
	16798480	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3930000	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	uM	0.044
	16798481	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	16798484	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3966263	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	uM	0.072
	16798487	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL3960012	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
	16798489	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3969716	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	uM	0.082
	16798492	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3948901	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	16798495	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3921081	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	uM	0.13
	16798496	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3914282	=	IC50	nM	146.0	CHEMBL3130	Homo sapiens	IC50	uM	0.146
	16798499	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3905342	=	IC50	nM	162.0	CHEMBL3130	Homo sapiens	IC50	uM	0.162
	16798500	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2cnnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3933360	=	IC50	nM	188.0	CHEMBL3130	Homo sapiens	IC50	uM	0.188
	16798507	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3910692	=	IC50	nM	256.0	CHEMBL3130	Homo sapiens	IC50	uM	0.256
	16798522	CHEMBL3868297	Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay	B	CCC(=O)N1CC[C@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3939028	=	IC50	nM	488.0	CHEMBL3130	Homo sapiens	IC50	uM	0.488
	16798527	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)nc23)C1		CHEMBL3977135	=	IC50	nM	646.0	CHEMBL3130	Homo sapiens	IC50	uM	0.646
	16798556	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	Ratio IC50		1.4	CHEMBL3130	Homo sapiens	Ratio IC50		1.4
	16798582	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2cnnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3933360	=	IC50	nM	2840.0	CHEMBL3130	Homo sapiens	IC50	uM	2.84
	16798584	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3896413	=	Ratio IC50		3.0	CHEMBL3130	Homo sapiens	Ratio IC50		3.0
	16798597	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	Ratio IC50		4.0	CHEMBL3130	Homo sapiens	Ratio IC50		4.0
	16798598	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3930000	=	Ratio IC50		4.0	CHEMBL3130	Homo sapiens	Ratio IC50		4.0
	16798603	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3966263	=	Ratio IC50		5.0	CHEMBL3130	Homo sapiens	Ratio IC50		5.0
	16798604	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3969716	=	Ratio IC50		5.0	CHEMBL3130	Homo sapiens	Ratio IC50		5.0
	16798608	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	Ratio IC50		7.0	CHEMBL3130	Homo sapiens	Ratio IC50		7.0
	16798615	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2cnnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3933360	=	Ratio IC50		13.0	CHEMBL3130	Homo sapiens	Ratio IC50		13.0
	16798616	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL3905342	=	Ratio IC50		15.0	CHEMBL3130	Homo sapiens	Ratio IC50		15.0
	16798617	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL3960012	=	Ratio IC50		16.0	CHEMBL3130	Homo sapiens	Ratio IC50		16.0
	16798618	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2ccnc3ccc(-c4ccc(OC)nc4)nc23)C1		CHEMBL3977135	=	Ratio IC50		29.0	CHEMBL3130	Homo sapiens	Ratio IC50		29.0
Not Determined	16798629	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	CCC(=O)N1CC[C@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3939028		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16798630	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3910692		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16798631	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3921081		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16798632	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3948901		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16798633	CHEMBL3868300	Inhibition of myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells assessed as inhibition of Akt phosphorylation	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3914282		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16798655	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	CCC(=O)N1CC[C@H](Oc2cnc3ccc(-c4ccc(OC)c(OC)c4)cc3n2)C1		CHEMBL3939028		Ratio IC50			CHEMBL3130	Homo sapiens	Ratio IC50		
Not Determined	16798656	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1OC		CHEMBL3910692		Ratio IC50			CHEMBL3130	Homo sapiens	Ratio IC50		
Not Determined	16798657	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3921081		Ratio IC50			CHEMBL3130	Homo sapiens	Ratio IC50		
Not Determined	16798658	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C)C4)c3c2)cc1OC		CHEMBL3948901		Ratio IC50			CHEMBL3130	Homo sapiens	Ratio IC50		
Not Determined	16798659	CHEMBL3868306	Selectivity ratio of IC50 for myristoylated PI3K-delta (unknown origin) overexpressed in Rat1 cells to IC50 for PI3K-delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@@H]4CCN(C(C)=O)C4)c3c2)cc1OC		CHEMBL3914282		Ratio IC50			CHEMBL3130	Homo sapiens	Ratio IC50		
	16801187	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccncc4)cc23)cc1		CHEMBL3953521	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	16801188	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1		CHEMBL3982233		IC50			CHEMBL3130	Homo sapiens	IC50		
	16801189	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5[nH]ccc5c4)cc23)cc1		CHEMBL3962279	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	16801190	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc5c4sc4ccccc45)cc23)cc1		CHEMBL3893253		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801191	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc5c4oc4ccccc45)cc23)cc1		CHEMBL3973256		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801192	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cc5ccccc5s4)cc23)cc1		CHEMBL3902235		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801193	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cc5ccccc5o4)cc23)cc1		CHEMBL3908424		IC50			CHEMBL3130	Homo sapiens	IC50		
	16801194	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cc1		CHEMBL3978826	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16801195	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5c(c4)OCCO5)cc23)cc1		CHEMBL3899361	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	16801196	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc5ccccc5c4)cc23)cc1		CHEMBL3970545		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801197	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(-c5ccccc5)cc4F)cc23)cc1		CHEMBL3890403		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801198	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	CCOc1ccc(-c2ccc(-c3ccc4ncnc(Nc5ccc(CC#N)cc5)c4c3)cc2)cc1		CHEMBL3959481		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801199	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(-c5ccccc5)cc4)cc23)cc1		CHEMBL3979727		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801200	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	CC(=O)Nc1cccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)c1		CHEMBL3950768		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801201	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(OCc5ccc(F)cc5)cc4)cc23)cc1		CHEMBL3971633		IC50			CHEMBL3130	Homo sapiens	IC50		
	16801202	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	C=Cc1ccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)cc1		CHEMBL3942049	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	16801203	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	Cc1ccccc1-c1ccc2ncnc(Nc3ccc(CC#N)cc3)c2c1		CHEMBL3966044		IC50			CHEMBL3130	Homo sapiens	IC50		
	16801204	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc([N+](=O)[O-])c4)cc23)cc1		CHEMBL3894691	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16801205	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cccc(O)c4)cc23)cc1		CHEMBL3919405	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	16801206	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	CC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(CC#N)cc4)c3c2)cc1		CHEMBL3890572	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
Not Determined	16801207	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccccc4C=O)cc23)cc1		CHEMBL3910480		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	16801208	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccc(F)cc4F)cc23)cc1		CHEMBL3938413		IC50			CHEMBL3130	Homo sapiens	IC50		
	16801209	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4ccccc4)cc23)cc1		CHEMBL3937311	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16801260	CHEMBL3868771	Inhibition of PI3Kdelta (unknown origin) using PI:PS as substrate after 2 hrs in presence of [33P]ATP by liquid scintillation counting method	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	16801264	CHEMBL3868767	Inhibition of human recombinant PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 20 mins by aplhascreen assay	B	Cc1cc([C@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL3979323	=	IC50	nM	1090.0	CHEMBL3130	Homo sapiens	IC50	nM	1090.0
	16801268	CHEMBL3868763	Inhibition of PI3Kdelta (unknown origin)	B	Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1		CHEMBL3935857	=	IC50	nM	13900.0	CHEMBL3130	Homo sapiens	IC50	nM	13900.0
	16801273	CHEMBL3868758	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus co-expressing p85 using l-alpha-phosphatidylinositol as substrate after 120 mins by kinase-glo assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	16801277	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	N#CCc1ccc(Nc2ncnc3ccc(-c4cncc5ccccc45)cc23)cc1		CHEMBL3974237	=	IC50	nM	880.0	CHEMBL3130	Homo sapiens	IC50	uM	0.88
	16801278	CHEMBL3868774	Inhibition of PI3Kdelta (unknown origin) using diC8 PIP2 as substrate after 120 mins by ADP-glo assay	B	COc1cc2ncnc(Nc3ccc(CC#N)cc3)c2cc1OC		CHEMBL3944796	=	IC50	nM	55000.0	CHEMBL3130	Homo sapiens	IC50	uM	55.0
	16830357	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3957154	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	16830358	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1nc(N)nc2[nH]cnc12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3985833	=	IC50	nM	6.5	CHEMBL3130	Homo sapiens	IC50	nM	6.5
	16830359	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3981636	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	16830360	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc2[nH]cc(F)c12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3902629	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	16830361	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1F)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3973614	=	IC50	nM	210.0	CHEMBL3130	Homo sapiens	IC50	nM	210.0
	16830362	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3901527	=	IC50	nM	4.7	CHEMBL3130	Homo sapiens	IC50	nM	4.7
	16830363	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1nc(N)nc(N)n1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3920579	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	nM	76.0
	16830364	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	CC[C@H](Nc1ncnc(N)c1C#N)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3957244	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	16830365	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	N#Cc1c(N)ncnc1N[C@@H](CCO)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3985921	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	16830366	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	N#Cc1c(N)ncnc1N[C@@H](CO)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3898391	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	16830367	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	N#Cc1c(N)ncnc1NC(CC(F)(F)F)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3925368	=	IC50	nM	1600.0	CHEMBL3130	Homo sapiens	IC50	nM	1600.0
	16830368	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3976777	=	IC50	nM	6.6	CHEMBL3130	Homo sapiens	IC50	nM	6.6
	16830369	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	N#Cc1c(N)ncnc1N1CC(F)(F)C[C@H]1c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3906055	=	IC50	nM	370.0	CHEMBL3130	Homo sapiens	IC50	nM	370.0
	16830370	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3C#N)n(-c3ccccc3)c(=O)c12		CHEMBL3897116	=	IC50	nM	1.6	CHEMBL3130	Homo sapiens	IC50	nM	1.6
	16830371	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(CO)c2c(=O)n1-c1ccccc1		CHEMBL3901256	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	16830372	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3924058	=	IC50	nM	3.8	CHEMBL3130	Homo sapiens	IC50	nM	3.8
	16830373	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3910904	=	IC50	nM	7.8	CHEMBL3130	Homo sapiens	IC50	nM	7.8
	16830374	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3980944	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	16830375	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2cc(F)cc2c(=O)n1-c1ccccc1		CHEMBL3919847	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	16830376	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	Cc1ccc2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#N)nn12		CHEMBL3963227	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	16830377	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2c(C#N)ccc2c(=O)n1-c1ccccc1		CHEMBL3928750	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	16830378	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2c(C(F)(F)F)ccc2c(=O)n1-c1ccccc1		CHEMBL3900775	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	nM	380.0
	16830379	CHEMBL3875074	Inhibition of PI3Kdelta in human THP1 cells assessed as reduction in MCSF-stimulated akt phosphorylation at Thr308 preincubated for 30 mins followed by MCSF stimulation for 3 mins by ELISA	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccnc2c(=O)n1-c1ccccc1		CHEMBL3986289	=	IC50	nM	210.0	CHEMBL3130	Homo sapiens	IC50	nM	210.0
	16830454	CHEMBL3875066	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 30 mins followed by IgD activation for 2 hrs by FITC/PE-based FACS analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3910904	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	nM	4.6
	16830455	CHEMBL3875065	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 30 mins followed by IgD activation for 2 hrs by lysis reagent-based FACS analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3910904	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	16839668	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	nM	54.0
	16839669	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCOc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884541	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16839670	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1OCCN1CCOCC1		CHEMBL3884860	=	IC50	nM	94.0	CHEMBL3130	Homo sapiens	IC50	nM	94.0
	16839671	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1OCc1ccccn1		CHEMBL3884661	=	IC50	nM	950.0	CHEMBL3130	Homo sapiens	IC50	nM	950.0
	16839672	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCNc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885234	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16839673	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1NCCN1CCOCC1		CHEMBL3883482	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	16839674	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1NCc1ccccn1		CHEMBL3884692	=	IC50	nM	350.0	CHEMBL3130	Homo sapiens	IC50	nM	350.0
	16839675	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCN)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883357	=	IC50	nM	470.0	CHEMBL3130	Homo sapiens	IC50	nM	470.0
	16839676	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CNCCN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885014	=	IC50	nM	280.0	CHEMBL3130	Homo sapiens	IC50	nM	280.0
	16839677	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885320	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	16839678	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCCN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884928	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	16839679	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CCN(CC)CCN(C)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885111	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	nM	66.0
	16839680	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCN1CCCCC1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885182	=	IC50	nM	450.0	CHEMBL3130	Homo sapiens	IC50	nM	450.0
	16839681	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCN1CCOCC1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884798	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	16839682	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCCN1CCOCC1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884691	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	16839683	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(Cc1ccccn1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885380	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	16839684	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(Cc1cccnc1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883632	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	nM	160.0
	16839685	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(Cc1ccncc1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3885168	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	16839686	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCc1ccccn1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883536	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
	16839687	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCc1cccnc1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883515	=	IC50	nM	55.0	CHEMBL3130	Homo sapiens	IC50	nM	55.0
	16839688	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCc1ccncc1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884092	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	nM	61.0
	16839689	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCn1ccnc1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883390	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	16839690	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCc1c[nH]cn1)c1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883989	=	IC50	nM	88.0	CHEMBL3130	Homo sapiens	IC50	nM	88.0
	16839691	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(C#N)cc12)S(=O)(=O)c1cc(C#N)ccc1OCCN1CCOCC1		CHEMBL3883961	=	IC50	nM	680.0	CHEMBL3130	Homo sapiens	IC50	nM	680.0
	16839692	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCN(C)c1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3883926	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	nM	380.0
	16839693	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(CCCN1CCOCC1)c1ccc(C#N)cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884166	=	IC50	nM	370.0	CHEMBL3130	Homo sapiens	IC50	nM	370.0
	16839694	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(/N=C/c1cnn2ccc(Br)cc12)S(=O)(=O)c1cc([N+](=O)[O-])ccc1OCCN1CCOCC1		CHEMBL3884306	=	IC50	nM	350.0	CHEMBL3130	Homo sapiens	IC50	nM	350.0
	16839695	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	CN(C)CCN(C)c1ccc([N+](=O)[O-])cc1C(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL3884071	=	IC50	nM	68.0	CHEMBL3130	Homo sapiens	IC50	nM	68.0
	16839696	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)CCN(C)C)c1cnn2ccc(C#N)cc12		CHEMBL3885000	=	IC50	nM	676.0	CHEMBL3130	Homo sapiens	IC50	nM	676.0
	16839697	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)Cc1ccccn1)c1cnn2ccc(C#N)cc12		CHEMBL3884950	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	16839698	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)CCN(C)C)c1cnn2ccc(Br)cc12		CHEMBL3884711	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16839699	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\NS(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)Cc1ccccn1)c1cnn2ccc(Br)cc12		CHEMBL3884910	=	IC50	nM	292.0	CHEMBL3130	Homo sapiens	IC50	nM	292.0
	16839700	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)CCN(C)C)c1cnn2ccc(C#N)cc12		CHEMBL3885459	=	IC50	nM	658.0	CHEMBL3130	Homo sapiens	IC50	nM	658.0
	16839701	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)Cc1ccccn1)c1cnn2ccc(C#N)cc12		CHEMBL3884669	=	IC50	nM	575.0	CHEMBL3130	Homo sapiens	IC50	nM	575.0
	16839702	CHEMBL3876605	Inhibition of p110delta (unknown origin) using L-alpha phosphatidylinositol as substrate after 1 hr in presence of [gamma33]-ATP by thin layer chromatographic analysis	B	C/C(=N\N(C)S(=O)(=O)c1cc([N+](=O)[O-])ccc1N(C)CCN(C)C)c1cnn2ccc(Br)cc12		CHEMBL3885416	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	16844176	CHEMBL3877206	Inhibition of immobilized N-LY294002 bead binding to PI3Kdelta (unknown origin) expressed in HEK293T cells incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1530.0	CHEMBL3130	Homo sapiens	IC50	uM	1.53
	16896814	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896815	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(=O)Nc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3893037	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896816	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3nc(N)oc3c2)c2c(N)ncnc21		CHEMBL3962632	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896817	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CCOCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3965413	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896818	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CCC(N5CCOCC5)CC4)c4ncnc(N)c34)ccc2o1		CHEMBL3925171	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896819	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(=O)N1CCC(n2nc(-c3ccc4oc(N)nc4c3)c3c(N)ncnc32)CC1		CHEMBL3914396	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896820	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CNc1noc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc12		CHEMBL3907354	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896821	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	[2H]C([2H])([2H])C([2H])(n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)C([2H])([2H])[2H]		CHEMBL3943182	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896822	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CC(=O)C4)c4ncnc(N)c34)ccc2o1		CHEMBL3901250	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896823	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3nn(C4CC(O)C4)c4ncnc(N)c34)ccc2o1		CHEMBL3894734	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896824	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)(CO)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3891983	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896825	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(=O)Nc1nc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2o1		CHEMBL3958537	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896826	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3c(NC4CC4)noc3c2)c2c(N)ncnc21		CHEMBL3972495	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896827	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CNc1noc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc12		CHEMBL3969807	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896828	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)n1nc(-c2ccc3onc(NC4CC4)c3c2)c2c(N)ncnc21		CHEMBL3981745	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896829	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1noc2ccc(-c3nn(CC(=O)N4CCOCC4)c4ncnc(N)c34)cc12		CHEMBL3913555	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896830	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1noc2ccc(-c3nn(CCN4CCOCC4)c4ncnc(N)c34)cc12		CHEMBL3928767	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896831	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	COC(=O)Nc1noc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc12		CHEMBL3946594	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896832	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	COC(=O)Nc1noc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc12		CHEMBL3975796	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896833	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Cc1nc(N)c2c(-c3ccc4oc(N)nc4c3)nn(C(C)C)c2n1		CHEMBL3978294	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896834	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(CO)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3945869	<	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896835	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CCOC(=O)C(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3896957	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	16896849	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	CC(C)n1cc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3890780	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16896850	CHEMBL3882343	Inhibition of human PI3Kdelta using PIP2 as substrate by HTRF assay	B	Nc1nc2cc(-c3cn(C4CCOCC4)c4ncnc(N)c34)ccc2o1		CHEMBL3961477	<	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	16897215	CHEMBL3882566	Inhibition of PI3K-delta (unknown origin)	B	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1		CHEMBL3360203	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
223793	17612347	CHEMBL3705144	Biochemical Assays: Compounds of the invention were tested for inhibitory activity and potency against PI3Kδ.	B	CC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3642827	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
223794	17612348	CHEMBL3705144	Biochemical Assays: Compounds of the invention were tested for inhibitory activity and potency against PI3Kδ.	B	CCC(Nc1ncnc2nc[nH]c12)c1nc2ccccc2c(=O)n1-c1ccccc1		CHEMBL3642826	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
223795	17612349	CHEMBL3705144	Biochemical Assays: Compounds of the invention were tested for inhibitory activity and potency against PI3Kδ.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
223796	17612350	CHEMBL3705144	Biochemical Assays: Compounds of the invention were tested for inhibitory activity and potency against PI3Kδ.	B	CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1c(F)cccc1F		CHEMBL3642828	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
223797	17612351	CHEMBL3705144	Biochemical Assays: Compounds of the invention were tested for inhibitory activity and potency against PI3Kδ.	B	CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(C)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3642829	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
246871	17630246	CHEMBL3705185	Enzyme Assay: The relative efficacies of compounds as inhibitors of an enzyme activity (or other biological activity) can be established by determining the concentrations at which each compound inhibits the activity to a predefined extent and then comparing the results.	B	CC(c1nc2ccsc2c(=O)n1-c1ccccc1)n1cnc2c(N)ncnc21		CHEMBL3675615	=	Ki	nM	40.0	CHEMBL3130	Homo sapiens	Ki	nM	40.0
246872	17630247	CHEMBL3705185	Enzyme Assay: The relative efficacies of compounds as inhibitors of an enzyme activity (or other biological activity) can be established by determining the concentrations at which each compound inhibits the activity to a predefined extent and then comparing the results.	B	Cc1cccc2nc(C(C)n3cnc4c(N)ncnc43)n(-c3ccccc3)c(=O)c12		CHEMBL2216871	=	Ki	nM	7.0	CHEMBL3130	Homo sapiens	Ki	nM	7.0
246873	17630248	CHEMBL3705185	Enzyme Assay: The relative efficacies of compounds as inhibitors of an enzyme activity (or other biological activity) can be established by determining the concentrations at which each compound inhibits the activity to a predefined extent and then comparing the results.	B	CC(Nc1ncnc2nc[nH]c12)c1nc2ccsc2c(=O)n1-c1ccccc1		CHEMBL3675616	=	Ki	nM	6.0	CHEMBL3130	Homo sapiens	Ki	nM	6.0
246874	17630249	CHEMBL3705185	Enzyme Assay: The relative efficacies of compounds as inhibitors of an enzyme activity (or other biological activity) can be established by determining the concentrations at which each compound inhibits the activity to a predefined extent and then comparing the results.	B	Cc1cccc2nc(C(C)Nc3ncnc4nc[nH]c34)n(-c3ccccc3)c(=O)c12		CHEMBL3675617	=	Ki	nM	5.0	CHEMBL3130	Homo sapiens	Ki	nM	5.0
253165	17636115	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(Cn3nc(I)c4c(N)ncnc43)c(-c3cccc(F)c3)c(=O)n12		CHEMBL3680903	=	Ki	nM	84.9	CHEMBL3130	Homo sapiens	Ki	nM	84.9
253166	17636116	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1ccccc1-c1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)n2c1=O		CHEMBL3680904	=	Ki	nM	6283.0	CHEMBL3130	Homo sapiens	Ki	nM	6283.0
253167	17636117	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc([C@@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL3680905	=	Ki	nM	802.4	CHEMBL3130	Homo sapiens	Ki	nM	802.4
253168	17636118	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL3680906	=	Ki	nM	23.1	CHEMBL3130	Homo sapiens	Ki	nM	23.1
253169	17636119	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(CNc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL3680907	=	Ki	nM	710.7	CHEMBL3130	Homo sapiens	Ki	nM	710.7
253170	17636120	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(C(C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL3680908	=	Ki	nM	27.7	CHEMBL3130	Homo sapiens	Ki	nM	27.7
253171	17636121	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@@H](Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccc1S(C)(=O)=O		CHEMBL3680909	=	Ki	nM	24600.0	CHEMBL3130	Homo sapiens	Ki	nM	24600.0
253172	17636122	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@@H](Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccc1		CHEMBL3680910	=	Ki	nM	6320.0	CHEMBL3130	Homo sapiens	Ki	nM	6320.0
253173	17636123	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(O)c1-c1cc(F)cc(F)c1		CHEMBL3680911	=	Ki	nM	63.7	CHEMBL3130	Homo sapiens	Ki	nM	63.7
253174	17636124	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1cccc(F)c1		CHEMBL3680912	=	Ki	nM	15.7	CHEMBL3130	Homo sapiens	Ki	nM	15.7
253175	17636125	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1ccnc(-c2c([C@H](C)Nc3ncnc(N)c3C#N)nc3ccccn3c2=O)c1		CHEMBL3680913	=	Ki	nM	230.0	CHEMBL3130	Homo sapiens	Ki	nM	230.0
253176	17636126	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccn1		CHEMBL3680914	=	Ki	nM	42.4	CHEMBL3130	Homo sapiens	Ki	nM	42.4
253177	17636127	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccc1		CHEMBL3680915	=	Ki	nM	8.2	CHEMBL3130	Homo sapiens	Ki	nM	8.2
253178	17636128	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccn3)c(=O)n12		CHEMBL3680916	=	Ki	nM	21.4	CHEMBL3130	Homo sapiens	Ki	nM	21.4
253179	17636129	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL2216893	=	Ki	nM	5.0	CHEMBL3130	Homo sapiens	Ki	nM	5.0
253180	17636130	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccc1S(C)(=O)=O		CHEMBL3680917	=	Ki	nM	52.8	CHEMBL3130	Homo sapiens	Ki	nM	52.8
253181	17636131	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1cc(F)cc(F)c1		CHEMBL3680918	=	Ki	nM	89.0	CHEMBL3130	Homo sapiens	Ki	nM	89.0
253182	17636132	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1c(-c2cc(F)cc(F)c2)c(=O)c2cc(F)ccc2n1C		CHEMBL3680919	=	Ki	nM	33.0	CHEMBL3130	Homo sapiens	Ki	nM	33.0
253183	17636133	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1cccc(F)c1		CHEMBL3680920	=	Ki	nM	57.1	CHEMBL3130	Homo sapiens	Ki	nM	57.1
253184	17636134	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1ccnc(-c2c(C(C)Nc3ncnc(N)c3C#N)nc3ccccn3c2=O)c1		CHEMBL3680921	=	Ki	nM	471.0	CHEMBL3130	Homo sapiens	Ki	nM	471.0
253185	17636135	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccn1		CHEMBL3680922	=	Ki	nM	104.0	CHEMBL3130	Homo sapiens	Ki	nM	104.0
253186	17636136	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccccn2c(=O)c1-c1ccccc1		CHEMBL3680923	=	Ki	nM	15.9	CHEMBL3130	Homo sapiens	Ki	nM	15.9
253187	17636137	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(C(C)Nc3ncnc(N)c3C#N)c(-c3ccccn3)c(=O)n12		CHEMBL3680924	=	Ki	nM	10.8	CHEMBL3130	Homo sapiens	Ki	nM	10.8
253188	17636138	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(C(C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL3680925	=	Ki	nM	12.6	CHEMBL3130	Homo sapiens	Ki	nM	12.6
253189	17636139	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1cccc2nc(C(C)Nc3ncnc4[nH]cnc34)c(-c3ccccn3)c(=O)n12		CHEMBL3680926	=	Ki	nM	80.2	CHEMBL3130	Homo sapiens	Ki	nM	80.2
253190	17636140	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	Cc1ccccc1-c1c(CSc2ncnc3nc[nH]c23)nc2cccc(C)n2c1=O		CHEMBL3680927	=	Ki	nM	9714.0	CHEMBL3130	Homo sapiens	Ki	nM	9714.0
253191	17636141	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1ccccn1		CHEMBL3680928	=	Ki	nM	21452.2	CHEMBL3130	Homo sapiens	Ki	nM	21452.2
253192	17636142	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1ccccn1		CHEMBL3680929	=	Ki	nM	183.7	CHEMBL3130	Homo sapiens	Ki	nM	183.7
253193	17636143	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1ccccn1		CHEMBL3680930	=	Ki	nM	658.7	CHEMBL3130	Homo sapiens	Ki	nM	658.7
253194	17636144	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1cccc(F)c1		CHEMBL3680931	=	Ki	nM	19840.0	CHEMBL3130	Homo sapiens	Ki	nM	19840.0
253195	17636145	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1cccc(F)c1		CHEMBL3680932	=	Ki	nM	110.1	CHEMBL3130	Homo sapiens	Ki	nM	110.1
253196	17636146	CHEMBL3705197	Alphascreen Assays : A PI3K Alphascreen assay (PerkinElmer, Waltham, Mass.) was used to measure the activity of a panel of four phosphoinositide 3-kinases: PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ. Enzyme reaction buffer was prepared using sterile water (Baxter, Deerfield, Ill.) and 50 mM Tris HCl pH 7, 14 mM MgCl2, 2 mM sodium cholate, and 100 mM NaCl. 2 mM DTT was added fresh the day of the experiment. The Alphascreen buffer was made using sterile water and 10 mM Tris HCl pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA. 1 mM DTT was added fresh the day of the experiment. Compound source plates used for this assay were 384-well Greiner clear polypropylene plates containing test compounds at 5 mM and diluted 1:2 over 22 concentrations.	B	CC(Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cn2c(=O)c1-c1cccc(F)c1		CHEMBL3680933	=	Ki	nM	360.3	CHEMBL3130	Homo sapiens	Ki	nM	360.3
272661	17654981	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1ccc(OC)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc3c(c2)sc(=O)n3C)c1		CHEMBL3695326	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	nM	240.0
272662	17654982	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1ccc(OC)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cn(C)cn2)c1		CHEMBL3695325	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	nM	80.0
272663	17654983	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1ccc(OC)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(C#N)c2)c1		CHEMBL3695324	=	IC50	nM	430.0	CHEMBL3130	Homo sapiens	IC50	nM	430.0
272664	17654984	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1ccc(OC)c(Nc2nc3ncccc3nc2NS(=O)(=O)c2ccccc2)c1		CHEMBL3695328	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	nM	73.0
272665	17654985	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1ccc(OC)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccnc2)c1		CHEMBL3695327	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	nM	56.0
272666	17654986	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(C(=O)NCCCN(C)C)c2)cc(OC)c1		CHEMBL3695329	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
272667	17654987	CHEMBL3705928	Scintillation Proximity Assay: The assay combines the scintillation proximity assay technology (SPA, Amersham) with the capacity of neomycin (a polycationic antibiotic) to bind phospholipids with high affinity and specificity. The Scintillation Proximity Assay is based on the properties of weakly emitting isotopes (such as 3H, 125I, 33P). Coating SPA beads with neomycin allows the detection of phosphorylated lipid substrates after incubation with recombinant PI3K and radioactive ATP in the same well, by capturing the radioactive phospholipids to the SPA beads through their specific binding to neomycin.To a 96 wells MTP containing 10 ul of the test compound of Formula (I) (solubilized in 10% DMSO; to yield a concentration of 100, 25, 5.0, 1.25, 0.312, 0.078, 0.0195, 0.00488, 0.00122 and 0.0003 uM of the test compound), the following assay components are added: 1) 10 ul of lipid micelles 2) 20ul of Kinase buffer ([33P]-gamma-ATP 162uM/300 nCi, MgCl2 2.5mM, DTT 2.5mM, Na3VO4 25uM in Hepes.	B	COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(CN(C)C)cc2)cc(OC)c1		CHEMBL2216880	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
289534	17671945	CHEMBL3706231	Biochemical Assay: Using the method described in Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kdelta, and for selectivity for PI3Kdelta versus other Class I PI3K isozymes. In Table 1, IC50 values (uM) are given for PI3Kdelta (Delta), and may be calculated for the other isoforms using the ratios of IC50 values discussed below. To illustrate selectivity of the compounds, the ratios of the IC50 values of the compounds for PI3Kalpha, PI3Kbeta, and PI3Kgamma relative to PI3Kdelta are given, respectively, as Alpha/Delta Ratio, Beta/Delta Ratio, and Gamma/Delta Ratio.The initial selectivity assays were performed identically to the selectivity assay protocol in Example 2, except, using 100 uL Ecosint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3 substrate stocks except they contained 0.05 mCi/mL gamma [32P] ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3 enzyme stocks.	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccccc2c(=O)n1-c1cccc(F)c1		CHEMBL3654359	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
289535	17671946	CHEMBL3706231	Biochemical Assay: Using the method described in Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kdelta, and for selectivity for PI3Kdelta versus other Class I PI3K isozymes. In Table 1, IC50 values (uM) are given for PI3Kdelta (Delta), and may be calculated for the other isoforms using the ratios of IC50 values discussed below. To illustrate selectivity of the compounds, the ratios of the IC50 values of the compounds for PI3Kalpha, PI3Kbeta, and PI3Kgamma relative to PI3Kdelta are given, respectively, as Alpha/Delta Ratio, Beta/Delta Ratio, and Gamma/Delta Ratio.The initial selectivity assays were performed identically to the selectivity assay protocol in Example 2, except, using 100 uL Ecosint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3 substrate stocks except they contained 0.05 mCi/mL gamma [32P] ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3 enzyme stocks.	B	Cc1c[nH]c2ncnc(NC(C)c3nc4cccc(C)c4c(=O)n3-c3cccc(F)c3)c12		CHEMBL3654358	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
289536	17671947	CHEMBL3706231	Biochemical Assay: Using the method described in Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kdelta, and for selectivity for PI3Kdelta versus other Class I PI3K isozymes. In Table 1, IC50 values (uM) are given for PI3Kdelta (Delta), and may be calculated for the other isoforms using the ratios of IC50 values discussed below. To illustrate selectivity of the compounds, the ratios of the IC50 values of the compounds for PI3Kalpha, PI3Kbeta, and PI3Kgamma relative to PI3Kdelta are given, respectively, as Alpha/Delta Ratio, Beta/Delta Ratio, and Gamma/Delta Ratio.The initial selectivity assays were performed identically to the selectivity assay protocol in Example 2, except, using 100 uL Ecosint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3 substrate stocks except they contained 0.05 mCi/mL gamma [32P] ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3 enzyme stocks.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
289537	17671948	CHEMBL3706231	Biochemical Assay: Using the method described in Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kdelta, and for selectivity for PI3Kdelta versus other Class I PI3K isozymes. In Table 1, IC50 values (uM) are given for PI3Kdelta (Delta), and may be calculated for the other isoforms using the ratios of IC50 values discussed below. To illustrate selectivity of the compounds, the ratios of the IC50 values of the compounds for PI3Kalpha, PI3Kbeta, and PI3Kgamma relative to PI3Kdelta are given, respectively, as Alpha/Delta Ratio, Beta/Delta Ratio, and Gamma/Delta Ratio.The initial selectivity assays were performed identically to the selectivity assay protocol in Example 2, except, using 100 uL Ecosint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3 substrate stocks except they contained 0.05 mCi/mL gamma [32P] ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3 enzyme stocks.	B	CC(Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3654360	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
289538	17671949	CHEMBL3706231	Biochemical Assay: Using the method described in Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kdelta, and for selectivity for PI3Kdelta versus other Class I PI3K isozymes. In Table 1, IC50 values (uM) are given for PI3Kdelta (Delta), and may be calculated for the other isoforms using the ratios of IC50 values discussed below. To illustrate selectivity of the compounds, the ratios of the IC50 values of the compounds for PI3Kalpha, PI3Kbeta, and PI3Kgamma relative to PI3Kdelta are given, respectively, as Alpha/Delta Ratio, Beta/Delta Ratio, and Gamma/Delta Ratio.The initial selectivity assays were performed identically to the selectivity assay protocol in Example 2, except, using 100 uL Ecosint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3 substrate stocks except they contained 0.05 mCi/mL gamma [32P] ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3 enzyme stocks.	B	CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(C)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3642829	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
304942	17685809	CHEMBL3705659	Scintillation Proximity Assay: The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P] ATP, 4 nM PI3Kdelta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL. After the plate sealing, plates were shaken overnight at room temperature and centrifuged at 1800 rpm for 10 minutes.	B	CC(Nc1ncnc(N)c1C#N)c1cc(Cl)c2ccnnc2c1-c1cccc(F)c1		CHEMBL3701383	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
304943	17685810	CHEMBL3705659	Scintillation Proximity Assay: The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P] ATP, 4 nM PI3Kdelta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL. After the plate sealing, plates were shaken overnight at room temperature and centrifuged at 1800 rpm for 10 minutes.	B	Cc1c(C(=O)N(c2ccc(O)cc2)c2cnc3c(c2)CCN3C)cc(-c2cc(Cl)ccc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCOCC2)n1C		CHEMBL3701384	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
317530	17697658	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cnc(N4CCCC4C4CCCCN4C)cc2OCC3)n(CC(F)(F)F)n1		CHEMBL3704656	=	IC50	nM	0.102	CHEMBL3130	Homo sapiens	IC50	nM	0.102
317531	17697659	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cnc(N4CCCC4C4CCCCN4C)cc2OCC3)n(CC(F)(F)F)n1		CHEMBL3704656	=	IC50	nM	0.107	CHEMBL3130	Homo sapiens	IC50	nM	0.107
317532	17697660	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cnc(N4CCCC4C4CCCCN4C)cc2OCC3)n(CC(F)(F)F)n1		CHEMBL3704656	=	IC50	nM	0.106	CHEMBL3130	Homo sapiens	IC50	nM	0.106
317533	17697661	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cnc(N4CCCC4C4CCCCN4C)cc2OCC3)n(CC(F)(F)F)n1		CHEMBL3704656	=	IC50	nM	0.587	CHEMBL3130	Homo sapiens	IC50	nM	0.587
317534	17697662	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cnc(N3CCCC3CN3CCCC3)cc1OCC2		CHEMBL3704657	=	IC50	nM	0.707	CHEMBL3130	Homo sapiens	IC50	nM	0.707
317535	17697663	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cnc(N3CCCC3C3CCN(C)CC3)cc1OCC2		CHEMBL3704658	=	IC50	nM	0.541	CHEMBL3130	Homo sapiens	IC50	nM	0.541
317536	17697664	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(CN3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL3704659	=	IC50	nM	2.46	CHEMBL3130	Homo sapiens	IC50	nM	2.46
317537	17697665	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1ccc(-c3ccccc3S(N)(=O)=O)cc1OCC2		CHEMBL3704660	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
317538	17697666	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(C(=O)N3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL3704661	=	IC50	nM	0.919	CHEMBL3130	Homo sapiens	IC50	nM	0.919
317539	17697667	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(Oc1ccc2c(c1)OCCn1cc(-c3ncnn3C(C)C)nc1-2)C1CCN(C(C)C)CC1		CHEMBL3704662	=	IC50	nM	0.442	CHEMBL3130	Homo sapiens	IC50	nM	0.442
317540	17697668	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704663	=	IC50	nM	0.445	CHEMBL3130	Homo sapiens	IC50	nM	0.445
317541	17697669	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ncnn4C4CCN(C(C)(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704664	=	IC50	nM	82.1	CHEMBL3130	Homo sapiens	IC50	nM	82.1
317542	17697670	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(CN5CCN(C)CC5)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704665	=	IC50	nM	3.31	CHEMBL3130	Homo sapiens	IC50	nM	3.31
317543	17697671	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4CC(C)CN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704666	=	IC50	nM	2.56	CHEMBL3130	Homo sapiens	IC50	nM	2.56
317544	17697672	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(C)CCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704667	=	IC50	nM	0.638	CHEMBL3130	Homo sapiens	IC50	nM	0.638
317545	17697673	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCCN(Cc5ccccc5)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704668	=	IC50	nM	8.53	CHEMBL3130	Homo sapiens	IC50	nM	8.53
317546	17697674	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC[C@@H]4C4CCN(C(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704669	=	IC50	nM	0.584	CHEMBL3130	Homo sapiens	IC50	nM	0.584
317547	17697675	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1cc2c(cc1-c1ccnn1C1CCN(C)CC1)OCCn1cc(-c3ncnn3C(C)C)nc1-2		CHEMBL3704670	=	IC50	nM	17.3	CHEMBL3130	Homo sapiens	IC50	nM	17.3
317548	17697676	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC[C@H]4C4CCN(C(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704671	=	IC50	nM	0.51	CHEMBL3130	Homo sapiens	IC50	nM	0.51
317549	17697677	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704672	=	IC50	nM	0.596	CHEMBL3130	Homo sapiens	IC50	nM	0.596
317550	17697678	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCN(C(C)(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704673	=	IC50	nM	4.57	CHEMBL3130	Homo sapiens	IC50	nM	4.57
317551	17697679	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc([S+]([O-])C3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL3704674	=	IC50	nM	0.811	CHEMBL3130	Homo sapiens	IC50	nM	0.811
317552	17697680	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(C)CNC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704675	=	IC50	nM	0.633	CHEMBL3130	Homo sapiens	IC50	nM	0.633
317553	17697681	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCN(CC(C)(C)O)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704676	=	IC50	nM	0.986	CHEMBL3130	Homo sapiens	IC50	nM	0.986
317554	17697682	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(=O)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704677	=	IC50	nM	2.73	CHEMBL3130	Homo sapiens	IC50	nM	2.73
317555	17697683	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCN(CC(C)(C)O)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704676	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
317556	17697684	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(c5ccccc5)CN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704678	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
317557	17697685	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(O)C4CCN(C)CC4)ccc2OCC3)n(C(C)C)n1		CHEMBL3704679	=	IC50	nM	17.9	CHEMBL3130	Homo sapiens	IC50	nM	17.9
317558	17697686	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)C)c4CN4CCN(C(C)(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704680	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
317559	17697687	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)C)c4CN4CCN(C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704681	=	IC50	nM	3.34	CHEMBL3130	Homo sapiens	IC50	nM	3.34
317560	17697688	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704682	=	IC50	nM	0.324	CHEMBL3130	Homo sapiens	IC50	nM	0.324
317561	17697689	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cn(C)nc4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704683	=	IC50	nM	0.878	CHEMBL3130	Homo sapiens	IC50	nM	0.878
317562	17697690	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(=O)N4CCN(C(C)(C)CO)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704684	=	IC50	nM	5.63	CHEMBL3130	Homo sapiens	IC50	nM	5.63
317563	17697691	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CC(C)N(C)C(C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704685	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
317564	17697692	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(CC5CC5)CN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704686	=	IC50	nM	0.936	CHEMBL3130	Homo sapiens	IC50	nM	0.936
317565	17697693	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(CC5CC5)CNC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704687	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
317566	17697694	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCCN(C5(C)COC5)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704688	=	IC50	nM	1.39	CHEMBL3130	Homo sapiens	IC50	nM	1.39
317567	17697695	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC4C4CCN(C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704689	=	IC50	nM	0.529	CHEMBL3130	Homo sapiens	IC50	nM	0.529
317568	17697696	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704672	=	IC50	nM	0.292	CHEMBL3130	Homo sapiens	IC50	nM	0.292
317569	17697697	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704672	=	IC50	nM	2.01	CHEMBL3130	Homo sapiens	IC50	nM	2.01
317570	17697698	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCCN4CC(C)(C)O)cc2OCC3)n(C(C)C)n1		CHEMBL3704690	=	IC50	nM	0.852	CHEMBL3130	Homo sapiens	IC50	nM	0.852
317571	17697699	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1nc(CO)nc1-c1cn2c(n1)-c1ccc(-c3ccnn3C3CCN(C)CC3)cc1OCC2		CHEMBL3704691	=	IC50	nM	2.42	CHEMBL3130	Homo sapiens	IC50	nM	2.42
317572	17697700	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704682	=	IC50	nM	0.494	CHEMBL3130	Homo sapiens	IC50	nM	0.494
317573	17697701	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704682	=	IC50	nM	0.293	CHEMBL3130	Homo sapiens	IC50	nM	0.293
317574	17697702	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC4C4CCN(C(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704692	=	IC50	nM	1.47	CHEMBL3130	Homo sapiens	IC50	nM	1.47
317575	17697703	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704693	=	IC50	nM	0.777	CHEMBL3130	Homo sapiens	IC50	nM	0.777
317576	17697704	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	0.721	CHEMBL3130	Homo sapiens	IC50	nM	0.721
317577	17697705	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4ccnn4C4CCN(C(C)C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704695	=	IC50	nM	1.06	CHEMBL3130	Homo sapiens	IC50	nM	1.06
317578	17697706	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704696	=	IC50	nM	2.42	CHEMBL3130	Homo sapiens	IC50	nM	2.42
317579	17697707	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1nc(N)nc1-c1cn2c(n1)-c1ccc(-c3ccnn3C3CCN(C)CC3)cc1OCC2		CHEMBL3704697	=	IC50	nM	0.705	CHEMBL3130	Homo sapiens	IC50	nM	0.705
317580	17697708	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704698	=	IC50	nM	0.479	CHEMBL3130	Homo sapiens	IC50	nM	0.479
317581	17697709	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704699	=	IC50	nM	0.881	CHEMBL3130	Homo sapiens	IC50	nM	0.881
317582	17697710	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(OC4(CC(C)C)CN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704700	=	IC50	nM	8.67	CHEMBL3130	Homo sapiens	IC50	nM	8.67
317583	17697711	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	1.65	CHEMBL3130	Homo sapiens	IC50	nM	1.65
317584	17697712	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704701	=	IC50	nM	1.92	CHEMBL3130	Homo sapiens	IC50	nM	1.92
317585	17697713	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CCN1CCC(C2CCCN2c2ccc3c(c2)OCCn2cc(-c4nc(C)nn4C(C)C)nc2-3)CC1		CHEMBL3704702	=	IC50	nM	0.52	CHEMBL3130	Homo sapiens	IC50	nM	0.52
317586	17697714	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704703	=	IC50	nM	2.81	CHEMBL3130	Homo sapiens	IC50	nM	2.81
317587	17697715	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCN(S(C)(=O)=O)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704704	=	IC50	nM	1.18	CHEMBL3130	Homo sapiens	IC50	nM	1.18
317588	17697716	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC4C4CCN(C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704689	=	IC50	nM	0.708	CHEMBL3130	Homo sapiens	IC50	nM	0.708
317589	17697717	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC4C4CCN(C)CC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704689	=	IC50	nM	0.419	CHEMBL3130	Homo sapiens	IC50	nM	0.419
317590	17697718	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704663	=	IC50	nM	0.485	CHEMBL3130	Homo sapiens	IC50	nM	0.485
317591	17697719	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CCCN(C(C)(C)CO)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704663	=	IC50	nM	0.262	CHEMBL3130	Homo sapiens	IC50	nM	0.262
317592	17697720	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCN(C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704705	=	IC50	nM	1.35	CHEMBL3130	Homo sapiens	IC50	nM	1.35
317593	17697721	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	0.735	CHEMBL3130	Homo sapiens	IC50	nM	0.735
317594	17697722	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	0.951	CHEMBL3130	Homo sapiens	IC50	nM	0.951
317595	17697723	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC45CCCN(C)C5)cc2OCC3)n(C(C)C)n1		CHEMBL3704706	=	IC50	nM	0.335	CHEMBL3130	Homo sapiens	IC50	nM	0.335
317596	17697724	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C(C)C)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704707	=	IC50	nM	0.44	CHEMBL3130	Homo sapiens	IC50	nM	0.44
317597	17697725	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C(C)C)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704707	<	IC50	nM	0.035	CHEMBL3130	Homo sapiens	IC50	nM	0.035
317598	17697726	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnc(C)n4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704708	=	IC50	nM	6.51	CHEMBL3130	Homo sapiens	IC50	nM	6.51
317599	17697727	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC45CCCN(C)C5)cc2OCC3)n(C(C)C)n1		CHEMBL3704706	=	IC50	nM	0.178	CHEMBL3130	Homo sapiens	IC50	nM	0.178
317600	17697728	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCN(C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704705	=	IC50	nM	2.81	CHEMBL3130	Homo sapiens	IC50	nM	2.81
317601	17697729	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC45CCCN(C)C5)cc2OCC3)n(C(C)C)n1		CHEMBL3704706	=	IC50	nM	0.236	CHEMBL3130	Homo sapiens	IC50	nM	0.236
317602	17697730	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCN(C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704705	=	IC50	nM	2.52	CHEMBL3130	Homo sapiens	IC50	nM	2.52
317603	17697731	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCN(C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704705	=	IC50	nM	5.68	CHEMBL3130	Homo sapiens	IC50	nM	5.68
317604	17697732	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCCN4C)cc2OCC3)n(C(C)C)n1		CHEMBL3704709	=	IC50	nM	1.94	CHEMBL3130	Homo sapiens	IC50	nM	1.94
317605	17697733	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4C4CCCCN4C)cc2OCC3)n(C(C)C)n1		CHEMBL3704709	=	IC50	nM	139.0	CHEMBL3130	Homo sapiens	IC50	nM	139.0
317606	17697734	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC[C@H]4CN4CCCC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704710	=	IC50	nM	0.313	CHEMBL3130	Homo sapiens	IC50	nM	0.313
317607	17697735	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC[C@@H]4CN4CCCC4)cc2OCC3)n(C(C)C)n1		CHEMBL3704711	=	IC50	nM	0.416	CHEMBL3130	Homo sapiens	IC50	nM	0.416
317608	17697736	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CC(C)n1nc(N)nc1-c1cn2c(n1)-c1ccc(-c3ccnn3C3CCN(C(C)(C)C)CC3)cc1OCC2		CHEMBL3704712	=	IC50	nM	3.89	CHEMBL3130	Homo sapiens	IC50	nM	3.89
317609	17697737	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704713	=	IC50	nM	2.29	CHEMBL3130	Homo sapiens	IC50	nM	2.29
317610	17697738	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	0.864	CHEMBL3130	Homo sapiens	IC50	nM	0.864
317611	17697739	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	0.63	CHEMBL3130	Homo sapiens	IC50	nM	0.63
317612	17697740	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704714	=	IC50	nM	0.865	CHEMBL3130	Homo sapiens	IC50	nM	0.865
317613	17697741	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704715	=	IC50	nM	0.678	CHEMBL3130	Homo sapiens	IC50	nM	0.678
317614	17697742	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CCN(CC)C1CCOC(c2c(-c3ccc4c(c3)OCCn3cc(-c5nc(C)nn5C(C)C)nc3-4)cnn2C)C1		CHEMBL3704716	=	IC50	nM	2.37	CHEMBL3130	Homo sapiens	IC50	nM	2.37
317615	17697743	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(CC(C)(C)O)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704717	=	IC50	nM	10.5	CHEMBL3130	Homo sapiens	IC50	nM	10.5
317616	17697744	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704718	=	IC50	nM	2.27	CHEMBL3130	Homo sapiens	IC50	nM	2.27
317617	17697745	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(CC(C)(C)O)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704719	=	IC50	nM	26.8	CHEMBL3130	Homo sapiens	IC50	nM	26.8
317618	17697746	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC45CCCN(C(C)C)C5)cc2OCC3)n(C(C)C)n1		CHEMBL3704720	=	IC50	nM	1.52	CHEMBL3130	Homo sapiens	IC50	nM	1.52
317619	17697747	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704721	=	IC50	nM	1.48	CHEMBL3130	Homo sapiens	IC50	nM	1.48
317620	17697748	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CCN(CC)C1CCOC(c2c(-c3ccc4c(c3)OCCn3cc(-c5nc(C)nn5C(C)C)nc3-4)cnn2C)C1		CHEMBL3704716	=	IC50	nM	1.07	CHEMBL3130	Homo sapiens	IC50	nM	1.07
317621	17697749	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704722	=	IC50	nM	2.32	CHEMBL3130	Homo sapiens	IC50	nM	2.32
317622	17697750	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CCN(CC)C1CCOC(c2c(-c3ccc4c(c3)OCCn3cc(-c5nc(C)nn5C(C)C)nc3-4)cnn2C)C1		CHEMBL3704716	=	IC50	nM	0.771	CHEMBL3130	Homo sapiens	IC50	nM	0.771
317623	17697751	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCC4[C@@H]4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704723	=	IC50	nM	0.16	CHEMBL3130	Homo sapiens	IC50	nM	0.16
317624	17697752	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704718	=	IC50	nM	0.939	CHEMBL3130	Homo sapiens	IC50	nM	0.939
317625	17697753	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704718	=	IC50	nM	1.23	CHEMBL3130	Homo sapiens	IC50	nM	1.23
317626	17697754	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(C)N4CCN(C5COC5)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704724	=	IC50	nM	8.82	CHEMBL3130	Homo sapiens	IC50	nM	8.82
317627	17697755	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4CN(C)C)cc2OCC3)n(C(C)C)n1		CHEMBL3704725	=	IC50	nM	0.288	CHEMBL3130	Homo sapiens	IC50	nM	0.288
317628	17697756	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)CO)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704726	=	IC50	nM	5.53	CHEMBL3130	Homo sapiens	IC50	nM	5.53
317629	17697757	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(N4CCCC4CN(C)C)cc2OCC3)n(C(C)C)n1		CHEMBL3704725	=	IC50	nM	0.445	CHEMBL3130	Homo sapiens	IC50	nM	0.445
317630	17697758	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(C)N4CCN(CC(C)(C)O)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704727	=	IC50	nM	4.21	CHEMBL3130	Homo sapiens	IC50	nM	4.21
317631	17697759	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)CO)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704728	=	IC50	nM	1.99	CHEMBL3130	Homo sapiens	IC50	nM	1.99
317632	17697760	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C5COC5)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704729	=	IC50	nM	2.21	CHEMBL3130	Homo sapiens	IC50	nM	2.21
317633	17697761	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C5COC5)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704729	=	IC50	nM	11.5	CHEMBL3130	Homo sapiens	IC50	nM	11.5
317634	17697762	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C(C)(C)CO)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704730	=	IC50	nM	0.314	CHEMBL3130	Homo sapiens	IC50	nM	0.314
317635	17697763	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4cnn(C)c4C4CC(N(C)C)CCO4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704731	=	IC50	nM	0.66	CHEMBL3130	Homo sapiens	IC50	nM	0.66
317636	17697764	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4ccnn4C4CCCN(C(C)(C)CO)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704730	=	IC50	nM	0.415	CHEMBL3130	Homo sapiens	IC50	nM	0.415
317637	17697765	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	COc1cc2c(cc1[C@@H](C)N1CCN(C(C)(C)C)CC1)-c1nc(-c3nc(C)nn3C(C)C)cn1CCO2		CHEMBL3704732	=	IC50	nM	1.05	CHEMBL3130	Homo sapiens	IC50	nM	1.05
317638	17697766	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	COc1cc2c(cc1[C@H](C)N1CCN(C(C)(C)C)CC1)-c1nc(-c3nc(C)nn3C(C)C)cn1CCO2		CHEMBL3704733	=	IC50	nM	0.784	CHEMBL3130	Homo sapiens	IC50	nM	0.784
317639	17697767	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4cnn(C)c4C4CCCN(C(C)C)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704734	=	IC50	nM	1.56	CHEMBL3130	Homo sapiens	IC50	nM	1.56
317640	17697768	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(-c4cnn(C)c4C4CCCN(C(C)C)C4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704734	=	IC50	nM	0.37	CHEMBL3130	Homo sapiens	IC50	nM	0.37
317641	17697769	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cn[nH]c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704735	=	IC50	nM	0.311	CHEMBL3130	Homo sapiens	IC50	nM	0.311
317642	17697770	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cn[nH]c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704735	=	IC50	nM	0.972	CHEMBL3130	Homo sapiens	IC50	nM	0.972
317643	17697771	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	1.08	CHEMBL3130	Homo sapiens	IC50	nM	1.08
317644	17697772	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CC(N(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704694	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
317645	17697773	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)CO)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704736	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
317646	17697774	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)CO)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704737	=	IC50	nM	2.63	CHEMBL3130	Homo sapiens	IC50	nM	2.63
317647	17697775	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CN(C(C)C)CCN4C)cc2OCC3)n(C(C)C)n1		CHEMBL3704738	<	IC50	nM	0.035	CHEMBL3130	Homo sapiens	IC50	nM	0.035
317648	17697776	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4N4CCN(C)[C@H](C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704739	=	IC50	nM	0.048	CHEMBL3130	Homo sapiens	IC50	nM	0.048
317649	17697777	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	COc1cc2c(cc1[C@@H](C)N1CCN(C(C)(C)C)CC1)-c1nc(-c3nc(C)nn3C(C)C)cn1CCO2		CHEMBL3704732	=	IC50	nM	1.06	CHEMBL3130	Homo sapiens	IC50	nM	1.06
317650	17697778	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-n4ccnc4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704740	=	IC50	nM	3.09	CHEMBL3130	Homo sapiens	IC50	nM	3.09
317651	17697779	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cnc(-c4cnn(C)c4C4CCCN(C(C)C)C4)cc2OCC3)n(C(C)C)n1		CHEMBL3704741	=	IC50	nM	0.571	CHEMBL3130	Homo sapiens	IC50	nM	0.571
317652	17697780	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	COc1cc2c(cc1[C@H](C)N1CCN(C(C)(C)C)CC1)-c1nc(-c3nc(C)nn3C(C)C)cn1CCO2		CHEMBL3704733	=	IC50	nM	5.3	CHEMBL3130	Homo sapiens	IC50	nM	5.3
317653	17697781	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C)c4C4CN(C(C)C)CCO4)cc2OCC3)n(C(C)C)n1		CHEMBL3704742	=	IC50	nM	0.992	CHEMBL3130	Homo sapiens	IC50	nM	0.992
317654	17697782	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	Cc1nc(-c2cn3c(n2)-c2cc(C(C)N4CCN(C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704743	=	IC50	nM	3.13	CHEMBL3130	Homo sapiens	IC50	nM	3.13
317655	17697783	CHEMBL3705837	Inhibition Assay: PI3K enzymatic activity was assayed by measuring the amount of product phosphatidylinositol 3,4,5-phosphate (PIP3) formed from substrate 4,5 phosphatidylinositol 4,5-phosphate (PIP2) using a fluorescence polarization displacement assay. The decrease in fluorescence polarization of a fluorescent PIP.sub.3 probe is measured as it is displaced from a PIP.sub.3-binding protein GRP-1 detector by PI3K-catalyzed product. Assays were conducted in 384-well black Proxiplates in the presence of 10 mM Tris (pH 7.5), 50 mM NaCl, 4 mM MgCl.sub.2, 5% glycerol, 25 .mu.M ATP, 10 .mu.M PIP.sub.2 (Echelon Biosciences), 0.05% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 1 mM dithiothreitol, and 2% DMSO. The kinase reactions were initiated by the addition of 40 ng/mL p110.alpha./p85.alpha., 300 ng/mL p110.beta./p85.alpha., 40 ng/mL p110.gamma., or 40 ng/mL p110.delta./p85.alpha. (Upstate Group, Millipore; Dundee, UK), and 10 .mu.M PIP.sub.2 (Echelon Biosciences) to the wells.	B	CCN1CCN(C(C)c2cc3c(cc2F)OCCn2cc(-c4nc(C)nn4C(C)C)nc2-3)CC1		CHEMBL3704744	=	IC50	nM	4.85	CHEMBL3130	Homo sapiens	IC50	nM	4.85
325906	17704654	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1cncc(S(C)(=O)=O)c1		CHEMBL3922696	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325907	17704655	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1cncc(C#N)c1		CHEMBL3907185	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325908	17704656	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1cnc(N)nc1		CHEMBL3980980	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325909	17704657	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1ccc(S(C)(=O)=O)cc1		CHEMBL3978713	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325910	17704658	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1cncc(C(=O)N2CCOCC2)c1		CHEMBL3908292	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325911	17704659	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(F)c1-c1cncc(C#N)c1		CHEMBL3983521	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325912	17704660	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(F)c1-c1cncc(F)c1		CHEMBL3917246	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325913	17704661	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(F)c1-c1cncc(S(C)(=O)=O)c1		CHEMBL3902476	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325914	17704662	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(F)c1-c1ccc(S(C)(=O)=O)cc1		CHEMBL3930461	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325915	17704663	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(F)c1-c1cnc(N)nc1		CHEMBL3932231	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325916	17704664	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(Cl)c1-c1cncc(S(C)(=O)=O)c1		CHEMBL3928842	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325917	17704665	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(Cl)c1-c1cncc(F)c1		CHEMBL3951142	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325918	17704666	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(Cl)c1-c1ccc(S(C)(=O)=O)cc1		CHEMBL3923423	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
325919	17704667	CHEMBL3887226	Scintillation Proximity Assay (SPA): The kinase reaction was conducted in polystyrene 384-well matrix white plate from Thermo Fisher Scientific in a final volume of 25 uL. Inhibitors were first diluted serially in DMSO and added to the plate wells before the addition of other reaction components. The final concentration of DMSO in the assay was 0.5%. The PI3K assays were carried out at room temperature in 20 mM MOPS, pH 6.7, 10 mM MgCl2, 5 mM DTT and CHAPS 0.03%. Reactions were initiated by the addition of ATP, the final reaction mixture consisted of 20 uM PIP2, 20 uM ATP, 0.2 uCi [gamma-33P]ATP, 4 nM PI3K delta. Reactions were incubated for 210 min and terminated by the addition of 40 uL SPA beads suspended in quench buffer: 150 mM potassium phosphate pH 8.0, 20% glycerol. 25 mM EDTA, 400 uM ATP. The final concentration of SPA beads was 1.0 mg/mL.	B	COc1c(C(C)Nc2ncnc(N)c2C#N)cc(Cl)c(Cl)c1-c1cnc(N)nc1		CHEMBL3946571	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
330411	17709001	CHEMBL3887314	Biochemical Assay: Using the method described in US9149477, Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kδ, and for selectivity for PI3Kδ versus other Class I PI3K isozymes. The initial selectivity assays were performed identically to the selectivity assay protocol in US9149477, Example 2, except using 100 μL Ecoscint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3× substrate stocks except they contained 0.05 mCi/mL γ[32P]ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3× enzyme stocks, except they now contained 3 nM of any given PI3K isoform.	B	CC[C@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3642827	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
330412	17709002	CHEMBL3887314	Biochemical Assay: Using the method described in US9149477, Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kδ, and for selectivity for PI3Kδ versus other Class I PI3K isozymes. The initial selectivity assays were performed identically to the selectivity assay protocol in US9149477, Example 2, except using 100 μL Ecoscint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3× substrate stocks except they contained 0.05 mCi/mL γ[32P]ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3× enzyme stocks, except they now contained 3 nM of any given PI3K isoform.	B	CCC(Nc1ncnc2nc[nH]c12)c1nc2ccccc2c(=O)n1-c1ccccc1		CHEMBL3642826	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
330413	17709003	CHEMBL3887314	Biochemical Assay: Using the method described in US9149477, Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kδ, and for selectivity for PI3Kδ versus other Class I PI3K isozymes. The initial selectivity assays were performed identically to the selectivity assay protocol in US9149477, Example 2, except using 100 μL Ecoscint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3× substrate stocks except they contained 0.05 mCi/mL γ[32P]ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3× enzyme stocks, except they now contained 3 nM of any given PI3K isoform.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
330414	17709004	CHEMBL3887314	Biochemical Assay: Using the method described in US9149477, Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kδ, and for selectivity for PI3Kδ versus other Class I PI3K isozymes. The initial selectivity assays were performed identically to the selectivity assay protocol in US9149477, Example 2, except using 100 μL Ecoscint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3× substrate stocks except they contained 0.05 mCi/mL γ[32P]ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3× enzyme stocks, except they now contained 3 nM of any given PI3K isoform.	B	CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1c(F)cccc1F		CHEMBL3642828	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
330415	17709005	CHEMBL3887314	Biochemical Assay: Using the method described in US9149477, Example 2, compounds of the invention were tested for inhibitory activity and potency against PI3Kδ, and for selectivity for PI3Kδ versus other Class I PI3K isozymes. The initial selectivity assays were performed identically to the selectivity assay protocol in US9149477, Example 2, except using 100 μL Ecoscint for radiolabel detection. Subsequent selectivity assays were done similarly using the same 3× substrate stocks except they contained 0.05 mCi/mL γ[32P]ATP and 3 mM PIP2. Subsequent selectivity assays also used the same 3× enzyme stocks, except they now contained 3 nM of any given PI3K isoform.	B	CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(C)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3642829	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
332804	17711152	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn(C(C)c3oc4ccccc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3980557	=	IC50	nM	37.32	CHEMBL3130	Homo sapiens	IC50	nM	37.32
332805	17711153	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccccc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3904566	=	IC50	nM	13.83	CHEMBL3130	Homo sapiens	IC50	nM	13.83
332806	17711154	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn([C@H](C)c3oc4ccccc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL4111394	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
332807	17711155	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn(C(C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3978564	=	IC50	nM	24.89	CHEMBL3130	Homo sapiens	IC50	nM	24.89
332808	17711156	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3948730	=	IC50	nM	22.33	CHEMBL3130	Homo sapiens	IC50	nM	22.33
332809	17711157	CHEMBL3887329	Homogenous Time Resolved Fluorescence (HTRF) Assay: The homogenous time resolved fluorescence (HTRF) assay allows detection of 3,4,5-triphosphate (PIP3) formed as a result of phosphorylation of phosphotidylinositol 4,5-biphosphate (PIP2) by PI3K isoforms such as alpha, beta, gamma or delta PI3K isoform activity for alpha, beta, gamma or delta was determined using a PI3K human HTRF Assay Kit (Millipore, Billerica, Mass.) with modifications. All incubations were carried out at room temperature. Briefly, 0.5 ul of 40x inhibitor (in 100% DMSO) or 100% DMSO were added to each well of a 384-well black plate (Greiner Bio-One, Monroe, N.C.) containing 14.5ul 1x reaction buffer/PIP2 (10 mM MgCl2, 5 mM DTT, 1.38 uM PIP2) mix with or without enzyme and incubated for 10 min. After the initial incubation, 5 ul/well of 400 uM ATP was added and incubated for an additional 30 minutes. Reaction was terminated by adding 5 ul/well stop solution (Millipore, Billerica, Mass.).	B	CC(C)Oc1ccc(-c2nn([C@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL4115084	=	IC50	nM	1447.0	CHEMBL3130	Homo sapiens	IC50	nM	1447.0
334280	17712524	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3920043	<	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
334281	17712525	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3894518	<	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
334282	17712526	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	<	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
334283	17712527	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](O)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL3890694	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
334284	17712528	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	C[C@H](CO)C(=O)N1CCC(c2nc(-c3cnc(N)c(-c4nnc(C(C)(C)C)o4)n3)n(C)n2)CC1		CHEMBL4107650	<	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
334285	17712529	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)C(C)(C)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3935719	<	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
334286	17712530	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	Cn1nc(C2CCN(C(=O)CC(=O)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3926852	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
334287	17712531	CHEMBL3887340	In Vitro Enzyme Inhibition Assay: The inhibition of PI3K-beta, PI3K-alpha, PI3K-gamma and PI3K-delta was evaluated in a Kinase Glo based enzyme activity assay using human recombinant enzymes. Compounds in 100% DMSO were added to assay plates by acoustic dispensing. PI3K enzyme was added in a Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM magnesium chloride) and allowed to preincubate with compound for 20 minutes prior to addition of substrate solution containing PIP2 and ATP. The enzyme reaction was stopped after 80 minutes by the addition of Kinase Glo detection solution containing Lucferin and Luciferase (from Kinase Glo® Plus Luminecent Kinase Assay kit (Promega #V3772). Plates were left for 30 minutes at room temperature then read on a Pherastar Instrument with a standard Luminescence filter block. The final concentration of DMSO, ATP and PIP2 in the assay were, 1%, 8 uM, and 80 uM respectively.	B	CCn1nc(C2CCN(C(=O)CC(=O)O)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1		CHEMBL3897192	<	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
348892	17725269	CHEMBL3887697	PI3K Inhibition Assay: PI3K inhibition assay (PI3K Assay (Emmanuelle M, Huang Y, Yan H G et al. Targeting Protein Translation in Human Non-Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression. Cancer Res 67:(23). (2007).) was carried out by PI3 Kinase activity/inhibitor assay kit, where PI3 kinase reaction was set up in Glutathione-coated strips/plate for inhibitor reaction. Kinase and inhibitors were pre-incubated for 10 minutes prior to the addition of PIP2 substrate. 5 uL of 5x kinase reaction buffer were added in each well followed by the further addition of 5 uL/well of PIP2 substrate. Then distilled H2O was added to each well so as to make up a final volume of 25 uL/well. Incubation was done at rt for 1 hour which was followed by washing the wells 3 times with 200 uL of 1xTBST per well and then 2 times with 200 uL of IX TBS per well. Then 100 uL of the Substrate TMB per well was added and then to keep for colour development in the dark.	B	CC1(C)CCCC2(C)c3c(oc4c(B(O)O)c(O)c(O)cc34)CCC12	Outside typical range	CHEMBL3959396	=	IC50	nM	303000.0	CHEMBL3130	Homo sapiens	IC50	nM	303000.0
351148	17727317	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	O=c1c2c(F)cccc2nc([C@H](CC(F)(F)F)Nc2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL3934646	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	nM	80.0
351149	17727318	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3927331	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351150	17727319	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(CC(F)(F)F)c1		CHEMBL3930489	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
351151	17727320	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(CC(F)(F)F)c1		CHEMBL3896043	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
351152	17727321	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3906887	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
351153	17727322	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3944735	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
351154	17727323	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccc(OCC(F)(F)F)cc1		CHEMBL3965450	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351155	17727324	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	CC[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1ccc(OCC(F)(F)F)cc1		CHEMBL3955875	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	nM	90.0
351156	17727325	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]cc(F)c12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3921325	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351157	17727326	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(F)c2c(=O)n1-c1cccc(OCC(F)(F)C(F)(F)F)c1		CHEMBL3896805	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
351158	17727327	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	C[C@H](Nc1ncnc2[nH]ccc12)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3946161	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
351159	17727328	CHEMBL3887747	Homogeneous Time Resolved Fluorescence Assay: The ability of the compounds of the present invention to inhibit the activity of four PI3K isoforms, PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ, were determined using a commercially available lipid kinase assay run in Homogeneous Time Resolved Fluorescence (HTRF) format. Assay DescriptionAssay principle: The PIP3 product is detected by displacement of biotin-PIP3 from an energy transfer complex consisting of Europium labeled anti-GST monoclonal antibody, a GST-tagged pleckstrin homology (PH) domain, biotinylated PIP3 and Streptavidin-Allophycocyanin (APC). Excitation of Europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm. The PIP3 product formed by PI 3-Kinase(h) activity displaces biotin-PIP3 from the complex resulting in a loss of energy transfer and thus a decrease in signal.This is a 3-step reaction: First, the kinase reaction with PIP2 substrate is carried out in the presence of ATP, and the reaction is quenched.	B	O=c1c2c(F)cccc2nc(CNc2ncnc3[nH]ccc23)n1-c1cccc(OCC(F)(F)F)c1		CHEMBL3903447	=	IC50	nM	2100.0	CHEMBL3130	Homo sapiens	IC50	nM	2100.0
351485	17727654	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3928926	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351486	17727655	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3897420	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351487	17727656	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3942165	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351488	17727657	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@@H](CC1CC1)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3914170	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
351489	17727658	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)cc2c(=O)n1-c1cccnc1		CHEMBL3981564	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
351490	17727659	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cccc2nc([C@H](C)Nc3nc(N)nc(N)c3C#N)n(-c3cccnc3)c(=O)c12		CHEMBL3908006	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
351491	17727660	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1cccnc1		CHEMBL3947434	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351492	17727661	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1cccnc1		CHEMBL3927130	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351493	17727662	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#N)c2c(=O)n1-c1cccnc1		CHEMBL3890147	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351494	17727663	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cccc2nc([C@H](C)Nc3nc(N)nc(N)c3C#N)n(-c3cncc(F)c3)c(=O)c12		CHEMBL3921732	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
351495	17727664	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3982635	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351496	17727665	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(Cl)c1		CHEMBL3912748	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351497	17727666	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	COc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3cccc(Cl)c3c2=O)c1		CHEMBL3919440	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351498	17727667	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C(F)F)c1		CHEMBL3943844	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351499	17727668	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3cccc(Cl)c3c2=O)c1		CHEMBL3896596	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351500	17727669	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cncc(-n2c([C@@H](Nc3nc(N)nc(N)c3C#N)C3CC3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3971257	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351501	17727670	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C(F)(F)F)c1		CHEMBL3985378	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
351502	17727671	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C2CC2)c1		CHEMBL3956715	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
351503	17727672	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3980395	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
351504	17727673	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1)C1CC1		CHEMBL3948051	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351505	17727674	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cccc2c(=O)n1-c1cccnc1		CHEMBL3972344	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
351506	17727675	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3942725	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
351507	17727676	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3915848	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
351508	17727677	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3933760	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351509	17727678	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3900451	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351510	17727679	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351511	17727680	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3905829	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351512	17727681	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@@H](CC1CC1)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3937412	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351513	17727682	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3914829	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351514	17727683	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3917562	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351515	17727684	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3c(F)ccc(Cl)c3c2=O)c1		CHEMBL3927360	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351516	17727685	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cncc(F)c1)C1CC1		CHEMBL3951571	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351517	17727686	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(C#N)c2c(=O)n1-c1cccnc1		CHEMBL3908784	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
351518	17727687	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(C#N)c2c(=O)n1-c1cccnc1		CHEMBL3920698	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
351519	17727688	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3954776	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351520	17727689	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2ccc(F)c(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3927128	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
351521	17727690	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ncccc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3894708	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
351522	17727691	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ncccc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3894708	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351523	17727692	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3900134	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351524	17727693	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3900134	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
351525	17727694	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2ccc(F)c(Cl)c2c1=O		CHEMBL3909179	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
351526	17727695	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2ccc(F)c(Cl)c2c1=O		CHEMBL3909179	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351527	17727696	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ncc(F)cc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3919299	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
351528	17727697	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ncc(F)cc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3919299	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
351529	17727698	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3909674	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
351530	17727699	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3909674	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
351531	17727700	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3917562	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351532	17727701	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1cccnc1		CHEMBL3947710	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	nM	67.0
351533	17727702	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C(N)=O)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3976101	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351534	17727703	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3901860	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
351535	17727704	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3961903	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
351536	17727705	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3892884	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351537	17727706	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(C#N)cc(F)cc2c(=O)n1-c1cccnc1		CHEMBL3931616	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
351538	17727707	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(C#N)cc(F)cc2c(=O)n1-c1cncc(F)c1		CHEMBL3920988	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
351539	17727708	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(C#N)cc(F)cc2c(=O)n1-c1cncc(F)c1)C1CC1		CHEMBL3943752	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
351540	17727709	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC(C)C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3915789	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
351541	17727710	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC(C)C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3938347	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
351542	17727711	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1ccc(F)c2nc([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)n(-c3cccnc3)c(=O)c12		CHEMBL3910412	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	nM	380.0
351543	17727712	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Br)c2c(=O)n1-c1cncc(F)c1		CHEMBL3958629	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351544	17727713	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Br)c2c(=O)n1-c1cccnc1		CHEMBL3909181	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351545	17727714	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(C#N)c2c(=O)n1-c1cncc(F)c1		CHEMBL3952478	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
351546	17727715	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(C#N)c2c(=O)n1-c1cccnc1		CHEMBL3924789	=	IC50	nM	95.0	CHEMBL3130	Homo sapiens	IC50	nM	95.0
351547	17727716	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Br)c2c(=O)n1-c1cccnc1		CHEMBL3954692	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351548	17727717	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(F)ccc(Cl)c2c1=O		CHEMBL3923554	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
351549	17727718	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(F)ccc(Cl)c2c1=O		CHEMBL3923554	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
351550	17727719	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(F)c2c1=O		CHEMBL3909686	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
351551	17727720	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(F)c2c1=O		CHEMBL3909686	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
351552	17727721	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2cccc(Cl)c2c1=O		CHEMBL3918604	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
351553	17727722	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2cccc(Cl)c2c1=O		CHEMBL3918604	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
351554	17727723	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1C		CHEMBL3966390	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
351555	17727724	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1C		CHEMBL3966390	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351556	17727725	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(F)ccc(Cl)c2c1=O		CHEMBL3964528	=	IC50	nM	59.0	CHEMBL3130	Homo sapiens	IC50	nM	59.0
351557	17727726	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(F)ccc(Cl)c2c1=O		CHEMBL3964528	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351558	17727727	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2ccc(F)cc2c1=O		CHEMBL3943088	=	IC50	nM	510.0	CHEMBL3130	Homo sapiens	IC50	nM	510.0
351559	17727728	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2ccc(F)cc2c1=O		CHEMBL3943088	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
351560	17727729	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3935702	=	IC50	nM	75.0	CHEMBL3130	Homo sapiens	IC50	nM	75.0
351561	17727730	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3935702	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
351562	17727731	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(C(F)(F)F)c2c1=O		CHEMBL3948071	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351563	17727732	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1ccncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(C(F)(F)F)c2c1=O		CHEMBL3948071	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
351564	17727733	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1ccc(N)nc1		CHEMBL3921336	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	nM	84.0
351565	17727734	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1ccc(N)nc1		CHEMBL3957788	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
351566	17727735	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3926774	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
351567	17727736	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3899696	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
351568	17727737	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3970845	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
351569	17727738	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3933314	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351570	17727739	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3957355	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351571	17727740	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3920883	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
351572	17727741	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Nc1ccc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3948693	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351573	17727742	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1)C1CC1		CHEMBL3911944	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351574	17727743	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cc1C		CHEMBL3943356	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351575	17727744	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cc1C		CHEMBL3943356	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
351576	17727745	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3934385	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351577	17727746	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL3934385	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
351578	17727747	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3921986	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
351579	17727748	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@H](C)Nc2nc(N)nc(N)c2C#N)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3921986	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351580	17727749	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3962159	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
351581	17727750	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3924661	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
351582	17727751	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1cc(N)ncc1-n1c([C@@H](Nc2nc(N)nc(N)c2C#N)C2CC2)nc2c(Cl)ccc(Cl)c2c1=O		CHEMBL3924661	=	IC50	nM	640.0	CHEMBL3130	Homo sapiens	IC50	nM	640.0
351583	17727752	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3905431	=	IC50	nM	48.0	CHEMBL3130	Homo sapiens	IC50	nM	48.0
351584	17727753	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3970492	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
351585	17727754	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3938252	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
351586	17727755	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3956754	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351587	17727756	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3969816	=	IC50	nM	94.0	CHEMBL3130	Homo sapiens	IC50	nM	94.0
351588	17727757	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CCC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2ccc(F)c(Cl)c2c(=O)n1-c1ccc(N)nc1		CHEMBL3898636	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351589	17727758	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Nc1ccc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3c(F)ccc(Cl)c3c2=O)cn1		CHEMBL3940119	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
351590	17727759	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccc(N)nc1)C1CC1		CHEMBL3908617	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
351591	17727760	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(N)c1		CHEMBL3931089	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
351592	17727761	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(N)c1		CHEMBL3903107	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
351593	17727762	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL4108278	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	nM	61.0
351594	17727763	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	CC[C@@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL4113570	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
351595	17727764	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	N#Cc1c(N)nc(N)nc1N[C@@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL4108664	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
351596	17727765	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	C[C@@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL4114854	=	IC50	nM	620.0	CHEMBL3130	Homo sapiens	IC50	nM	620.0
351597	17727766	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL4113405	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	nM	220.0
351598	17727767	CHEMBL3887754	Time-Resolved Fluorescence Resonance Energy transfer (TR-FRET) Assay: Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2× Km ATP (75-500 μM), 2 μM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoforms: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 pM, and PI3Kγ at 2 nM. After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 10lps delay and 500 μs read window).	B	Cc1c(F)cncc1-n1c([C@@H](C)Nc2nc(N)nc(N)c2C#N)nc2cccc(Cl)c2c1=O		CHEMBL4113405	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
356699	17732362	CHEMBL3887829	Enzyme Inhibition Assay: The PI3K enzymes catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF PI3K enzyme assay, Millipore). Excitation, at 330 nm, of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic wavelength of 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal).The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate.	B	COCCOCCOCC#Cc1cccc2nc(Cn3nc(-c4cc(O)cc(F)c4)c4c(N)ncnc43)n(Cc3ccccc3C(F)(F)F)c(=O)c12		CHEMBL3934989	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
356700	17732363	CHEMBL3887829	Enzyme Inhibition Assay: The PI3K enzymes catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF PI3K enzyme assay, Millipore). Excitation, at 330 nm, of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic wavelength of 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal).The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate.	B	COCCN(CCOC)C(=O)CCCC#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3ccccc3Cl)c(=O)c12		CHEMBL3919512	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
356701	17732364	CHEMBL3887829	Enzyme Inhibition Assay: The PI3K enzymes catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF PI3K enzyme assay, Millipore). Excitation, at 330 nm, of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic wavelength of 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal).The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate.	B	COCCOCCOCC#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3ccccc3F)c(=O)c12		CHEMBL3946385	=	IC50	nM	5.7	CHEMBL3130	Homo sapiens	IC50	nM	5.7
356705	17732368	CHEMBL3887831	Cell Based Assay: As a means of assessing PI3K δ activation in response to stimuli, the phosphorylation status of the protein, Akt, a downstream product of PI3Kδ, signaling was determined.U937 cells, obtained from a human, leukemic, monocyte lymphoma cell line, were differentiated to macrophage-type cells by incubation with PMA (100 ng/mL) for 48 to 72 hr. Cells were then pre-incubated with either the test compound or vehicle for 2 hr and were then stimulated briefly by exposure to H2O2 (10 mM, 5-7 min) and the reaction stopped by replacing the media with 4% formaldehyde solution. Endogenous peroxide activity and formaldehyde were inactivated by incubating with quenching buffer (0.1% sodium azide, 1% H2O2 in PBS with 0.1% Triton X-100) for 20 min. The cells were washed with buffer (PBS containing 0.1% Triton X-100) and were incubated with blocking solution (1% BSA in PBS) for 1 hr and were then re-washed with buffer and incubated overnight with either anti-pAkt antibody or anti-pan-Akt antibody.	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2Cc1nc2cccc(C#CCOCCOCCO)c2c(=O)n1Cc1ccccc1C(F)(F)F		CHEMBL3963503	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
369142	17744008	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3922388	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369143	17744009	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)cccc2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3890805	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369144	17744010	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC(=O)c1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3906822	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369145	17744011	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3950633	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369146	17744012	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(Cl)cccc2c(=O)n1-c1ccccc1		CHEMBL3928621	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369147	17744013	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3956195	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369148	17744014	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3919714	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369149	17744015	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3950928	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369150	17744016	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3914201	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369151	17744017	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(Cl)ccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3963325	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369152	17744018	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3964862	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369153	17744019	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)cccc3c(=O)n2-c2ccccc2)nc1		CHEMBL3929687	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369154	17744020	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)cccc2c(=O)n1-c1ccccc1		CHEMBL3967711	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369155	17744021	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3806228	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369156	17744022	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(N)n1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3976222	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369157	17744023	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3804882	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369158	17744024	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)cc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3951402	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369159	17744025	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)cc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3923690	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369160	17744026	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3960130	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369161	17744027	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4106652	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369162	17744028	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3908201	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369163	17744029	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)C#Cc1c(N)ncnc1N[C@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL4111669	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369164	17744030	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CC1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3902091	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369165	17744031	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3973117	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369166	17744032	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccccc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3935531	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369167	17744033	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(OC(F)(F)F)cc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3907586	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369168	17744034	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(OC(F)(F)F)cc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3944491	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369169	17744035	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC(C)(C)O)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3913035	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369170	17744036	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC(C)(C)O)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3949799	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369171	17744037	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3922036	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369172	17744038	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(N)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3930845	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369173	17744039	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)nc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3906328	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369174	17744040	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnc(N)nc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3943275	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369175	17744041	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(N)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3915305	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369176	17744042	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(N)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3943827	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369177	17744043	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N2CCCC[C@H]2c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccccn1		CHEMBL3976500	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369178	17744044	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N2CCC[C@H]2c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccccn1		CHEMBL3938430	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369179	17744045	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL3967978	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369180	17744046	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCNS(=O)(=O)c1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccccn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3986194	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369181	17744047	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(S(N)(=O)=O)c1		CHEMBL3961122	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369182	17744048	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cncnc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3952571	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369183	17744049	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cncnc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3981331	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369184	17744050	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnc1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3951359	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369185	17744051	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccnc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805337	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369186	17744052	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3970591	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369187	17744053	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc2nc(N)sc2c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3937519	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369188	17744054	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3959531	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369189	17744055	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805019	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369190	17744056	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cn[nH]c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3806195	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369191	17744057	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3958476	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369192	17744058	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805061	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369193	17744059	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(O)c2c(=O)n1-c1ccccc1		CHEMBL3946382	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369194	17744060	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(Cl)c2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3960691	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369195	17744061	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3ccccc3)c(=O)c12		CHEMBL3935980	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369196	17744062	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3907068	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369197	17744063	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3947550	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369198	17744064	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCCCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3891379	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369199	17744065	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(S(C)(=O)=O)c1		CHEMBL3915903	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369200	17744066	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C(C)(C)C)c1		CHEMBL3892650	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369201	17744067	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(-c2ccccc2)c1		CHEMBL3920650	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369202	17744068	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3898042	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369203	17744069	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3ccccc3)c(=O)c12		CHEMBL3935121	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369204	17744070	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)ccc(F)c3c(=O)n2-c2ccccc2)c1		CHEMBL3914780	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369205	17744071	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3c(F)cccc3c(=O)n2-c2ccccc2)c1		CHEMBL3942778	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369206	17744072	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(F)c3c(=O)n2-c2ccccc2)c1		CHEMBL3901264	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369207	17744073	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3959485	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369208	17744074	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3910328	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369209	17744075	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3983551	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369210	17744076	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2c(=O)n(-c3ccccc3)c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc12		CHEMBL3984593	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369211	17744077	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3900762	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369212	17744078	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3895810	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369213	17744079	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3cccc(C#N)c3)c(=O)c12		CHEMBL3961281	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369214	17744080	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccc(C#N)c3)c(=O)c12		CHEMBL3893512	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369215	17744081	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3962518	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369216	17744082	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(F)c2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3943986	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369217	17744083	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1ccccc1		CHEMBL3970101	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369218	17744084	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(C(F)F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3931513	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369219	17744085	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3959013	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369220	17744086	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3922602	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369221	17744087	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3964884	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369222	17744088	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ncccc3F)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3917126	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369223	17744089	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ncccc3F)nc3cccc(Cl)c3c2=O)c1C		CHEMBL3917126	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369224	17744090	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncc(F)cc1F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945040	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369225	17744091	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1nc(N)nc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908150	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369226	17744092	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3932612	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369227	17744093	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3972643	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369228	17744094	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3946520	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369229	17744095	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3961581	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369230	17744096	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(Cl)c1		CHEMBL3934086	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369231	17744097	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL3902512	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369232	17744098	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL3925201	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369233	17744099	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3946133	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369234	17744100	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3919742	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369235	17744101	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(C#N)c1		CHEMBL3979594	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369236	17744102	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(C#N)c1		CHEMBL3954063	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369237	17744103	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(Cl)c1		CHEMBL3919058	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369238	17744104	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2ccc(F)cc2c(=O)n1-c1cccc(Cl)c1		CHEMBL3946867	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369239	17744105	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3924491	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369240	17744106	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3955573	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369241	17744107	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2c(F)cccc2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3957723	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369242	17744108	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3960871	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369243	17744109	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945844	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369244	17744110	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3985129	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369245	17744111	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ncccn3)n(-c3ccccc3)c(=O)c12		CHEMBL3954547	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369246	17744112	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ncccn3)n(-c3cc(F)cc(F)c3)c(=O)c12		CHEMBL3983189	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369247	17744113	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccc(F)c3)c(=O)c12		CHEMBL3937838	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369248	17744114	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3909896	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369249	17744115	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(C)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3969032	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369250	17744116	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL3915257	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369251	17744117	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccc(C#N)c1		CHEMBL3924120	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369252	17744118	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccc(F)c1		CHEMBL3896111	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369253	17744119	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1ccccc1		CHEMBL3955690	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369254	17744120	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(S(C)(=O)=O)c2c(=O)n1-c1ccccc1		CHEMBL3908658	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369255	17744121	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(C#N)c2c(=O)n1-c1ccccc1		CHEMBL3963832	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369256	17744122	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3972988	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369257	17744123	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccccc1)c1nc2cccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3905764	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369258	17744124	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3909257	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369259	17744125	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3900390	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369260	17744126	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cccnc3)c(=O)c12		CHEMBL3944692	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369261	17744127	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3cnccn3)n(-c3cncc(F)c3)c(=O)c12		CHEMBL3899091	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369262	17744128	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1N1CCOCC1		CHEMBL3923649	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369263	17744129	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COc1cc(F)cc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2N2CCOCC2)c1		CHEMBL3984444	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369264	17744130	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CNS(C)(=O)=O)c1		CHEMBL3914621	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369265	17744131	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1C1C[C@@H]2CC[C@H](C1)N2C		CHEMBL3901439	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369266	17744132	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1C1C[C@@H]2CC[C@H](C1)N2C		CHEMBL3901439	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369267	17744133	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cnccn1)c1nc2cccc(Cl)c2c(=O)n1N1CCCCCC1		CHEMBL3908091	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369268	17744134	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1N1CCNCC1		CHEMBL3936046	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369269	17744135	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc2nc([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)n(-c3cccc(CN(C)S(C)(=O)=O)c3)c(=O)c12		CHEMBL3936315	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369270	17744136	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@@H](c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CN(C)S(C)(=O)=O)c1)N(C)c1ncnc(N)c1C#Cc1ccc(F)cn1		CHEMBL3916948	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369271	17744137	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cccc(CNS(C)(=O)=O)c1		CHEMBL3894395	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369272	17744138	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(C)CS(=O)(=O)NCc1cccc(-n2c([C@H](C)Nc3ncnc(N)c3C#Cc3ccc(F)cn3)nc3cccc(Cl)c3c2=O)c1		CHEMBL3922409	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369273	17744139	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(F)(F)F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3906875	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369274	17744140	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3931327	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369275	17744141	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(F)(F)F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3971322	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369276	17744142	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(N)=O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3953484	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369277	17744143	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(N)=O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3940834	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369278	17744144	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(C)OC(=O)c1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)nc1		CHEMBL3952804	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
369279	17744145	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(C(=O)O)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3948382	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369280	17744146	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Nc1ncnc(N[C@H](CO)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1C#Cc1ccc(F)cn1		CHEMBL4111963	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369281	17744147	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1nc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)ccc1F		CHEMBL3926413	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369282	17744148	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3923008	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369283	17744149	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1C(F)(F)F)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3945447	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369284	17744150	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3917559	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369285	17744151	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CCCC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3965130	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369286	17744152	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#CC1CCCCC1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908612	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369287	17744153	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC[C@@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2cccc(Cl)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL4109343	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369288	17744154	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3911495	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369289	17744155	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(F)(F)F)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3973482	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369290	17744156	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(F)F)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3902489	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369291	17744157	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CCc1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3962520	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369292	17744158	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(C(F)(F)F)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3896991	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369293	17744159	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccnc1C#Cc1c(N)ncnc1N[C@@H](C)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3908064	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369294	17744160	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3985786	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369295	17744161	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(CO)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3894743	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369296	17744162	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CO)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3919255	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369297	17744163	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(N)=O)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3907367	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369298	17744164	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)n1		CHEMBL3977922	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369299	17744165	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	COC(=O)c1ccnc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3916345	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369300	17744166	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CN)n1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3891821	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369301	17744167	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cc(C(=O)O)ccn1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3892931	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369302	17744168	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	CC(=O)c1cccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2ccccc2)c1		CHEMBL3961942	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369303	17744169	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1cccc(CO)c1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3901914	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
369304	17744170	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	C[C@H](Nc1ncnc(N)c1C#Cc1ncccc1CO)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3969543	>	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
369305	17744171	CHEMBL3888036	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (100-300 uM), 10 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 1% (v/v) DMSO at the following concentrations for each isoform: PI3K alpha, beta, delta, and gamma at 50 picomolar (pM) and PI3Kgamma at 2 nanomolar (nM). After an assay reaction time of 30 minutes at 25° C., reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window).	B	Cc1ccc(C#Cc2c(N)ncnc2N[C@@H](C)c2nc3cccc(Cl)c3c(=O)n2-c2cc(F)cc(F)c2)nc1		CHEMBL3915079	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
392382	17763427	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	C#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3ccccc3Cl)c(=O)c12		CHEMBL3922023	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
392383	17763428	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	Nc1ncnc2c1c(-c1ccc(O)cc1)nn2Cc1nc2cccc(C#CCCCC(=O)O)c2c(=O)n1Cc1ccccc1Cl		CHEMBL3893961	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
392384	17763429	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	Nc1ncnc2c1c(-c1ccc(O)cc1)nn2Cc1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1Cc1ccccc1Cl		CHEMBL3983494	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
392385	17763430	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	C#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3cccc(OC)c3)c(=O)c12		CHEMBL2216862	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
392386	17763431	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	COCC#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3cccc(C(F)(F)F)c3)c(=O)c12		CHEMBL3931407	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
392387	17763432	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	CC(C)NC(=O)CCCC#Cc1cccc2nc(Cn3nc(-c4ccc(O)cc4)c4c(N)ncnc43)n(Cc3ccccc3Cl)c(=O)c12		CHEMBL3906959	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
392388	17763433	CHEMBL3888353	Inhibition Assay: PI3 kinases catalyse the phosphorylation of phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the presence of ATP and Mg2+ ions. The PIP3 product can be detected by displacement of biotin-PIP3 from energy transfer complexes consisting of europium labelled anti-GST monoclonal antibody, a GST-tagged Pleckstrin homology (PH) domain, biotinylated PIP3 and streptavidin-allophycocyanin (APC) by the time-resolved fluorescence resonance energy transfer (TR-FRET) (HTRF® PI3K enzyme assay, Millipore). Excitation (330 nm) of europium in the complex results in an energy transfer to the APC and a fluorescent emission at 665 nm although europium itself emits at its characteristic 620 nm. The PIP3 product formed by PI3K activity displaces biotin-PIP3 from the complex and results in a loss of energy transfer (decreasing signal). The compound to be tested was added, at the desired final concentrations, to a mixture of PIP2 substrate and recombinant PI3 kinase α, δ or γ enzymes (Millipore), and the mixture incubated for 2 hr at RT. Following this incubation period, ATP (20 μM) was added to the enzyme/compound/PIP2 substrate mixture and the resulting mixture was incubated for 30 min at RT. A stopping solution containing biotinylated PIP3 and the detection mix containing the GST tagged GRP1 pleckstrin homology (PH) domain and fluorophores were then added and the mixture was incubated at RT for 15-18 hr, prior to detection in a fluorescence microplate reader (Varioskan® Flash, ThermoFisher Scientific).	B	Nc1ncnc2c1c(-c1ccc(O)cc1)nn2Cc1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1Cc1ccccc1Cl		CHEMBL3950328	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412801	17777516	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1nnn[nH]1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3982040	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
412802	17777517	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1nccs1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3985188	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
412803	17777518	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1ccc(N)nc1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3936781	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
412804	17777519	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1cnn(CCO)c1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3910322	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
412805	17777520	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1cc(O)cc(F)c1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3932755	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
412806	17777521	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(Br)c3c(=O)n2-c2ccccc2)cc1NS(C)(=O)=O		CHEMBL3904750	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
412807	17777522	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3ccc4cc[nH]c4c3)n(-c3ccccc3)c(=O)c12		CHEMBL3928013	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412808	17777523	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cnc(N)nc3)n(-c3ccccc3)c(=O)c12		CHEMBL3903544	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412809	17777524	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	N#Cc1c(N)ncnc1N[C@@H](CCOCc1ccccc1)c1nn2ccc(C#N)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3919111	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
412810	17777525	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	N#Cc1c(N)ncnc1N[C@@H](CCSCc1ccccc1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3891052	=	IC50	nM	95.0	CHEMBL3130	Homo sapiens	IC50	nM	95.0
412811	17777526	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	N#Cc1c(N)ncnc1N[C@@H](CCOc1ccccc1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3905787	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412812	17777527	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc1NS(=O)(=O)c1ccc(F)cc1		CHEMBL3973370	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
412813	17777528	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	N#Cc1ccn2nc([C@H](CCOCc3ccccc3)Nc3ncnc(N)c3-c3cc(O)cc(F)c3)n(-c3cc(F)cc(F)c3)c(=O)c12		CHEMBL3893366	=	IC50	nM	97.0	CHEMBL3130	Homo sapiens	IC50	nM	97.0
412814	17777529	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(O)cc(F)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3901855	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412815	17777530	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cc(O)cc(C(F)(F)F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3984124	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412816	17777531	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1-c1cc(O)cc(F)c1)c1nn2ccc(Sc3ccccc3)c2c(=O)n1-c1ccccc1		CHEMBL3910887	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
412817	17777532	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncncc3-c3cc(O)cc(F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3956509	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
412818	17777533	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3C(=O)Nc3cccc(O)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3975942	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412819	17777534	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(C(=O)OCc5ccccc5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3961902	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412820	17777535	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1cccc(Cc2ccn3nc([C@H](C)Nc4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)c1		CHEMBL3896378	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
412821	17777536	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(Cc5cccc(O)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3979863	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412822	17777537	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ncc(-c2c[nH]c3ncnc(N[C@@H](C)c4nn5ccc(C)c5c(=O)n4-c4ccccc4)c23)cc1NS(C)(=O)=O		CHEMBL3909699	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412823	17777538	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cccc6[nH]ncc56)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3922483	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412824	17777539	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4sccc34)n(-c3ccccc3)c(=O)c12		CHEMBL3894468	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
412825	17777540	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3Cc3cccc(O)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3946001	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
412826	17777541	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(Cc3cccc(O)c3)c2c(=O)n1-c1ccccc1		CHEMBL3896743	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
412827	17777542	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)cc(N(C)C)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3936115	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
412828	17777543	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(Cc5cc(O)cc(F)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3908163	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412829	17777544	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(C#Cc5ccccc5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3917021	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
412830	17777545	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nn2ccc(Sc3ccc(O)c(F)c3)c2c(=O)n1-c1ccccc1		CHEMBL3913611	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412831	17777546	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3C(=O)Nc3ccc(O)c(F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3914643	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
412832	17777547	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cccc(S(=O)(=O)N6CCOCC6)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3984467	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
412833	17777548	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(C(=O)NCCc5cn[nH]c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3930649	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
412834	17777549	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc1NS(=O)(=O)C(F)(F)F		CHEMBL3954751	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412835	17777550	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(Sc5ccc(O)cc5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3968495	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412836	17777551	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3C(=O)Nc3cc(C(N)=O)ccc3O)n(-c3ccccc3)c(=O)c12		CHEMBL3936888	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412837	17777552	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cccc(Cl)c5O)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3937301	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412838	17777553	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cccc(NS(=O)(=O)c4ccc(O)cc4)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3940714	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412839	17777554	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cnn(CCN(C)C)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3948478	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412840	17777555	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cncc(C(F)(F)F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3959322	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
412841	17777556	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cnn(CCO)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3922886	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412842	17777557	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@@H](C)Nc3ncnc(N)c3C(=O)N3CC[C@H](O)C3)n(-c3ccccc3)c(=O)c12		CHEMBL3947183	=	IC50	nM	156.0	CHEMBL3130	Homo sapiens	IC50	nM	156.0
412843	17777558	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	CCNc1nnc(-c2c[nH]c3ncnc(N[C@@H](C)c4nn5ccc(C)c5c(=O)n4-c4ccccc4)c23)s1		CHEMBL3949490	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412844	17777559	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(O)cc(NS(=O)(=O)c6ccc(O)cc6)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3925216	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
412845	17777560	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cncc(OC(F)F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3912595	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412846	17777561	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	CC(C)N1CCN(C(=O)CCCC#Cc2ccn3nc([C@H](C)Nc4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL3982507	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
412847	17777562	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cc(O)cc(NS(=O)(=O)c4ccc(F)cc4F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3907104	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412848	17777563	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cncc(OCC(F)(F)F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3974496	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412849	17777564	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1cc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc(C(F)(F)F)n1		CHEMBL3898084	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
412850	17777565	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cnc6[nH]ccc6c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3969288	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412851	17777566	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cnn(CCCO)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3985740	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412852	17777567	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccn(CCN6CCOCC6)n5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3960519	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412853	17777568	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccn(CC(F)(F)F)n5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3947405	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412854	17777569	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1cc(C#N)cc(-c2c[nH]c3ncnc(N[C@@H](C)c4nn5ccc(C)c5c(=O)n4-c4ccccc4)c23)c1		CHEMBL3976670	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412855	17777570	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(O)cc(NS(=O)(=O)CCN(C)C)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3952760	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412856	17777571	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(C(F)(F)F)nn5C)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3984759	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412857	17777572	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3)n(-c3ccccc3)c(=O)c12		CHEMBL3961441	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
412858	17777573	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccn(CC(C)(C)CO)n5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3892452	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
412859	17777574	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cc(O)cc(C(=O)N(C)C)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3905026	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412860	17777575	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc1NS(=O)(=O)c1ccc(O)cc1		CHEMBL3929491	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412861	17777576	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccn(Cc6ccccc6O)n5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3914025	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
412862	17777577	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3ccc(N4CCNCC4)cc3)n(-c3ccccc3)c(=O)c12		CHEMBL3963315	=	IC50	nM	132.0	CHEMBL3130	Homo sapiens	IC50	nM	132.0
412863	17777578	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccn(-c6cccc(O)c6)n5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3979599	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412864	17777579	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc2[nH]cc(-c3cc(NS(C)(=O)=O)cc4[nH]ccc34)c12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3950624	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412865	17777580	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cccc(C(=O)Nc4cccc(O)c4)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3890258	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
412866	17777581	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc(CNc3ncnc(N)c3-c3cncc(C(F)F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3955921	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412867	17777582	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cc(O)c4ccn(S(=O)(=O)c5ccc(O)cc5F)c4c3)n(-c3ccccc3)c(=O)c12		CHEMBL3895749	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412868	17777583	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(O)cc(NC(N)=O)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3967037	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
412869	17777584	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	C[C@H](Nc1ncnc2[nH]cc(-c3cc(NS(C)(=O)=O)cc(OS(C)(=O)=O)c3)c12)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3904698	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
412870	17777585	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)cc6[nH]ncc56)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3978674	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412871	17777586	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ccc(S(=O)(=O)n2ncc3ccc(-c4c(N)ncnc4N[C@@H](C)c4nn5ccc(C)c5c(=O)n4-c4ccccc4)cc32)cc1		CHEMBL3914806	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412872	17777587	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	CCOc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc1NS(=O)(=O)c1ccc(O)cc1		CHEMBL3972876	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
412873	17777588	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1nnc(-c2cccc(-c3c[nH]c4ncnc(N[C@@H](C)c5nn6ccc(C)c6c(=O)n5-c5ccccc5)c34)c2)o1		CHEMBL3972794	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412874	17777589	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3cc(NS(=O)(=O)c4ccc(O)cc4)c4cc[nH]c4c3)n(-c3ccccc3)c(=O)c12		CHEMBL3905176	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
412875	17777590	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3C(=O)Oc3cc(O)cc(NS(C)(=O)=O)c3)n(-c3ccccc3)c(=O)c12		CHEMBL3967455	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412876	17777591	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	COc1ccc(S(=O)(=O)n2ccc3ccc(-c4c(N)ncnc4N[C@@H](C)c4nn5ccc(C)c5c(=O)n4-c4ccccc4)cc32)cc1		CHEMBL3896227	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
412877	17777592	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)c6cc[nH]c6c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3895194	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
412878	17777593	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	CCNc1ncc(-c2c(N)ncnc2N[C@@H](C)c2nn3ccc(C)c3c(=O)n2-c2ccccc2)cc1NS(=O)(=O)c1ccc(O)cc1		CHEMBL3919684	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
412879	17777594	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)cc(C(=O)N(C)C)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3980811	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
412880	17777595	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccnc(N6CCC(N(C)C)CC6)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3910737	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
412881	17777596	CHEMBL3888730	HTRF Assay : PI-3 Kinase HTRF kit (ref. #33-037) and the different PI3K recombinant isoforms (ref. #14-602, ref. #14-603, ref. #14-604, ref. #15-558 for Alpha, Beta, Delta and Gamma respectively) were purchased at Millipore (expressed in insect cells). ATP was purchased at Sigma Aldrich (ref. #A7699).The compounds were pre-incubated with the enzyme for 30 min before starting of the catalytic reaction. [PIP2] was used at its Km. [ATP] was used at 15 μM for all isoforms for technical reasons (Km values varied between 10 and 20 μM depending on the isoform). Time of assay and [Enzyme] were optimized to work in the linear range. Stop and Detection mixtures were used as specified in the Millipore PI-3 Kinase kit.	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccc(NS(=O)(=O)N(C)C)cc5O)c34)n(-c3ccccc3)c(=O)c12		CHEMBL3898556	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
445481	17805189	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3929977	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
445482	17805190	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3915208	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
445483	17805191	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3919381	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
445484	17805192	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc2[nH]nnc12)c1nc2c(F)cccc2c(=O)n1-c1cnc(N)cn1		CHEMBL3922845	=	IC50	nM	2700.0	CHEMBL3130	Homo sapiens	IC50	nM	2700.0
445485	17805193	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc2occc12)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3943639	=	IC50	nM	2300.0	CHEMBL3130	Homo sapiens	IC50	nM	2300.0
445486	17805194	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3913858	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
445487	17805195	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3983697	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
445488	17805196	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3937257	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
445489	17805197	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1)C1CC1		CHEMBL3912814	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
445490	17805198	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1)C1CC1		CHEMBL3928265	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
445491	17805199	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3954098	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
445492	17805200	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3nc(N)nc(N)c3Cl)C3CC3)nc3c(Cl)ccc(Cl)c3c2=O)cn1		CHEMBL3945462	=	IC50	nM	97.0	CHEMBL3130	Homo sapiens	IC50	nM	97.0
445493	17805201	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3981609	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
445494	17805202	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(F)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3963307	=	IC50	nM	340.0	CHEMBL3130	Homo sapiens	IC50	nM	340.0
445495	17805203	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3906405	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	nM	53.0
445496	17805204	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3968564	=	IC50	nM	780.0	CHEMBL3130	Homo sapiens	IC50	nM	780.0
445497	17805205	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3937355	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
445498	17805206	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1ncnc(N)c1Cl)c1nc2cccc(Cl)c2c(=O)n1-c1cnc(N)cn1		CHEMBL3957550	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	nM	500.0
445499	17805207	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3ncnc(N)c3Cl)C3CC3)nc3c(Cl)ccc(Cl)c3c2=O)cn1		CHEMBL3937861	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	nM	54.0
445500	17805208	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	Nc1cnc(-n2c([C@@H](Nc3ncnc(N)c3Cl)C3CC3)nc3cccc(Cl)c3c2=O)cn1		CHEMBL3905253	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
445501	17805209	CHEMBL3889294	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The activities were measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. TR-FRET monitored the formation of 3,4,5-inositol triphosphate molecule that competed with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product resulted in a decrease in TR-FRET signal as the labeled fluorophore was displaced from the GRP-1 protein binding site. Class I PI3K isoforms were expressed and purified as heterodimeric recombinant proteins. All assay reagents and buffers for the TR-FRET assay were purchased from Millipore. PI3K isoforms were assayed under initial rate conditions in the presence of 25 mM Hepes (pH 7.4), and 2xKm ATP (75-500 uM), 2 uM PIP2, 5% glycerol, 5 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 1% (v/v) DMSO at the following concentrations for each isoform: PI3Kα, PI3Kβ, and PI3Kδ between 25 and 50 uM, and PI3Kγ at 2 nM. The compounds of Table 1 and Compound X ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) and Compound Y ((S)-2,4-diamino-6-((1-(5-chloro-4-oxo-3-(pyridin-3-yl)-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile) were added to the assay solution and incubated for 30 minutes at 25° C. The reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM Europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex: 340 nm; Em: 615/665 nm; 100 us delay and 500 us read window). The results were normalized based on positive (1 uM wortmanin) and negative (DMSO) controls, and the IC50 values for PI3K α, β, δ and γ were calculated from the fit of the dose-response curves to a four-parameter equation.	B	C[C@H](Nc1nc(N)nc(C(F)F)c1C#N)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cnc(N)cn1		CHEMBL3981093	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
445588	17805296	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CS(=O)(=O)N1CCN(Cc2csc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3970288	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
445589	17805297	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CS(=O)(=O)N1CCN(Cc2csc3c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)nc23)CC1		CHEMBL3940735	=	IC50	nM	62.0	CHEMBL3130	Homo sapiens	IC50	nM	62.0
445590	17805298	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)nc2c(CN3CCN(S(C)(=O)=O)CC3)csc12		CHEMBL3956830	=	IC50	nM	28.3	CHEMBL3130	Homo sapiens	IC50	nM	28.3
445591	17805299	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CS(=O)(=O)N1CCN(Cc2csc3c(-c4ccc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3937004	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
445592	17805300	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CS(=O)(=O)N1CCN(Cc2csc3c(-c4cccc(O)c4)nc(N4CCOCC4)nc23)CC1		CHEMBL3954647	=	IC50	nM	327.0	CHEMBL3130	Homo sapiens	IC50	nM	327.0
445593	17805301	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CS(=O)(=O)N1CCN(Cc2csc3c(-c4cncnc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3927016	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
445594	17805302	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CC(C)(O)C1CCN(Cc2csc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3965846	=	IC50	nM	65.4	CHEMBL3130	Homo sapiens	IC50	nM	65.4
445595	17805303	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	C[C@H](O)C(=O)N1CCN(Cc2csc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3932807	=	IC50	nM	12.6	CHEMBL3130	Homo sapiens	IC50	nM	12.6
445596	17805304	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	C[C@@H](O)C(=O)N1CCN(Cc2csc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL4112992	=	IC50	nM	31.9	CHEMBL3130	Homo sapiens	IC50	nM	31.9
445597	17805305	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CC(C)(O)C(=O)N1CCN(Cc2csc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc23)CC1		CHEMBL3904801	=	IC50	nM	52.0	CHEMBL3130	Homo sapiens	IC50	nM	52.0
445598	17805306	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)nc2c(CN3CCN(C(=O)[C@@H](C)O)CC3)csc12		CHEMBL4110117	=	IC50	nM	4.7	CHEMBL3130	Homo sapiens	IC50	nM	4.7
445599	17805307	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)nc2c(CN3CCN(C(=O)[C@H](C)O)CC3)csc12		CHEMBL3918067	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
445600	17805308	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	C[C@@H](O)C(=O)N1CCN(Cc2csc3c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)nc23)CC1		CHEMBL4108281	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
445601	17805309	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1sc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2c1CN1CCN(C(=O)[C@H](C)O)CC1		CHEMBL3891554	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	nM	8.3
445602	17805310	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1sc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2c1CN1CCN(C(=O)[C@@H](C)O)CC1		CHEMBL4112511	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
445603	17805311	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	O=C(CO)N1CCN(Cc2csc3c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)nc23)CC1		CHEMBL3943594	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
445604	17805312	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	C[C@H](O)C(=O)N1CCN(Cc2csc3c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)nc23)CC1		CHEMBL3952164	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
445605	17805313	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Nc1ncc(-c2nc(N3CCOCC3)nc3c(CN4CCN(C(=O)CO)CC4)csc23)cn1		CHEMBL3904305	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
445606	17805314	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1sc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2c1CN1CCN(C(=O)CO)CC1		CHEMBL3950275	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
445607	17805315	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1sc2c(-c3cccc4[nH]ncc34)nc(N3CCOCC3)nc2c1CN1CCN(S(C)(=O)=O)CC1		CHEMBL3920552	=	IC50	nM	60.4	CHEMBL3130	Homo sapiens	IC50	nM	60.4
445608	17805316	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Nc1ncc(-c2nc(N3CCOCC3)nc3ccoc23)cn1		CHEMBL3980779	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	nM	290.0
445609	17805317	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	CN(CO)Cc1csc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc12		CHEMBL3930276	=	IC50	nM	137.0	CHEMBL3130	Homo sapiens	IC50	nM	137.0
445610	17805318	CHEMBL3889298	Enzymatic Inhibitory Activity Assay:   1. Buffer preparation: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS.  2. Compound was formulated in 100% DMSO in a concentration gradient, deposited to a 384-well plate to make final DMSO concentration of 1%.  3. PI3Kα and PI3Kδ enzymes were diluted to be the optimum concentration with the following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT. Transferred to a 384-well plate and incubated with the compound for a certain time.  4. Substrate was diluted to an optimum concentration with following buffer: 50 mM HEPES, pH 7.5, 3 mM MgCl2, 1 mM EGTA, 100 mM NaCl, 0.03% CHAPS, 2 mM DTT, 50 μM PIP2, Km ATP. The reaction was performed in a 384-well plate for 1 h at room temperature for PI3Kα and 2 hrs at room temperature for PI3Kδ.  5. Read the conversion rate using Caliper Reader, and calculate the inhibition rate as the average of two tests.	B	Cc1sc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2c1CN1CCN(CCO)CC1		CHEMBL3926887	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	nM	56.0
	17957630	CHEMBL3993905	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate after 1 hr by ADP-Glo kinase assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	89.06	CHEMBL3130	Homo sapiens	IC50	nM	89.06
	17957631	CHEMBL3993905	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate after 1 hr by ADP-Glo kinase assay	B	COc1ncc(-c2ccc3ncc(NC(=O)CN4CCOCC4)c(OC)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4083504	=	IC50	nM	0.87	CHEMBL3130	Homo sapiens	IC50	nM	0.87
	17973853	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cncc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4083212	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	17973854	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	COc1cc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)cc(N2[C@@H](C)CN(C(C)=O)C[C@H]2C)c1		CHEMBL4070023	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
	17973855	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cc(F)cc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4091002	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	17973856	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	C[C@H]1CN(C(=O)C(C)(C)O)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4091906	=	IC50	nM	3.9	CHEMBL3130	Homo sapiens	IC50	nM	3.9
	17973857	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	C[C@H]1CN(C(=O)CO)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4064155	=	IC50	nM	1.5	CHEMBL3130	Homo sapiens	IC50	nM	1.5
	17973858	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	COC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4099634	=	IC50	nM	4.5	CHEMBL3130	Homo sapiens	IC50	nM	4.5
	17973859	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	C[C@H]1CN(C2COC2)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4072750	=	IC50	nM	9.6	CHEMBL3130	Homo sapiens	IC50	nM	9.6
	17973860	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	C[C@H]1CN(C)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4087086	=	IC50	nM	6.4	CHEMBL3130	Homo sapiens	IC50	nM	6.4
	17973861	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	C[C@H]1CNC[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4065659	=	IC50	nM	10.7	CHEMBL3130	Homo sapiens	IC50	nM	10.7
	17973862	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4068514	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	17973863	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(=O)C1		CHEMBL4081103	=	IC50	nM	5.5	CHEMBL3130	Homo sapiens	IC50	nM	5.5
	17973864	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1c1cccnc1		CHEMBL4091410	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
	17973865	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1c1ccccc1		CHEMBL4070480	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	17973866	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1[C@@H](C)CN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C[C@H]1C		CHEMBL4083625	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	17973867	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4061855	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	17973868	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(c2ccc(Cl)cc2)C1		CHEMBL4073217	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	17973869	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(c2cccnc2)C1		CHEMBL4100063	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	17973870	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(c2ccccc2)C1		CHEMBL4079663	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	17973871	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(C(F)(F)F)C1		CHEMBL4097699	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	17973872	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@@H](C)C1		CHEMBL4083101	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	17973873	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)CC1		CHEMBL4101075	=	IC50	nM	5.5	CHEMBL3130	Homo sapiens	IC50	nM	5.5
	17973874	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4COC4)c4c(N)ncnn34)c2)CC1		CHEMBL4072625	=	IC50	nM	6.6	CHEMBL3130	Homo sapiens	IC50	nM	6.6
	17973875	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C(C)C)c4c(N)ncnn34)c2)CC1		CHEMBL4093336	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	17973876	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CC4)c4c(N)ncnn34)c2)CC1		CHEMBL4098611	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	17973877	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4071580	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	17973878	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(N4CCN(C5COC5)CC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4090888	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	17973879	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4062954	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	17973880	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(N4CCNCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4098095	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	17973881	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)ccn2)CC1		CHEMBL4080063	=	IC50	nM	5.2	CHEMBL3130	Homo sapiens	IC50	nM	5.2
	17973882	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3ccnc(N4CCN(C5COC5)CC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4072054	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	17973883	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN1CCN(c2cc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)ccn2)CC1		CHEMBL4099020	=	IC50	nM	4.7	CHEMBL3130	Homo sapiens	IC50	nM	4.7
	17973884	CHEMBL3996844	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3ccnc(N4CCNCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4082528	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	17973965	CHEMBL3996849	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4071580	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	nM	66.0
	17973966	CHEMBL3996849	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CC4)c4c(N)ncnn34)c2)CC1		CHEMBL4098611	=	IC50	nM	681.0	CHEMBL3130	Homo sapiens	IC50	nM	681.0
	17973967	CHEMBL3996849	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C(C)C)c4c(N)ncnn34)c2)CC1		CHEMBL4093336	=	IC50	nM	422.0	CHEMBL3130	Homo sapiens	IC50	nM	422.0
	17973968	CHEMBL3996849	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4061855	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	17973969	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4071580	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	17973970	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4COC4)c4c(N)ncnn34)c2)CC1		CHEMBL4072625	=	IC50	nM	1208.0	CHEMBL3130	Homo sapiens	IC50	nM	1208.0
	17973971	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)CC1		CHEMBL4101075	=	IC50	nM	143.0	CHEMBL3130	Homo sapiens	IC50	nM	143.0
	17973972	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	CC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4061855	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	17973973	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	C[C@H]1CNC[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4065659	=	IC50	nM	314.0	CHEMBL3130	Homo sapiens	IC50	nM	314.0
	17973974	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	C[C@H]1CN(C)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4087086	=	IC50	nM	239.0	CHEMBL3130	Homo sapiens	IC50	nM	239.0
	17973975	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	C[C@H]1CN(C2COC2)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4072750	=	IC50	nM	193.0	CHEMBL3130	Homo sapiens	IC50	nM	193.0
	17973976	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	COC(=O)N1C[C@H](C)N(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)[C@H](C)C1		CHEMBL4099634	=	IC50	nM	81.0	CHEMBL3130	Homo sapiens	IC50	nM	81.0
	17973977	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	C[C@H]1CN(C(=O)CO)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4064155	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	17973978	CHEMBL3996850	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression incubated for 60 mins	B	C[C@H]1CN(C(=O)C(C)(C)O)C[C@@H](C)N1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4091906	=	IC50	nM	291.0	CHEMBL3130	Homo sapiens	IC50	nM	291.0
	17997599	CHEMBL4001606	Inhibition of PI3Kdelta-mediated AKT phosphorylation at ser473 residue in human JeKo1 cells preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	Cn1nc(-c2cnc(N)c(-c3cn[nH]c3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4091640	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	uM	0.11
	17997600	CHEMBL4001606	Inhibition of PI3Kdelta-mediated AKT phosphorylation at ser473 residue in human JeKo1 cells preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	Cn1nc(-c2cnc(N)c(-c3nnc(C(C)(C)C)o3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4089227	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	17997601	CHEMBL4001606	Inhibition of PI3Kdelta-mediated AKT phosphorylation at ser473 residue in human JeKo1 cells preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	CN(C)S(=O)(=O)n1cc(-c2nc(-c3nc(C4(c5ccccc5)CC4)n(C)n3)cnc2N)cn1		CHEMBL4072500	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	uM	0.09
	17997602	CHEMBL4001606	Inhibition of PI3Kdelta-mediated AKT phosphorylation at ser473 residue in human JeKo1 cells preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	Cn1nc(-c2cnc(N)c(-c3ccc(C(N)=O)cc3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4091680	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	uM	0.05
	17997603	CHEMBL4001606	Inhibition of PI3Kdelta-mediated AKT phosphorylation at ser473 residue in human JeKo1 cells preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	Cn1nc(-c2cnc(N)c(-c3ccc(C(N)=O)c(F)c3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4101902	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	18069817	CHEMBL4015051	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2ccc(F)cc2)c2oc(N3CCOCC3)cc(=O)c2c1		CHEMBL4102511	=	IC50	nM	8.2	CHEMBL3130	Homo sapiens	IC50	uM	0.0082
	18069818	CHEMBL4015051	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	=	IC50	nM	8.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0086
	18069819	CHEMBL4015051	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate preincubated for 20 mins followed by substrate addition measured after 80 mins in presence of ATP by Kinase Glo luminescence assay	B	O=C(c1cc([C@H]2CCCN2c2cccc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4090811	=	IC50	nM	5.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0051
	18069821	CHEMBL4015052	Inhibition of PI3Kdelta in human JeKo1 B cells assessed as decrease in AKT phosphorylation at Ser473 measured after 1 hr	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	18073263	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	18073264	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	18073265	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1cccc2nc(Cn3cnc4c(N)ncnc43)n(-c3ccccc3)c(=O)c12		CHEMBL4090825	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	18073266	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c([C@H](C)n2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL4069027	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
Not Determined	18073267	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c([C@@H](C)n2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL4080605		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18073268	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c([C@H](C)n2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL4069027	=	IC50	nM	1.259	CHEMBL3130	Homo sapiens	pIC50		8.9
Not Determined	18073269	CHEMBL4015804	Inhibition of PI3Kdelta in human PBMC assessed as reduction in anti-human CD28 antibody stimulated IL-6 secretion levels after 72 hrs by ELISA	B	Cc1ccccc1-n1c([C@@H](C)n2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL4080605		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18075054	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4073594	=	IC50	nM	0.7943	CHEMBL3130	Homo sapiens	pIC50		9.1
	18075055	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(Cc3cccc(CN)c3)c(=O)n12		CHEMBL4092688	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	18075056	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	CNCc1cccc(Cc2c([C@H](C)Nc3ncnc(N)c3C#N)cc3scc(C)n3c2=O)c1		CHEMBL4065004	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	18075057	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(Cc3cccc(CN(C)C)c3)c(=O)n12		CHEMBL4104746	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
	18075058	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	COCCNCc1cccc(Cc2c([C@H](C)Nc3ncnc(N)c3C#N)cc3scc(C)n3c2=O)c1		CHEMBL4080523	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18075059	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(Cc3cccc(CN(C)CC(C)C)c3)c(=O)n12		CHEMBL4069417	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
	18075060	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(Cc3cccc(CN4CCC4)c3)c(=O)n12		CHEMBL4096646	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18075061	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(Cc3cccc(CNCCCCOCCc4ccccc4)c3)c(=O)n12		CHEMBL4060741	=	IC50	nM	1.259	CHEMBL3130	Homo sapiens	pIC50		8.9
	18075062	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CCN(C)C)c3)c(=O)n12		CHEMBL4088952	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18075063	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(OCCN(C)C)c3)c(=O)n12		CHEMBL4099101	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	18075064	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CC4CCN(C(C)C)CC4)c3)c(=O)n12		CHEMBL4081062	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
	18075065	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CNCCN4CCOCC4)c3)c(=O)n12		CHEMBL4091365	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	18075066	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCC(N(C)C)CC4)c3)c(=O)n12		CHEMBL4070433	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	18075067	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCC(CN(C)CC(C)C)CC4)c3)c(=O)n12		CHEMBL4083582	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18075068	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCN(CCN5CCOCC5)CC4)c3)c(=O)n12		CHEMBL4061810	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	pIC50		9.0
	18075069	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCC(N(C)CCC(F)(F)F)CC4)c3)c(=O)n12		CHEMBL4073335	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	18075070	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCC(N(C)CC(C)C)CC4)c3)c(=O)n12		CHEMBL4094000	=	IC50	nM	1.259	CHEMBL3130	Homo sapiens	pIC50		8.9
	18075071	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN4CCC(CN(C)Cc5ccccn5)CC4)c3)c(=O)n12		CHEMBL4083733	=	IC50	nM	1.995	CHEMBL3130	Homo sapiens	pIC50		8.7
	18075072	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	CCN(CCN1CCOCC1)Cc1cccc(-c2c([C@H](C)Nc3ncnc(N)c3C#N)cc3scc(C)n3c2=O)c1		CHEMBL4101730	=	IC50	nM	1.259	CHEMBL3130	Homo sapiens	pIC50		8.9
	18075073	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN(C)CCCN(C)Cc4ccc(Cl)cc4)c3)c(=O)n12		CHEMBL4102634	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	18075074	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN(C)CCCN4C[C@H](C)O[C@H](C)C4)c3)c(=O)n12		CHEMBL4078365	=	IC50	nM	5.012	CHEMBL3130	Homo sapiens	pIC50		8.3
	18075075	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN(C)CCCCN4C[C@H](C)O[C@H](C)C4)c3)c(=O)n12		CHEMBL4064748	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	18075076	CHEMBL4016128	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in Akt phosphorylation at Ser473 residue preincubated for 60 mins followed by Anti-IgM stimulation for 10 mins by TR-FRET assay	B	Cc1csc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3cccc(CN(C)CCCCN(C)Cc4ccccc4)c3)c(=O)n12		CHEMBL4086230	=	IC50	nM	1.995	CHEMBL3130	Homo sapiens	pIC50		8.7
	18077541	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4104044	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	18077542	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(C(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4064543	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	18077543	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(C#N)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4092240	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	18077544	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(C)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4102444	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	18077545	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3ccc4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4084490	>	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	18077546	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cc(C(C)C)no4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4094693	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	18077547	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4nnc(C(C)C)o4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4074193	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	18077548	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cscn4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4087001	=	IC50	nM	5.5	CHEMBL3130	Homo sapiens	IC50	nM	5.5
	18077549	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4nnc(C)s4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4076137	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	18077550	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ncco4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4070164	=	IC50	nM	4.2	CHEMBL3130	Homo sapiens	IC50	nM	4.2
	18077551	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnc(Cl)n4C)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4091840	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	18077552	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnn(C5CC5)c4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4087215	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	18077553	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnn(C)c4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4105075	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	18077554	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4059848	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	18077555	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4081766	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18077556	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4068514	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	18077557	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4086128	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	18077558	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(Br)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4066316	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	18077559	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(I)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4093883	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18077560	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2C)C(=O)C1(C)C		CHEMBL4088567	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	18077561	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C)C(=O)C1(C)C		CHEMBL4067315	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	18077562	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(C)cc(-c3cc(Cl)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4096288	=	IC50	nM	4.5	CHEMBL3130	Homo sapiens	IC50	nM	4.5
	18077563	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4078237	=	IC50	nM	1.6	CHEMBL3130	Homo sapiens	IC50	nM	1.6
	18077564	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	COc1ccc(-c2cc(Cl)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4070029	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
	18077565	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2Cl)C(=O)C1(C)C		CHEMBL4097222	=	IC50	nM	1.5	CHEMBL3130	Homo sapiens	IC50	nM	1.5
	18077566	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4084604	=	IC50	nM	2.3	CHEMBL3130	Homo sapiens	IC50	nM	2.3
	18077567	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4102552	=	IC50	nM	4.8	CHEMBL3130	Homo sapiens	IC50	nM	4.8
	18077568	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4074315	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18077569	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4094814	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	18077570	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	COc1ccc(-c2cc(C(F)(F)F)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4100099	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	18077571	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4073255	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	18077572	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4092344	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
	18077573	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4064666	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	18077574	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@@H](C)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4095752	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	18077575	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4068408	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	18077576	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@@H](C)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4083358	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	18077577	CHEMBL4016540	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate after 3 hrs by ADP-Glo assay	B	CC(=O)N1C[C@H](C)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4071965	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	18077639	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4068514	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	18077640	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4C4CC4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4081766	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	18077641	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4059848	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	18077642	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnn(C)c4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4105075	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	18077643	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnn(C5CC5)c4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4087215	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	18077644	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cnc(Cl)n4C)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4091840	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	18077645	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ncco4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4070164	=	IC50	nM	410.0	CHEMBL3130	Homo sapiens	IC50	nM	410.0
	18077646	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4nnc(C)s4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4076137	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	nM	160.0
	18077647	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cscn4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4087001	=	IC50	nM	500.0	CHEMBL3130	Homo sapiens	IC50	nM	500.0
	18077648	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4nnc(C(C)C)o4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4074193	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	nM	140.0
	18077649	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4cc(C(C)C)no4)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4094693	=	IC50	nM	280.0	CHEMBL3130	Homo sapiens	IC50	nM	280.0
Not Determined	18077650	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3ccc4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4084490		IC50			CHEMBL3130	Homo sapiens	IC50		
	18077651	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(C)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4102444	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	18077652	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(C#N)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4092240	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	18077653	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(C(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4064543	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	nM	72.0
	18077654	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4104044	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	nM	570.0
	18077655	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4086128	=	IC50	nM	95.0	CHEMBL3130	Homo sapiens	IC50	nM	95.0
	18077656	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(Br)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4066316	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	18077657	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(I)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4093883	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
Not Determined	18077658	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2C)C(=O)C1(C)C		CHEMBL4088567		IC50			CHEMBL3130	Homo sapiens	IC50		
	18077659	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C)C(=O)C1(C)C		CHEMBL4067315	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	18077660	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(C)cc(-c3cc(Cl)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4096288	=	IC50	nM	550.0	CHEMBL3130	Homo sapiens	IC50	nM	550.0
	18077661	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4078237	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	nM	220.0
	18077662	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	COc1ccc(-c2cc(Cl)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4070029	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	18077663	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2Cl)C(=O)C1(C)C		CHEMBL4097222	=	IC50	nM	370.0	CHEMBL3130	Homo sapiens	IC50	nM	370.0
	18077664	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4084604	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	18077665	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4102552	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	18077666	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4074315	=	IC50	nM	90.0	CHEMBL3130	Homo sapiens	IC50	nM	90.0
	18077667	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4094814	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	18077668	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	COc1ccc(-c2cc(C(F)(F)F)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4100099	=	IC50	nM	92.0	CHEMBL3130	Homo sapiens	IC50	nM	92.0
	18077669	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4073255	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	nM	79.0
	18077670	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4092344	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	18077671	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4064666	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	18077672	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1C[C@@H](C)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4095752	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	nM	66.0
	18077673	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1C[C@H](C)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4068408	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	18077674	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1C[C@@H](C)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4083358	=	IC50	nM	105.0	CHEMBL3130	Homo sapiens	IC50	nM	105.0
	18077675	CHEMBL4016543	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgD-mediated B-cell activation by measuring decrease in CD19+ cells expressing CD69 preincubated for 1 hr followed by IgD activation measured after overnight incubation	B	CC(=O)N1C[C@H](C)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4071965	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	18077736	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C(=O)C1(C)C		CHEMBL4059848	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	nM	71.0
	18077737	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4078237	=	IC50	nM	98.0	CHEMBL3130	Homo sapiens	IC50	nM	98.0
	18077738	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	COc1ccc(-c2cc(Cl)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4070029	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	18077739	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2Cl)C(=O)C1(C)C		CHEMBL4097222	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18077740	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4084604	=	IC50	nM	560.0	CHEMBL3130	Homo sapiens	IC50	nM	560.0
	18077741	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4102552	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	18077742	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4074315	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
	18077743	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(F)(F)F)C(=O)C1(C)C		CHEMBL4094814	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	nM	82.0
	18077744	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	COc1ccc(-c2cc(C(F)(F)F)c3c(N)ncnn23)cc1N1CCN(C(C)=O)C(C)(C)C1=O		CHEMBL4100099	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	nM	56.0
	18077745	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2S(C)(=O)=O)C(=O)C1(C)C		CHEMBL4073255	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	nM	140.0
	18077746	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C(C)O)C(=O)C1(C)C		CHEMBL4092344	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	18077747	CHEMBL4016546	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD3/anti-CD28-mediated IFNgamma production preincubated for 1 hr followed by anti-CD3/anti-CD28 activation measured after overnight incubation by AlphaLisa assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4064666	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	18077897	CHEMBL4016574	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C		CHEMBL4064666	<	IC50	nM	0.1	CHEMBL3130	Homo sapiens	IC50	nM	0.1
	18077974	CHEMBL4016644	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18077975	CHEMBL4016644	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	18088155	CHEMBL4019292	Inhibition of PI3Kdelta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	18088156	CHEMBL4019292	Inhibition of PI3Kdelta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL4084907	=	IC50	nM	451.0	CHEMBL3130	Homo sapiens	IC50	nM	451.0
	18088202	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL4084907	=	Kd	nM	25.0	CHEMBL3130	Homo sapiens	Kd	nM	25.0
	18088203	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1ncc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1		CHEMBL4102855	=	Kd	nM	3.5	CHEMBL3130	Homo sapiens	Kd	nM	3.5
	18088204	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	Kd	nM	76.0	CHEMBL3130	Homo sapiens	Kd	nM	76.0
	18088205	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	Kd	nM	260.0	CHEMBL3130	Homo sapiens	Kd	nM	260.0
	18088206	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	3.3	CHEMBL3130	Homo sapiens	Kd	nM	3.3
	18088207	CHEMBL4019282	Binding affinity to human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan assay	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	3.3	CHEMBL3130	Homo sapiens	Kd	nM	3.3
	18113972	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18113973	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	18113974	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(-c3ccnn3CC(F)(F)F)c12		CHEMBL4086343	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	18113975	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(Cl)c12		CHEMBL4080945	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	18113976	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(C(F)(F)F)c12		CHEMBL4105190	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	18113977	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)c2)C1=O		CHEMBL4088828	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	18113978	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(Cl)c4c(N)ncnn34)c2)C1=O		CHEMBL4067592	=	IC50	nM	7.4	CHEMBL3130	Homo sapiens	IC50	nM	7.4
	18113979	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cccc(-c3cc(C(F)(F)F)c4c(N)ncnn34)c2)C1=O		CHEMBL4061641	=	IC50	nM	9.8	CHEMBL3130	Homo sapiens	IC50	nM	9.8
	18113980	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(-c3ccnn3CC(F)(F)F)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4089756	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	18113981	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(Cl)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4063245	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	18113982	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	COc1ccc(-c2cc(C(F)(F)F)c3c(N)ncnn23)cc1N1CCOC(C)(C)C1=O		CHEMBL4084897	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	18113983	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(-c4ccnn4CC(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4071877	=	IC50	nM	9.4	CHEMBL3130	Homo sapiens	IC50	nM	9.4
	18113984	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4092654	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	18113985	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC1(C)OCCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4093593	=	IC50	nM	4.9	CHEMBL3130	Homo sapiens	IC50	nM	4.9
	18113986	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4065999	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	18113987	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4105636	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	18113988	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4077544	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	18113989	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4101245	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18113990	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4084394	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	18113991	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4072098	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18113992	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4077248	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	18113993	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4067250	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	18113994	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4060977	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
	18113995	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4080090	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	18113996	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4090297	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
	18113997	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	CC[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4076745	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18113998	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4069213	<	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	18113999	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4096456	<	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	18114000	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4099608	<	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	18114001	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4081613	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	18114002	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4091875	<	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	18114003	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4071039	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	18114004	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	[2H]C1([2H])OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1([2H])[2H]		CHEMBL4069993	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	18114005	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	[2H]C1([2H])OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1([2H])[2H]		CHEMBL4097187	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
	18114006	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	[2H]C([2H])([2H])C1([2H])N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)OC1([2H])[2H]		CHEMBL4061320	=	IC50	nM	0.3	CHEMBL3130	Homo sapiens	IC50	nM	0.3
	18114007	CHEMBL4024906	Inhibition of PI3Kdelta (unknown origin) after 60 mins using fluorescein-labeled kinase tracer by HTRF assay	B	[2H]C([2H])([2H])C1([2H])N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)OC1([2H])[2H]		CHEMBL4089489	=	IC50	nM	0.5	CHEMBL3130	Homo sapiens	IC50	nM	0.5
	18114050	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(-c3ccnn3CC(F)(F)F)c12		CHEMBL4086343	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	nM	1900.0
	18114051	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC1(C)OCCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4092654	=	IC50	nM	140.0	CHEMBL3130	Homo sapiens	IC50	nM	140.0
	18114052	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC1(C)OCCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4093593	=	IC50	nM	400.0	CHEMBL3130	Homo sapiens	IC50	nM	400.0
	18114053	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4065999	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	18114054	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4105636	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	nM	82.0
	18114055	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4077544	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	18114056	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4101245	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	18114057	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4084394	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	18114058	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4072098	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	18114059	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4077248	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	nM	56.0
	18114060	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4067250	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	18114061	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4060977	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	18114062	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4080090	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	18114063	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4090297	=	IC50	nM	88.0	CHEMBL3130	Homo sapiens	IC50	nM	88.0
	18114064	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	CC[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4076745	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	18114065	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4069213	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	nM	56.0
	18114066	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4096456	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	18114067	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4099608	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	18114068	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4081613	=	IC50	nM	210.0	CHEMBL3130	Homo sapiens	IC50	nM	210.0
	18114069	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4091875	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	18114070	CHEMBL4024910	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in IFNgammaX production measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4071039	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	18114071	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	Nc1ncnn2c(-c3cccc(N4CCOCC4=O)c3)cc(-c3ccnn3CC(F)(F)F)c12		CHEMBL4086343	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	18114072	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC1(C)OCCN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4092654	=	IC50	nM	290.0	CHEMBL3130	Homo sapiens	IC50	nM	290.0
	18114073	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC1(C)OCCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1=O		CHEMBL4093593	=	IC50	nM	390.0	CHEMBL3130	Homo sapiens	IC50	nM	390.0
	18114074	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4065999	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	18114075	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4105636	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	18114076	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4077544	=	IC50	nM	78.0	CHEMBL3130	Homo sapiens	IC50	nM	78.0
	18114077	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4101245	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	18114078	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4084394	=	IC50	nM	77.0	CHEMBL3130	Homo sapiens	IC50	nM	77.0
	18114079	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4072098	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
	18114080	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4077248	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	18114081	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4067250	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	18114082	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4060977	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	18114083	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC[C@@H]1CN(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4080090	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	18114084	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC[C@H]1COC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4090297	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	18114085	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	CC[C@@H]1CN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)O1		CHEMBL4076745	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	18114086	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4069213	=	IC50	nM	260.0	CHEMBL3130	Homo sapiens	IC50	nM	260.0
	18114087	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(Cl)c3c(N)ncnn23)ccc1C#N		CHEMBL4096456	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	18114088	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4099608	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	18114089	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@@H]1C		CHEMBL4081613	=	IC50	nM	91.0	CHEMBL3130	Homo sapiens	IC50	nM	91.0
	18114090	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@H]1[C@@H](C)OC(C)(C)C(=O)N1c1cc(-c2cc(C(F)(F)F)c3c(N)ncnn23)ccc1C#N		CHEMBL4091875	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	18114091	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	C[C@@H]1OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)[C@H]1C		CHEMBL4071039	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	18114092	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	[2H]C1([2H])OC(C)(C)C(=O)N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C1([2H])[2H]		CHEMBL4069993	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	nM	240.0
	18114093	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	[2H]C1([2H])OC(C)(C)C(=O)N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C1([2H])[2H]		CHEMBL4097187	=	IC50	nM	240.0	CHEMBL3130	Homo sapiens	IC50	nM	240.0
	18114094	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	[2H]C([2H])([2H])C1([2H])N(c2cc(-c3cc(Cl)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)OC1([2H])[2H]		CHEMBL4061320	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	18114095	CHEMBL4024911	Inhibition of PI3Kdelta in ACD-treated human whole blood assessed as reduction in CD69 expression measured after 1 hr	B	[2H]C([2H])([2H])C1([2H])N(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C(C)(C)OC1([2H])[2H]		CHEMBL4089489	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	18114787	CHEMBL4025317	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	18161860	CHEMBL4035991	Inhibition of PI3Kdelta (unknown origin)	B	CN(C)CC(=O)N1CCC(n2cc(-c3cnc(N)c(-n4nnc5ccccc54)n3)cn2)CC1		CHEMBL3590219	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	18161861	CHEMBL4035991	Inhibition of PI3Kdelta (unknown origin)	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)c(C)nc2N)n(C)n1		CHEMBL4072637	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	18196967	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1ncnc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1		CHEMBL4088632	=	IC50	nM	112.0	CHEMBL3130	Homo sapiens	IC50	nM	112.0
	18196968	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1		CHEMBL4060396	=	IC50	nM	6.73	CHEMBL3130	Homo sapiens	IC50	nM	6.73
	18196969	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1ncnc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4100702	=	IC50	nM	96.8	CHEMBL3130	Homo sapiens	IC50	nM	96.8
	18196970	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929	=	IC50	nM	3.82	CHEMBL3130	Homo sapiens	IC50	nM	3.82
	18196971	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCO)c2c(=O)n1-c1ccccc1		CHEMBL4087312	=	IC50	nM	12.2	CHEMBL3130	Homo sapiens	IC50	nM	12.2
	18196972	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4065896	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	18196973	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	18196974	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CC[C@H]1c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1		CHEMBL4074526	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	nM	440.0
	18196975	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1nc(N)nc(N2CC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4102744	=	IC50	nM	19.6	CHEMBL3130	Homo sapiens	IC50	nM	19.6
	18196976	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1ncnc(N2CC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCOCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4084802	=	IC50	nM	620.0	CHEMBL3130	Homo sapiens	IC50	nM	620.0
	18196977	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1nc(N)nc(N2CC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCOCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4064856	=	IC50	nM	16.8	CHEMBL3130	Homo sapiens	IC50	nM	16.8
	18196978	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCCCC(=O)N3CCCC3)c2c(=O)n1-c1ccccc1		CHEMBL4092557	=	IC50	nM	11.5	CHEMBL3130	Homo sapiens	IC50	nM	11.5
	18196979	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1nc(N)nc(N2CCC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4098370	=	IC50	nM	7.1	CHEMBL3130	Homo sapiens	IC50	nM	7.1
	18196980	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4080347	=	IC50	nM	13.8	CHEMBL3130	Homo sapiens	IC50	nM	13.8
	18196981	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Cc1nc(N)nc(N2CCC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCOCC4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4093653	=	IC50	nM	11.8	CHEMBL3130	Homo sapiens	IC50	nM	11.8
	18196982	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	Nc1nc(N)nc(N2CCC[C@H]2c2nc3cccc(C#CCCCC(=O)N4CCOCC4)c3c(=O)n2-c2ccccc2)n1		CHEMBL4066080	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196983	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#Cc3cccc(F)c3)c2c(=O)n1-c1ccccc1		CHEMBL4101380	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196984	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#Cc3cccnc3)c2c(=O)n1-c1ccccc1		CHEMBL4074688	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196985	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#Cc3ccccn3)c2c(=O)n1-c1ccccc1		CHEMBL4063308	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196986	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#Cc3cccs3)c2c(=O)n1-c1ccccc1		CHEMBL4084960	=	IC50	nM	41.5	CHEMBL3130	Homo sapiens	IC50	nM	41.5
	18196987	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CCOC(=O)c1cnc(C#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)s1		CHEMBL4071934	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196988	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(C)N1CCN(Cc2cnc(C#Cc3cccc4nc([C@@H]5CCCN5c5ncnc(N)c5C#N)n(-c5ccccc5)c(=O)c34)s2)CC1		CHEMBL4092712	>	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18196989	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCN3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4104722	=	IC50	nM	107.0	CHEMBL3130	Homo sapiens	IC50	nM	107.0
	18196990	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(C)(C)N1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4080494	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	18196991	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCN3C[C@@H]4C[C@H]3CN4)c2c(=O)n1-c1ccccc1		CHEMBL4090122	=	IC50	nM	135.0	CHEMBL3130	Homo sapiens	IC50	nM	135.0
	18196992	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(C)(C)N1CCN(C(=O)C#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4069844	=	IC50	nM	97.7	CHEMBL3130	Homo sapiens	IC50	nM	97.7
	18196993	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4082276	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	18196994	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCN3CCC(C4CC(F)(F)C4)CC3)c2c(=O)n1-c1ccccc1		CHEMBL4060367	=	IC50	nM	141.0	CHEMBL3130	Homo sapiens	IC50	nM	141.0
	18196995	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCN3CCC(C4CC(F)C4)CC3)c2c(=O)n1-c1ccccc1		CHEMBL4105575	=	IC50	nM	78.1	CHEMBL3130	Homo sapiens	IC50	nM	78.1
	18196996	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(C#CCN3CCN(CC4CC4)CC3)c2c(=O)n1-c1ccccc1		CHEMBL4087697	=	IC50	nM	107.0	CHEMBL3130	Homo sapiens	IC50	nM	107.0
	18196997	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(F)CN1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4097840	=	IC50	nM	80.2	CHEMBL3130	Homo sapiens	IC50	nM	80.2
	18196998	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(C)(F)CN1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4079811	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	18196999	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(C)(CO)N1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4101244	=	IC50	nM	67.1	CHEMBL3130	Homo sapiens	IC50	nM	67.1
	18197000	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	CC(COC(F)F)N1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4083244	=	IC50	nM	188.0	CHEMBL3130	Homo sapiens	IC50	nM	188.0
	18197001	CHEMBL4042388	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 30 mins by HTRF assay	B	C=CC(O)C(C)(C)N1CCN(CC#Cc2cccc3nc([C@@H]4CCCN4c4ncnc(N)c4C#N)n(-c4ccccc4)c(=O)c23)CC1		CHEMBL4102933	=	IC50	nM	60.2	CHEMBL3130	Homo sapiens	IC50	nM	60.2
Dose-dependent effect	18197055	CHEMBL4042394	Inhibition of PI3Kdelta-mediated Akt phosphorylation at Ser437 in human SUDHL6 cells measured after 1 hr by Western blot analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	18197056	CHEMBL4042395	Inhibition of PI3Kdelta-mediated Akt phosphorylation at Ser437 in human MOLT4 cells measured after 1 hr by Western blot analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	18197057	CHEMBL4042396	Inhibition of PI3Kdelta-mediated S6k1 phosphorylation at T389 in human SUDHL6 cells measured after 1 hr by Western blot analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	18197058	CHEMBL4042397	Inhibition of PI3Kdelta-mediated S6k1 phosphorylation at T389 in human MOLT4 cells measured after 1 hr by Western blot analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	18197059	CHEMBL4042398	Inhibition of PI3Kdelta-mediated Akt phosphorylation in human SUDHL6 cells at 3 nM measured after 1 hr by Western blot analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(C#CCCCC(=O)N3CCOCC3)c2c(=O)n1-c1ccccc1		CHEMBL4073929		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	18197122	CHEMBL4042419	Inhibition of human full length His-tagged PI3Kdelta expressed in baculovirus expression system	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	18197126	CHEMBL4042423	Inhibition of PI3Kdelta (unknown origin) using biotinylated PIP2 as substrate after 2 hrs by TR-FRET assay	B	COCCOCCNC(=O)CCCC#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3ccccc3Cl)c(=O)c12		CHEMBL4075540	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	18203841	CHEMBL4044128	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	93.0	CHEMBL3130	Homo sapiens	Activity	%	93.0
	18211703	CHEMBL4045799	Inhibition of PIK3CD ATP binding site (TKVNWLAHNVSKDNRQ) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	4.0	CHEMBL3130	Homo sapiens	INH	%	4.0
	18211704	CHEMBL4045800	Inhibition of PIK3CD ATP binding site (VNWLAHNVSKDNRQ) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	8.0	CHEMBL3130	Homo sapiens	INH	%	8.0
	18211944	CHEMBL4046040	Inhibition of PIK3CD ATP binding site (TKVNWLAHNVSKDNRQ) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-11.0	CHEMBL3130	Homo sapiens	INH	%	-11.0
	18211945	CHEMBL4046041	Inhibition of PIK3CD ATP binding site (VNWLAHNVSKDNRQ) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	0.5	CHEMBL3130	Homo sapiens	INH	%	0.5
	18215188	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccccc3)ccc12		CHEMBL4064166	=	Inhibition	%	58.7	CHEMBL3130	Homo sapiens	INH	%	58.7
	18215189	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccccc3)ccc12		CHEMBL4085734	=	Inhibition	%	27.4	CHEMBL3130	Homo sapiens	INH	%	27.4
	18215190	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccccc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4077056	=	Inhibition	%	65.7	CHEMBL3130	Homo sapiens	INH	%	65.7
	18215191	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccccc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4075379	=	Inhibition	%	63.4	CHEMBL3130	Homo sapiens	INH	%	63.4
	18215192	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccccc3)ccc12		CHEMBL4089833	=	Inhibition	%	9.2	CHEMBL3130	Homo sapiens	INH	%	9.2
	18215193	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccccc3)ccc12		CHEMBL4075347	=	Inhibition	%	39.5	CHEMBL3130	Homo sapiens	INH	%	39.5
	18215194	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccccc3)ccc12		CHEMBL4097015	=	Inhibition	%	1.1	CHEMBL3130	Homo sapiens	INH	%	1.1
	18215195	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)c(OCc3ccccc3)ccc12		CHEMBL4076608	=	Inhibition	%	6.3	CHEMBL3130	Homo sapiens	INH	%	6.3
	18215196	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3oc3ccccc34)c(OCc3ccccc3)ccc12		CHEMBL4061599	=	Inhibition	%	-2.9	CHEMBL3130	Homo sapiens	INH	%	-2.9
	18215197	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(CO)cc3)c(OCc3ccccc3)ccc12		CHEMBL4088661	=	Inhibition	%	84.7	CHEMBL3130	Homo sapiens	INH	%	84.7
	18215198	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccnc3)c(OCc3ccccc3)ccc12		CHEMBL4059469	=	Inhibition	%	34.5	CHEMBL3130	Homo sapiens	INH	%	34.5
	18215199	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4ccccc34)c(OCc3ccccc3)ccc12		CHEMBL4087811	=	Inhibition	%	9.5	CHEMBL3130	Homo sapiens	INH	%	9.5
	18215200	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccc4c3Sc3ccccc3S4)c(OCc3ccccc3)ccc12		CHEMBL4076848	=	Inhibition	%	-1.0	CHEMBL3130	Homo sapiens	INH	%	-1.0
	18215201	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccccn3)ccc12		CHEMBL4077367	=	Inhibition	%	88.87	CHEMBL3130	Homo sapiens	INH	%	88.87
	18215202	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccccn3)ccc12		CHEMBL4105146	=	Inhibition	%	62.1	CHEMBL3130	Homo sapiens	INH	%	62.1
	18215203	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccccn3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4074385	=	Inhibition	%	85.4	CHEMBL3130	Homo sapiens	INH	%	85.4
	18215204	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccccn3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4070804	=	Inhibition	%	47.6	CHEMBL3130	Homo sapiens	INH	%	47.6
	18215205	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccccn3)ccc12		CHEMBL4091681	=	Inhibition	%	21.8	CHEMBL3130	Homo sapiens	INH	%	21.8
	18215206	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccccn3)ccc12		CHEMBL4062189	=	Inhibition	%	18.0	CHEMBL3130	Homo sapiens	INH	%	18.0
	18215207	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccccn3)ccc12		CHEMBL4083912	=	Inhibition	%	24.6	CHEMBL3130	Homo sapiens	INH	%	24.6
	18215208	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3cccnc3)ccc12		CHEMBL4061587	=	Inhibition	%	85.5	CHEMBL3130	Homo sapiens	INH	%	85.5
	18215209	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3cccnc3)ccc12		CHEMBL4071051	=	Inhibition	%	64.9	CHEMBL3130	Homo sapiens	INH	%	64.9
	18215210	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3cccnc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4079378	=	Inhibition	%	87.8	CHEMBL3130	Homo sapiens	INH	%	87.8
	18215211	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3cccnc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4075461	=	Inhibition	%	41.9	CHEMBL3130	Homo sapiens	INH	%	41.9
	18215212	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3cccnc3)ccc12		CHEMBL4077277	=	Inhibition	%	20.7	CHEMBL3130	Homo sapiens	INH	%	20.7
	18215213	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3cccnc3)ccc12		CHEMBL4076504	=	Inhibition	%	16.6	CHEMBL3130	Homo sapiens	INH	%	16.6
	18215214	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3cccnc3)ccc12		CHEMBL4103756	=	Inhibition	%	75.6	CHEMBL3130	Homo sapiens	INH	%	75.6
	18215215	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccncc3)ccc12		CHEMBL4084755	=	Inhibition	%	80.8	CHEMBL3130	Homo sapiens	INH	%	80.8
	18215216	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccncc3)ccc12		CHEMBL4094832	=	Inhibition	%	63.3	CHEMBL3130	Homo sapiens	INH	%	63.3
	18215217	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccncc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4104565	=	Inhibition	%	96.3	CHEMBL3130	Homo sapiens	INH	%	96.3
	18215218	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	Nc1cccc(-c2c(OCc3ccncc3)ccc3c(=O)nc(N4CCOCC4)oc23)c1		CHEMBL4069955	=	Inhibition	%	9.7	CHEMBL3130	Homo sapiens	INH	%	9.7
	18215219	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cccs3)c(OCc3ccncc3)ccc12		CHEMBL4093073	=	Inhibition	%	24.0	CHEMBL3130	Homo sapiens	INH	%	24.0
	18215220	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccsc3)c(OCc3ccncc3)ccc12		CHEMBL4076512	=	Inhibition	%	72.2	CHEMBL3130	Homo sapiens	INH	%	72.2
	18215221	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3ccncc3)ccc12		CHEMBL4072665	=	Inhibition	%	27.2	CHEMBL3130	Homo sapiens	INH	%	27.2
	18215222	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCCBr)ccc12		CHEMBL4061393	=	Inhibition	%	75.9	CHEMBL3130	Homo sapiens	INH	%	75.9
	18215223	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCCBr)ccc12		CHEMBL4095309	=	Inhibition	%	53.6	CHEMBL3130	Homo sapiens	INH	%	53.6
	18215224	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCBr)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4071376	=	Inhibition	%	88.8	CHEMBL3130	Homo sapiens	INH	%	88.8
	18215225	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	CN1CCN(CCOc2ccc3c(=O)nc(N4CCOCC4)oc3c2-c2ccccc2)CC1		CHEMBL4076379	=	Inhibition	%	53.4	CHEMBL3130	Homo sapiens	INH	%	53.4
	18215226	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	CN1CCN(CCOc2ccc3c(=O)nc(N4CCOCC4)oc3c2-c2ccc(Cl)cc2)CC1		CHEMBL4083132	=	Inhibition	%	49.4	CHEMBL3130	Homo sapiens	INH	%	49.4
	18215227	CHEMBL4046830	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption at 10 uM using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCN3CCN(C)CC3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4075473	=	Inhibition	%	73.9	CHEMBL3130	Homo sapiens	INH	%	73.9
	18215228	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(CO)cc3)c(OCc3ccccc3)ccc12		CHEMBL4088661	=	IC50	nM	3070.0	CHEMBL3130	Homo sapiens	IC50	uM	3.07
	18215229	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccccn3)ccc12		CHEMBL4077367	=	IC50	nM	4000.0	CHEMBL3130	Homo sapiens	IC50	uM	4.0
	18215230	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccccn3)ccc12		CHEMBL4105146	=	IC50	nM	14700.0	CHEMBL3130	Homo sapiens	IC50	uM	14.7
	18215231	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccccn3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4074385	=	IC50	nM	2700.0	CHEMBL3130	Homo sapiens	IC50	uM	2.7
	18215232	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3cccnc3)ccc12		CHEMBL4061587	=	IC50	nM	7200.0	CHEMBL3130	Homo sapiens	IC50	uM	7.2
	18215233	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3cccnc3)ccc12		CHEMBL4071051	=	IC50	nM	10100.0	CHEMBL3130	Homo sapiens	IC50	uM	10.1
	18215234	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3cccnc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4079378	=	IC50	nM	2800.0	CHEMBL3130	Homo sapiens	IC50	uM	2.8
	18215235	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3cc4ccccc4s3)c(OCc3cccnc3)ccc12		CHEMBL4103756	=	IC50	nM	2700.0	CHEMBL3130	Homo sapiens	IC50	uM	2.7
	18215236	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccccc3)c(OCc3ccncc3)ccc12		CHEMBL4084755	=	IC50	nM	5800.0	CHEMBL3130	Homo sapiens	IC50	uM	5.8
	18215237	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	O=c1nc(N2CCOCC2)oc2c(-c3ccc(Cl)cc3)c(OCc3ccncc3)ccc12		CHEMBL4094832	=	IC50	nM	9200.0	CHEMBL3130	Homo sapiens	IC50	uM	9.2
	18215238	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCc3ccncc3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4104565	=	IC50	nM	2900.0	CHEMBL3130	Homo sapiens	IC50	uM	2.9
	18215239	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCBr)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4071376	=	IC50	nM	2700.0	CHEMBL3130	Homo sapiens	IC50	uM	2.7
	18215240	CHEMBL4046831	Inhibition of wild type PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and ATP measured after 60 mins by Kinase-Glo reagent based luminescence assay	B	COc1ccc(-c2c(OCCN3CCN(C)CC3)ccc3c(=O)nc(N4CCOCC4)oc23)cc1		CHEMBL4075473	=	IC50	nM	5680.0	CHEMBL3130	Homo sapiens	IC50	uM	5.68
	18245872	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	18245873	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
	18245874	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4068098	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
	18245875	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4089288	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	18245876	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4105669	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
	18245877	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CCC(n5cnnc5C(F)(F)F)CC4)cc3n2)c1		CHEMBL4081413	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18245878	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4086820	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	18245879	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nncn1C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4104716	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	18245880	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4078972	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	18245881	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CC[C@H]5[C@H](CCc6nnc(C(F)(F)F)n65)C4)cc3n2)c1		CHEMBL4096987	=	IC50	nM	0.631	CHEMBL3130	Homo sapiens	pIC50		9.2
	18245882	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4100380	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	18245883	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4068538	=	IC50	nM	0.7943	CHEMBL3130	Homo sapiens	pIC50		9.1
	18245884	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@H]1CC2		CHEMBL4081998	=	IC50	nM	0.7943	CHEMBL3130	Homo sapiens	pIC50		9.1
	18245885	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4092258	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	18245886	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Oc1cccc(-c2nc(N3CCOCC3)c3sc(CN4CC[C@H]5[C@@H](CCc6nnc(C(F)(F)F)n65)C4)cc3n2)c1		CHEMBL4071462	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	pIC50		9.0
	18245887	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ncc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4070417	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
	18245888	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	FC(F)(F)c1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4097593	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
	18245889	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4061794	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	pIC50		9.0
	18245890	CHEMBL4053407	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of ATP by HTRF method	B	Cc1nnc2n1[C@H]1CCN(Cc3cc4nc(-c5cccc(O)c5)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4094734	=	IC50	nM	0.7943	CHEMBL3130	Homo sapiens	pIC50		9.1
	18253291	CHEMBL4054929	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	44.0	CHEMBL3130	Homo sapiens	Activity	%	44.0
	18253292	CHEMBL4054929	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	18281197	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4130282	=	Kd	nM	15.0	CHEMBL3130	Homo sapiens	Kd	nM	15.0
	18281198	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc([C@@H]2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127012	=	Kd	nM	16407.0	CHEMBL3130	Homo sapiens	Kd	nM	16407.0
	18281199	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	CN(C)C(=O)c1cc(C2CCCN2c2cc(F)cc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4129062	=	Kd	nM	117.0	CHEMBL3130	Homo sapiens	Kd	nM	117.0
	18281200	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H]1CN(C(=O)c2cc(C3CCCN3c3cc(F)cc(F)c3)c3nc(N4CCOCC4)cnc3c2)C[C@@H](C)N1		CHEMBL4125781	=	Kd	nM	7.0	CHEMBL3130	Homo sapiens	Kd	nM	7.0
	18281201	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4127822	=	Kd	nM	324.0	CHEMBL3130	Homo sapiens	Kd	nM	324.0
	18281202	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H](Nc1cccc(F)c1)c1cc(C(=O)NCCO)cc2ncc(N3CCOCC3)nc12		CHEMBL4129223	=	Kd	nM	10192.0	CHEMBL3130	Homo sapiens	Kd	nM	10192.0
	18281203	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127116	=	Kd	nM	102.0	CHEMBL3130	Homo sapiens	Kd	nM	102.0
	18281204	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128507	=	Kd	nM	57.0	CHEMBL3130	Homo sapiens	Kd	nM	57.0
	18281205	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	C[C@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4128821	=	Kd	nM	5370.0	CHEMBL3130	Homo sapiens	Kd	nM	5370.0
	18281206	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	CNCCNC(=O)c1cc(C(C)Nc2cccc(F)c2)c2nc(N3CCOCC3)cnc2c1		CHEMBL4127425	=	Kd	nM	68.0	CHEMBL3130	Homo sapiens	Kd	nM	68.0
	18281207	CHEMBL4119782	Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay	B	Cc1c(F)cccc1NCc1cc(C(=O)NCCN(C)C)cc2ncc(N3CCOCC3)nc12		CHEMBL4127570	=	Kd	nM	324.0	CHEMBL3130	Homo sapiens	Kd	nM	324.0
	18281671	CHEMBL4119824	Inhibition of PI3K delta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1		CHEMBL2387080	<	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	18281672	CHEMBL4119824	Inhibition of PI3K delta (unknown origin)	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	<	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	18298599	CHEMBL4124217	Inhibition of PI3Kdelta in human JeKo1B cells assessed as reduction in AKT phosphorylation at ser473 residue preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	CNS(=O)(=O)c1cc(-c2sc(NC(C)=O)nc2C)cc2c1C(=O)N([C@@H](C)C1CC1)C2		CHEMBL4129600	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	18298600	CHEMBL4124217	Inhibition of PI3Kdelta in human JeKo1B cells assessed as reduction in AKT phosphorylation at ser473 residue preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	CC(=O)Nc1nc(C)c(-c2cc3c(c(S(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1		CHEMBL4126156	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18298601	CHEMBL4124217	Inhibition of PI3Kdelta in human JeKo1B cells assessed as reduction in AKT phosphorylation at ser473 residue preincubated for 60 mins followed by anti-IgM stimulation measured after 10 mins by TR-FRET assay	B	CC(=O)Nc1nc(C)c(-c2cc3c(c(NS(C)(=O)=O)c2)C(=O)N([C@@H](C)C2CC2)C3)s1		CHEMBL4127396	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	18319919	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(CN3CCC(C(C)(C)O)CC3)ccc1OCC2		CHEMBL4168260	=	Ki	nM	20.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	20.0
	18319920	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(CN3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL3704659	=	Ki	nM	2.5	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.5
	18319921	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(C(=O)N3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL3704661	=	Ki	nM	1.7	CHEMBL3130	Homo sapiens	Ki(app)	nM	1.7
	18319922	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc(S(=O)(=O)N3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL4167171	=	Ki	nM	1.2	CHEMBL3130	Homo sapiens	Ki(app)	nM	1.2
	18319923	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc([S@@+]([O-])C3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL4175041	=	Ki	nM	0.81	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.81
	18319924	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	CC(C)n1ncnc1-c1cn2c(n1)-c1cc([S@+]([O-])C3CCN(C(C)(C)C)CC3)ccc1OCC2		CHEMBL4170565	=	Ki	nM	12.0	CHEMBL3130	Homo sapiens	Ki(app)	nM	12.0
	18319925	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704698	=	Ki	nM	0.48	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.48
	18319926	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704699	=	Ki	nM	0.88	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.88
	18319927	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704693	=	Ki	nM	0.78	CHEMBL3130	Homo sapiens	Ki(app)	nM	0.78
	18319928	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704696	=	Ki	nM	2.4	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.4
	18319929	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704703	=	Ki	nM	2.8	CHEMBL3130	Homo sapiens	Ki(app)	nM	2.8
	18319930	CHEMBL4134135	Binding affinity to PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704701	=	Ki	nM	1.9	CHEMBL3130	Homo sapiens	Ki(app)	nM	1.9
	18319955	CHEMBL4134139	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(C)cc2OCC3)n(C(C)C)n1		CHEMBL3704698	=	IC50	nM	4.9	CHEMBL3130	Homo sapiens	IC50	nM	4.9
	18319956	CHEMBL4134139	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression	B	Cc1nc(-c2cn3c(n2)-c2cc([C@@H](C)N4CCN(C(C)(C)C)CC4)c(F)cc2OCC3)n(C(C)C)n1		CHEMBL3704693	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	18319957	CHEMBL4134139	Inhibition of PI3Kdelta in human whole blood assessed as suppression of CD69 expression	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704701	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
	18320203	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	18320204	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	18320205	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ccc(N2CCc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4164149	=	IC50	nM	65.0	CHEMBL3130	Homo sapiens	IC50	uM	0.065
	18320206	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ccc(N2CCc3ncnc(-c4cccc(OC5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4163245	=	IC50	nM	83.0	CHEMBL3130	Homo sapiens	IC50	uM	0.083
	18320207	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2ccc(OC)nc2)CC3)C1		CHEMBL4171158	=	IC50	nM	132.0	CHEMBL3130	Homo sapiens	IC50	uM	0.132
	18320208	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	18320209	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	uM	0.076
	18320210	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643407	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	18320211	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643429	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	uM	0.03
	18320212	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643414	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	18320213	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)C1		CHEMBL3643427	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	18320214	CHEMBL4134211	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins by Alexa Fluor647-labelled ADP tracer based TR-FRET assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	uM	0.011
	18320239	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	18320240	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	18320241	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ccc(N2CCc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4164149	=	IC50	nM	2630.0	CHEMBL3130	Homo sapiens	IC50	uM	2.63
	18320242	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ccc(N2CCc3ncnc(-c4cccc(OC5CCN(C(C)=O)CC5)c4)c3C2)cn1		CHEMBL4163245	=	IC50	nM	374.0	CHEMBL3130	Homo sapiens	IC50	uM	0.374
	18320243	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2ccc(OC)nc2)CC3)C1		CHEMBL4171158	=	IC50	nM	5390.0	CHEMBL3130	Homo sapiens	IC50	uM	5.39
	18320244	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	131.0	CHEMBL3130	Homo sapiens	IC50	uM	0.131
	18320245	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	143.0	CHEMBL3130	Homo sapiens	IC50	uM	0.143
	18320246	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643407	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	uM	0.037
	18320247	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643429	=	IC50	nM	358.0	CHEMBL3130	Homo sapiens	IC50	uM	0.358
	18320248	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	COc1ncc(N2CCc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C(F)(F)F		CHEMBL3643414	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	uM	0.053
	18320249	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)C1		CHEMBL3643427	=	IC50	nM	246.0	CHEMBL3130	Homo sapiens	IC50	uM	0.246
	18320250	CHEMBL4134214	Inhibition of recombinant human myristoylated PI3Kdelta catalytic domain expressed in Rat1 cells assessed as reduction in Akt phosphorylation at Ser47 residue after 1 hr by alpha screen Surefire assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	56.0	CHEMBL3130	Homo sapiens	IC50	uM	0.056
	18320276	CHEMBL4134218	Inhibition of PI3Kdelta in human B cells assessed as reduction in anti-IgM-induced AKT phosphorylation at ser473 residue pretreated for 1.5 hrs followed by anti-IgM stimulation after 20 mins by flow cytometric analysis	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	144.0	CHEMBL3130	Homo sapiens	IC50	uM	0.144
	18320277	CHEMBL4134219	Inhibition of PI3Kdelta in 90% human whole blood assessed as reduction in anti-IgM/IL4 stimulated CD86 expression pretreated for 1 hr followed by anti-IgM/IL4 stimulation after 24 hrs by flow cytometric analysis	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	202.0	CHEMBL3130	Homo sapiens	IC50	uM	0.202
	18320278	CHEMBL4134220	Inhibition of PI3Kdelta in 90% human whole blood assessed as reduction in anti-IgM/IL4 stimulated CD69 expression pretreated for 1 hr followed by anti-IgM/IL4 stimulation after 24 hrs by flow cytometric analysis	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	193.0	CHEMBL3130	Homo sapiens	IC50	uM	0.193
	18320281	CHEMBL4134223	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cell proliferation by measuring [3H]thymidine incorporation measured last 16 hrs of 4 days incubation by beta counting based mixed lymphocyte reaction assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	79.0	CHEMBL3130	Homo sapiens	IC50	uM	0.079
	18320282	CHEMBL4134224	Inhibition of PI3Kdelta in anti-CD3 stimulated human PBMC assessed as reduction in cell proliferation by measuring [3H]thymidine incorporation pretreated for 1 hr followed by anti-CD3 addition measured last 16 hrs of 56 hrs incubation by beta counting method	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	159.0	CHEMBL3130	Homo sapiens	IC50	uM	0.159
	18320283	CHEMBL4134225	Inhibition of PI3Kdelta in anti-CD3/CD28 stimulated human PBMC derived CD4-positive T cells assessed as reduction in T cell differentiation to Th2 cells by measuring IL-13 level after 72 hrs by ELISA	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	95.0	CHEMBL3130	Homo sapiens	IC50	uM	0.095
	18320284	CHEMBL4134226	Inhibition of PI3Kdelta in anti-CD3/CD28 stimulated human PBMC derived CD4-positive T cells assessed as reduction in T cell differentiation to Th17 cells by measuring IL-17A level after 72 hrs by ELISA	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	uM	0.073
	18320285	CHEMBL4134227	Inhibition of PI3Kdelta in anti-CD3/CD28 stimulated human PBMC derived CD4-positive T cells assessed as reduction in cell proliferation by measuring [3H]thymidine incorporation by beta counting method	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643413	=	IC50	nM	1150.0	CHEMBL3130	Homo sapiens	IC50	uM	1.15
	18327917	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18327918	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)C1CC1		CHEMBL4172211	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	18327919	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)c1ccccn1		CHEMBL4161596	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18327920	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccccc2)cc2[nH]ncc12)C1CC1		CHEMBL4168859	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	18327921	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)C1CC1		CHEMBL4176717	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	18327922	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4174177	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	18327923	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)C1CC1		CHEMBL4163479	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18327924	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)c1ccccn1		CHEMBL4165288	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	18327925	CHEMBL4135739	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate pretreated for 15 mins followed by substrate addition measured after 1 hr	B	O=C(Nc1cc(-c2ccc3cc[nH]c3c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4175904	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	18333026	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCOc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2F)c1		CHEMBL4164450	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333027	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2F)c1		CHEMBL4175737	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333028	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(Cl)c(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4167878	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333029	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(COC(=O)C(C)(C)C)c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4174937	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333030	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCOC(=O)CN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4164289	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333031	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)C(C)C		CHEMBL4164720	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333032	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCCN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4172619	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333033	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCN(c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1)S(=O)(=O)c1cc(N2CCOCC2)cnc1OC		CHEMBL4168162	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333034	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(C)c1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4176011	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333035	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)N(C)c1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4176410	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333036	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CN(C)c1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4165802	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333037	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CC(C)N1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4N(C)C)ccn3)c(F)c2)CC1		CHEMBL4161306	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333038	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCNCC3)cc2F)c1		CHEMBL4169235	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333039	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCOCC3)cc2)c1		CHEMBL4173426	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333040	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)c1		CHEMBL4165501	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333041	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCC(C(C)(C)O)CC3)cc2F)c1		CHEMBL4174874	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333042	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCCC3)cc2F)c1.O=CO		CHEMBL4166983	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333043	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3C)cc2F)c1		CHEMBL4171432	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333044	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCC(C)C3)cc2F)c1		CHEMBL4163532	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333045	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COCCN1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4OC)ccn3)c(F)c2)CC1.O=CO		CHEMBL4163118	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333046	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(F)c(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4173828	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333047	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4CCC4)CC3)cc2F)c1.O=CO		CHEMBL4159756	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333048	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4COC4)CC3)cc2F)c1.O=CO.O=CO.O=CO		CHEMBL4170389	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333049	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2F)c1		CHEMBL4170075	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333050	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4COC4)CC3)cc2)c1		CHEMBL4159454	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333051	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2cc(F)c(CN3CCN(C(C)C)CC3)c(F)c2)c1		CHEMBL4175405	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333052	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3)c(F)c2)c1		CHEMBL4164780	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333053	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCCC3)cc2F)c1		CHEMBL4171961	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333054	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	CCC(C)N1CCN(Cc2ccc(-c3cc(NS(=O)(=O)c4cc(N5CCOCC5)cnc4OC)ccn3)cc2)CC1		CHEMBL4161366	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333055	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2c(F)cc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4168604	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333056	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C4CCC4)CC3)cc2)c1		CHEMBL4176468	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333057	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2)c1		CHEMBL4165185	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333058	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2)c1		CHEMBL4173087	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333059	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN(C)C)cc2)c1		CHEMBL4177053	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333060	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2)c1		CHEMBL4169192	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333061	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4175571	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18333062	CHEMBL4136595	Inhibition of GST-tagged PI3Kdelta PH domain (unknown origin) using PIP2 as subtrate after 1 hr in presence of biotin-labeled PIP3 by TR-FRET assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4167702	>=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18402506	CHEMBL4150390	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4166144	=	IC50	nM	0.18	CHEMBL3130	Homo sapiens	IC50	nM	0.18
	18402540	CHEMBL4150412	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4166144	=	Activity	%	2.4	CHEMBL3130	Homo sapiens	Activity	%	2.4
	18402607	CHEMBL4150390	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4176771	=	IC50	nM	0.23	CHEMBL3130	Homo sapiens	IC50	nM	0.23
	18402700	CHEMBL4150390	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1		CHEMBL4166594	=	IC50	nM	0.35	CHEMBL3130	Homo sapiens	IC50	nM	0.35
	18402781	CHEMBL4150390	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate by ADP-Glo assay	B	CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1		CHEMBL4174909	=	IC50	nM	0.37	CHEMBL3130	Homo sapiens	IC50	nM	0.37
	18420342	CHEMBL4153808	Inhibition of human PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system	B	CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1		CHEMBL3960662	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	uM	0.27
	18439931	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4174132	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18439932	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CCC(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4166220	=	IC50	nM	6.8	CHEMBL3130	Homo sapiens	IC50	nM	6.8
	18439933	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170707	=	IC50	nM	25.8	CHEMBL3130	Homo sapiens	IC50	nM	25.8
	18439934	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	COc1ncc(-c2sc(NC(=O)CN)nc2C)cc1NS(=O)(=O)c1ccccc1		CHEMBL4162773	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	18439935	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cnc(O)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4162361	=	IC50	nM	109.4	CHEMBL3130	Homo sapiens	IC50	nM	109.4
	18439936	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ncc(-c2sc(NC(=O)CN)nc2C)cc1NS(=O)(=O)c1ccccc1		CHEMBL4173039	=	IC50	nM	420.4	CHEMBL3130	Homo sapiens	IC50	nM	420.4
	18439937	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4177502	=	IC50	nM	375.9	CHEMBL3130	Homo sapiens	IC50	nM	375.9
	18439938	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)CN)sc1-c1ccc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4169638	=	IC50	nM	2134.0	CHEMBL3130	Homo sapiens	IC50	nM	2134.0
	18439939	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](C)N)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4169244	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	18439940	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@H](C)N)sc1-c1cncc(NS(=O)(=O)c2ccccc2)c1		CHEMBL4161316	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	18439941	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C(C)(C)N)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4175297	=	IC50	nM	53.9	CHEMBL3130	Homo sapiens	IC50	nM	53.9
	18439942	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C2(N)CC2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4164664	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	18439943	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)CO)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4160179	=	IC50	nM	17.4	CHEMBL3130	Homo sapiens	IC50	nM	17.4
	18439944	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)[C@@H](C)O)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4168101	=	IC50	nM	751.0	CHEMBL3130	Homo sapiens	IC50	nM	751.0
	18439945	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4168490	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	18439946	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4176347	=	IC50	nM	11.5	CHEMBL3130	Homo sapiens	IC50	nM	11.5
	18439947	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4171850	=	IC50	nM	5.3	CHEMBL3130	Homo sapiens	IC50	nM	5.3
	18439948	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4161241	=	IC50	nM	135.2	CHEMBL3130	Homo sapiens	IC50	nM	135.2
	18439949	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)C(N)C2CC2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170400	=	IC50	nM	20.5	CHEMBL3130	Homo sapiens	IC50	nM	20.5
	18439950	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)CC(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4159763	=	IC50	nM	8.6	CHEMBL3130	Homo sapiens	IC50	nM	8.6
	18439951	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CCC(C)[C@H](N)C(=O)Nc1nc(C)c(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)s1		CHEMBL4159469	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	18439952	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)Cc2ccccc2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4170084	=	IC50	nM	156.5	CHEMBL3130	Homo sapiens	IC50	nM	156.5
	18439953	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL4162831	=	IC50	nM	87.8	CHEMBL3130	Homo sapiens	IC50	nM	87.8
	18439954	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(C)C)cc2)c1		CHEMBL4173536	=	IC50	nM	25.6	CHEMBL3130	Homo sapiens	IC50	nM	25.6
	18439955	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1		CHEMBL4166285	=	IC50	nM	100.4	CHEMBL3130	Homo sapiens	IC50	nM	100.4
	18439956	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)c1		CHEMBL4176901	=	IC50	nM	291.5	CHEMBL3130	Homo sapiens	IC50	nM	291.5
	18439957	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2c(F)cccc2F)c1		CHEMBL4169697	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
	18439958	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ccccc1S(=O)(=O)Nc1cc(-c2sc(NC(=O)[C@@H](N)C(C)C)nc2C)cnc1Cl		CHEMBL4161766	=	IC50	nM	11.5	CHEMBL3130	Homo sapiens	IC50	nM	11.5
	18439959	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1ccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)cc1		CHEMBL4164334	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	18439960	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	18439961	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2Cl)c1		CHEMBL4160624	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	18439962	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cccc(Cl)c2)c1		CHEMBL4168546	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	18439963	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)cc2)c1		CHEMBL4175738	=	IC50	nM	12.3	CHEMBL3130	Homo sapiens	IC50	nM	12.3
	18439964	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cccc(Cl)c2Cl)c1		CHEMBL4165122	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18439965	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1		CHEMBL4167465	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18439966	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2cc(Cl)ccc2Cl)c1		CHEMBL4175347	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	18439967	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	Cc1nc(NC(=O)[C@@H](N)C(C)C)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1		CHEMBL4164028	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	18439968	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	5.9	CHEMBL3130	Homo sapiens	IC50	nM	5.9
	18439969	CHEMBL4156827	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr in presence of 50 uM ATP by ADP-Glo luminescence assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	15.7	CHEMBL3130	Homo sapiens	IC50	nM	15.7
	18440006	CHEMBL4156841	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Thr308 residues preincubated for 1 hr followed by anti-IgM antibody stimulation and measured after 5 mins by PAGE analysis	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	EC50	nM	4.3	CHEMBL3130	Homo sapiens	EC50	nM	4.3
	18440383	CHEMBL4157207	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	3.6	CHEMBL3130	Homo sapiens	Activity	%	3.6
	18448391	CHEMBL4158784	Inhibition of PI3Kdelta in human THP-1 cells assessed as reduction in M-CSF-stimulated AKT phosphorylation at Thr308 preincubated for 30 mins followed by M-CSF addition for 3 mins by ELISA	B	Cc1ccn2nc([C@H](C)Nc3ncnc(N)c3-c3ccc(O)c(F)c3)n(-c3ccccc3)c(=O)c12		CHEMBL4176794	=	IC50	nM	4.4	CHEMBL3130	Homo sapiens	IC50	nM	4.4
	18448392	CHEMBL4158784	Inhibition of PI3Kdelta in human THP-1 cells assessed as reduction in M-CSF-stimulated AKT phosphorylation at Thr308 preincubated for 30 mins followed by M-CSF addition for 3 mins by ELISA	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cc(NS(C)(=O)=O)cc6[nH]ccc56)c34)n(-c3ccccc3)c(=O)c12		CHEMBL4167561	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	18484339	CHEMBL4185986	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	55.0	CHEMBL3130	Homo sapiens	Activity	%	55.0
	18484823	CHEMBL4185986	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	75.0	CHEMBL3130	Homo sapiens	Activity	%	75.0
	18507931	CHEMBL4190837	Inhibition of PI3Kdelta (unknown origin)	B	Nc1nc2c(s1)CC(n1nc(-c3cc(F)c4[nH]ccc4c3)c3c(N)ncnc31)CC2		CHEMBL4216036	=	IC50	nM	307.0	CHEMBL3130	Homo sapiens	IC50	uM	0.307
	18507932	CHEMBL4190837	Inhibition of PI3Kdelta (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1Cc2ccccc2C1		CHEMBL3964073	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	18507933	CHEMBL4190837	Inhibition of PI3Kdelta (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCc2ccccc21		CHEMBL4211185	=	IC50	nM	155.0	CHEMBL3130	Homo sapiens	IC50	uM	0.155
Not Determined	18507934	CHEMBL4190837	Inhibition of PI3Kdelta (unknown origin)	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4207265		IC50			CHEMBL3130	Homo sapiens	IC50		
	18507958	CHEMBL4190834	Inhibition of PI3Kdelta (unknown origin) at 100 nM	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCc2ccccc2C1		CHEMBL4207265	=	Inhibition	%	52.0	CHEMBL3130	Homo sapiens	INH	%	52.0
	18536363	CHEMBL4196438	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate by ELISA	B	CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cnc1OC		CHEMBL4207750	=	IC50	nM	8672.0	CHEMBL3130	Homo sapiens	IC50	nM	8672.0
	18536364	CHEMBL4196438	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate by ELISA	B	CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4cccc(C(=O)OC)c4)c3c2)cnc1OC		CHEMBL4206585	=	IC50	nM	4364.0	CHEMBL3130	Homo sapiens	IC50	nM	4364.0
Not Determined	18536365	CHEMBL4196438	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		IC50			CHEMBL3130	Homo sapiens	IC50		
	18536366	CHEMBL4196438	Inhibition of PI3K p110delta (unknown origin) using PIP2 as substrate by ELISA	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	78.4	CHEMBL3130	Homo sapiens	IC50	nM	78.4
	18556318	CHEMBL4200473	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate pretreated for 20 mins followed by substrate addition and measured after 80 mins by luminescence assay	B	C[C@H](Nc1c(C(N)=O)nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc12)C1CCOCC1		CHEMBL4217549	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	18556319	CHEMBL4200473	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate pretreated for 20 mins followed by substrate addition and measured after 80 mins by luminescence assay	B	CNC(=O)c1nnc2ccc(-c3ccc(OCCCN(C)C)nc3)cc2c1N[C@@H](C)C1CCOCC1		CHEMBL4218854	=	IC50	nM	730.0	CHEMBL3130	Homo sapiens	IC50	uM	0.73
	18569200	CHEMBL4220374	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by Kinase-Glo luminescence assay	B	COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4226082	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	18569201	CHEMBL4220374	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by Kinase-Glo luminescence assay	B	COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4228946	=	IC50	nM	4.2	CHEMBL3130	Homo sapiens	IC50	nM	4.2
	18573178	CHEMBL4221471	Inhibition of PI3K-delta (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins in presence of [gamma-32P]ATP by radioligand binding assay	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	18573179	CHEMBL4221472	Inhibition of human recombinant PI3K-delta	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	18573355	CHEMBL4221487	Inhibition of PI3K-delta (unknown origin) by cell free biochemical assay	B	Cc1ccccc1-n1c(Cn2cc(-c3ccccc3)nn2)nc2cccc(C)c2c1=O		CHEMBL4229035	=	IC50	nM	5000.0	CHEMBL3130	Homo sapiens	IC50	uM	5.0
	18573356	CHEMBL4221487	Inhibition of PI3K-delta (unknown origin) by cell free biochemical assay	B	COc1ccc(-c2cn(Cc3nc4cccc(C)c4c(=O)n3-c3ccccc3C)nn2)c(C)c1		CHEMBL4228200	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	18573357	CHEMBL4221487	Inhibition of PI3K-delta (unknown origin) by cell free biochemical assay	B	Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1213082	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	nM	160.0
	18578141	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(C)=O)C4)c3c2)cn1		CHEMBL4224931	=	Inhibition	%	79.0	CHEMBL3130	Homo sapiens	INH	%	79.0
	18578142	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cn1		CHEMBL4228563	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	18578143	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCC5)C4)c3c2)cn1		CHEMBL4229019	=	Inhibition	%	98.0	CHEMBL3130	Homo sapiens	INH	%	98.0
	18578144	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCCC5)C4)c3c2)cn1		CHEMBL4225061	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	18578145	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCCCC5)C4)c3c2)cn1		CHEMBL4227461	=	Inhibition	%	85.0	CHEMBL3130	Homo sapiens	INH	%	85.0
	18578146	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cn1		CHEMBL4229081	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	18578147	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)c5ccccc5)C4)c3c2)cn1		CHEMBL4225346	=	Inhibition	%	87.0	CHEMBL3130	Homo sapiens	INH	%	87.0
	18578154	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cc1C(N)=O		CHEMBL4229017	=	Inhibition	%	84.0	CHEMBL3130	Homo sapiens	INH	%	84.0
	18578155	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C(N)=O		CHEMBL4228715	=	Inhibition	%	92.0	CHEMBL3130	Homo sapiens	INH	%	92.0
	18578156	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	O=C(C1CC1)N1CC[C@H](Nc2ncnc3ccc(-c4ccc(OC(F)(F)F)cc4)cc23)C1		CHEMBL4227066	=	Inhibition	%	13.0	CHEMBL3130	Homo sapiens	INH	%	13.0
	18578157	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1[N+](=O)[O-]		CHEMBL4228571	=	Inhibition	%	99.0	CHEMBL3130	Homo sapiens	INH	%	99.0
	18578158	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cc1C#N		CHEMBL4226800	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	18578159	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C#N		CHEMBL4227381	=	Inhibition	%	99.0	CHEMBL3130	Homo sapiens	INH	%	99.0
	18578160	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	CC(C)(C)OC(=O)N1CC[C@H](Nc2ncnc3ccc(-c4cnc(N)nc4)cc23)C1		CHEMBL4226534	=	Inhibition	%	44.0	CHEMBL3130	Homo sapiens	INH	%	44.0
	18578161	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	CC(C)(C)OC(=O)N1CC[C@H](Nc2ncnc3ccc(-c4ccc(N)nc4)cc23)C1		CHEMBL4224825	=	Inhibition	%	17.0	CHEMBL3130	Homo sapiens	INH	%	17.0
	18578162	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1cc(C(N)=O)cc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)c1		CHEMBL4226270	=	Inhibition	%	82.0	CHEMBL3130	Homo sapiens	INH	%	82.0
	18578163	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1C(N)=O		CHEMBL4226860	=	Inhibition	%	74.0	CHEMBL3130	Homo sapiens	INH	%	74.0
	18578164	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	CC(C)(C)OC(=O)N1CC[C@H](Nc2ncnc3ccc(-c4ccc(OC(F)(F)F)cc4)cc23)C1		CHEMBL4226205	=	Inhibition	%	2.0	CHEMBL3130	Homo sapiens	INH	%	2.0
	18578165	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1[N+](=O)[O-]		CHEMBL4227310	=	Inhibition	%	51.0	CHEMBL3130	Homo sapiens	INH	%	51.0
	18578166	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1C#N		CHEMBL4226119	=	Inhibition	%	88.0	CHEMBL3130	Homo sapiens	INH	%	88.0
	18578167	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cn1		CHEMBL4226178	=	Inhibition	%	46.0	CHEMBL3130	Homo sapiens	INH	%	46.0
	18578168	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cn1		CHEMBL4226728	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	18578169	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(S(=O)(=O)C5CC5)C4)c3c2)cn1		CHEMBL4226776	=	Inhibition	%	83.0	CHEMBL3130	Homo sapiens	INH	%	83.0
	18578170	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	C=CC(=O)N1CC[C@H](Nc2ncnc3ccc(-c4ccc(OC)nc4)cc23)C1		CHEMBL4227525	=	Inhibition	%	0.0	CHEMBL3130	Homo sapiens	INH	%	0.0
	18578171	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)Cc5ccccc5)C4)c3c2)cn1		CHEMBL4227992	=	Inhibition	%	79.0	CHEMBL3130	Homo sapiens	INH	%	79.0
	18578172	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)c5ccco5)C4)c3c2)cn1		CHEMBL4226448	=	Inhibition	%	97.0	CHEMBL3130	Homo sapiens	INH	%	97.0
	18578173	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C(C)(C)C)C4)c3c2)cn1		CHEMBL4228694	=	Inhibition	%	79.0	CHEMBL3130	Homo sapiens	INH	%	79.0
	18578174	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)CC(C)(C)C)C4)c3c2)cn1		CHEMBL4225718	=	Inhibition	%	94.0	CHEMBL3130	Homo sapiens	INH	%	94.0
	18578175	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCNC4)c3c2)cn1		CHEMBL4224872	=	Inhibition	%	38.0	CHEMBL3130	Homo sapiens	INH	%	38.0
	18578176	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cn1		CHEMBL4229265	=	Inhibition	%	91.0	CHEMBL3130	Homo sapiens	INH	%	91.0
	18578177	CHEMBL4222369	Inhibition of PI3K p110delta (unknown origin) at 100 nM using lipid substrate after 40 mins by kinase-Glo assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	Inhibition	%	96.0	CHEMBL3130	Homo sapiens	INH	%	96.0
	18578178	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C(N)=O		CHEMBL4228715	=	IC50	nM	7.8	CHEMBL3130	Homo sapiens	IC50	nM	7.8
	18578179	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1[N+](=O)[O-]		CHEMBL4228571	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	nM	3.1
	18578180	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cc1C#N		CHEMBL4226800	=	IC50	nM	5.5	CHEMBL3130	Homo sapiens	IC50	nM	5.5
	18578181	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C#N		CHEMBL4227381	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	18578182	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cc1C#N		CHEMBL4226119	=	IC50	nM	18.7	CHEMBL3130	Homo sapiens	IC50	nM	18.7
	18578183	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(S(=O)(=O)C5CC5)C4)c3c2)cn1		CHEMBL4226776	=	IC50	nM	13.5	CHEMBL3130	Homo sapiens	IC50	nM	13.5
	18578184	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)c5ccco5)C4)c3c2)cn1		CHEMBL4226448	=	IC50	nM	5.5	CHEMBL3130	Homo sapiens	IC50	nM	5.5
	18578185	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)c5ccccc5)C4)c3c2)cn1		CHEMBL4225346	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	18578186	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cn1		CHEMBL4229081	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	18578187	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCCCC5)C4)c3c2)cn1		CHEMBL4227461	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
	18578188	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCCC5)C4)c3c2)cn1		CHEMBL4225061	=	IC50	nM	4.4	CHEMBL3130	Homo sapiens	IC50	nM	4.4
	18578189	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCC5)C4)c3c2)cn1		CHEMBL4229019	=	IC50	nM	5.2	CHEMBL3130	Homo sapiens	IC50	nM	5.2
	18578190	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CC5)C4)c3c2)cn1		CHEMBL4228563	=	IC50	nM	4.5	CHEMBL3130	Homo sapiens	IC50	nM	4.5
	18578191	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)CC(C)(C)C)C4)c3c2)cn1		CHEMBL4225718	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	nM	4.6
	18578192	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	COc1ccc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)OC(C)(C)C)C4)c3c2)cn1		CHEMBL4229265	=	IC50	nM	8.1	CHEMBL3130	Homo sapiens	IC50	nM	8.1
	18578193	CHEMBL4222368	Inhibition of PI3K p110delta (unknown origin) using lipid substrate after 40 mins by kinase-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	18578194	CHEMBL4222367	Inhibition of PI3Kdelta (unknown origin)	B	NC(=O)c1cc(-c2ccc3ncnc(-c4cccc(C(=O)NCCN5CCOCC5)c4)c3c2)ccc1Cl		CHEMBL4229214	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	18578195	CHEMBL4222367	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	18580279	CHEMBL4222679	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	uM	0.007
	18580306	CHEMBL4222700	Inhibition of PI3Kdelta (unknown origin) at 1 uM	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	Inhibition	%	70.0	CHEMBL3130	Homo sapiens	INH	%	70.0
	18585725	CHEMBL4223397	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol as substrate after 90 mins by scintillation proximity assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	18655349	CHEMBL4230886	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	18658738	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3ccccc3C)c3ncnc(N)c23)cn1		CHEMBL4241373	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	18658739	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4cc(O)ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4251492	=	IC50	nM	227.0	CHEMBL3130	Homo sapiens	IC50	nM	227.0
	18658740	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cnc4ccccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4246053	=	IC50	nM	86.0	CHEMBL3130	Homo sapiens	IC50	nM	86.0
	18658741	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4[nH]ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4250311	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	18658742	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3ccccc3C)c3ncnc(N)c23)cc1OC		CHEMBL4249850	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	18658743	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4239740	=	IC50	nM	106.0	CHEMBL3130	Homo sapiens	IC50	nM	106.0
Not Determined	18658744	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(OC(F)(F)F)c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4239308		IC50			CHEMBL3130	Homo sapiens	IC50		
	18658745	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3c(C)cccc3C)c3ncnc(N)c23)cn1		CHEMBL4243529	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
	18658746	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4cc(O)ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4243064	=	IC50	nM	416.0	CHEMBL3130	Homo sapiens	IC50	nM	416.0
	18658747	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3cnc4ccccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4250842	=	IC50	nM	81.0	CHEMBL3130	Homo sapiens	IC50	nM	81.0
	18658748	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4[nH]ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4245221	=	IC50	nM	8.6	CHEMBL3130	Homo sapiens	IC50	nM	8.6
	18658749	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3c(C)cccc3C)c3ncnc(N)c23)cc1OC		CHEMBL4249477	=	IC50	nM	8.4	CHEMBL3130	Homo sapiens	IC50	nM	8.4
	18658750	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4238027	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	nM	84.0
Not Determined	18658751	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3cccc(OC(F)(F)F)c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4248031		IC50			CHEMBL3130	Homo sapiens	IC50		
	18658752	CHEMBL4231676	Inhibition of PI3Kdelta (unknown origin) using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	1.6	CHEMBL3130	Homo sapiens	IC50	nM	1.6
	18658753	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3ccccc3C)c3ncnc(N)c23)cn1		CHEMBL4241373	=	Inhibition	%	92.68	CHEMBL3130	Homo sapiens	INH	%	92.68
	18658754	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4cc(O)ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4251492	=	Inhibition	%	73.02	CHEMBL3130	Homo sapiens	INH	%	73.02
	18658755	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cnc4ccccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4246053	=	Inhibition	%	89.99	CHEMBL3130	Homo sapiens	INH	%	89.99
	18658756	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4[nH]ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4250311	=	Inhibition	%	94.66	CHEMBL3130	Homo sapiens	INH	%	94.66
	18658757	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3ccccc3C)c3ncnc(N)c23)cc1OC		CHEMBL4249850	=	Inhibition	%	90.78	CHEMBL3130	Homo sapiens	INH	%	90.78
	18658758	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4239740	=	Inhibition	%	89.56	CHEMBL3130	Homo sapiens	INH	%	89.56
	18658759	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(OC(F)(F)F)c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4239308	=	Inhibition	%	70.83	CHEMBL3130	Homo sapiens	INH	%	70.83
	18658760	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3c(C)cccc3C)c3ncnc(N)c23)cn1		CHEMBL4243529	=	Inhibition	%	94.7	CHEMBL3130	Homo sapiens	INH	%	94.7
	18658761	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4cc(O)ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4243064	=	Inhibition	%	77.29	CHEMBL3130	Homo sapiens	INH	%	77.29
	18658762	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3cnc4ccccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4250842	=	Inhibition	%	91.96	CHEMBL3130	Homo sapiens	INH	%	91.96
	18658763	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4[nH]ccc4c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4245221	=	Inhibition	%	96.85	CHEMBL3130	Homo sapiens	INH	%	96.85
	18658764	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	COc1ccc(-c2nn(Cc3nc4cccc(F)c4c(=O)n3-c3c(C)cccc3C)c3ncnc(N)c23)cc1OC		CHEMBL4249477	=	Inhibition	%	96.77	CHEMBL3130	Homo sapiens	INH	%	96.77
	18658765	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4238027	=	Inhibition	%	89.14	CHEMBL3130	Homo sapiens	INH	%	89.14
	18658766	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	Cc1cccc(C)c1-n1c(Cn2nc(-c3cccc(OC(F)(F)F)c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4248031	=	Inhibition	%	29.56	CHEMBL3130	Homo sapiens	INH	%	29.56
	18658767	CHEMBL4231677	Inhibition of PI3Kdelta (unknown origin) at 1 uM using Biotin-S11S12 as substrate after 120 mins in presence of ATP by ADPGlo luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	Inhibition	%	91.91	CHEMBL3130	Homo sapiens	INH	%	91.91
	18664632	CHEMBL4233133	Inhibition of recombinant human PI3K-delta using PIP2:3PS as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by ADP-Glo assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	78.4	CHEMBL3130	Homo sapiens	IC50	nM	78.4
	18664633	CHEMBL4233133	Inhibition of recombinant human PI3K-delta using PIP2:3PS as substrate preincubated for 15 mins followed by ATP addition measured after 1 hr by ADP-Glo assay	B	COc1ncc(-c2ccc3c(c2)N(CCCN2CCOCC2)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4251210	=	IC50	nM	425.2	CHEMBL3130	Homo sapiens	IC50	nM	425.2
	18673663	CHEMBL4235177	Inhibition of PI3Kdelta (unknown origin)	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	18694018	CHEMBL4253471	Inhibition of PI3K delta (unknown origin) at 0.1 uM by ADP-Glo assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	2.0	CHEMBL3130	Homo sapiens	INH	%	2.0
	18694100	CHEMBL4253553	Inhibition of PI3K delta (unknown origin) at 1 uM by ADP-Glo assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	14.0	CHEMBL3130	Homo sapiens	INH	%	14.0
	18752138	CHEMBL4264475	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	85.0	CHEMBL3130	Homo sapiens	Activity	%	85.0
	18769610	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cccc(OC)c1/C=C/C(=O)c1c(OC)cccc1OC		CHEMBL260655	=	Activity	%	94.0	CHEMBL3130	Homo sapiens	Activity	%	94.0
	18769611	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1ccc(C(=O)/C=C/c2c(OC)cc(OC)cc2OC)c(O)c1		CHEMBL259655	=	Activity	%	95.0	CHEMBL3130	Homo sapiens	Activity	%	95.0
	18769612	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1		CHEMBL260867	=	Activity	%	92.0	CHEMBL3130	Homo sapiens	Activity	%	92.0
	18769613	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cccc(/C=C/C(=O)c2c(OC)cccc2OC)c1		CHEMBL259698	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	18769614	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cccc2OC)c(OC)c1		CHEMBL260216	=	Activity	%	78.0	CHEMBL3130	Homo sapiens	Activity	%	78.0
	18769615	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)cc2OC)c(OC)c1		CHEMBL429864	=	Activity	%	67.0	CHEMBL3130	Homo sapiens	Activity	%	67.0
	18769616	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2ccc(OC)c(OC)c2)c(OC)c1		CHEMBL4278257	=	Activity	%	91.0	CHEMBL3130	Homo sapiens	Activity	%	91.0
	18769617	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cccc(OC)c1C(=O)/C=C/c1ccc(C(F)(F)F)cc1		CHEMBL260426	=	Activity	%	64.0	CHEMBL3130	Homo sapiens	Activity	%	64.0
	18769618	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(N)cc2OC)c(OC)c1		CHEMBL261210	=	Activity	%	63.0	CHEMBL3130	Homo sapiens	Activity	%	63.0
	18769619	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1ccc(C(=O)/C=C/c2c(OC)cc(OC)cc2OC)c(OC)c1		CHEMBL406122	=	Activity	%	76.0	CHEMBL3130	Homo sapiens	Activity	%	76.0
	18769620	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(O)c(C(=O)/C=C/c2c(OC)cccc2OC)c(OC)c1		CHEMBL260654	=	Activity	%	81.0	CHEMBL3130	Homo sapiens	Activity	%	81.0
	18769621	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2ccc(OC)c(O)c2)c(OC)c1		CHEMBL4289440	=	Activity	%	40.0	CHEMBL3130	Homo sapiens	Activity	%	40.0
	18769622	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(OC)c1		CHEMBL2335481	=	Activity	%	53.0	CHEMBL3130	Homo sapiens	Activity	%	53.0
	18769623	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2ccccc2OC)c(OC)c1		CHEMBL32584	=	Activity	%	48.0	CHEMBL3130	Homo sapiens	Activity	%	48.0
	18769624	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(OC)cc1/C=C/C(=O)c1cc(OC)c(OC)cc1OC		CHEMBL459334	=	Activity	%	66.0	CHEMBL3130	Homo sapiens	Activity	%	66.0
	18769625	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)cc2OC)cc1O		CHEMBL4282639	=	Activity	%	49.0	CHEMBL3130	Homo sapiens	Activity	%	49.0
	18769626	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1ccccc1/C=C/C(=O)c1cc(OC)c(OC)cc1OC		CHEMBL498860	=	Activity	%	55.0	CHEMBL3130	Homo sapiens	Activity	%	55.0
	18769627	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1		CHEMBL4287949	=	Activity	%	2.0	CHEMBL3130	Homo sapiens	Activity	%	2.0
	18769628	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cccc(OC)c1/C=C/C(=O)c1c(OC)cc(OC)c(C2CCN(C)CC2)c1O		CHEMBL4279485	=	Activity	%	4.0	CHEMBL3130	Homo sapiens	Activity	%	4.0
	18769629	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(C2CCN(C)CC2)c(O)c1C(=O)/C=C/c1c(Cl)cccc1Cl		CHEMBL4287396	=	Activity	%	6.0	CHEMBL3130	Homo sapiens	Activity	%	6.0
Not Active	18769630	CHEMBL4267978	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD63 expression level at 100 uM by flow cast assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1.Cl		CHEMBL4294204		Activity			CHEMBL3130	Homo sapiens	Activity		
	18769631	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cccc(OC)c1/C=C/C(=O)c1c(OC)cccc1OC		CHEMBL260655	=	Activity	%	96.0	CHEMBL3130	Homo sapiens	Activity	%	96.0
	18769632	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1ccc(C(=O)/C=C/c2c(OC)cc(OC)cc2OC)c(O)c1		CHEMBL259655	=	Activity	%	91.0	CHEMBL3130	Homo sapiens	Activity	%	91.0
	18769633	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1		CHEMBL260867	=	Activity	%	93.0	CHEMBL3130	Homo sapiens	Activity	%	93.0
	18769634	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cccc(/C=C/C(=O)c2c(OC)cccc2OC)c1		CHEMBL259698	=	Activity	%	82.0	CHEMBL3130	Homo sapiens	Activity	%	82.0
	18769635	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cccc2OC)c(OC)c1		CHEMBL260216	=	Activity	%	81.0	CHEMBL3130	Homo sapiens	Activity	%	81.0
	18769636	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)cc2OC)c(OC)c1		CHEMBL429864	=	Activity	%	68.0	CHEMBL3130	Homo sapiens	Activity	%	68.0
	18769637	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2ccc(OC)c(OC)c2)c(OC)c1		CHEMBL4278257	=	Activity	%	95.0	CHEMBL3130	Homo sapiens	Activity	%	95.0
	18769638	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cccc(OC)c1C(=O)/C=C/c1ccc(C(F)(F)F)cc1		CHEMBL260426	=	Activity	%	81.0	CHEMBL3130	Homo sapiens	Activity	%	81.0
	18769639	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(N)cc2OC)c(OC)c1		CHEMBL261210	=	Activity	%	75.0	CHEMBL3130	Homo sapiens	Activity	%	75.0
	18769640	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1ccc(C(=O)/C=C/c2c(OC)cc(OC)cc2OC)c(OC)c1		CHEMBL406122	=	Activity	%	86.0	CHEMBL3130	Homo sapiens	Activity	%	86.0
	18769641	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(O)c(C(=O)/C=C/c2c(OC)cccc2OC)c(OC)c1		CHEMBL260654	=	Activity	%	85.0	CHEMBL3130	Homo sapiens	Activity	%	85.0
	18769642	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2ccc(OC)c(O)c2)c(OC)c1		CHEMBL4289440	=	Activity	%	54.0	CHEMBL3130	Homo sapiens	Activity	%	54.0
	18769643	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(OC)c1		CHEMBL2335481	=	Activity	%	51.0	CHEMBL3130	Homo sapiens	Activity	%	51.0
	18769644	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(C(=O)/C=C/c2ccccc2OC)c(OC)c1		CHEMBL32584	=	Activity	%	65.0	CHEMBL3130	Homo sapiens	Activity	%	65.0
	18769645	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(OC)cc1/C=C/C(=O)c1cc(OC)c(OC)cc1OC		CHEMBL459334	=	Activity	%	70.0	CHEMBL3130	Homo sapiens	Activity	%	70.0
	18769646	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)cc2OC)cc1O		CHEMBL4282639	=	Activity	%	62.0	CHEMBL3130	Homo sapiens	Activity	%	62.0
	18769647	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1ccccc1/C=C/C(=O)c1cc(OC)c(OC)cc1OC		CHEMBL498860	=	Activity	%	65.0	CHEMBL3130	Homo sapiens	Activity	%	65.0
	18769648	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1		CHEMBL4287949	=	Activity	%	7.0	CHEMBL3130	Homo sapiens	Activity	%	7.0
	18769649	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cccc(OC)c1/C=C/C(=O)c1c(OC)cc(OC)c(C2CCN(C)CC2)c1O		CHEMBL4279485	=	Activity	%	41.0	CHEMBL3130	Homo sapiens	Activity	%	41.0
	18769650	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(C2CCN(C)CC2)c(O)c1C(=O)/C=C/c1c(Cl)cccc1Cl		CHEMBL4287396	=	Activity	%	24.0	CHEMBL3130	Homo sapiens	Activity	%	24.0
Not Active	18769651	CHEMBL4267979	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring CD203c expression level at 100 uM by fluorescence assay relative to control	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1.Cl		CHEMBL4294204		Activity			CHEMBL3130	Homo sapiens	Activity		
Dose-dependent effect	18769679	CHEMBL4267999	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by measuring decrease in CD63 expression level by flow cast assay	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1		CHEMBL4287949		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	18769680	CHEMBL4268000	Inhibition of PI3Kdelta in human basophils assessed as reduction in IgE-induced degranulation by decrease in measuring CD203c expression level by fluorescence assay	B	COc1cc(OC)c(/C=C/C(=O)c2c(OC)cc(OC)c(C3CCN(C)CC3)c2O)c(OC)c1		CHEMBL4287949		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	18771140	CHEMBL4268354	Inhibition of PI3Kdelta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	Oc1ccc(-c2n[nH]cc2-c2ccc(Cl)c(Cl)c2)c(O)c1O		CHEMBL4280001	=	EC50	nM	19100.0	CHEMBL3130	Homo sapiens	EC50	uM	19.1
	18771181	CHEMBL4268354	Inhibition of PI3Kdelta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	EC50	nM	10.0	CHEMBL3130	Homo sapiens	EC50	uM	0.01
	18771194	CHEMBL4268354	Inhibition of PI3Kdelta (unknown origin) after 40 mins by kinase-Glo reagent based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	EC50	nM	93.0	CHEMBL3130	Homo sapiens	EC50	uM	0.093
	18780183	CHEMBL4269918	Binding affinity to human PI3Kdelta after 1 hr by KINOMEscan assay	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Kd	nM	5.5	CHEMBL3130	Homo sapiens	Kd	nM	5.5
	18780184	CHEMBL4269918	Binding affinity to human PI3Kdelta after 1 hr by KINOMEscan assay	B	CO/C=C/C(=O)c1cc2c3c(c(N)cc(NC(=O)C(C)C)c3n1)N=C2		CHEMBL4293970	=	Kd	nM	4.9	CHEMBL3130	Homo sapiens	Kd	nM	4.9
	18797215	CHEMBL4273928	Inhibition of PI3K-delta (unknown origin) after 40 mins by Kinase-Glo assay	A	Fc1ccccc1-c1cc2nc(-c3ccco3)c(-c3ccco3)nc2cc1Br		CHEMBL4291904	=	EC50	nM	15670.0	CHEMBL3130	Homo sapiens	EC50	uM	15.67
	18797216	CHEMBL4273928	Inhibition of PI3K-delta (unknown origin) after 40 mins by Kinase-Glo assay	A	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	EC50	nM	10.0	CHEMBL3130	Homo sapiens	EC50	uM	0.01
	18797217	CHEMBL4273928	Inhibition of PI3K-delta (unknown origin) after 40 mins by Kinase-Glo assay	A	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	EC50	nM	93.0	CHEMBL3130	Homo sapiens	EC50	uM	0.093
	18813249	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1		CHEMBL4286698	=	Kd	nM	23000.0	CHEMBL3130	Homo sapiens	Kd	nM	23000.0
	18813250	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	=	Kd	nM	30.0	CHEMBL3130	Homo sapiens	Kd	nM	30.0
	18813251	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CCC(CC)n1cnc2c(-c3cnc(N)cn3)nc(N3CC4CCC(C3)O4)nc21		CHEMBL4279703	>	Kd	nM	30000.0	CHEMBL3130	Homo sapiens	Kd	nM	30000.0
	18813252	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	31.0	CHEMBL3130	Homo sapiens	Kd	nM	31.0
	18813253	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CO[C@H]1CC[C@H](N2C(=O)CNc3ncc(-c4ccc(C(C)(C)O)nc4)nc32)CC1		CHEMBL3586404	=	Kd	nM	6200.0	CHEMBL3130	Homo sapiens	Kd	nM	6200.0
	18813254	CHEMBL4276432	Inhibition of human PI3Kdelta (108 to 1044 residues) expressed in mammalian expression system by KINOMEscan assay	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	=	Kd	nM	1500.0	CHEMBL3130	Homo sapiens	Kd	nM	1500.0
	18851042	CHEMBL4305780	Inhibition of PI3K delta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCOCC4)c3c2)cc1NS(C)(=O)=O		CHEMBL4439145	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
	18851043	CHEMBL4305780	Inhibition of PI3K delta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(C)=O)C4)c3c2)cc1NS(C)(=O)=O		CHEMBL4449091	=	IC50	nM	6.8	CHEMBL3130	Homo sapiens	IC50	nM	6.8
	18851044	CHEMBL4305780	Inhibition of PI3K delta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1NS(C)(=O)=O		CHEMBL4542688	=	IC50	nM	7.4	CHEMBL3130	Homo sapiens	IC50	nM	7.4
	18851045	CHEMBL4305780	Inhibition of PI3K delta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	204.0	CHEMBL3130	Homo sapiens	IC50	nM	204.0
	18851046	CHEMBL4305780	Inhibition of PI3K delta (unknown origin) using lipid substrate measured after 40 mins in presence of ATP by Kinase-Glo plus reagent based luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	3.1	CHEMBL3130	Homo sapiens	IC50	nM	3.1
	18858139	CHEMBL4307985	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	78.0	CHEMBL3130	Homo sapiens	Activity	%	78.0
	18861677	CHEMBL4308989	Inhibition of PI3K delta (unknown origin) after 60 mins by ADP-Glo assay	B	Cc1nc(NC(=O)CN)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)c1		CHEMBL4447963	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	18861729	CHEMBL4308958	Inhibition of PI3K p110delta (unknown origin)	B	CC(C)C(=O)CN1c2nc(N3CCOC[C@H]3C)cc(=O)n2CC[C@H]1C(F)(F)F		CHEMBL4586628	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	18861730	CHEMBL4308958	Inhibition of PI3K p110delta (unknown origin)	B	CS(=O)(=O)O.CS(=O)(=O)O.O.O.c1cnc2ccc(Nc3nc(NC4CC4)c4nc[nH]c4n3)cc2c1		CHEMBL4545915	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	nM	2.8
	18861744	CHEMBL4308953	Inhibition of wild type human PI3K p110delta using PIP2 as substrate by TR-FRET assay	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
	18883689	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc(N3CCOCC3)n2)c1		CHEMBL4559414	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	18883690	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	C[C@H]1COCCN1c1ccnc(-c2cccc(O)c2)n1		CHEMBL4442844	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18883691	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc(C3=CCOCC3)n2)c1		CHEMBL4566726	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	18883692	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc(C3CCOCC3)n2)c1		CHEMBL4457633	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	18883693	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc(C34CCOCC3C4)n2)c1		CHEMBL4553989	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	18883694	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc([C@@]34CCOC[C@@H]3C4)n2)c1		CHEMBL4569401	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	18883695	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	Oc1cccc(-c2nccc([C@]34CCOC[C@H]3C4)n2)c1		CHEMBL4567602	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	18883696	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc(N3CCOCC3)n2)cc1		CHEMBL4526968	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18883697	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc(N3CCOC[C@@H]3C)n2)cc1		CHEMBL4476698	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	18883698	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc(C3=CCOCC3)n2)cc1		CHEMBL4563252	=	IC50	nM	15848.93	CHEMBL3130	Homo sapiens	pIC50		4.8
	18883699	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc(C34CCOCC3C4)n2)cc1		CHEMBL4520553	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	18883700	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc([C@@]34CCOC[C@@H]3C4)n2)cc1		CHEMBL4529541	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18883701	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nccc([C@]34CCOC[C@H]3C4)n2)cc1		CHEMBL4444931	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18883702	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	C[C@H]1COCCN1c1cc(CS(C)(=O)=O)nc(-c2cccc(O)c2)n1		CHEMBL4436156	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18883703	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CS(=O)(=O)Cc1cc(C2=CCOCC2)nc(-c2cccc(O)c2)n1		CHEMBL4591800	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	18883704	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CS(=O)(=O)Cc1cc([C@@]23CCOC[C@@H]2C3)nc(-c2cccc(O)c2)n1		CHEMBL4455107	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	18883705	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CS(=O)(=O)Cc1cc([C@]23CCOC[C@H]2C3)nc(-c2cccc(O)c2)n1		CHEMBL4585940	=	IC50	nM	15848.93	CHEMBL3130	Homo sapiens	pIC50		4.8
	18883706	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	C[C@H]1COCCN1c1cc(C(C)(C)S(C)(=O)=O)nc(-c2cccc(O)c2)n1		CHEMBL4529162	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	18883707	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CC(C)(c1cc([C@@]23CCOC[C@@H]2C3)nc(-c2cccc(O)c2)n1)S(C)(=O)=O		CHEMBL4522844	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	18883708	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CC(C)(c1cc([C@]23CCOC[C@H]2C3)nc(-c2cccc(O)c2)n1)S(C)(=O)=O		CHEMBL4472452	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	pIC50		5.0
	18883709	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc(N3CCOCC3)n2)cc1		CHEMBL3410675	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	18883710	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc(N3CCOC[C@@H]3C)n2)cc1		CHEMBL3410542	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	18883711	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc([C@@]34CCOC[C@@H]3C4)n2)cc1		CHEMBL4528454	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18883712	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc([C@]34CCOC[C@H]3C4)n2)cc1		CHEMBL4518889	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	18883713	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)cc(C(C)(C)S(C)(=O)=O)n2)cc1		CHEMBL4585887	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	18883714	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(C(C)(C)S(C)(=O)=O)cc([C@@]34CCOC[C@@H]3C4)n2)cc1		CHEMBL4561361	=	IC50	nM	15848.93	CHEMBL3130	Homo sapiens	pIC50		4.8
	18883715	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CCNC(=O)Nc1ccc(-c2nc(C(C)(C)S(C)(=O)=O)cc([C@]34CCOC[C@H]3C4)n2)cc1		CHEMBL4525912	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18883716	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc(N3CCOC[C@@H]3C)n2)cc1		CHEMBL4442262	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	18883717	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc([C@@]34CCOC[C@@H]3C4)n2)cc1		CHEMBL4576265	=	IC50	nM	15848.93	CHEMBL3130	Homo sapiens	pIC50		4.8
	18883718	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(CS(C)(=O)=O)cc([C@]34CCOC[C@H]3C4)n2)cc1		CHEMBL4585467	<	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	18883719	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(N3CCOC[C@@H]3C)cc(C(C)(C)S(C)(=O)=O)n2)cc1		CHEMBL4434739	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	18883720	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(C(C)(C)S(C)(=O)=O)cc([C@@]34CCOC[C@@H]3C4)n2)cc1		CHEMBL4441996	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	18883721	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CNCC(=O)Nc1ccc(-c2nc(C(C)(C)S(C)(=O)=O)cc([C@]34CCOC[C@H]3C4)n2)cc1		CHEMBL4593323	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	18883888	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	C[C@H]1COCCN1c1cc(C(C)(C)S(C)(=O)=O)nc(-c2ccc(NC(=S)NCCO)cc2)n1		CHEMBL3410664	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	18883889	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CC(C)(c1cc([C@@]23CCOC[C@@H]2C3)nc(-c2ccc(NC(=S)NCCO)cc2)n1)S(C)(=O)=O		CHEMBL4571609	=	IC50	nM	25118.86	CHEMBL3130	Homo sapiens	pIC50		4.6
	18883890	CHEMBL4312769	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition and measured after 1 hr by HTRF assay	B	CC(C)(c1cc([C@]23CCOC[C@H]2C3)nc(-c2ccc(NC(=S)NCCO)cc2)n1)S(C)(=O)=O		CHEMBL4439590	=	IC50	nM	31622.78	CHEMBL3130	Homo sapiens	pIC50		4.5
	18916434	CHEMBL4322150	Inhibition of PIK3CD (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	18918191	CHEMBL4322506	Binding affinity to human wild-type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2ccc(N)nc2)nc2c1C[C@@H]1COCCN21		CHEMBL4594206	=	Kd	nM	6200.0	CHEMBL3130	Homo sapiens	Kd	nM	6200.0
	18918192	CHEMBL4322506	Binding affinity to human wild-type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)nc2)nc2c1C[C@@H]1COCCN21		CHEMBL4436124	=	Kd	nM	1900.0	CHEMBL3130	Homo sapiens	Kd	nM	1900.0
	18918193	CHEMBL4322506	Binding affinity to human wild-type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by kinome scan assay	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)cn2)nc2c1C[C@@H]1COCCN21		CHEMBL4551080	=	Kd	nM	12000.0	CHEMBL3130	Homo sapiens	Kd	nM	12000.0
	18918194	CHEMBL4322506	Binding affinity to human wild-type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1		CHEMBL4286698	=	Kd	nM	23000.0	CHEMBL3130	Homo sapiens	Kd	nM	23000.0
	18929484	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CC4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4521097	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	18929485	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)C[C@H]4C[C@H](C)O[C@H](C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4467351	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18929486	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4C[C@H](C)O[C@H](C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4554783	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18929487	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(C(=O)NC[C@@H]4C[C@H](C)O[C@H](C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561182	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18929488	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(CC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4588903	=	IC50	nM	19952.62	CHEMBL3130	Homo sapiens	pIC50		4.7
	18929489	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(CCCN3C[C@H](C)O[C@H](C)C3)c3c(c2)COC3)cc1NS(C)(=O)=O		CHEMBL4457454	=	IC50	nM	5011.87	CHEMBL3130	Homo sapiens	pIC50		5.3
	18929490	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4472815	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	18929491	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4C[C@H](C)O[C@H](C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4453668	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	18929492	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)C4CCCN(C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4522200	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	18929493	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCC4CCCN(C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4444082	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	18929494	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCC4CCCN(C)C4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4444082	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	18929495	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OC[C@@H]4CN(C)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4518196	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18929496	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OC[C@H]4CN(C)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4519361	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	18929497	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCN(C)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4467361	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	18929498	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCN(C(C)C)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4582886	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	18929499	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4466729	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	18929500	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NCCN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4445958	=	IC50	nM	1995.26	CHEMBL3130	Homo sapiens	pIC50		5.7
	18929501	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4556087	=	IC50	nM	31.62	CHEMBL3130	Homo sapiens	pIC50		7.5
	18929502	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(OCCN3CCC(C(C)(C)O)CC3)c3c(c2Cl)COC3)cc1NS(C)(=O)=O		CHEMBL4571612	<	IC50	nM	39810.72	CHEMBL3130	Homo sapiens	pIC50		4.4
	18929503	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(OCCN3CCC(C(C)(C)O)CC3)c3c(c2F)COC3)cc1NS(C)(=O)=O		CHEMBL4580436	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	18929504	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2F)COC3)cc1NS(C)(=O)=O		CHEMBL4560410	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18929505	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)n2)COC3)cc1NS(C)(=O)=O		CHEMBL4472036	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	18929506	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(OC[C@H]3CN(C)CCO3)c3c(n2)COC3)cc1NS(C)(=O)=O		CHEMBL4444773	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	18929507	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(OCCN3CCC(C(C)(C)O)CC3)c3c(c2)[C@@H](C)OC3)cc1NS(C)(=O)=O		CHEMBL4567736	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	18929508	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(=O)(=O)CC#N		CHEMBL4462123	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	18929509	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4538635	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	18929510	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H](C)N4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4561242	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	18929511	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@@H](C)N4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4449047	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	18929512	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(O[C@@H](C)CN4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4447804	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	18929513	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(O[C@H](C)CN4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4521647	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	18929514	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)CCOC3)cc1NS(C)(=O)=O		CHEMBL4466265	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	18929515	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)CCOC3)cnc1OC		CHEMBL4545906	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	18929516	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OC[C@H]4CN(CC(C)(C)O)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4518946	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	18929517	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(CC(C)(C)O)CCO4)c2)COC3)cnc1OC		CHEMBL4553962	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	18929518	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCN1CCO[C@@H](COc2cc(-c3cnc(OC)c(NS(C)(=O)=O)c3)cc3c2COC3)C1		CHEMBL4533741	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	18929519	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C(C)C)CCO4)c2)COC3)cnc1OC		CHEMBL4580593	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	18929520	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5CCC5)CCO4)c2)COC3)cnc1OC		CHEMBL4436659	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	18929521	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4436797	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	18929522	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4448491	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	18929523	CHEMBL4325264	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4579923	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	18929582	CHEMBL4325290	Binding affinity to PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4556087	=	Kd	nM	0.2512	CHEMBL3130	Homo sapiens	pKd(app)		9.6
	18929583	CHEMBL4325290	Binding affinity to PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4579923	=	Kd	nM	0.1995	CHEMBL3130	Homo sapiens	pKd(app)		9.7
	18929588	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H](C)N4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4561242	=	IC50	nM	5.012	CHEMBL3130	Homo sapiens	pIC50		8.3
	18929589	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@@H](C)N4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4449047	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	18929590	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(O[C@@H](C)CN4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4447804	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
Not Determined	18929591	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(O[C@H](C)CN4CCC(C(C)(C)O)CC4)c2)COC3)cnc1OC		CHEMBL4521647		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18929592	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COc1ncc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)CCOC3)cc1NS(C)(=O)=O		CHEMBL4466265	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
Not Determined	18929593	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OCCN4CCC(C(C)(C)O)CC4)c2)CCOC3)cnc1OC		CHEMBL4545906		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18929594	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COc1ncc(-c2cc3c(c(OC[C@H]4CN(CC(C)(C)O)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4518946	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
Not Determined	18929595	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(CC(C)(C)O)CCO4)c2)COC3)cnc1OC		CHEMBL4553962		pIC50			CHEMBL3130	Homo sapiens	pIC50		
Not Determined	18929596	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCN1CCO[C@@H](COc2cc(-c3cnc(OC)c(NS(C)(=O)=O)c3)cc3c2COC3)C1		CHEMBL4533741		pIC50			CHEMBL3130	Homo sapiens	pIC50		
Not Determined	18929597	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C(C)C)CCO4)c2)COC3)cnc1OC		CHEMBL4580593		pIC50			CHEMBL3130	Homo sapiens	pIC50		
Not Determined	18929598	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5CCC5)CCO4)c2)COC3)cnc1OC		CHEMBL4436659		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18929599	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COc1ncc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4436797	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
Not Determined	18929600	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4448491		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	18929601	CHEMBL4325293	Inhibition of PI3Kdelta in human HL60 cell extract measured after 2 hrs by kinobeads based pull down assay	B	COCCS(=O)(=O)Nc1cc(-c2cc3c(c(OC[C@H]4CN(C5COC5)CCO4)c2)COC3)cnc1OC		CHEMBL4579923	=	IC50	nM	5.012	CHEMBL3130	Homo sapiens	pIC50		8.3
	18952532	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	18952533	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1		CHEMBL568150	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	18952534	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	IC50	nM	235.0	CHEMBL3130	Homo sapiens	IC50	nM	235.0
	18952535	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1		CHEMBL3984425	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	18952536	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	Fc1ccc2[nH]ccc2c1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC4CC4)CC3)cc2n1		CHEMBL4450504	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	18952537	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	Cc1csc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL2216863	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	18952538	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3948730	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
	18952539	CHEMBL4331745	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	18958621	CHEMBL4333570	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	78.0	CHEMBL3130	Homo sapiens	Activity	%	78.0
	18994009	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccccc3)cc12		CHEMBL4532366	=	IC50	nM	56190.0	CHEMBL3130	Homo sapiens	IC50	uM	56.19
	18994010	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4520000	=	IC50	nM	23680.0	CHEMBL3130	Homo sapiens	IC50	uM	23.68
	18994011	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	COc1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4573905	=	IC50	nM	44740.0	CHEMBL3130	Homo sapiens	IC50	uM	44.74
	18994012	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	CC(C)(C)c1ccc(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)cc1		CHEMBL4518471	=	IC50	nM	23680.0	CHEMBL3130	Homo sapiens	IC50	uM	23.68
	18994013	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(F)cc3)cc12		CHEMBL4581364	=	IC50	nM	67810.0	CHEMBL3130	Homo sapiens	IC50	uM	67.81
	18994014	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Cl)cc3)cc12		CHEMBL4451925	=	IC50	nM	38160.0	CHEMBL3130	Homo sapiens	IC50	uM	38.16
	18994015	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Br)cc3)cc12		CHEMBL4586115	=	IC50	nM	47920.0	CHEMBL3130	Homo sapiens	IC50	uM	47.92
	18994016	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccccc3[N+](=O)[O-])cc12		CHEMBL4536655	=	IC50	nM	28610.0	CHEMBL3130	Homo sapiens	IC50	uM	28.61
	18994017	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3cccc([N+](=O)[O-])c3)cc12		CHEMBL4545402	=	IC50	nM	11160.0	CHEMBL3130	Homo sapiens	IC50	uM	11.16
	18994018	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc([N+](=O)[O-])cc3)cc12		CHEMBL4440911	=	IC50	nM	8140.0	CHEMBL3130	Homo sapiens	IC50	uM	8.14
	18994019	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4451013	=	IC50	nM	9490.0	CHEMBL3130	Homo sapiens	IC50	uM	9.49
	18994020	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1ccc(C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c1		CHEMBL4469594	=	IC50	nM	3910.0	CHEMBL3130	Homo sapiens	IC50	uM	3.91
	18994021	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(S(=O)(=O)c3ccc(Cl)c([N+](=O)[O-])c3)cc12		CHEMBL4566022	=	IC50	nM	4620.0	CHEMBL3130	Homo sapiens	IC50	uM	4.62
	18994022	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	Cc1cc(C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c(C)c1		CHEMBL4591567	=	IC50	nM	1780.0	CHEMBL3130	Homo sapiens	IC50	uM	1.78
	18994023	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	CC(C)c1cc(C(C)C)c(S(=O)(=O)n2cc3c(=O)oc4ccccc4c3n2)c(C(C)C)c1		CHEMBL4532073	=	IC50	nM	990.0	CHEMBL3130	Homo sapiens	IC50	uM	0.99
	18994024	CHEMBL4341862	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs by fluorescence polarization assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1360.0	CHEMBL3130	Homo sapiens	IC50	uM	1.36
	19027951	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(N[C@@H](C)C(=O)N4CCOCC4)ncnc3n2C)c1C		CHEMBL4583776	=	IC50	nM	719.0	CHEMBL3130	Homo sapiens	IC50	nM	719.0
	19027952	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CC[C@H](Nc1ncnc2c1nc(-c1cnn(CC)c1C)n2C)C(=O)N1CCOCC1		CHEMBL4468074	=	IC50	nM	106.0	CHEMBL3130	Homo sapiens	IC50	nM	106.0
	19027953	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CC[C@H](Nc1ncnc2c1nc(-c1cnn(CC)c1C)n2C)C(=O)N1C[C@H](C)O[C@H](C)C1		CHEMBL4582480	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	19027954	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CC[C@H](Nc1ncnc2c1nc(-c1cnn(CC)c1C)n2C)C(=O)N(C)C		CHEMBL4591038	=	IC50	nM	1470.0	CHEMBL3130	Homo sapiens	IC50	nM	1470.0
	19027955	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(N[C@H]4CC[C@@H](C(=O)N5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4462856	=	IC50	nM	153.0	CHEMBL3130	Homo sapiens	IC50	nM	153.0
	19027956	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC(Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4528393	=	IC50	nM	2210.0	CHEMBL3130	Homo sapiens	IC50	nM	2210.0
	19027957	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(NC4CN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4483370	=	IC50	nM	2770.0	CHEMBL3130	Homo sapiens	IC50	nM	2770.0
	19027958	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4445755	=	IC50	nM	187.0	CHEMBL3130	Homo sapiens	IC50	nM	187.0
	19027959	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4441262	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	19027960	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CCC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4483321	=	IC50	nM	309.0	CHEMBL3130	Homo sapiens	IC50	nM	309.0
	19027961	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCCN1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4522133	=	IC50	nM	1290.0	CHEMBL3130	Homo sapiens	IC50	nM	1290.0
	19027962	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(N[C@H]4CCN(C(=O)C5CC5)C4)ncnc3n2C)c1C		CHEMBL4435694	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	19027963	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(O[C@H]4CCN(C(=O)C5CC5)C4)ncnc3n2C)c1C		CHEMBL4475824	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
	19027964	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(N[C@H]4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4575012	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	19027965	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(O[C@H]4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4570812	=	IC50	nM	62.0	CHEMBL3130	Homo sapiens	IC50	nM	62.0
	19027966	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(S[C@H]4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4474475	=	IC50	nM	572.0	CHEMBL3130	Homo sapiens	IC50	nM	572.0
	19027967	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(CC4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4440093	=	IC50	nM	8330.0	CHEMBL3130	Homo sapiens	IC50	nM	8330.0
	19027968	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(Oc4csc(C(=O)N5CCOCC5)c4)ncnc3n2C)c1C		CHEMBL4435158	=	IC50	nM	970.0	CHEMBL3130	Homo sapiens	IC50	nM	970.0
	19027969	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(NC4CCN(CC(C)C)C4=O)ncnc3n2C)c1C		CHEMBL4589857	=	IC50	nM	8330.0	CHEMBL3130	Homo sapiens	IC50	nM	8330.0
	19027970	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(NC4CC(=O)N(CC(C)C)C4)ncnc3n2C)c1C		CHEMBL4546631	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	19027971	CHEMBL4348832	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1ncc(-c2nc3c(N4CCC(n5c(=O)[nH]c6ncccc65)CC4)ncnc3n2C)c1C		CHEMBL4447337	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
	19027994	CHEMBL4348834	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1ncc(-c2nc3c(N[C@H]4CCN(C(=O)C5CC5)C4)ncnc3n2C)c1C		CHEMBL4435694	=	IC50	nM	35.0	CHEMBL3130	Homo sapiens	IC50	nM	35.0
	19027995	CHEMBL4348834	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1ncc(-c2nc3c(O[C@H]4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4570812	=	IC50	nM	360.0	CHEMBL3130	Homo sapiens	IC50	nM	360.0
	19027996	CHEMBL4348834	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1ncc(-c2nc3c(N4CCC(n5c(=O)[nH]c6ncccc65)CC4)ncnc3n2C)c1C		CHEMBL4447337	=	IC50	nM	810.0	CHEMBL3130	Homo sapiens	IC50	nM	810.0
	19027997	CHEMBL4348835	Inhibition of PI3Kdelta in human whole blood assessed as reduction in antihuman IgE antibody-stimulated CD63 expression preincubated for 30 mins followed by antihuman IgE antibody stimulation and measured after 20 mins by FACS analysis	B	CCn1ncc(-c2nc3c(N[C@H]4CCN(C(=O)C5CC5)C4)ncnc3n2C)c1C		CHEMBL4435694	=	IC50	nM	330.0	CHEMBL3130	Homo sapiens	IC50	nM	330.0
	19027998	CHEMBL4348835	Inhibition of PI3Kdelta in human whole blood assessed as reduction in antihuman IgE antibody-stimulated CD63 expression preincubated for 30 mins followed by antihuman IgE antibody stimulation and measured after 20 mins by FACS analysis	B	CCn1ncc(-c2nc3c(O[C@H]4CCN(C(=O)C5CCOCC5)C4)ncnc3n2C)c1C		CHEMBL4570812	=	IC50	nM	415.0	CHEMBL3130	Homo sapiens	IC50	nM	415.0
	19027999	CHEMBL4348835	Inhibition of PI3Kdelta in human whole blood assessed as reduction in antihuman IgE antibody-stimulated CD63 expression preincubated for 30 mins followed by antihuman IgE antibody stimulation and measured after 20 mins by FACS analysis	B	CCn1ncc(-c2nc3c(N4CCC(n5c(=O)[nH]c6ncccc65)CC4)ncnc3n2C)c1C		CHEMBL4447337	=	IC50	nM	790.0	CHEMBL3130	Homo sapiens	IC50	nM	790.0
	19028153	CHEMBL4348835	Inhibition of PI3Kdelta in human whole blood assessed as reduction in antihuman IgE antibody-stimulated CD63 expression preincubated for 30 mins followed by antihuman IgE antibody stimulation and measured after 20 mins by FACS analysis	B	CC[C@H](Nc1ncnc2c1nc(-c1cnn(CC)c1C)n2C)C(=O)N1C[C@H](C)O[C@H](C)C1		CHEMBL4582480	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	19036748	CHEMBL4351051	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4CCN(C(C)C)CC4)o3)c3cn[nH]c3c2)cc1C(=O)Oc1ccc(C)cc1C		CHEMBL4446645	=	Ki	nM	7800.0	CHEMBL3130	Homo sapiens	Ki	uM	7.8
	19036749	CHEMBL4351051	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4CCN(C(C)C)CC4)o3)c3cn[nH]c3c2)cc1C(=O)Oc1ccc([N+](=O)[O-])cc1		CHEMBL4445040	=	IC50	nM	0.6166	CHEMBL3130	Homo sapiens	pIC50		9.21
	19036750	CHEMBL4351051	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4CCN(C(C)C)CC4)o3)c3cn[nH]c3c2)cc1C(=O)Oc1ccc([N+](=O)[O-])cc1		CHEMBL4445040	=	Ki	nM	40.0	CHEMBL3130	Homo sapiens	Ki	nM	40.0
	19036751	CHEMBL4351051	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4CCN(C(C)C)CC4)o3)c3cn[nH]c3c2)cc1C(=O)Oc1ccc([N+](=O)[O-])cc1		CHEMBL4445040	=	Kinact	10'-3/s	5.5	CHEMBL3130	Homo sapiens	Kinact	10'-3/s	5.5
	19036824	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(-c2cn3c(n2)-c2cc([C@H](C)N4CCN(C(C)(C)C)CC4)ncc2OCC3)n(C(C)C)n1		CHEMBL3704701	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	19036825	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cn1nc(-c2cnc(N)c(-c3ccc(C(N)=O)c(F)c3)n2)nc1C1(c2ccccc2)CC1		CHEMBL4101902	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	19036826	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19036827	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(Nc2cccc(N3CCCC3=O)n2)sc1-c1cc2c(c(S(C)(=O)=O)c1)C(=O)N([C@@H](C)C1CC1)C2		CHEMBL4558527	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19036828	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(NC(=O)CNC(=O)c2ccccc2)sc1-c1cnc(Cl)c(NS(=O)(=O)c2ccccc2)c1		CHEMBL4460140	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	19036829	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	CC(c1cc2ccccn2c1-c1ccc(=O)n(CCN2CCOCC2)n1)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL4444179	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19036830	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc2nc([C@H](C)Nc3ncnc4[nH]cnc34)n(-c3cc(F)cc(F)c3)c2n1		CHEMBL4457478	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19036831	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(N)nc(N[C@@H](C)c2nc3ccn(C)c3cc2N2CCNCC2)c1C#N		CHEMBL4557936	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19036832	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc2ncc(Cl)n2cc1-c1ccccc1		CHEMBL4470131	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19036833	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	N#Cc1c[nH]c2ncnc(N3CCC[C@H]3c3nn4cccc4c(=O)n3-c3ccccc3)c12		CHEMBL4530831	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19036834	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	CC(c1oc(=O)c2ccccc2c1C1=CCN(C)CC1)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL4543628	<	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19036835	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2-c2ccc(F)cc2)c1C#N		CHEMBL4463183	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19036836	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	CC(Nc1ncnc2[nH]cnc12)c1cc2ccccn2c(=O)c1-c1ccccc1		CHEMBL4541570	=	IC50	nM	0.1	CHEMBL3130	Homo sapiens	IC50	nM	0.1
	19036837	CHEMBL4351072	Inhibition of PI3Kdelta in basophil derived from B-cell malignant patient	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	19036838	CHEMBL4351072	Inhibition of PI3Kdelta in basophil derived from B-cell malignant patient	B	Cc1csc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL2216863	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	19036847	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1		CHEMBL4297584	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
	19036848	CHEMBL4351077	Inhibition of PI3Kdelta (unknown origin)	B	CC(Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)[nH]c2c(Cl)cccc2c1=O		CHEMBL4516283	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	19036872	CHEMBL4351085	Inhibition of PI3Kdelta in human SU-DHL6 cells	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cn2ncc(Cl)c2nc1-c1cccc(F)c1		CHEMBL4584110	<	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	19036875	CHEMBL4351087	Inhibition of PI3Kdelta in human B-cells	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19036877	CHEMBL4351089	Inhibition of PI3Kdelta in human Pfeiffer cells	B	Cc1c(Cl)cc(C(C)Nc2ncnc3nc[nH]c23)c(-c2cccc(F)c2)c1C(N)=O		CHEMBL4565403	<	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	19036884	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19036885	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	C[C@H](Nc1ncnc(N)c1-c1nnn[nH]1)c1nn2cccc2c(=O)n1-c1ccccc1		CHEMBL3982040	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19036886	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	CC[C@H](Nc1ncnc(N)c1-c1nnc(C)o1)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4440839	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19036887	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	C[C@H](Nc1ncnc(N)c1C#Cc1ccc(F)cn1)c1nc2c(F)ccc(F)c2c(=O)n1-c1cc(F)cc(F)c1		CHEMBL3922388	<	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	19036888	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	Cc1cccc2nc([C@H](C)Nc3ncnc4[nH]cc(-c5cccc(NS(C)(=O)=O)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL4441003	=	IC50	nM	0.04	CHEMBL3130	Homo sapiens	IC50	nM	0.04
	19036889	CHEMBL4351094	Inhibition of PI3Kdelta (unknown origin) preincubated for 30 mins followed by insulin stimulation for 5 mins by Western blot analysis	B	Cc1ccn2nc([C@H](C)Nc3ncnc4[nH]cc(-c5ccc(O)c(CN6CCC(N(C)C)CC6)c5)c34)n(-c3ccccc3)c(=O)c12		CHEMBL4567071	=	IC50	nM	0.43	CHEMBL3130	Homo sapiens	IC50	nM	0.43
	19036893	CHEMBL4351096	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate in presence of [33P]ATP by by scintillation proximity assay	B	COc1ncc(N2CCOc3cnc(O[C@H]4CCN(C(=O)C5CCS(=O)(=O)CC5)C4)cc32)cc1C		CHEMBL4442510	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19036914	CHEMBL4351105	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 10 mins followed by ATP addition measured after 30 mins by HTRF assay	B	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3948730	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	19036920	CHEMBL4351111	Inhibition of PI3Kdelta in human Neutrophil cells	B	[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1		CHEMBL4297648	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	19036925	CHEMBL4351116	Inhibition of PI3Kdelta in human Raji cells	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	19036930	CHEMBL4351121	Inhibition of GST-tagged PI3Kdelta in human U937 cells using PIP2 as substrate preincubated for 10 mins followed by ATP addition measured after 30 mins by HTRF assay	B	COCCN(CCOC)C(=O)CCCC#Cc1cccc2nc(Cn3nc(-c4cccc(O)c4)c4c(N)ncnc43)n(Cc3ccccc3Cl)c(=O)c12		CHEMBL3919512	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	19036931	CHEMBL4351121	Inhibition of GST-tagged PI3Kdelta in human U937 cells using PIP2 as substrate preincubated for 10 mins followed by ATP addition measured after 30 mins by HTRF assay	B	COCCOCCOCC#Cc1cccc2nc(Cn3nc(-c4cc(O)cc(F)c4)c4c(N)ncnc43)n(Cc3ccccc3C(F)(F)F)c(=O)c12		CHEMBL3934989	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	19036939	CHEMBL4351126	Inhibition of PI3Kdelta in human SUDHL6 cells	B	C[C@H](Nc1ncnc2[nH]cnc12)C1=Nc2cccc(Cl)c2S(=O)(=O)N1c1ccccc1	Outside typical range	CHEMBL4468379	=	IC50	nM	0.0	CHEMBL3130	Homo sapiens	IC50	nM	0.0
	19041568	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	uM	0.004
	19041569	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	uM	0.001
Not Determined	19041570	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2c(Cl)ccn2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL4438693		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19041571	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1c[nH]c2ncnc(N3CCC[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4514752		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19041572	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2c(F)ccn2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL4446644		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19041573	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2cccn2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL4443601		IC50			CHEMBL3130	Homo sapiens	IC50		
	19041574	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2c(Cl)ccn2nc([C@@H]2C[C@H](F)CN2c2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL4548876	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	uM	0.001
	19041575	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2c(Cl)ccn2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1-c1cccc(F)c1		CHEMBL4574883	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	19041576	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1c[nH]c2ncnc(N3CCC[C@H]3c3nn4cccc4c(=O)n3-c3ccccc3)c12		CHEMBL4530831	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
Not Determined	19041577	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1c[nH]c2ncnc(N3C[C@@H](F)C[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4471912		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19041578	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC(=O)c1c[nH]c2ncnc(N3CCC[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4446047		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19041579	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC(=O)c1c[nH]c2ncnc(N3C[C@@H](F)C[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4520300		IC50			CHEMBL3130	Homo sapiens	IC50		
	19041580	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC(=O)c1c[nH]c2ncnc(N3CCC[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3cccc(F)c3)c12		CHEMBL4522342	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	19041581	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC(=O)c1c[nH]c2ncnc(N3CCC[C@H]3c3nn4ccc(F)c4c(=O)n3-c3ccccc3)c12		CHEMBL4463472	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	19041582	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1cnc(N)nc1N1CCC[C@H]1c1nn2ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4549473	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
Not Determined	19041583	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	O=c1c2c(Cl)ccn2nc([C@@H]2CCN2c2ncnc3[nH]cnc23)n1-c1ccccc1		CHEMBL4442420		IC50			CHEMBL3130	Homo sapiens	IC50		
	19041584	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1c[nH]c2ncnc(N3CC[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4445566	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	uM	0.021
	19041585	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	CC(=O)c1c[nH]c2ncnc(N3CC[C@H]3c3nn4ccc(Cl)c4c(=O)n3-c3ccccc3)c12		CHEMBL4468887	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	uM	0.021
	19041586	CHEMBL4352646	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in antihuman IgM-stimulated AKT phosphorylation at Ser473 residue preincubated for 60 mins followed by antihuman IgM stimulation and measured after 15 mins	B	N#Cc1cnc(N)nc1N1CC[C@H]1c1nn2ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4467526	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	19041627	CHEMBL4352651	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression on B-cells preincubated for 60 mins followed by anti-IgM stimulation and measured after overnight incubation by flow cytometry	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	19041628	CHEMBL4352651	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgM-stimulated CD69 expression on B-cells preincubated for 60 mins followed by anti-IgM stimulation and measured after overnight incubation by flow cytometry	B	CC(=O)c1cnc(N)nc1N1CC[C@H]1c1nn2ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4513442	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	uM	0.063
	19041633	CHEMBL4352655	Inhibition of PI3Kdelta in human whole blood assessed as reduction in fMLP-stimulated CD63 expression in basophils preincubated for 30 mins followed by fMLP stimulation	B	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3039502	=	IC50	nM	2206.0	CHEMBL3130	Homo sapiens	IC50	uM	2.206
	19041634	CHEMBL4352655	Inhibition of PI3Kdelta in human whole blood assessed as reduction in fMLP-stimulated CD63 expression in basophils preincubated for 30 mins followed by fMLP stimulation	B	CC(=O)c1cnc(N)nc1N1CC[C@H]1c1nn2ccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL4513442	=	IC50	nM	337.0	CHEMBL3130	Homo sapiens	IC50	uM	0.337
	19059763	CHEMBL4358064	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	19078320	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	CC(C)(C)c1ccc(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)cc1		CHEMBL4519664	=	IC50	nM	750.0	CHEMBL3130	Homo sapiens	IC50	uM	0.75
	19078321	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(F)cc4)CC3)cc12		CHEMBL4513423	=	IC50	nM	9760.0	CHEMBL3130	Homo sapiens	IC50	uM	9.76
	19078322	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)cc12		CHEMBL4441408	=	IC50	nM	4720.0	CHEMBL3130	Homo sapiens	IC50	uM	4.72
	19078323	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Br)cc4)CC3)cc12		CHEMBL4540508	=	IC50	nM	9310.0	CHEMBL3130	Homo sapiens	IC50	uM	9.31
	19078324	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)cc12		CHEMBL4568307	=	IC50	nM	5450.0	CHEMBL3130	Homo sapiens	IC50	uM	5.45
	19078325	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)cc12		CHEMBL4469318	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	uM	10.0
	19078326	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccccc4[N+](=O)[O-])CC3)cc12		CHEMBL4593416	=	IC50	nM	6150.0	CHEMBL3130	Homo sapiens	IC50	uM	6.15
	19078327	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(C(F)(F)F)cc4)CC3)cc12		CHEMBL4452143	=	IC50	nM	7510.0	CHEMBL3130	Homo sapiens	IC50	uM	7.51
	19078328	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cc1ccc(C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c1		CHEMBL4445433	=	IC50	nM	1420.0	CHEMBL3130	Homo sapiens	IC50	uM	1.42
	19078329	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1oc2ccccc2c2nn(CN3CCN(S(=O)(=O)c4ccc(Cl)c([N+](=O)[O-])c4)CC3)cc12		CHEMBL4468039	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	uM	0.12
	19078330	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cc1cc(C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c(C)c1		CHEMBL4437551	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	uM	0.23
	19078331	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	CC(C)c1cc(C(C)C)c(S(=O)(=O)N2CCN(Cn3cc4c(=O)oc5ccccc5c4n3)CC2)c(C(C)C)c1		CHEMBL4448759	=	IC50	nM	420.0	CHEMBL3130	Homo sapiens	IC50	uM	0.42
	19078332	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	1360.0	CHEMBL3130	Homo sapiens	IC50	uM	1.36
	19078333	CHEMBL4363191	Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	uM	0.021
	19090328	CHEMBL4365902	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	98.0	CHEMBL3130	Homo sapiens	Activity	%	98.0
Active	19107003	CHEMBL4369720	Inhibition of PI3Kdelta in human SU-DHL6 cells assessed as reduction in Akt phosphorylation at S473 residue at 100 nM after 2 hrs by Western blot analysis	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	19107004	CHEMBL4369719	Inhibition of PI3Kdelta in human SU-DHL6 cells assessed as reduction in S6K1 phosphorylation at T389 residue after 2 hrs by Western blot analysis	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Dose-dependent effect	19107005	CHEMBL4369718	Inhibition of PI3Kdelta in human SU-DHL6 cells assessed as reduction in Akt phosphorylation at S473 residue after 2 hrs by Western blot analysis	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19107035	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	5.8	CHEMBL3130	Homo sapiens	IC50	nM	5.8
	19107036	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	19107037	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557	=	IC50	nM	6.3	CHEMBL3130	Homo sapiens	IC50	nM	6.3
	19107038	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1Cc1ccccc1		CHEMBL4592798	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	19107039	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2nc(F)nc3[nH]cnc23)n1C1CCCC1		CHEMBL4578696	=	IC50	nM	178.0	CHEMBL3130	Homo sapiens	IC50	nM	178.0
	19107040	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2nc(F)nc3[nH]cnc23)n1Cc1ccccc1		CHEMBL4542850	=	IC50	nM	91.0	CHEMBL3130	Homo sapiens	IC50	nM	91.0
	19107041	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	CCCCn1c([C@@H]2CCCN2c2ncnc3[nH]cnc23)nc2cccc(F)c2c1=O		CHEMBL4440781	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19107042	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1C1CCCCC1		CHEMBL4532200	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	19107043	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1C1CCCC1		CHEMBL4445029	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	19107044	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1C1CCC1		CHEMBL4526482	=	IC50	nM	635.0	CHEMBL3130	Homo sapiens	IC50	nM	635.0
	19107045	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1Cc1ccccc1		CHEMBL4461870	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	19107046	CHEMBL4369710	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate after 2 hrs by ADP-Glo assay	B	O=c1c2ccccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1Cc1ccccc1		CHEMBL4554096	=	IC50	nM	498.0	CHEMBL3130	Homo sapiens	IC50	nM	498.0
Active	19107047	CHEMBL4369721	Inhibition of PI3Kdelta in human SU-DHL6 cells assessed as reduction in S6K1 phosphorylation at T389 residue a at 100 nM after 2 hrs by Western blot analysis	B	N#Cc1c(N)ncnc1N1CCC[C@H]1c1nc2cccc(F)c2c(=O)n1C1CCCC1		CHEMBL4591557		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19112731	CHEMBL4370793	Inhibition of recombinant human PI3Kdelta at 0.1 uM using PIP2 as substrate after 35 to 40 mins by HTRF assay relative to control	B	COc1ncc(N2CCc3ncnc(Nc4ccccc4)c3C2)cc1C		CHEMBL4463870	=	Inhibition	%	14.0	CHEMBL3130	Homo sapiens	INH	%	14.0
	19112732	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	CCN1CCC(Nc2cc(-c3ncnc4c3CN(c3cnc(OC)c(C)c3)CC4)ccn2)CC1		CHEMBL4528263	=	IC50	nM	8.5	CHEMBL3130	Homo sapiens	IC50	nM	8.5
	19112733	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCNCC5)c4)c3C2)cc1C		CHEMBL4514389	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	nM	25.0
	19112734	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(OC5CCN(C)CC5)c4)c3C2)cc1C		CHEMBL4459455	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	19112735	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCN(C)CC5)c4)c3C2)cc1C		CHEMBL4453747	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	19112736	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COCC(=O)N1CCC(Nc2cc(-c3ncnc4c3CN(c3cnc(OC)c(C)c3)CC4)ccn2)CC1		CHEMBL4530810	=	IC50	nM	9.2	CHEMBL3130	Homo sapiens	IC50	nM	9.2
	19112737	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCN(S(C)(=O)=O)CC5)c4)c3C2)cc1C		CHEMBL4518787	=	IC50	nM	9.6	CHEMBL3130	Homo sapiens	IC50	nM	9.6
	19112738	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(N[C@H]5CC[C@H](O)CC5)c4)c3C2)cc1C		CHEMBL4581474	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	19112739	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COCCNc1cc(-c2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)ccn1		CHEMBL4457611	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	19112740	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NCc5ccccc5)c4)c3C2)cc1C		CHEMBL4450211	=	IC50	nM	87.0	CHEMBL3130	Homo sapiens	IC50	nM	87.0
	19112741	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NC5CCOCC5)c4)c3C2)cc1C		CHEMBL4554894	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19112742	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccnc(NCC5CCOCC5)c4)c3C2)cc1C		CHEMBL4467692	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
	19112743	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccc(NC5CCOCC5)nc4)c3C2)cc1C		CHEMBL4591775	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	19112744	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4ccc(NCC5CCOCC5)nc4)c3C2)cc1C		CHEMBL4582553	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19112745	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4cnn(C5CCOCC5)c4)c3C2)cc1C		CHEMBL4569467	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	19112746	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(-c4cnn(CC5CCOCC5)c4)c3C2)cc1C		CHEMBL4475876	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	19112747	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(Nc4cccc(C(=O)N5CCOCC5)c4)c3C2)cc1C		CHEMBL4535334	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	19112748	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(Nc4cccc(C(=O)NC5CCOCC5)c4)c3C2)cc1C		CHEMBL4518858	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	19112749	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	CCOC(=O)c1cccc(Nc2ncnc3c2CN(c2cnc(OC)c(C)c2)CC3)c1		CHEMBL4558301	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	19112750	CHEMBL4370794	Inhibition of recombinant human PI3Kdelta using PIP2 as substrate after 35 to 40 mins by HTRF assay	B	COc1ncc(N2CCc3ncnc(Nc4cccc(C)c4)c3C2)cc1C		CHEMBL4544121	=	IC50	nM	220.0	CHEMBL3130	Homo sapiens	IC50	nM	220.0
	19112755	CHEMBL4370790	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of [33P]ATP by Scintillation proximity assay	B	CCC(=O)N1CC[C@H](Oc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1		CHEMBL3643409	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	19112756	CHEMBL4370790	Inhibition of PI3Kdelta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of [33P]ATP by Scintillation proximity assay	B	COc1ncc(N2CCc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3C2)cc1C		CHEMBL3643349	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	19133277	CHEMBL4375325	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	7110.0	CHEMBL3130	Homo sapiens	Kd	uM	7.11
	19139803	CHEMBL4376368	Inhibition of PI3Kdelta (unknown origin)	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	75.0	CHEMBL3130	Homo sapiens	IC50	nM	75.0
	19139808	CHEMBL4376364	Reversible competitive inhibition of PI3K p110delta (unknown origin)	B	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1		CHEMBL3360203	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	19139813	CHEMBL4376359	Inhibition of PI3K p110delta (unknown origin)	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	19139818	CHEMBL4376372	Competitive inhibition of PI3Kdelta (unknown origin)	B	FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1		CHEMBL586702	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19139820	CHEMBL4376368	Inhibition of PI3Kdelta (unknown origin)	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	6.4	CHEMBL3130	Homo sapiens	IC50	nM	6.4
	19139823	CHEMBL4376359	Inhibition of PI3K p110delta (unknown origin)	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	116.0	CHEMBL3130	Homo sapiens	IC50	nM	116.0
	19139828	CHEMBL4376368	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1		CHEMBL4297584	=	IC50	nM	24.5	CHEMBL3130	Homo sapiens	IC50	nM	24.5
	19139829	CHEMBL4376368	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL4303323	=	IC50	nM	12.7	CHEMBL3130	Homo sapiens	IC50	nM	12.7
	19151939	CHEMBL4380330	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	Nc1cc(C(F)(F)F)c(-c2nc3c(c(N4CCOCC4)n2)CCN(C(=O)c2cc(Cc4n[nH]c(=O)c5ccccc45)ccc2F)C3)cn1		CHEMBL4470724	=	IC50	nM	7.413	CHEMBL3130	Homo sapiens	pIC50		8.13
	19151940	CHEMBL4380330	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	=	IC50	nM	114.82	CHEMBL3130	Homo sapiens	pIC50		6.94
	19156944	CHEMBL4381559	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cc[nH]n3)sc2n1		CHEMBL4518369	=	IC50	nM	1700.0	CHEMBL3130	Homo sapiens	IC50	uM	1.7
	19156945	CHEMBL4381559	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H]1COCCN1c1nc(N2CCOC[C@H]2C)c2nc(-c3cccc4[nH]ccc34)[nH]c2n1		CHEMBL4514031	=	IC50	nM	800.0	CHEMBL3130	Homo sapiens	IC50	uM	0.8
	19159591	CHEMBL4382695	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	75.0	CHEMBL3130	Homo sapiens	Activity	%	75.0
	19172288	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	19172289	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccncc2)c2cc[nH]c2c1		CHEMBL4590704	=	IC50	nM	79432.82	CHEMBL3130	Homo sapiens	pIC50		4.1
	19172290	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccc3ccncc3c2)cnc1Cl		CHEMBL4438305	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	19172291	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccc3ccncc3c2)c2cc[nH]c2c1		CHEMBL4580395	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	19172292	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(C2=CCOCC2)cnc1Cl		CHEMBL4476588	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19172293	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2cnc(N)nc2)cnc1Cl		CHEMBL4462877	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19172294	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	O=S(=O)(Nc1cc(C2=CCOCC2)cnc1Cl)c1ccccc1		CHEMBL4466854	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	19172295	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	O=S(=O)(Nc1cc(-c2ccccc2)cnc1Cl)c1ccccc1		CHEMBL4555426	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	19172296	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4469876	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19172297	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1cn(Cc2ccccc2)c(C)n1		CHEMBL4435246	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19172316	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CS(=O)(=O)Nc1cc(-c2ccc3cn[nH]c3c2)cnc1Cl		CHEMBL4437969	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	19172317	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2nnc(CN3CCOCC3)o2)c2cn[nH]c2c1	Outside typical range	CHEMBL4552815	=	IC50	nM	158489.32	CHEMBL3130	Homo sapiens	pIC50		3.8
	19172318	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(-c2ccc3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4468849	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	19172319	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	c1cc(-c2ccc3cn[nH]c3c2)c2cc[nH]c2c1		CHEMBL4449676	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	19172320	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	Ki	nM	0.07943	CHEMBL3130	Homo sapiens	pKi		10.1
	19172321	CHEMBL4385120	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins by HTRF method	B	CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1		CHEMBL2216859	=	Ki	nM	0.1259	CHEMBL3130	Homo sapiens	pKi		9.9
	19183166	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4ccc5c(c4)C(C)(CC4CC4)C(=O)N5)c3n2)cn1		CHEMBL4449778	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	19183167	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4ccc5c(c4)C(N4CCOCC4)CC5)c3n2)cn1		CHEMBL4522603	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	19183168	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4ccc5c(c4)[C@](C)(Cc4ccccc4)C(=O)N5)c3n2)cn1		CHEMBL4452905	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19183169	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4cccc(S(=O)(=O)N5CCOCC5)c4)c3n2)cn1		CHEMBL4452117	=	IC50	nM	94.0	CHEMBL3130	Homo sapiens	IC50	nM	94.0
	19183170	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4cccc(C(=O)N5CCOCC5)c4)c3n2)cn1		CHEMBL4444468	=	IC50	nM	689.0	CHEMBL3130	Homo sapiens	IC50	nM	689.0
	19183171	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4cnn(Cc5ccccc5)c4)c3n2)cn1		CHEMBL4549113	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	19183172	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4cccc(CN5CCOCC5)c4)c3n2)cn1		CHEMBL4451433	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	19183173	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4cccc(C5(C#N)CCOCC5)c4)c3n2)cn1		CHEMBL4438805	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
	19183174	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4ccnc(C5CCOCC5)c4)c3n2)cn1		CHEMBL4447681	=	IC50	nM	343.0	CHEMBL3130	Homo sapiens	IC50	nM	343.0
	19183175	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3ncc(-c4ccnc(N5CCOCC5)c4)c3n2)cn1		CHEMBL4456087	=	IC50	nM	89.0	CHEMBL3130	Homo sapiens	IC50	nM	89.0
	19183176	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	Cc1ncc(-c2ccn3nccc3n2)cn1		CHEMBL4454950	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	19183177	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccn3nccc3c2)cc1NS(C)(=O)=O		CHEMBL4461221	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	19183178	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3nonc3c2)cc1NS(C)(=O)=O		CHEMBL4562183	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	nM	61.0
	19183179	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccn3nccc3n2)cc1NS(C)(=O)=O		CHEMBL4575776	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19183180	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3c(c2)OCO3)cc1NS(C)(=O)=O		CHEMBL4475748	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	19183181	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4468849	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	19183182	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3nsnc3c2)cc1NS(C)(=O)=O		CHEMBL4440095	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19183183	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccn3ncnc3c2)cc1NS(C)(=O)=O		CHEMBL4517406	=	IC50	nM	7.2	CHEMBL3130	Homo sapiens	IC50	nM	7.2
	19183184	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3ncnn3c2)cc1NS(C)(=O)=O		CHEMBL4515312	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	19183185	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3ccncc3c2)cc1NS(C)(=O)=O		CHEMBL4436827	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	19183186	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2ccc3c(c2)COCC3)cc1NS(C)(=O)=O		CHEMBL4586842	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	19183187	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	C[C@@]1(Cc2ccccc2)C(=O)Nc2ccc(-c3cnn4cccnc34)cc21		CHEMBL4435654	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	19183188	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3ccn4nccc4c3)cc21		CHEMBL4455359	=	IC50	nM	530.0	CHEMBL3130	Homo sapiens	IC50	nM	530.0
	19183189	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3nccn4nccc34)cc21		CHEMBL4436565	=	IC50	nM	540.0	CHEMBL3130	Homo sapiens	IC50	nM	540.0
	19183190	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3ccc4nccnc4n3)cc21		CHEMBL4471570	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	19183191	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3ccnc4cnccc34)cc21		CHEMBL4435568	=	IC50	nM	374.0	CHEMBL3130	Homo sapiens	IC50	nM	374.0
	19183192	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3ccc4nccnc4c3)cc21		CHEMBL4562428	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	19183193	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	CC1(Cc2ccccc2)C(=O)Nc2ccc(-c3ccc4ncnc(O)c4c3)cc21		CHEMBL4549128	=	IC50	nM	179.0	CHEMBL3130	Homo sapiens	IC50	nM	179.0
	19183194	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	O=C(C1CC1)N1CCC[C@]12C(=O)Nc1ncc(-c3ccc4nccnc4c3)cc12		CHEMBL4474516	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	19183195	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	O=C(C1CC1)N1CCC[C@]12C(=O)Nc1ccc(-c3ccc4nccnc4c3)cc12		CHEMBL4524356	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19183196	CHEMBL4387673	Inhibition of PI3KD (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	IC50	nM	0.33	CHEMBL3130	Homo sapiens	IC50	nM	0.33
	19191416	CHEMBL4389414	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	99.0	CHEMBL3130	Homo sapiens	INH	%	99.0
	19192077	CHEMBL4389891	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	19200333	CHEMBL4391517	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL3130	Homo sapiens	Activity	%	100.0
	19207779	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4454741	=	Inhibition	%	98.0	CHEMBL3130	Homo sapiens	INH	%	98.0
	19207780	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	CC(C)c1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4462149	=	Inhibition	%	73.0	CHEMBL3130	Homo sapiens	INH	%	73.0
	19207781	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cn1c(=O)n(Cc2ccc(C(C)(C)C#N)cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4461158	=	Inhibition	%	56.0	CHEMBL3130	Homo sapiens	INH	%	56.0
	19207782	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Inhibition	%	92.0	CHEMBL3130	Homo sapiens	INH	%	92.0
	19207783	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cn1c(=O)n(Cc2ccccc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4514522	=	Inhibition	%	22.0	CHEMBL3130	Homo sapiens	INH	%	22.0
	19207784	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cn1c(=O)n(Cc2ccc(F)cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4438163	=	Inhibition	%	51.0	CHEMBL3130	Homo sapiens	INH	%	51.0
	19207785	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cn1c(=O)n(Cc2ccc([N+](=O)[O-])cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4558021	=	Inhibition	%	62.0	CHEMBL3130	Homo sapiens	INH	%	62.0
	19207786	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	Cc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4536349	=	Inhibition	%	80.0	CHEMBL3130	Homo sapiens	INH	%	80.0
	19207788	CHEMBL4392570	Inhibition of human PI3Kalpha using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3cnc4ccc(-c5cnc(OC)c(NS(C)(=O)=O)c5)cc4c32)cc1		CHEMBL4550603	=	IC50	nM	289.0	CHEMBL3130	Homo sapiens	IC50	nM	289.0
	19207789	CHEMBL4392570	Inhibition of human PI3Kalpha using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4560054	=	IC50	nM	891.0	CHEMBL3130	Homo sapiens	IC50	nM	891.0
	19207790	CHEMBL4392570	Inhibition of human PI3Kalpha using PIP2 as substrate after 1 hr	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	831.0	CHEMBL3130	Homo sapiens	IC50	nM	831.0
	19207791	CHEMBL4392570	Inhibition of human PI3Kalpha using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19207792	CHEMBL4392570	Inhibition of human PI3Kalpha using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4454741	=	IC50	nM	421.0	CHEMBL3130	Homo sapiens	IC50	nM	421.0
Not Determined	19207793	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(CCn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4515364		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19207794	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(C(C)n2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4564102		IC50			CHEMBL3130	Homo sapiens	IC50		
	19207795	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3cnc4ccc(-c5cnc(OC)c(NS(C)(=O)=O)c5)cc4c32)cc1		CHEMBL4550603	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	19207796	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(=O)(=O)C6CC6)c5)ccc4ncc32)cc1		CHEMBL4535169	=	IC50	nM	5.9	CHEMBL3130	Homo sapiens	IC50	nM	5.9
	19207797	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(=O)(=O)C(C)C)c5)ccc4ncc32)cc1		CHEMBL4440218	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
	19207798	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4560054	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
Not Determined	19207799	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(-n6cnnc6)c5)ccc4ncc32)cc1		CHEMBL4474240		IC50			CHEMBL3130	Homo sapiens	IC50		
	19207800	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(C)c5)ccc4ncc32)cc1		CHEMBL4467333	=	IC50	nM	11.1	CHEMBL3130	Homo sapiens	IC50	nM	11.1
	19207801	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc(OC)nc5)ccc4ncc32)cc1		CHEMBL4589873	=	IC50	nM	11.4	CHEMBL3130	Homo sapiens	IC50	nM	11.4
	19207802	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cccnc5)ccc4ncc32)cc1		CHEMBL4542493	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	19207803	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccccc5)ccc4ncc32)cc1		CHEMBL4563971	=	IC50	nM	29.4	CHEMBL3130	Homo sapiens	IC50	nM	29.4
Not Determined	19207804	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc6nc(N)sc6c5)ccc4ncc32)cc1		CHEMBL4537987		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19207805	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc6nc(NC(C)=O)sc6c5)ccc4ncc32)cc1		CHEMBL4450071		IC50			CHEMBL3130	Homo sapiens	IC50		
	19207806	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	19207807	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
Not Determined	19207808	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(Cc2ccccc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4514522		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19207809	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(Cc2ccc(F)cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4438163		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19207810	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(Cc2ccc([N+](=O)[O-])cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4558021		IC50			CHEMBL3130	Homo sapiens	IC50		
	19207811	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4536349	=	IC50	nM	18.4	CHEMBL3130	Homo sapiens	IC50	nM	18.4
	19207812	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4454741	=	IC50	nM	9.5	CHEMBL3130	Homo sapiens	IC50	nM	9.5
	19207813	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	CC(C)c1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc6ccccc6c5)ccc4ncc32)cc1		CHEMBL4462149	=	IC50	nM	28.3	CHEMBL3130	Homo sapiens	IC50	nM	28.3
Not Determined	19207814	CHEMBL4392569	Inhibition of human PI3Kdelta using PIP2 as substrate after 1 hr	B	Cn1c(=O)n(Cc2ccc(C(C)(C)C#N)cc2)c2cnc3ccc(-c4cnc5ccccc5c4)cc3c21		CHEMBL4461158		IC50			CHEMBL3130	Homo sapiens	IC50		
	19207815	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(CCn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4515364	=	Inhibition	%	56.0	CHEMBL3130	Homo sapiens	INH	%	56.0
	19207816	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(C(C)n2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4564102	=	Inhibition	%	60.0	CHEMBL3130	Homo sapiens	INH	%	60.0
	19207817	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3cnc4ccc(-c5cnc(OC)c(NS(C)(=O)=O)c5)cc4c32)cc1		CHEMBL4550603	=	Inhibition	%	98.0	CHEMBL3130	Homo sapiens	INH	%	98.0
	19207818	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(=O)(=O)C6CC6)c5)ccc4ncc32)cc1		CHEMBL4535169	=	Inhibition	%	93.0	CHEMBL3130	Homo sapiens	INH	%	93.0
	19207819	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(=O)(=O)C(C)C)c5)ccc4ncc32)cc1		CHEMBL4440218	=	Inhibition	%	91.0	CHEMBL3130	Homo sapiens	INH	%	91.0
	19207820	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(NS(C)(=O)=O)c5)ccc4ncc32)cc1		CHEMBL4560054	=	Inhibition	%	99.0	CHEMBL3130	Homo sapiens	INH	%	99.0
	19207821	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(-n6cnnc6)c5)ccc4ncc32)cc1		CHEMBL4474240	=	Inhibition	%	62.0	CHEMBL3130	Homo sapiens	INH	%	62.0
	19207822	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cnc(OC)c(C)c5)ccc4ncc32)cc1		CHEMBL4467333	=	Inhibition	%	88.0	CHEMBL3130	Homo sapiens	INH	%	88.0
	19207823	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc(OC)nc5)ccc4ncc32)cc1		CHEMBL4589873	=	Inhibition	%	87.0	CHEMBL3130	Homo sapiens	INH	%	87.0
	19207824	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5cccnc5)ccc4ncc32)cc1		CHEMBL4542493	=	Inhibition	%	81.0	CHEMBL3130	Homo sapiens	INH	%	81.0
	19207825	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccccc5)ccc4ncc32)cc1		CHEMBL4563971	=	Inhibition	%	72.0	CHEMBL3130	Homo sapiens	INH	%	72.0
	19207826	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc6nc(N)sc6c5)ccc4ncc32)cc1		CHEMBL4537987	=	Inhibition	%	58.0	CHEMBL3130	Homo sapiens	INH	%	58.0
	19207827	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	COc1ccc(Cn2c(=O)n(C)c3c4cc(-c5ccc6nc(NC(C)=O)sc6c5)ccc4ncc32)cc1		CHEMBL4450071	=	Inhibition	%	52.0	CHEMBL3130	Homo sapiens	INH	%	52.0
	19207828	CHEMBL4392568	Inhibition of human PI3Kdelta using PIP2 as substrate at 100 nM after 1 hr relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	Inhibition	%	96.0	CHEMBL3130	Homo sapiens	INH	%	96.0
	19214482	CHEMBL4393770	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nnc2n1[C@@H]1CCN(Cc3cc4nc(-c5cccc6[nH]ccc56)nc(N5CCOCC5)c4s3)C[C@@H]1CC2		CHEMBL4541013	=	IC50	nM	0.7943	CHEMBL3130	Homo sapiens	pIC50		9.1
	19214492	CHEMBL4393770	Inhibition of PI3Kdelta (unknown origin)	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	19214499	CHEMBL4393770	Inhibition of PI3Kdelta (unknown origin)	B	Cc1nc(C(=O)Nc2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc3[nH]ncc23)cs1		CHEMBL4576860	=	IC50	nM	1.995	CHEMBL3130	Homo sapiens	pIC50		8.7
	19214503	CHEMBL4393770	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	Ki	nM	0.07943	CHEMBL3130	Homo sapiens	pKi		10.1
	19242037	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C5CCOCC5)C4)c3c2)cc1C#N		CHEMBL4561357	=	IC50	nM	7.7	CHEMBL3130	Homo sapiens	IC50	nM	7.7
	19242038	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C5CCN(C)CC5)C4)c3c2)cc1C#N		CHEMBL4533939	=	IC50	nM	9.4	CHEMBL3130	Homo sapiens	IC50	nM	9.4
	19242039	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C5CCNCC5)C4)c3c2)cc1C#N		CHEMBL4563455	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	19242040	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C(C)N)C4)c3c2)cc1C#N		CHEMBL4473306	=	IC50	nM	3.7	CHEMBL3130	Homo sapiens	IC50	nM	3.7
	19242041	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)CN(C)C)C4)c3c2)cc1C#N		CHEMBL4476303	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	19242042	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)CCl)C4)c3c2)cc1C#N		CHEMBL4562892	=	IC50	nM	8.9	CHEMBL3130	Homo sapiens	IC50	nM	8.9
	19242043	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)CCBr)C4)c3c2)cc1C#N		CHEMBL4544144	=	IC50	nM	14.3	CHEMBL3130	Homo sapiens	IC50	nM	14.3
	19242044	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5cccnc5)C4)c3c2)cc1C#N		CHEMBL4468088	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19242045	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5coc([N+](=O)[O-])c5)C4)c3c2)cc1C#N		CHEMBL4457318	=	IC50	nM	3.9	CHEMBL3130	Homo sapiens	IC50	nM	3.9
	19242046	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C(F)(F)F)C4)c3c2)cc1C#N		CHEMBL4568130	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	19242047	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	CCOC(=O)CN1CCC[C@H](Nc2ncnc3ccc(-c4cnc(OC)c(C#N)c4)cc23)C1		CHEMBL4515495	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	19242048	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)C(F)(F)F)C4)c3c2)cc1[N+](=O)[O-]		CHEMBL4530540	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	19242049	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	CCOC(=O)CN1CCC[C@H](Nc2ncnc3ccc(-c4cnc(OC)c(C(F)(F)F)c4)cc23)C1		CHEMBL4457688	=	IC50	nM	6.8	CHEMBL3130	Homo sapiens	IC50	nM	6.8
	19242050	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(CCO)C4)c3c2)cc1C#N		CHEMBL4459721	=	IC50	nM	4.7	CHEMBL3130	Homo sapiens	IC50	nM	4.7
	19242051	CHEMBL4399809	Inhibition of PI3K delta (unknown origin) using phosphatidyl inositol as substrate measured after 60 mins in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
Dose-dependent effect	19242111	CHEMBL4399821	Inhibition of PI3K delta in human SUDHL6 cells assessed as reduction in AKT phosphorylation at S473 measured after 8 hrs by Western blot analysis	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5cccnc5)C4)c3c2)cc1C#N		CHEMBL4468088		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19242112	CHEMBL4399823	Potency index, ratio of i-delalisib IC50 to compound IC50 for inhibition of PI3K delta (unknown origin)	B	COc1ncc(-c2ccc3ncnc(N[C@H]4CCCN(C(=O)c5cccnc5)C4)c3c2)cc1C#N		CHEMBL4468088	=	Ratio IC50		2.0	CHEMBL3130	Homo sapiens	Ratio IC50		2.0
	19242113	CHEMBL4399822	Inhibition of PI3K delta (unknown origin)	B	COc1ccc(-c2ccc3ncnc(O[C@H]4CCCN(C(=O)C5CC5)C4)c3c2)cn1		CHEMBL4461031	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19242114	CHEMBL4399822	Inhibition of PI3K delta (unknown origin)	B	COc1ncc(-c2ccc3ncnc(O[C@H]4CCN(C(=O)C5CCOCC5)C4)c3c2)cc1C#N		CHEMBL4557999	=	IC50	nM	4.9	CHEMBL3130	Homo sapiens	IC50	nM	4.9
	19260485	CHEMBL4403988	Inhibition of PI3Kdelta in human JeKo1 cells assessed as reduction in anti-human IgM-induced AKT phosphorylation at T208 residue preincubated for 1 hr followed by anti-human IgM addition and measured after 10 mins by QuantaBlu substrate based fluorescence assay	A	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C		CHEMBL4439259	>	IC50	nM	30000.0	CHEMBL3130	Homo sapiens	IC50	uM	30.0
	19265865	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNC(=O)c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4464003	=	IC50	nM	0.6	CHEMBL3130	Homo sapiens	IC50	nM	0.6
	19265866	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNc3ncc(C(=O)NO)cn3)c2c(=O)n1-c1ccccc1		CHEMBL4581057	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	19265867	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CNC(=O)c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4522666	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19265868	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CNc3ncc(C(=O)NO)cn3)c2c(=O)n1-c1ccccc1		CHEMBL4583074	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19265869	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc(CCCCC(=O)NO)c2ccccc2n1		CHEMBL4571886	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	19265870	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc(CCCCCC(=O)NO)c2ccccc2n1		CHEMBL4539040	=	IC50	nM	68.0	CHEMBL3130	Homo sapiens	IC50	nM	68.0
	19265871	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc(NCCCC(=O)NO)c2ccccc2n1		CHEMBL4439820	=	IC50	nM	520.0	CHEMBL3130	Homo sapiens	IC50	nM	520.0
	19265872	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4445342	<	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19265873	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4451623	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19265874	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4555432	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19265875	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4563838	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19265876	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4588261	=	IC50	nM	46.0	CHEMBL3130	Homo sapiens	IC50	nM	46.0
	19265877	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4516095	=	IC50	nM	47.0	CHEMBL3130	Homo sapiens	IC50	nM	47.0
	19265878	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)c(C)c3)c2c(=O)n1-c1ccccc1		CHEMBL4586038	=	IC50	nM	41.0	CHEMBL3130	Homo sapiens	IC50	nM	41.0
Not Determined	19265879	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)nc3)c2c(=O)n1-c1ccccc1		CHEMBL4445210		IC50			CHEMBL3130	Homo sapiens	IC50		
	19265880	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)cn3)c2c(=O)n1-c1ccccc1		CHEMBL4443548	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	19265881	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)N(C)O)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4449106	=	IC50	nM	81.0	CHEMBL3130	Homo sapiens	IC50	nM	81.0
	19265882	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4550648	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	19265883	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4443378	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19265884	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)ncc1C)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4525968	=	IC50	nM	96.0	CHEMBL3130	Homo sapiens	IC50	nM	96.0
	19265885	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(CCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4450613	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19265886	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4544187	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19265887	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4464812	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	19265888	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	19265889	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc(N)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4578757	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
	19265890	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc(N)c1Cl)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4467927	=	IC50	nM	133.0	CHEMBL3130	Homo sapiens	IC50	nM	133.0
	19265891	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1ncnc(N)c1Cl)c1nc2cccc(NCc3ccc(C(=O)NO)cn3)c2c(=O)n1-c1ccccc1		CHEMBL4456827	=	IC50	nM	189.0	CHEMBL3130	Homo sapiens	IC50	nM	189.0
	19265892	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C)c1Cl)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4449301	=	IC50	nM	663.0	CHEMBL3130	Homo sapiens	IC50	nM	663.0
	19265893	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC[C@H](Nc1nc(N)nc(C(F)F)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4435002	=	IC50	nM	390.0	CHEMBL3130	Homo sapiens	IC50	nM	390.0
	19265894	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4460447	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	19265895	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	Cc1nc(N)nc(N[C@@H](C)c2nc3cccc(NCc4ccc(C(=O)NO)cc4)c3c(=O)n2-c2ccccc2)c1C#N		CHEMBL4526673	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	19265896	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
Not Determined	19265897	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1		CHEMBL3110004		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19265898	CHEMBL4405141	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay	B	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1		CHEMBL99		IC50			CHEMBL3130	Homo sapiens	IC50		
	19265929	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNc3ncc(C(=O)NO)s3)c2c(=O)n1-c1ccccc1		CHEMBL4439884	=	Inhibition	%	95.2	CHEMBL3130	Homo sapiens	INH	%	95.2
	19265930	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4563838	=	Inhibition	%	94.7	CHEMBL3130	Homo sapiens	INH	%	94.7
	19265931	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3ccc(CC(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4532505	=	Inhibition	%	95.8	CHEMBL3130	Homo sapiens	INH	%	95.8
	19265932	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(-c3nc4ccc(C(=O)NO)cc4s3)c2c(=O)n1-c1ccccc1		CHEMBL4445486	=	Inhibition	%	92.6	CHEMBL3130	Homo sapiens	INH	%	92.6
	19265933	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)nc3)c2c(=O)n1-c1ccccc1		CHEMBL4445210	=	Inhibition	%	88.3	CHEMBL3130	Homo sapiens	INH	%	88.3
	19265934	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(NCc3ccc(C(=O)NO)o3)c2c(=O)n1-c1ccccc1		CHEMBL4461365	=	Inhibition	%	61.2	CHEMBL3130	Homo sapiens	INH	%	61.2
	19265935	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNCc3nc(C(=O)NO)cs3)c2c(=O)n1-c1ccccc1		CHEMBL4454137	=	Inhibition	%	56.0	CHEMBL3130	Homo sapiens	INH	%	56.0
	19265936	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(CNCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4582716	=	Inhibition	%	20.5	CHEMBL3130	Homo sapiens	INH	%	20.5
	19265937	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Inhibition	%	7.0	CHEMBL3130	Homo sapiens	INH	%	7.0
Not Determined	19265938	CHEMBL4405145	Inhibition of human PI3Kdelta assessed as reduction in PIP3 product complex formation by measuring displacement of biotin-labelled PIP3 from complex at 1 uM using PIP2 as substrate measured after 30 mins in presence of ATP by HTRF assay relative to control	B	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1		CHEMBL99		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19266216	CHEMBL4405212	Inhibition of PI3Kdelta in human MOLM14 cells assessed as reduction in phosphorylated AKT level at 5 uM measured after 1 to 24 hrs by immunoblot analysis relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
Not Active	19266217	CHEMBL4405213	Inhibition of PI3Kdelta in human MOLM14 cells assessed as reduction in total AKT level at 5 uM measured after 1 to 24 hrs by immunoblot analysis	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	19266222	CHEMBL4405215	Binding affinity to PI3Kdelta in human MV4-11 cells assessed as increase in cellular protein stabilization at 1 uL preincubated for 1 hr followed by heating at 52 degree C for 3.5 mins by CETSA	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Activity			CHEMBL3130	Homo sapiens	Activity		
Not Active	19266223	CHEMBL4405215	Binding affinity to PI3Kdelta in human MV4-11 cells assessed as increase in cellular protein stabilization at 1 uL preincubated for 1 hr followed by heating at 52 degree C for 3.5 mins by CETSA	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(CCCCCC(=O)NO)c2c(=O)n1-c1ccccc1		CHEMBL4443378		Activity			CHEMBL3130	Homo sapiens	Activity		
Active	19266224	CHEMBL4405215	Binding affinity to PI3Kdelta in human MV4-11 cells assessed as increase in cellular protein stabilization at 1 uL preincubated for 1 hr followed by heating at 52 degree C for 3.5 mins by CETSA	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923		Activity			CHEMBL3130	Homo sapiens	Activity		
Not Active	19266225	CHEMBL4405215	Binding affinity to PI3Kdelta in human MV4-11 cells assessed as increase in cellular protein stabilization at 1 uL preincubated for 1 hr followed by heating at 52 degree C for 3.5 mins by CETSA	B	CC[C@H](Nc1cc(C)nc(N)n1)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4459679		Activity			CHEMBL3130	Homo sapiens	Activity		
	19290335	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	Cc1csc2nc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3cccc(F)c3)c(=O)n12		CHEMBL2216863	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	19290336	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CC(Nc1ncnc2[nH]cnc12)c1ccc2cccnc2c1-c1cccc(F)c1		CHEMBL4593849	=	IC50	nM	430.0	CHEMBL3130	Homo sapiens	IC50	nM	430.0
	19290337	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc(Cl)c2cccnc2c1-c1cccc(F)c1		CHEMBL4440146	=	IC50	nM	8.4	CHEMBL3130	Homo sapiens	IC50	nM	8.4
	19290338	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc(Cl)c2ccnnc2c1-c1cccc(F)c1		CHEMBL4471294	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	19290339	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	Cc1c(Cl)cc(C(C)Nc2ncnc3[nH]cnc23)c(-c2cccc(F)c2)c1C#N		CHEMBL4576207	=	IC50	nM	99.0	CHEMBL3130	Homo sapiens	IC50	nM	99.0
	19290340	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	Cc1c(Cl)cc(C(C)Nc2ncnc3[nH]cnc23)c(-c2cccc(F)c2)c1-c1cnn(C)c1		CHEMBL4570334	=	IC50	nM	5.3	CHEMBL3130	Homo sapiens	IC50	nM	5.3
	19290341	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)Nc2ncnc3[nH]cnc23)cc(Cl)c(C)c1-c1cnn(C)c1		CHEMBL4513857	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	nM	2.8
	19290342	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)Nc2ncnc3[nH]cnc23)cc(Cl)c(C)c1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4470672	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	nM	3.6
	19290343	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)Nc2ncnc3[nH]cnc23)cc(Cl)c(C)c1-c1cncc(S(C)(=O)=O)c1		CHEMBL4446120	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	19290344	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1cncc(S(C)(=O)=O)c1		CHEMBL4438376	=	IC50	nM	0.99	CHEMBL3130	Homo sapiens	IC50	nM	0.99
	19290345	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)Nc2ncnc(N)c2C#N)cc(Cl)c(C)c1-c1ccc(C(=O)N(C)C)cn1		CHEMBL4444112	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	19290346	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c(C(C)n2ncc3c(N)ncnc32)cc(Cl)c(C)c1-c1ccnc(C(=O)N(C)C)c1		CHEMBL4468580	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	19290347	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1-c1ccnc(C(=O)N(C)C)c1		CHEMBL4458634	=	IC50	nM	0.93	CHEMBL3130	Homo sapiens	IC50	nM	0.93
	19290348	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c(C(C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1C1CCN(C)CC1		CHEMBL4465303	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19290349	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C#N)c1C1CN(C[C@H](C)O)C1		CHEMBL4593387	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	nM	1.9
	19290350	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1C1CNC(=O)C1		CHEMBL4443149	=	IC50	nM	2.4	CHEMBL3130	Homo sapiens	IC50	nM	2.4
	19290351	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1C1CNC(=O)C1		CHEMBL4561896	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	19290352	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	<	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19290353	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C#N)c1C1CNC(=O)C1		CHEMBL4574593	<	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19290451	CHEMBL4410896	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in AKT phosphorylation incubated for 2 hrs by Alexa flour 488 based FACS analysis	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	19290452	CHEMBL4410914	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-IgE antibody-induced CD63 expression by flow cast kit method	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19290458	CHEMBL4410917	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]-ATP based scintillation counting method	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
Not Active	19290480	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C#N)c1C1CNC(=O)C1		CHEMBL4574593		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19290481	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1		CHEMBL4297615		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19290482	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1C1CNC(=O)C1		CHEMBL4561896		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19290487	CHEMBL4410897	Inhibition of PI3Kdelta (unknown origin) using D-myophosphatidylinositol 4,5-bisphosphate as substrate incubated for 120 mins by [gamma-33P]ATP based SPA assay	B	COc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(C)c1C1CNC(=O)C1		CHEMBL4443149		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19290497	CHEMBL4410968	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system at 10 uM by Kinomescan method	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(=O)[nH]cnc21		CHEMBL4585005		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19313637	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4589808	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	19313644	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4583106	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19313650	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4472462	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	19313657	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4580111	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19313664	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456577	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19313671	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4590897	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19313677	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4467891	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19313684	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4453879	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	19313691	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4538734	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19313698	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	19313702	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	19313706	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4580546	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	19313713	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4435258	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	19313720	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4465671	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313727	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4514181	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	19313734	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4569614	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	19313741	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4560843	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313748	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4469156	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19313755	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4470887	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	19313762	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4463677	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	19313769	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4464201	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19313776	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4579430	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	19313783	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4469603	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313790	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4441686	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	19313797	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4468444	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	19313804	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4585433	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313811	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4468356	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19313818	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456813	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19313825	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4575913	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	19313832	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456189	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	19313839	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4472147	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19313846	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4456953	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	19313853	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4581849	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19313860	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4451928	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19313867	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4555758	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	19313874	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4465563	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313881	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4448306	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313888	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4442020	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313895	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4584477	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	19313902	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4443297	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	19313909	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4440799	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19313916	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4593752	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	19313923	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4592893	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19313930	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4473276	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19313937	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4444453	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	19313944	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CS(=O)(=O)NC1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4476490	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	19313951	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4576565	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	19313958	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4472331	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19313965	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4441333	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19313972	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4461502	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	19313979	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4532070	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	19313986	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4543271	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19313993	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4534127	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19314000	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4458909	=	IC50	nM	31.62	CHEMBL3130	Homo sapiens	pIC50		7.5
	19314007	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4437468	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	19314014	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL4568963	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19314021	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)CC1		CHEMBL4580893	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	19314028	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4472123	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19314035	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1)S(C)(=O)=O		CHEMBL4445065	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19314042	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4516194	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	19314049	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4556864	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	19314056	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4443987	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	19314063	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4473394	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19314070	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	COCC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4437860	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	19314077	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cccc5[nH]ccc45)nc(N4CCOCC4)c3s2)C1		CHEMBL4452326	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	19314084	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CNC(=O)N(C)C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4569315	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	19314091	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4580720	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	19314098	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CN(C1CCCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1)S(C)(=O)=O		CHEMBL4456215	=	IC50	nM	5.012	CHEMBL3130	Homo sapiens	pIC50		8.3
	19314105	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N[C@@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4444263	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	19314113	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N[C@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4537126	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	19314121	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)[C@@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4462986	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	19314129	CHEMBL4416685	Inhibition of PI3Kdelta (unknown origin) using biotin-PIP3 as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence polarization assay	B	CC(=O)N(C)[C@H]1CCN(Cc2cc3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3s2)C1		CHEMBL4454271	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19363832	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)cc1		CHEMBL4246563	=	IC50	nM	275.0	CHEMBL3130	Homo sapiens	IC50	nM	275.0
	19363837	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	uM	0.022
Active	19363847	CHEMBL4423394	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in Akt phosphorylation at Ser473 residues at 0.25 to 1 uM after 4 hrs by Western blot analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	19363848	CHEMBL4423395	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in mTOR phosphorylation at Ser2481 residues at 0.25 to 1 uM after 4 hrs by Western blot analysis	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363851	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccc6[nH]ccc56)cc4c32)cc1		CHEMBL4554208		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363855	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)cc1		CHEMBL4546543		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363860	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5ccc(O)cc5)cc4c32)cc1		CHEMBL4455455		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363863	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(C5CCN(C(=O)OC(C)(C)C)CC5)cc4c32)cc1		CHEMBL4576325		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363866	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	CN(C)CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(C5CCNCC5)cc4c32)cc1		CHEMBL4587769		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19363869	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5ccc(F)nc5)cc4c32)cc1		CHEMBL4535121	=	Inhibition	%	31.7	CHEMBL3130	Homo sapiens	INH	%	31.7
	19363870	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ccc(-c5ccc(F)nc5)cc4c32)cc1		CHEMBL4535121	=	IC50	nM	1270.0	CHEMBL3130	Homo sapiens	IC50	uM	1.27
Not Active	19363875	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCN(C)CC6)cc5)c4c3c2)cn1		CHEMBL4247514		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363879	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN(C)C)cc5)c4c3c2)cn1		CHEMBL4248320		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363882	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCOCC6)cc5)c4c3c2)cn1		CHEMBL4241577		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363885	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2ccc3oc4ccc(=O)n(-c5ccc(NC(=O)CN)cc5)c4c3c2)cn1		CHEMBL4580021		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19363889	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5ccc(OC)nc5)cc4c32)c1		CHEMBL4557720	=	Inhibition	%	11.3	CHEMBL3130	Homo sapiens	INH	%	11.3
	19363894	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1		CHEMBL4559706	=	Inhibition	%	58.1	CHEMBL3130	Homo sapiens	INH	%	58.1
	19363895	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1		CHEMBL4559706	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	uM	0.17
Active	19363902	CHEMBL4423383	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in Akt phosphorylation at Ser473 residues at 0.25 to 4 uM after 4 hrs by Western blot analysis	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1		CHEMBL4559706		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	19363903	CHEMBL4423384	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in mTOR phosphorylation at Ser2481 residues at 0.25 to 4 uM after 4 hrs by Western blot analysis	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5cccnc5)cc4c32)c1		CHEMBL4559706		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19363916	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5ccc(F)nc5)cc4c32)c1		CHEMBL4564014	=	Inhibition	%	34.0	CHEMBL3130	Homo sapiens	INH	%	34.0
	19363917	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1cccc(-n2c(=O)ccc3oc4ccc(-c5ccc(F)nc5)cc4c32)c1		CHEMBL4564014	=	IC50	nM	920.0	CHEMBL3130	Homo sapiens	IC50	uM	0.92
Not Active	19363922	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2cnc3oc4ccc(=O)n(-c5ccc(NC(=O)CN(C)C)cc5)c4c3c2)cn1		CHEMBL4553092		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363925	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2cnc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCNCC6)cc5)c4c3c2)cn1		CHEMBL4587749		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19363929	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	COc1ccc(-c2cnc3oc4ccc(=O)n(-c5ccc(NC(=O)CN6CCCCC6)cc5)c4c3c2)cn1		CHEMBL4549348		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19363932	CHEMBL4423373	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-gloassay relative to control	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ncc(-c5cccnc5)cc4c32)cc1		CHEMBL4528988	=	Inhibition	%	34.2	CHEMBL3130	Homo sapiens	INH	%	34.2
	19363933	CHEMBL4423374	Inhibition of PI3Kdelta (unknown origin) by ADP-gloassay	B	C=CC(=O)Nc1ccc(-n2c(=O)ccc3oc4ncc(-c5cccnc5)cc4c32)cc1		CHEMBL4528988	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	uM	1.0
	19412561	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3ccncc3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4473775	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	19412562	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2ccc(-c3ccnn3C3CCCCC3)c12		CHEMBL4584812	=	IC50	nM	405.0	CHEMBL3130	Homo sapiens	IC50	nM	405.0
	19412563	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3ccccc3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4465646	=	IC50	nM	576.0	CHEMBL3130	Homo sapiens	IC50	nM	576.0
	19412564	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4543061	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	19412565	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(=O)Nc1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4584207	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19412566	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)C(=O)c1ccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)cc1		CHEMBL4515084	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	19412567	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)C(=O)c1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4474149	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	19412568	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	NCc1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4591668	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	19412569	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	NCc1ccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)cc1		CHEMBL4473919	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	19412570	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(C(=O)O)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4514569	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	19412571	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(CO)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4470734	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	nM	27.0
	19412572	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3ccc(CO)cc3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4459638	=	IC50	nM	31.0	CHEMBL3130	Homo sapiens	IC50	nM	31.0
	19412573	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Cn1cc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)cn1		CHEMBL4435523	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	19412574	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(S(N)(=O)=O)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4557802	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	19412575	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)c1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4551707	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19412576	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(C(=O)N4CCCC4)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4450960	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19412577	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CNS(=O)(=O)c1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4464762	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	19412578	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN1CCC(n2nccc2-c2cc(-c3cccnc3)n3ncnc(N)c23)CC1		CHEMBL4470921	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	19412579	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCCC3)c12		CHEMBL4448734	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	19412580	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(C)Cn1nccc1-c1cc(-c2cccnc2)n2ncnc(N)c12		CHEMBL4543151	=	IC50	nM	252.0	CHEMBL3130	Homo sapiens	IC50	nM	252.0
	19412581	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4437707	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19412582	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCCCCC3)c12		CHEMBL4532749	=	IC50	nM	231.0	CHEMBL3130	Homo sapiens	IC50	nM	231.0
	19412583	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCS(=O)(=O)CC3)c12		CHEMBL4441785	=	IC50	nM	163.0	CHEMBL3130	Homo sapiens	IC50	nM	163.0
	19412584	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)Cc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4460644	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19412585	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)Cc1cccc(-c2cc(-c3ccnn3C3CCC(F)(F)CC3)c3c(N)ncnn23)c1		CHEMBL4471824	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	19412586	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(CN4CCOCC4)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4593143	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	nM	3.0
	19412587	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(CN4CCOCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4446562	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19412588	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(C(=O)N4CCCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4434830	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	19412589	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)C(C)(C)c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4576417	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19412590	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN(C)C1(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)COC1		CHEMBL4549504	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19412591	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(C4(N5CCOCC5)COC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4574170	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	19412592	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CS(=O)(=O)NCc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4474793	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	nM	10.0
	19412593	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(C)[C@H]1COC(=O)N1Cc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4592486	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19412594	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	Nc1ncnn2c(-c3cccc(CN4CCCC4=O)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4453817	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19412595	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC1(C)OC(=O)NC1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4438127	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19412596	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CC(C)C(=O)N1C[C@H](O)C[C@H]1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4469521	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	19412597	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN1C[C@H](O)C[C@@H]1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4533914	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19412598	CHEMBL4427866	Inhibition of PI3Kdelta (unknown origin) using PIP2:PS as substrate incubated for 3 hrs by ADP-Glo assay	B	CN1CCN(Cc2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4469985	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	19412736	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN(C)c1cccc(-c2cc(-c3ccnn3C3CCCCC3)c3c(N)ncnn23)c1		CHEMBL4551707	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	19412737	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(C(=O)N4CCCC4)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4450960	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
Not Determined	19412738	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN1CCC(n2nccc2-c2cc(-c3cccnc3)n3ncnc(N)c23)CC1		CHEMBL4470921		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412739	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCCC3)c12		CHEMBL4448734		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412740	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(C)Cn1nccc1-c1cc(-c2cccnc2)n2ncnc(N)c12		CHEMBL4543151		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412741	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4437707		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412742	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCCCCC3)c12		CHEMBL4532749		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412743	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccnc3)cc(-c3ccnn3C3CCS(=O)(=O)CC3)c12		CHEMBL4441785		IC50			CHEMBL3130	Homo sapiens	IC50		
	19412744	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN(C)Cc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4460644	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	19412745	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN(C)Cc1cccc(-c2cc(-c3ccnn3C3CCC(F)(F)CC3)c3c(N)ncnn23)c1		CHEMBL4471824	=	IC50	nM	144.0	CHEMBL3130	Homo sapiens	IC50	nM	144.0
	19412746	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(CN4CCOCC4)c3)cc(-c3ccnn3C3CCCCC3)c12		CHEMBL4593143	=	IC50	nM	58.0	CHEMBL3130	Homo sapiens	IC50	nM	58.0
	19412747	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(CN4CCOCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4446562	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	19412748	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(C(=O)N4CCCC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4434830	=	IC50	nM	8.0	CHEMBL3130	Homo sapiens	IC50	nM	8.0
	19412749	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN(C)C(C)(C)c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4576417	=	IC50	nM	118.0	CHEMBL3130	Homo sapiens	IC50	nM	118.0
	19412750	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN(C)C1(c2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)COC1		CHEMBL4549504	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19412751	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(C4(N5CCOCC5)COC4)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4574170	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
Not Determined	19412752	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CS(=O)(=O)NCc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4474793		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412753	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(C)[C@H]1COC(=O)N1Cc1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4592486		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412754	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	Nc1ncnn2c(-c3cccc(CN4CCCC4=O)c3)cc(-c3ccnn3C3CCOCC3)c12		CHEMBL4453817		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19412755	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC1(C)OC(=O)NC1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4438127		IC50			CHEMBL3130	Homo sapiens	IC50		
	19412756	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CC(C)C(=O)N1C[C@H](O)C[C@H]1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4469521	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	19412757	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN1C[C@H](O)C[C@@H]1c1cccc(-c2cc(-c3ccnn3C3CCOCC3)c3c(N)ncnn23)c1		CHEMBL4533914	=	IC50	nM	424.0	CHEMBL3130	Homo sapiens	IC50	nM	424.0
	19412758	CHEMBL4427873	Inhibition of PI3Kdelta in BCR-stimulated human B cells assessed as suppression of CD86 expression after 18 hrs by FACS analysis	B	CN1CCN(Cc2cccc(-c3cc(-c4ccnn4C4CCOCC4)c4c(N)ncnn34)c2)CC1		CHEMBL4469985	=	IC50	nM	721.0	CHEMBL3130	Homo sapiens	IC50	nM	721.0
	19429731	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2cccc(F)c12		CHEMBL4443843	=	IC50	nM	4.6	CHEMBL3130	Homo sapiens	IC50	nM	4.6
	19429732	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNCCNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4525494	=	IC50	nM	4.8	CHEMBL3130	Homo sapiens	IC50	nM	4.8
	19429733	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CC(O)C2)c1-c1ccccn1		CHEMBL4594095	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	19429734	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCNCC2)c1-c1ccccn1		CHEMBL4442808	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	19429735	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CCNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4572863	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	nM	3.6
	19429736	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
	19429737	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNCCNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4438514	=	IC50	nM	9.5	CHEMBL3130	Homo sapiens	IC50	nM	9.5
	19429738	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CC(O)C2)c1-c1ccccc1		CHEMBL4542785	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	19429739	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCNCC2)c1-c1ccccc1		CHEMBL4449576	=	IC50	nM	0.2	CHEMBL3130	Homo sapiens	IC50	nM	0.2
	19429740	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N2CCS(=O)(=O)CC2)c1-c1ccccc1		CHEMBL4449366	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
	19429741	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CC(C)NC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4461539	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	19429742	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CCNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4464055	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	19429743	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(=O)N(C)C)c1-c1ccccc1		CHEMBL4570159	=	IC50	nM	0.8	CHEMBL3130	Homo sapiens	IC50	nM	0.8
	19429744	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	CNC(=O)c1c(-c2ccccc2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4516601	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	19429745	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(C(N)=O)c1-c1ccccc1		CHEMBL4555334	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	19429746	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2c(-c2ccccn2)c1-c1ccccn1		CHEMBL3403678	=	IC50	nM	2.8	CHEMBL3130	Homo sapiens	IC50	nM	2.8
	19429747	CHEMBL4428708	Inhibition of polyHis tagged full length recombinant PI3Kdelta (unknown origin) expressed in Sf9 cells co-expressing p85 incubated for 20 mins by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1		CHEMBL4303596	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	19429949	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1		CHEMBL4303596	=	IC50	nM	10.9	CHEMBL3130	Homo sapiens	IC50	nM	10.9
	19429950	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19429951	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2cccc(F)c12		CHEMBL4443843	=	IC50	nM	18.5	CHEMBL3130	Homo sapiens	IC50	nM	18.5
	19429977	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cc2nc1-c1ccccn1		CHEMBL4303596	=	fIC50	nM	1.7	CHEMBL3130	Homo sapiens	fIC50	nM	1.7
	19429978	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2ccc(F)cc12		CHEMBL4470291	=	fIC50	nM	4.6	CHEMBL3130	Homo sapiens	fIC50	nM	4.6
	19429979	CHEMBL4428725	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of Anti-IgD antibody-induced AKT Ser473 phosphorylation pre-incubated for 60 mins before Anti-IgD antibody stimulation	B	CNC(=O)c1c(-c2ccccn2)c([C@H](C)Nc2ncnc(N)c2C#N)nc2cccc(F)c12		CHEMBL4443843	=	fIC50	nM	7.7	CHEMBL3130	Homo sapiens	fIC50	nM	7.7
	19434371	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	25.0	CHEMBL3130	Homo sapiens	IC50	uM	0.025
	19434372	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	c1ccc2ncc(-c3ccc4ncncc4c3)cc2c1		CHEMBL4450615	=	IC50	nM	8100.0	CHEMBL3130	Homo sapiens	IC50	uM	8.1
	19434373	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	c1ccc(-c2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1		CHEMBL4521863	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	uM	0.32
	19434374	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ncnc3ccc(-c4cnc5ccccc5c4)cc23)cc1OC		CHEMBL4475622	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	uM	0.061
	19434375	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	CN1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4437791	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	19434376	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1OC		CHEMBL4588314	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	19434377	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C#N		CHEMBL4467868	=	IC50	nM	27.0	CHEMBL3130	Homo sapiens	IC50	uM	0.027
	19434378	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4453497	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	19434379	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4581278	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	uM	0.02
	19434380	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cncc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4460621	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	uM	0.1
	19434381	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(N4CCC[C@H](C(=O)N5CCN(C)CC5)C4)c3c2)cn1		CHEMBL4454454	=	IC50	nM	64.0	CHEMBL3130	Homo sapiens	IC50	uM	0.064
	19434382	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	CC(=O)N1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4469006	=	IC50	nM	3.0	CHEMBL3130	Homo sapiens	IC50	uM	0.003
	19434383	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	19434384	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	19434385	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4521888	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	uM	0.005
	19434386	CHEMBL4430045	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ADP formation using phosphatidyl inositol as substrate after 30 to 60 mins by TR-FRET assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	uM	0.009
	19434416	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	CN1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4437791	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	uM	0.038
	19434417	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1OC		CHEMBL4588314	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	uM	0.018
	19434418	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C#N		CHEMBL4467868	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	uM	0.037
	19434419	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4453497	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	19434420	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4581278	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	uM	0.037
	19434421	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cncc(C(=O)N5CCN(C)CC5)c4)c3c2)cn1		CHEMBL4460621	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	uM	0.036
	19434422	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(N4CCC[C@H](C(=O)N5CCN(C)CC5)C4)c3c2)cn1		CHEMBL4454454	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	uM	0.07
	19434423	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	CC(=O)N1CCN(C(=O)c2cccc(-c3ncnc4ccc(-c5cnc6ccccc6c5)cc34)c2)CC1		CHEMBL4469006	=	IC50	nM	62.0	CHEMBL3130	Homo sapiens	IC50	uM	0.062
	19434424	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1OC		CHEMBL3944013	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	uM	0.039
	19434425	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ccc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cn1		CHEMBL3947814	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	uM	0.028
	19434426	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C(F)(F)F		CHEMBL4521888	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	uM	0.014
	19434427	CHEMBL4430048	Inhibition of human PI3Kdelta expressed in rat-1 fibroblasts assessed as reduction in Akt phosphorylation at Ser 473 after 1 hr by alphascreen assay	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	uM	0.049
	19434500	CHEMBL4430041	Inhibition of PI3Kdelta in human B cells assessed as reduction in anti-human IgM stimulated intracellular Akt phosphorylation at Ser 473 preincubated for 1.5 hrs followed by anti-human IgM stimulation for 20 mins by flow cytometry	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	uM	0.029
	19434501	CHEMBL4430055	Inhibition of PI3Kdelta in human B cells assessed as reduction in anti-human IgM stimulated CD86 expression preincubated for 1 hr followed by anti-human IgM stimulation for 24 hrs by flow cytometry	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	107.0	CHEMBL3130	Homo sapiens	IC50	uM	0.107
	19434502	CHEMBL4430056	Inhibition of PI3Kdelta in human B cells assessed as reduction in anti-human IgM stimulated CD69 expression preincubated for 1 hr followed by anti-human IgM stimulation for 24 hrs by flow cytometry	B	COc1ncc(-c2ccc3ncnc(-c4cccc(C(=O)N5CCN(C(C)=O)CC5)c4)c3c2)cc1C#N		CHEMBL3977066	=	IC50	nM	125.0	CHEMBL3130	Homo sapiens	IC50	uM	0.125
	19447013	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	19447014	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(C[C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4555271	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	nM	22.0
	19447015	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(CN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)[C@H]1CCCN1		CHEMBL4469651	=	IC50	nM	52.0	CHEMBL3130	Homo sapiens	IC50	nM	52.0
	19447016	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C([C@@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4437231	=	IC50	nM	69.0	CHEMBL3130	Homo sapiens	IC50	nM	69.0
	19447017	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C([C@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4528472	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
	19447018	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	N[C@H]1CC[C@@H](C(=O)N2CCN(c3nc(N4CCOCC4)nc(-n4c(C(F)F)nc5ccccc54)n3)CC2)CC1		CHEMBL4552784	=	IC50	nM	143.0	CHEMBL3130	Homo sapiens	IC50	nM	143.0
	19447019	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4459584	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	19447020	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4522571	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	19447021	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	O=C(O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4563601	=	IC50	nM	163.0	CHEMBL3130	Homo sapiens	IC50	nM	163.0
	19447022	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4476840	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	nM	66.0
	19447023	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4446958	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
	19447024	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	C[C@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4463324	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
	19447025	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	C[C@@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4451597	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
	19447026	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](CO)NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4553967	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	19447027	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	CC(C)[C@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4560411	=	IC50	nM	144.0	CHEMBL3130	Homo sapiens	IC50	nM	144.0
	19447028	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4466025	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	19447029	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)CNC(=O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4459749	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	19447030	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4445145	=	IC50	nM	57.0	CHEMBL3130	Homo sapiens	IC50	nM	57.0
	19447031	CHEMBL4432767	Inhibition of PI3Kdelta (unknown origin) expressed in baculovirus expression system by kinase-glo luminescence assay	B	NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4551404	=	IC50	nM	263.0	CHEMBL3130	Homo sapiens	IC50	nM	263.0
	19447055	CHEMBL4432771	Inhibition of full length His-tagged human recombinant PI3Kdelta expressed in baculovirus by select screen kinase profiling assay	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	19447056	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
	19447057	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	19447058	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C(C[C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4555271	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	19447059	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C(CN1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)[C@H]1CCCN1		CHEMBL4469651	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	19447060	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4437231	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	19447061	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	O=C([C@H]1CCCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4528472	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	19447062	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC(=O)CNC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL4476840	=	IC50	nM	171.0	CHEMBL3130	Homo sapiens	IC50	nM	171.0
	19447063	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	C[C@@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4451597	=	IC50	nM	1900.0	CHEMBL3130	Homo sapiens	IC50	nM	1900.0
	19447064	CHEMBL4432772	Inhibition of PI3Kdelta N836D mutant (unknown origin) expressed in Sf21 cells co-expressing p85 by kinase-glo luminescence assay	B	NC(=O)CNC(=O)[C@H]1CCCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)C1		CHEMBL4466025	=	IC50	nM	95.0	CHEMBL3130	Homo sapiens	IC50	nM	95.0
Active	19447065	CHEMBL4432773	Inhibition of PI3Kdelta in human NAMALWA cells assessed as suppression of Akt S473 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	19447066	CHEMBL4432773	Inhibition of PI3Kdelta in human NAMALWA cells assessed as suppression of Akt S473 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis	B	C[C@@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4451597		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	19447067	CHEMBL4432773	Inhibition of PI3Kdelta in human NAMALWA cells assessed as suppression of Akt S473 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19447068	CHEMBL4432774	Inhibition of PI3Kdelta in human NAMALWA cells assessed as S6 S240/244 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis relative to untreated control	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447069	CHEMBL4432774	Inhibition of PI3Kdelta in human NAMALWA cells assessed as S6 S240/244 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis relative to untreated control	B	O=C([C@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL3982304	<	Activity	%	20.0	CHEMBL3130	Homo sapiens	Activity	%	20.0
Not Active	19447070	CHEMBL4432774	Inhibition of PI3Kdelta in human NAMALWA cells assessed as S6 S240/244 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis relative to untreated control	B	C[C@@H](NC(=O)C1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1)C(N)=O		CHEMBL4451597		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	19447071	CHEMBL4432774	Inhibition of PI3Kdelta in human NAMALWA cells assessed as S6 S240/244 phosphorylation levels at 2.5 uM after 2 hrs by Western blot analysis relative to untreated control	B	O=C([C@@H]1CCCN1)N1CCN(c2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1		CHEMBL2322668		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447072	CHEMBL4432775	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447073	CHEMBL4432775	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447074	CHEMBL4432776	Inhibition of PI3Kdelta in human KARPAS422 cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447075	CHEMBL4432776	Inhibition of PI3Kdelta in human KARPAS422 cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447076	CHEMBL4432777	Inhibition of PI3Kdelta in human CCRF-SB cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447077	CHEMBL4432777	Inhibition of PI3Kdelta in human CCRF-SB cells assessed as reduction in AktS473 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447078	CHEMBL4432778	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447079	CHEMBL4432778	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447080	CHEMBL4432779	Inhibition of PI3Kdelta in human KARPAS422 cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447081	CHEMBL4432779	Inhibition of PI3Kdelta in human KARPAS422 cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19447082	CHEMBL4432780	Inhibition of PI3Kdelta in human CCRF-SB cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008	=	EC50	nM	100.0	CHEMBL3130	Homo sapiens	EC50	uM	0.1
Dose-dependent effect	19447083	CHEMBL4432780	Inhibition of PI3Kdelta in human CCRF-SB cells assessed as reduction in S6 phosphorylation levels by Western blot analysis	B	CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL4095008		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	19474559	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2ccc3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4468849	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	19474560	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2ccc3c(c2)COC3)cc1NS(C)(=O)=O		CHEMBL4583379	=	IC50	nM	794.33	CHEMBL3130	Homo sapiens	pIC50		6.1
	19474561	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(-c4nnc(C)o4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4593011	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	19474562	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(-c4ccccn4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4582864	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	19474563	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(NC(C)=O)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4522018	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	19474564	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(NC(=O)c4csc(C)n4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4522825	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	19474565	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc(NC(=O)c3csc(C)n3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4592637	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	19474566	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	19474567	CHEMBL4479329	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate preincubated for 15 mins followed by substrate addition measured after 60 mins in presence of biotin-labeled PIP3 by HTRF assay	B	COc1ncc(-c2cc3c(c(NC(=O)c4cccc(C)n4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4564931	=	IC50	nM	5.012	CHEMBL3130	Homo sapiens	pIC50		8.3
	19474604	CHEMBL4479336	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cytostim-induced IFNgamma production after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc(-c3ncc(CN4C[C@H](C)O[C@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O		CHEMBL4434674	=	IC50	nM	3.981	CHEMBL3130	Homo sapiens	pIC50		8.4
	19474605	CHEMBL4479336	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cytostim-induced IFNgamma production after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(-c4nnc(C)o4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4593011	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	19474606	CHEMBL4479336	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cytostim-induced IFNgamma production after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	19474607	CHEMBL4479336	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cytostim-induced IFNgamma production after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)c4cccc(C)n4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4564931	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	19474608	CHEMBL4479336	Inhibition of PI3Kdelta in human PBMC assessed as reduction in cytostim-induced IFNgamma production after 20 hrs by electrochemiluminescence assay	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	19474656	CHEMBL4479349	Ratio of IC50 for PI3Kdelta in human PBMC to IC50 for PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc3c(c(-c4nnc(C)o4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4593011	>=	Ratio IC50		10.0	CHEMBL3130	Homo sapiens	Ratio IC50		10.0
	19474657	CHEMBL4479349	Ratio of IC50 for PI3Kdelta in human PBMC to IC50 for PI3Kdelta (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)c4cccc(C)n4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4564931	>=	Ratio IC50		10.0	CHEMBL3130	Homo sapiens	Ratio IC50		10.0
	19479784	CHEMBL4480260	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	204.0	CHEMBL3130	Homo sapiens	IC50	nM	204.0
	19479785	CHEMBL4480260	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCOCC4)c3c2)cc1C#N		CHEMBL4577046	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
Not Determined	19479786	CHEMBL4480260	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN4CCCCC4)c3c2)cc1[N+](=O)[O-]		CHEMBL4587019		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	19479787	CHEMBL4480260	Inhibition of PI3Kdelta (unknown origin) assessed as reduction in ATP depletion using lipid substrate after 40 mins by Kinase-Glo luminescent assay	B	COc1ncc(-c2ccc3ncnc(NCCN(C)C)c3c2)cc1C#N		CHEMBL4539481		IC50			CHEMBL3130	Homo sapiens	IC50		
	20600209	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	N#Cc1cnc(-c2ccnc3[nH]ccc23)nc1N1C[C@@H]2C[C@H]1CN2c1cccc(F)c1		CHEMBL4646478	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	20600210	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	Cn1cc(-c2ncc(C#N)c(N3C[C@@H]4C[C@H]3CN4c3cccc(F)c3)n2)cn1		CHEMBL4639951	=	IC50	nM	2956.0	CHEMBL3130	Homo sapiens	IC50	nM	2956.0
	20600211	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	N#Cc1cnc(N2Cc3cn[nH]c3C2)nc1N1C[C@@H]2C[C@H]1CN2c1cccc(F)c1		CHEMBL4643865	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	20600212	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	Cn1cc(-c2ncc(C#N)c(N3C[C@@H]4C[C@H]3CN4C(=O)C3CC3)n2)cn1		CHEMBL4635168	=	IC50	nM	258.0	CHEMBL3130	Homo sapiens	IC50	nM	258.0
	20600213	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	Cn1cc(-c2ncc(C#N)c(N3C[C@@H]4C[C@H]3CN4S(=O)(=O)C3CC3)n2)cn1		CHEMBL4635364	=	IC50	nM	4115.0	CHEMBL3130	Homo sapiens	IC50	nM	4115.0
	20600214	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	Cn1cc(-c2ncc(C#N)c(N3C[C@@H]4C[C@H]3CN4CC3CC3)n2)cn1		CHEMBL4640850	=	IC50	nM	6968.0	CHEMBL3130	Homo sapiens	IC50	nM	6968.0
	20600215	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2nc(-c3cnn(C)c3)ncc2C#N)CCN1c1cccc(F)c1		CHEMBL4647402	=	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	20600216	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	CCC(=O)N1CCN(c2nc(-c3cnn(C)c3)ncc2C#N)C[C@H]1C		CHEMBL4639546	=	IC50	nM	2316.0	CHEMBL3130	Homo sapiens	IC50	nM	2316.0
	20600217	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2nc(-c3cnn(C)c3)ncc2C#N)CCN1C(=O)C1CC1		CHEMBL4642225	=	IC50	nM	329.0	CHEMBL3130	Homo sapiens	IC50	nM	329.0
	20600218	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2nc(-c3cnn(C)c3)ncc2C#N)CCN1C(=O)C1CCC1		CHEMBL4637750	=	IC50	nM	1562.0	CHEMBL3130	Homo sapiens	IC50	nM	1562.0
	20600219	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2nc(-c3cnn(C)c3)ncc2C#N)CCN1C(=O)C1(C)CC1		CHEMBL4646437	=	IC50	nM	5707.0	CHEMBL3130	Homo sapiens	IC50	nM	5707.0
	20600220	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	CC1CC1C(=O)N1CCN(c2nc(-c3cnn(C)c3)ncc2C#N)C[C@H]1C		CHEMBL4642953	=	IC50	nM	557.0	CHEMBL3130	Homo sapiens	IC50	nM	557.0
	20600221	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2nc(-c3cnn(C)c3)ncc2C#N)C[C@H]1C		CHEMBL4633285	=	IC50	nM	187.0	CHEMBL3130	Homo sapiens	IC50	nM	187.0
	20600222	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2ncc(C#N)c(-c3cnn(C)c3)n2)CCN1C(=O)C1CC1		CHEMBL4648622	=	IC50	nM	764.0	CHEMBL3130	Homo sapiens	IC50	nM	764.0
	20600223	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2nc(-c3cnn(C)c3)cnc2C#N)CCN1C(=O)C1CC1		CHEMBL4649678	=	IC50	nM	737.0	CHEMBL3130	Homo sapiens	IC50	nM	737.0
	20600224	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1CN(c2cnc(C#N)c(-c3cnn(C)c3)n2)CCN1C(=O)C1CC1		CHEMBL4637209	=	IC50	nM	219.0	CHEMBL3130	Homo sapiens	IC50	nM	219.0
	20600225	CHEMBL4603237	Inhibition of PI3K delta in human whole blood assessed as inhibition of anti-IgE-stimulated CysLt release in basophils preincubated for 30 mins followed by anti-IgE stimulation and measured after 20 mins	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	65.0	CHEMBL3130	Homo sapiens	IC50	nM	65.0
	20600428	CHEMBL4603321	Inhibition of PI3K delta (unknown origin) by Adapta assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	<	IC50	nM	10.0	CHEMBL3130	Homo sapiens	IC50	uM	0.01
	20670757	CHEMBL4620661	Inhibition of human PI3K p110delta by HTRF assay	B	CNC(=O)c1cc2c(N3CCOCC3)nc(-c3cnc(N)cc3C(F)(F)F)nn2c1		CHEMBL4633095	=	IC50	nM	119.0	CHEMBL3130	Homo sapiens	IC50	nM	119.0
	20670758	CHEMBL4620661	Inhibition of human PI3K p110delta by HTRF assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	20676474	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNCc1ccc2c(c1)N(c1cnc(OC)c(S(=O)(=O)NC)c1)CCO2		CHEMBL4644887	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	20676475	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNS(=O)(=O)c1cc(N2CCOc3ccc(CN(C)C)cc32)cnc1OC		CHEMBL4646294	=	IC50	nM	2511.89	CHEMBL3130	Homo sapiens	pIC50		5.6
	20676476	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNC(=O)c1ccc2c(c1)N(c1cnc(OC)c(S(=O)(=O)NC)c1)CCO2		CHEMBL4632789	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	20676477	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNS(=O)(=O)c1cc(N2CCOc3ccc(C(=O)N(C)C)cc32)cnc1OC		CHEMBL4645872	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	20676478	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNCc1ccc2c(c1)N(c1cnc(OC)c(NS(C)(=O)=O)c1)CCO2		CHEMBL4636609	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	20676479	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(N2CCOc3ccc(CN(C)C)cc32)cc1NS(C)(=O)=O		CHEMBL4645570	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	20676480	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	CNC(=O)c1ccc2c(c1)N(c1cnc(OC)c(NS(C)(=O)=O)c1)CCO2		CHEMBL4646806	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	20676481	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(N2CCOc3ccc(C(=O)N(C)C)cc32)cc1NS(C)(=O)=O		CHEMBL4634067	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	20676482	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4649680	=	IC50	nM	7943.28	CHEMBL3130	Homo sapiens	pIC50		5.1
	20676483	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCN(C)C(=O)c1ccc3c(c1)N2CCO3		CHEMBL4633464	=	IC50	nM	12589.25	CHEMBL3130	Homo sapiens	pIC50		4.9
	20676484	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4638471	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	20676485	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCN(C)C(=O)c1ccc3c(c1)N2CCO3		CHEMBL4649257	=	IC50	nM	125.89	CHEMBL3130	Homo sapiens	pIC50		6.9
	20676486	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCNCc1ccc3c(c1)N2CCO3		CHEMBL4637133	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	20676487	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4640147	=	IC50	nM	1258.93	CHEMBL3130	Homo sapiens	pIC50		5.9
	20676488	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCNC(=O)c1ccc3c(c1)N2CCO3		CHEMBL4646959	=	IC50	nM	398.11	CHEMBL3130	Homo sapiens	pIC50		6.4
	20676489	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCN(C)C(=O)c1ccc3c(c1)N2CCO3		CHEMBL4632521	=	IC50	nM	6309.57	CHEMBL3130	Homo sapiens	pIC50		5.2
	20676490	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCCNCc1ccc3c(c1)N2CCO3		CHEMBL4633472	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	pIC50		7.0
	20676491	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCCNC(=O)c1ccc3c(c1)N2CCO3		CHEMBL4636926	=	IC50	nM	15.85	CHEMBL3130	Homo sapiens	pIC50		7.8
	20676492	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCCNCc1ccc3c(c1)N2CCO3		CHEMBL4647230	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	20676493	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4632438	=	IC50	nM	251.19	CHEMBL3130	Homo sapiens	pIC50		6.6
	20676494	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCCNC(=O)c1ccc3c(c1)N2CCO3		CHEMBL4647878	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	20676495	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1S(=O)(=O)NCCCCN(C)C(=O)c1ccc3c(c1)N2CCO3		CHEMBL4641762	=	IC50	nM	630.96	CHEMBL3130	Homo sapiens	pIC50		6.2
	20676496	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCCCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4640045	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	20676497	CHEMBL4621798	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc2cc1NS(=O)(=O)CCCCN(C)C(=O)c1ccc3c(c1)N2CCO3		CHEMBL4649799	=	IC50	nM	501.19	CHEMBL3130	Homo sapiens	pIC50		6.3
	20676498	CHEMBL4621799	Binding affinity to PI3Kdelta (unknown origin) by SPR based van't Hoff analysis	B	COc1ncc(N2CCOc3ccc(CN(C)C)cc32)cc1NS(C)(=O)=O		CHEMBL4645570	=	Kd	nM	251.19	CHEMBL3130	Homo sapiens	pKd		6.6
	20676502	CHEMBL4621803	Inhibition of PI3Kdelta in whole blood (unknown origin) assessed as reduction in cytostim-induced IFNgamma production	B	COc1ncc(N2CCOc3ccc(CN(C)C)cc32)cc1NS(C)(=O)=O		CHEMBL4645570	=	IC50	nM	1584.89	CHEMBL3130	Homo sapiens	pIC50		5.8
	20676519	CHEMBL4621799	Binding affinity to PI3Kdelta (unknown origin) by SPR based van't Hoff analysis	B	COc1ncc2cc1NS(=O)(=O)CCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4638471	=	Kd	nM	3.981	CHEMBL3130	Homo sapiens	pKd		8.4
	20676523	CHEMBL4621803	Inhibition of PI3Kdelta in whole blood (unknown origin) assessed as reduction in cytostim-induced IFNgamma production	B	COc1ncc2cc1NS(=O)(=O)CCN(C)Cc1ccc3c(c1)N2CCO3		CHEMBL4638471	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	20677476	CHEMBL4621934	Inhibition of PI3Kdelta in human Jeko1 cells assessed as reduction in AKT phosphorylation at residue S473 measured after 2 hrs by sandwich ELISA	A	CNC(=O)[C@H](C)Cn1cnc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4Cl)c3)cc2c1=O		CHEMBL4632970	=	IC50	nM	183.0	CHEMBL3130	Homo sapiens	IC50	nM	183.0
	22391704	CHEMBL4666974	Inhibition of recombinant human His-tagged full length PI3Kdelta expressed in baculovirus expression system using PIP:PS as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	7.0	CHEMBL3130	Homo sapiens	INH	%	7.0
	22391705	CHEMBL4666974	Inhibition of recombinant human His-tagged full length PI3Kdelta expressed in baculovirus expression system using PIP:PS as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	6.0	CHEMBL3130	Homo sapiens	INH	%	6.0
	22391706	CHEMBL4666974	Inhibition of recombinant human His-tagged full length PI3Kdelta expressed in baculovirus expression system using PIP:PS as substrate at 0.1 uM incubated for 60 mins by Adapta assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	6.0	CHEMBL3130	Homo sapiens	INH	%	6.0
Not Determined	22392393	CHEMBL4667356	Inhibition of PI3Kdelta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(C)(=O)=O		CHEMBL4745877		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	22392394	CHEMBL4667356	Inhibition of PI3Kdelta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4780201	=	IC50	nM	0.48	CHEMBL3130	Homo sapiens	IC50	nM	0.48
	22392395	CHEMBL4667356	Inhibition of PI3Kdelta (unknown origin) using lipid as substrate incubated for 15 mins followed by substrate addition and measured after 60 mins ADPGloTM reagent based assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	22419650	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2ccn3ncc(-c4ccc5c(c4)[C@](C)(Cc4ccccc4)C(=O)N5)c3n2)cn1		CHEMBL4452905	=	IC50	nM	48.0	CHEMBL3130	Homo sapiens	IC50	nM	48.0
	22419651	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2ccn3ncc(-c4ccc5c(c4)[C@](C)(CC4CC4)C(=O)N5)c3n2)cn1		CHEMBL4795757	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	22419652	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cn1cnc2c(-c3ccc4c(c3)[C@](C)(Cc3ccccc3)C(=O)N4)ncnc21		CHEMBL4791004	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	nM	250.0
	22419653	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cn1cnc2c(-c3ccc4c(c3)[C@](C)(CC3CC3)C(=O)N4)ncnc21		CHEMBL4800583	=	IC50	nM	450.0	CHEMBL3130	Homo sapiens	IC50	nM	450.0
	22419654	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1ncc(-c2nc3c(-c4ccc5c(c4)[C@](C)(CC4CC4)C(=O)N5)ncnc3n2C)c1C		CHEMBL4792586	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	22419655	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2nc3c(-c4ccc5c(c4)[C@](C)(CC4CC4)C(=O)N5)ncnc3n2C)cn1		CHEMBL4745746	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
	22419656	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(CC3CC3)C(=O)N4)ncnc21		CHEMBL4778656	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
	22419657	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(Cc3ccccc3)C(=O)N4)ncnc21		CHEMBL4744546	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	22419658	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(Cc3ccccc3)NC4=O)ncnc21		CHEMBL4750236	=	IC50	nM	230.0	CHEMBL3130	Homo sapiens	IC50	nM	230.0
	22419659	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(c3ccccc3)C(=O)N4)ncnc21		CHEMBL4762936	=	IC50	nM	85.0	CHEMBL3130	Homo sapiens	IC50	nM	85.0
	22419660	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(CC3COC3)C(=O)N4)ncnc21		CHEMBL4744508	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	nM	570.0
	22419661	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(CC3CCO3)C(=O)N4)ncnc21		CHEMBL4761378	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	22419662	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(NC3CCC3)C(=O)N4)ncnc21		CHEMBL4779781	=	IC50	nM	130.0	CHEMBL3130	Homo sapiens	IC50	nM	130.0
	22419663	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(N[C@H]3CCOC3)C(=O)N4)ncnc21		CHEMBL4753205	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	22419664	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(NCC(C)(C)F)C(=O)N4)ncnc21		CHEMBL4743715	=	IC50	nM	72.0	CHEMBL3130	Homo sapiens	IC50	nM	72.0
	22419665	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(NCC(C)(F)F)C(=O)N4)ncnc21		CHEMBL4745624	=	IC50	nM	190.0	CHEMBL3130	Homo sapiens	IC50	nM	190.0
	22419666	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@](C)(N3CC(C)(OC)C3)C(=O)N4)ncnc21		CHEMBL4781592	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	22419667	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(NC3CCC3)C(=O)N4)ncnc21		CHEMBL4781485	=	IC50	nM	440.0	CHEMBL3130	Homo sapiens	IC50	nM	440.0
	22419668	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2nc3c(-c4cnc5c(c4)[C@](C)(N[C@H]4CCOC4)C(=O)N5)ncnc3n2C)cn1		CHEMBL4800086	=	IC50	nM	320.0	CHEMBL3130	Homo sapiens	IC50	nM	320.0
	22419669	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(N[C@H]3CCOC3)C(=O)N4)ncnc21		CHEMBL4743750	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
	22419670	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(NCC(C)(C)F)C(=O)N4)ncnc21		CHEMBL4750385	=	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
	22419671	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(N3CC(C)(OC)C3)C(=O)N4)ncnc21		CHEMBL4745502	=	IC50	nM	180.0	CHEMBL3130	Homo sapiens	IC50	nM	180.0
	22419672	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@@]3(CCCN3C(C)C)C(=O)N4)ncnc21		CHEMBL4748947	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	22419673	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2nc3c(-c4ccc5c(c4)[C@@]4(CCCN4C(=O)C4CC4)C(=O)N5)ncnc3n2C)cn1		CHEMBL4757468	=	IC50	nM	55.0	CHEMBL3130	Homo sapiens	IC50	nM	55.0
	22419674	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@@]3(CCCN3C(=O)C3CC3)C(=O)N4)ncnc21		CHEMBL4787672	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	22419675	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	Cc1ncc(-c2nc3c(-c4ccc5c(c4)[C@@]4(CCCN4C(=O)C4CC4)C(=O)N5C)ncnc3n2C)cn1		CHEMBL4776201	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	nM	71.0
	22419676	CHEMBL4673080	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-induced AKT phosphorylation at Ser473 residue preincubated for 20 mins followed by anti-IgM stimulation for 30 mins	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@@]3(CCCN3C(=O)C3CC3)C(=O)N4C)ncnc21		CHEMBL4754014	=	IC50	nM	30.0	CHEMBL3130	Homo sapiens	IC50	nM	30.0
	22419677	CHEMBL4673081	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(N[C@H]3CCOC3)C(=O)N4)ncnc21		CHEMBL4743750	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	nM	84.0
	22419678	CHEMBL4673081	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(NCC(C)(C)F)C(=O)N4)ncnc21		CHEMBL4750385	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	nM	80.0
	22419679	CHEMBL4673081	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	Cc1ncc(-c2nc3c(-c4ccc5c(c4)[C@@]4(CCCN4C(=O)C4CC4)C(=O)N5C)ncnc3n2C)cn1		CHEMBL4776201	=	IC50	nM	38.0	CHEMBL3130	Homo sapiens	IC50	nM	38.0
	22419680	CHEMBL4673081	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@@]3(CCCN3C(=O)C3CC3)C(=O)N4C)ncnc21		CHEMBL4754014	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	nM	71.0
	22419901	CHEMBL4673107	Inhibition of PI3Kdelta in human whole blood assessed as unbound drug concentration required for reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(N[C@H]3CCOC3)C(=O)N4)ncnc21		CHEMBL4743750	=	fIC50	nM	50.0	CHEMBL3130	Homo sapiens	fIC50	nM	50.0
	22419902	CHEMBL4673107	Inhibition of PI3Kdelta in human whole blood assessed as unbound drug concentration required for reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3cnc4c(c3)[C@](C)(NCC(C)(C)F)C(=O)N4)ncnc21		CHEMBL4750385	=	fIC50	nM	40.0	CHEMBL3130	Homo sapiens	fIC50	nM	40.0
	22419903	CHEMBL4673107	Inhibition of PI3Kdelta in human whole blood assessed as unbound drug concentration required for reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	Cc1ncc(-c2nc3c(-c4ccc5c(c4)[C@@]4(CCCN4C(=O)C4CC4)C(=O)N5C)ncnc3n2C)cn1		CHEMBL4776201	=	fIC50	nM	13.0	CHEMBL3130	Homo sapiens	fIC50	nM	13.0
	22419904	CHEMBL4673107	Inhibition of PI3Kdelta in human whole blood assessed as unbound drug concentration required for reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation for 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(-c3ccc4c(c3)[C@@]3(CCCN3C(=O)C3CC3)C(=O)N4C)ncnc21		CHEMBL4754014	=	fIC50	nM	23.0	CHEMBL3130	Homo sapiens	fIC50	nM	23.0
	22421719	CHEMBL4673692	Inhibition of PI3K-delta (unknown origin) by HTRF assay	B	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21		CHEMBL3545097	>	IC50	nM	200.0	CHEMBL3130	Homo sapiens	IC50	nM	200.0
	22441640	CHEMBL4678713	Inhibition of recombinant human full length His-tagged PI3Kdelta expressed in baculovirus expression system using PIP2 as substrate by ADP-Glo reagent based assay	B	COc1ncc(-c2cc3c(N4CCOCC4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4745332	=	IC50	nM	3.9	CHEMBL3130	Homo sapiens	IC50	nM	3.9
	22441641	CHEMBL4678713	Inhibition of recombinant human full length His-tagged PI3Kdelta expressed in baculovirus expression system using PIP2 as substrate by ADP-Glo reagent based assay	B	COc1ncc(-c2nc3c(N4CCOCC4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4798343	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	22463040	CHEMBL4683367	Inhibition of human PI3Kdelta by ADP-Glo kinase assay	A	CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1		CHEMBL3325608	=	IC50	nM	3096.0	CHEMBL3130	Homo sapiens	IC50	nM	3096.0
	22463041	CHEMBL4683367	Inhibition of human PI3Kdelta by ADP-Glo kinase assay	A	CNC(=O)c1cncc(-c2cnc(Cl)c(NS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4752128	=	IC50	nM	104.0	CHEMBL3130	Homo sapiens	IC50	nM	104.0
	22488638	CHEMBL4689250	Inhibition of PI3Kdelta (unknown origin) measured after 1 hr by ADP-glo plus luminescence assay	B	O=S(=O)(c1ccc(O)cc1)N1CCN(c2nc(NCCN3CCOCC3)nc(N3CCOCC3)n2)CC1		CHEMBL4789747	=	IC50	nM	35.3	CHEMBL3130	Homo sapiens	IC50	nM	35.3
	22759649	CHEMBL4701777	Inhibition of human PI3kdelta at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)c1ccc(Oc2nc(-c3cnc(N)s3)nc(N3CCOCC3)n2)cc1		CHEMBL4782133	=	Inhibition	%	88.0	CHEMBL3130	Homo sapiens	INH	%	88.0
	22775085	CHEMBL4705402	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in anti-IgM stimulated AKT T308 phosphorylation incubated for 1 hr by Western blot analysis	B	CC[C@@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4781849	=	EC50	nM	67.0	CHEMBL3130	Homo sapiens	EC50	nM	67.0
	22775091	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	22775092	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F		CHEMBL3948730	=	IC50	nM	48.4	CHEMBL3130	Homo sapiens	IC50	nM	48.4
	22775093	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3-c3ccccc3)c3ncnc(N)c23)cc1F		CHEMBL4745977	=	IC50	nM	61.0	CHEMBL3130	Homo sapiens	IC50	nM	61.0
	22775094	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3-c3ccc(-c4ccccc4)cc3)c3ncnc(N)c23)cc1F		CHEMBL4782662	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	22775095	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3Cc3ccccc3)c3ncnc(N)c23)cc1F		CHEMBL4757731	=	IC50	nM	2368.0	CHEMBL3130	Homo sapiens	IC50	nM	2368.0
	22775096	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3-c3cnn(C)c3)c3ncnc(N)c23)cc1F		CHEMBL4797255	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	nM	53.0
	22775097	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3C3CCCCC3)c3ncnc(N)c23)cc1F		CHEMBL4760103	=	IC50	nM	608.0	CHEMBL3130	Homo sapiens	IC50	nM	608.0
	22775098	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3C3CCCC3)c3ncnc(N)c23)cc1F		CHEMBL4788763	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	22775099	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(c3nc4cccc(F)c4c(=O)n3C)C3CCC3)c3ncnc(N)c23)cc1F		CHEMBL4755404	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	22775100	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3C3CC3)c3ncnc(N)c23)cc1F		CHEMBL4800386	=	IC50	nM	18.0	CHEMBL3130	Homo sapiens	IC50	nM	18.0
	22775101	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3CC(C)C)c3ncnc(N)c23)cc1F		CHEMBL4793082	=	IC50	nM	40.0	CHEMBL3130	Homo sapiens	IC50	nM	40.0
	22775102	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3C(C)C)c3ncnc(N)c23)cc1F		CHEMBL4776308	=	IC50	nM	51.0	CHEMBL3130	Homo sapiens	IC50	nM	51.0
	22775103	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCn1c(C(C)n2nc(-c3ccc(OC)c(F)c3)c3c(N)ncnc32)nc2cccc(F)c2c1=O		CHEMBL4760455	=	IC50	nM	45.0	CHEMBL3130	Homo sapiens	IC50	nM	45.0
	22775104	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2nn(C(C)c3nc4cccc(F)c4c(=O)n3C)c3ncnc(N)c23)cc1F		CHEMBL4782030	=	IC50	nM	53.0	CHEMBL3130	Homo sapiens	IC50	nM	53.0
	22775105	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4746208	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	22775106	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1ncc2c(N)ncnc21		CHEMBL4757709	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	22775107	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccccc2)c2c(N)ncnc21		CHEMBL4760467	=	IC50	nM	2190.0	CHEMBL3130	Homo sapiens	IC50	nM	2190.0
	22775108	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)cc2)c2c(N)ncnc21		CHEMBL4790707	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	22775109	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(OC)c2)c2c(N)ncnc21		CHEMBL4796454	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	22775110	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(C)c2)c2c(N)ncnc21		CHEMBL4787521	=	IC50	nM	85.0	CHEMBL3130	Homo sapiens	IC50	nM	85.0
	22775111	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC(C)C)c(F)c2)c2c(N)ncnc21		CHEMBL4759176	=	IC50	nM	1749.0	CHEMBL3130	Homo sapiens	IC50	nM	1749.0
	22775112	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(C(=O)NC)cc2)c2c(N)ncnc21		CHEMBL4758236	=	IC50	nM	532.0	CHEMBL3130	Homo sapiens	IC50	nM	532.0
	22775113	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(NC(C)=O)cc2)c2c(N)ncnc21		CHEMBL4753627	=	IC50	nM	156.0	CHEMBL3130	Homo sapiens	IC50	nM	156.0
	22775114	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4785709	=	IC50	nM	1520.0	CHEMBL3130	Homo sapiens	IC50	nM	1520.0
	22775115	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL4798208	=	IC50	nM	2234.0	CHEMBL3130	Homo sapiens	IC50	nM	2234.0
	22775116	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2cnn(C)c2)c2c(N)ncnc21		CHEMBL4740560	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	22775117	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CCC(c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccsc2)c2c(N)ncnc21		CHEMBL4796458	=	IC50	nM	868.0	CHEMBL3130	Homo sapiens	IC50	nM	868.0
	22775118	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CC[C@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4756224	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
	22775119	CHEMBL4705408	Inhibition of human PI3Kdelta using substrate PIP2:PS and ATP incubated for 1 hr by ADP-Glo assay	B	CC[C@@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4781849	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
Active	22775207	CHEMBL4705412	Binding affinity to human PI3Kdelta at 1 uM by KINOMEscan binding assay	B	CC[C@@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc21		CHEMBL4781849		Activity			CHEMBL3130	Homo sapiens	Activity		
Not Determined	22780745	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851		IC50			CHEMBL3130	Homo sapiens	IC50		
	22780746	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ccc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4785064	=	IC50	nM	301.0	CHEMBL3130	Homo sapiens	IC50	nM	301.0
	22780747	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	O=C(CCCCCCn1cnc2c(N3CCOCC3)nc(-c3cccc(CO)c3)nc21)NO		CHEMBL4749655	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	22780748	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	O=C(CCCCCCn1cnc2c(N3CCOCC3)nc(-c3cccc(CO)c3)nc21)NO		CHEMBL4749655	=	Kd	nM	41.0	CHEMBL3130	Homo sapiens	Kd	nM	41.0
	22780749	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4787267	=	IC50	nM	133.0	CHEMBL3130	Homo sapiens	IC50	nM	133.0
	22780750	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	COc1ncc(-c2nc(N3CCOCC3)c3ncn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4799530	=	IC50	nM	331.0	CHEMBL3130	Homo sapiens	IC50	nM	331.0
	22780751	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4744689	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
	22780752	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4744689	=	Kd	nM	240.0	CHEMBL3130	Homo sapiens	Kd	nM	240.0
	22780753	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	6.3	CHEMBL3130	Homo sapiens	IC50	nM	6.3
	22780754	CHEMBL4707178	Inhibition of human PI3Kdelta incubated for 1 hr by ADP-Glo kinase assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	11.0	CHEMBL3130	Homo sapiens	IC50	nM	11.0
	22781420	CHEMBL4707347	Inhibition of human wild type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan method	B	O=C(CCCCCCn1cnc2c(N3CCOCC3)nc(-c3cccc(CO)c3)nc21)NO		CHEMBL4749655	=	Kd	nM	41.0	CHEMBL3130	Homo sapiens	Kd	nM	41.0
	22781421	CHEMBL4707347	Inhibition of human wild type partial length PI3Kdelta (R108 to Q1044 residues) expressed in mammalian expression system by Kinomescan method	B	Nc1ncc(-c2nc(N3CCOCC3)c3ccn(CCCCCCC(=O)NO)c3n2)cn1		CHEMBL4744689	=	Kd	nM	240.0	CHEMBL3130	Homo sapiens	Kd	nM	240.0
	22800306	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Oc2ncnc3ccc(-c4cccnc4)cc23)c1		CHEMBL4748164	=	Inhibition	%	41.8	CHEMBL3130	Homo sapiens	INH	%	41.8
	22800307	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Oc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)c1		CHEMBL4786191	=	Inhibition	%	29.5	CHEMBL3130	Homo sapiens	INH	%	29.5
	22800308	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Oc2ncnc3ccc(-c4ccc(Cl)nc4)cc23)c1		CHEMBL4759080	=	Inhibition	%	33.1	CHEMBL3130	Homo sapiens	INH	%	33.1
	22800309	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Oc2ncnc3ccc(-c4ccc(F)nc4)cc23)c1		CHEMBL4755943	=	Inhibition	%	23.4	CHEMBL3130	Homo sapiens	INH	%	23.4
	22800310	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Inhibition	%	66.3	CHEMBL3130	Homo sapiens	INH	%	66.3
	22800311	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Nc2ncnc3ccc(-c4ccc(Cl)nc4)cc23)c1		CHEMBL4783317	=	Inhibition	%	64.6	CHEMBL3130	Homo sapiens	INH	%	64.6
	22800312	CHEMBL4711310	Inhibition of PI3Kdelta (unknown origin) at 200 nM by ADP-Glo kinase assay relative to control	B	C=CC(=O)Nc1cccc(Nc2ncnc3ccc(-c4ccc(F)nc4)cc23)c1		CHEMBL4791688	=	Inhibition	%	46.6	CHEMBL3130	Homo sapiens	INH	%	46.6
	22800313	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)c1		CHEMBL4758031	=	IC50	nM	116.8	CHEMBL3130	Homo sapiens	IC50	nM	116.8
	22800314	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	C=CC(=O)Nc1cccc(Nc2ncnc3ccc(-c4ccc(Cl)nc4)cc23)c1		CHEMBL4783317	=	IC50	nM	104.0	CHEMBL3130	Homo sapiens	IC50	nM	104.0
	22800315	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	IC50	nM	56.75	CHEMBL3130	Homo sapiens	IC50	nM	56.75
	22800316	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	C/C=C/C(=O)Nc1cccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)c1		CHEMBL4740812	=	IC50	nM	129.3	CHEMBL3130	Homo sapiens	IC50	nM	129.3
	22800317	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	CC#CC(=O)Nc1cccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)c1		CHEMBL4787781	=	IC50	nM	409.8	CHEMBL3130	Homo sapiens	IC50	nM	409.8
	22800318	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	C=CC(=O)Nc1cc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)ccc1C		CHEMBL4796749	=	IC50	nM	27.5	CHEMBL3130	Homo sapiens	IC50	nM	27.5
	22800319	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	C=CC(=O)N1CCc2ccc(Nc3ncnc4ccc(-c5cnc6ccccc6c5)cc34)cc21		CHEMBL4741573	=	IC50	nM	495.2	CHEMBL3130	Homo sapiens	IC50	nM	495.2
	22800320	CHEMBL4711311	Inhibition of PI3Kdelta (unknown origin) by ADP-Glo kinase assay	B	CCC(=O)Nc1cccc(Nc2ncnc3ccc(-c4cnc5ccccc5c4)cc23)c1		CHEMBL4783183	=	IC50	nM	21.0	CHEMBL3130	Homo sapiens	IC50	nM	21.0
	22806086	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3901131	=	IC50	nM	92.0	CHEMBL3130	Homo sapiens	IC50	nM	92.0
	22806087	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(=O)N1CC[C@@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3949404	=	IC50	nM	74.0	CHEMBL3130	Homo sapiens	IC50	nM	74.0
	22806088	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CNC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3938876	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	22806089	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3963659	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	22806090	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	C[C@]1(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)CCN(S(C)(=O)=O)C1		CHEMBL3908620	=	IC50	nM	76.0	CHEMBL3130	Homo sapiens	IC50	nM	76.0
	22806091	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CNS(=O)(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3970592	=	IC50	nM	44.0	CHEMBL3130	Homo sapiens	IC50	nM	44.0
	22806092	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3920965	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	22806093	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)(O)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3954652	=	IC50	nM	150.0	CHEMBL3130	Homo sapiens	IC50	nM	150.0
	22806094	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)(N)C(=O)N1CC[C@](C)(N2CCc3c(-c4cnc(N)nc4)nc(N4CCOCC4)nc32)C1		CHEMBL3932221	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	22806095	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](C)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4754889	=	IC50	nM	460.0	CHEMBL3130	Homo sapiens	IC50	nM	460.0
	22806096	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)(C)OC(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4780701	=	IC50	nM	1200.0	CHEMBL3130	Homo sapiens	IC50	nM	1200.0
	22806097	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CC(C)C(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4742651	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	22806098	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4764484	=	IC50	nM	2300.0	CHEMBL3130	Homo sapiens	IC50	nM	2300.0
	22806099	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	CS(=O)(=O)N1CC[C@](CO)(Nc2cc(-c3cnc(N)nc3)nc(N3CCOCC3)n2)C1		CHEMBL4747197	>	IC50	nM	10000.0	CHEMBL3130	Homo sapiens	IC50	nM	10000.0
	22806100	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	Nc1ncc(-c2cc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)nc(N3CCOCC3)n2)cn1		CHEMBL4778025	=	IC50	nM	1000.0	CHEMBL3130	Homo sapiens	IC50	nM	1000.0
	22806101	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	COC(=O)N1CC[C@](CO)(Nc2nc(N3CCOCC3)nc(-c3cnc(N)nc3)c2F)C1		CHEMBL4752678	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	22806102	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	Nc1ncc(-c2nc(N3CCOCC3)nc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)c2F)cn1		CHEMBL4756555	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	nM	160.0
	22806103	CHEMBL4712571	Inhibition of recombinant human N-terminal Myr signal and C-terminal Flag-tagged PI3K p110delta expressed in rat Rat1 cells	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	510.0	CHEMBL3130	Homo sapiens	IC50	nM	510.0
	22815904	CHEMBL4714750	Inhibition of wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	CNC(=O)CN(Cc1ccccc1OC(F)F)C(=O)c1c[nH]c(C(=O)N2Cc3ccc(C(N)=O)cc3C2)n1		CHEMBL4752978	>	Inhibition	%	65.0	CHEMBL3130	Homo sapiens	INH	%	65.0
	22819513	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cccc(F)c1		CHEMBL4762294	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0083
	22819514	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cncc(F)c1		CHEMBL4754382	=	IC50	nM	6.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0065
	22819515	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@@H](Nc1ncnc(N)c1C#N)c1nc2cc(F)ccc2n1-c1cccc(S(C)(=O)=O)c1		CHEMBL4759169	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	22819516	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2cc(F)ccc2n1-c1cccc(S(C)(=O)=O)c1		CHEMBL4763925	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0083
	22819517	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccc(F)cc1		CHEMBL4780867	=	IC50	nM	57.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0573
	22819518	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cc(F)cc(F)c1		CHEMBL4790186	=	IC50	nM	4.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0044
	22819519	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1		CHEMBL2216895	=	IC50	nM	1.9	CHEMBL3130	Homo sapiens	IC50	uM	0.0019
	22819520	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccn1		CHEMBL4784595	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	uM	0.016
	22819521	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cccnc1		CHEMBL4763849	=	IC50	nM	6.4	CHEMBL3130	Homo sapiens	IC50	uM	0.0064
	22819522	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2cc(F)ccc2n1-c1cccc(S(C)(=O)=O)c1		CHEMBL4763925	=	IC50	nM	8.3	CHEMBL3130	Homo sapiens	IC50	uM	0.0083
	22819523	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@@H](Nc1ncnc(N)c1C#N)c1nc2cc(F)ccc2n1-c1cccc(S(C)(=O)=O)c1		CHEMBL4759169	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	22819524	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1S(C)(=O)=O		CHEMBL4800111	=	IC50	nM	250.0	CHEMBL3130	Homo sapiens	IC50	uM	0.25
	22819525	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1cccc(S(C)(=O)=O)c1		CHEMBL4756034	=	IC50	nM	142.0	CHEMBL3130	Homo sapiens	IC50	uM	0.142
	22819526	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1ccccc1S(C)(=O)=O		CHEMBL4740720	=	IC50	nM	282.0	CHEMBL3130	Homo sapiens	IC50	uM	0.282
	22819527	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1cc(F)cc(F)c1		CHEMBL4745140	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	uM	0.036000000000000004
	22819528	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1ccc(F)cc1		CHEMBL4747799	=	IC50	nM	90.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0905
	22819529	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1ccccc1		CHEMBL4756545	=	IC50	nM	57.6	CHEMBL3130	Homo sapiens	IC50	uM	0.0576
	22819530	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1cncc(F)c1		CHEMBL4744888	=	IC50	nM	35.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0355
	22819531	CHEMBL4716073	Inhibition of PI3Kdelta in antiIgM/CD40L-induced human B cells assessed as reduction in cell viability preincubated for 30 mins followed by antiIgM/CD40L addition and measured after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cn2c1-c1ccccn1		CHEMBL4761860	=	IC50	nM	103.0	CHEMBL3130	Homo sapiens	IC50	uM	0.10300000000000001
	22819536	CHEMBL4716075	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in CD69 expression measured after 6 hrs by immunostaining based flow cytometric analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cncc(F)c1		CHEMBL4754382	=	IC50	nM	19.5	CHEMBL3130	Homo sapiens	IC50	uM	0.0195
	22819537	CHEMBL4716075	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in CD69 expression measured after 6 hrs by immunostaining based flow cytometric analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccn1		CHEMBL4784595	=	IC50	nM	107.0	CHEMBL3130	Homo sapiens	IC50	uM	0.107
	22819538	CHEMBL4716075	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in CD69 expression measured after 6 hrs by immunostaining based flow cytometric analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1		CHEMBL2216895	=	IC50	nM	22.0	CHEMBL3130	Homo sapiens	IC50	uM	0.022000000000000002
	22819539	CHEMBL4716075	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in CD69 expression measured after 6 hrs by immunostaining based flow cytometric analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cc(F)cc(F)c1		CHEMBL4790186	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	uM	0.019
	22819540	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cncc(F)c1		CHEMBL4754382	=	fIC50	nM	5.7	CHEMBL3130	Homo sapiens	fIC50	nM	5.7
	22819541	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cccnc1		CHEMBL4763849	=	fIC50	nM	1.0	CHEMBL3130	Homo sapiens	fIC50	nM	1.0
	22819542	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccn1		CHEMBL4784595	=	fIC50	nM	35.4	CHEMBL3130	Homo sapiens	fIC50	nM	35.4
	22819543	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1		CHEMBL2216895	=	fIC50	nM	2.4	CHEMBL3130	Homo sapiens	fIC50	nM	2.4
	22819544	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cc(F)cc(F)c1		CHEMBL4790186	=	fIC50	nM	10.1	CHEMBL3130	Homo sapiens	fIC50	nM	10.1
	22819545	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cncc(F)c1		CHEMBL4754382	=	IC50	nM	19.1	CHEMBL3130	Homo sapiens	IC50	uM	0.0191
	22819546	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cccnc1		CHEMBL4763849	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	uM	0.0027
	22819547	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccn1		CHEMBL4784595	=	IC50	nM	131.0	CHEMBL3130	Homo sapiens	IC50	uM	0.131
	22819548	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1ccccc1		CHEMBL2216895	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	uM	0.032
	22819549	CHEMBL4716076	Inhibition of PI3kdelta in anti-IgD-induced human whole blood cells assessed as reduction in Akt phosphorylation at ser 473 residue pretreated with compound for 60 mins followed by anti-IgD stimulation measured after 7 mins by Alexa fluor 488 staining based flow cytometry analysis	B	C[C@H](Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cc(F)cc(F)c1		CHEMBL4790186	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	uM	0.084
	22849464	CHEMBL4723091	Inhibition of PI3K-delta (unknown origin)	B	O=C1COc2ccc(-c3ccnc(Cl)c3NS(=O)(=O)c3ccc(F)cc3)cc2N1c1ccc(Cl)cc1		CHEMBL4760517	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	22849465	CHEMBL4723091	Inhibition of PI3K-delta (unknown origin)	B	C=Cc1ccc2oc3ccc(=O)n(-c4cccc(NC(=O)c5ccc(OC)nc5)c4)c3c2c1		CHEMBL4781969	=	IC50	nM	170.0	CHEMBL3130	Homo sapiens	IC50	nM	170.0
	22849466	CHEMBL4723091	Inhibition of PI3K-delta (unknown origin)	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1		CHEMBL4303323	=	IC50	nM	12.7	CHEMBL3130	Homo sapiens	IC50	nM	12.7
	22850943	CHEMBL4723572	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method	B	C[C@H]1COC[C@@H](C)N1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOC[C@H]2C)n1		CHEMBL4749352	=	Kd	nM	3500.0	CHEMBL3130	Homo sapiens	Kd	nM	3500.0
	22850944	CHEMBL4723572	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method	B	C[C@@H]1COCCN1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOCC2(C)C)n1		CHEMBL4741511	=	Kd	nM	2450.0	CHEMBL3130	Homo sapiens	Kd	nM	2450.0
	22851162	CHEMBL4723690	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	IC50	nM	1150.0	CHEMBL3130	Homo sapiens	IC50	uM	1.15
	22851163	CHEMBL4723690	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	COc1ccc(CNC(=O)Cc2nnc(-c3ccc4ncccc4c3)o2)cc1OC		CHEMBL4750370	=	IC50	nM	14200.0	CHEMBL3130	Homo sapiens	IC50	uM	14.2
	22851164	CHEMBL4723690	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo plus luminescence assay	B	O=C(Cc1nnc(-c2ccc3ncccc3c2)o1)NCCc1ccc(Cl)cc1		CHEMBL4786631	=	IC50	nM	16600.0	CHEMBL3130	Homo sapiens	IC50	uM	16.6
	22852536	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2-c2ccc(F)cc2)c1C#N		CHEMBL4463183	=	Inhibition	%	82.8	CHEMBL3130	Homo sapiens	INH	%	82.8
	22852537	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2C)c1C#N		CHEMBL4784743	=	Inhibition	%	73.3	CHEMBL3130	Homo sapiens	INH	%	73.3
	22852538	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852539	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	COc1ccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)c(-c3ccccc3)c(=O)n3cc(F)ccc23)cc1		CHEMBL4795389	=	Inhibition	%	99.5	CHEMBL3130	Homo sapiens	INH	%	99.5
	22852540	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(C(N)=O)cc1		CHEMBL4750646	=	Inhibition	%	96.2	CHEMBL3130	Homo sapiens	INH	%	96.2
	22852541	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4749521	=	Inhibition	%	87.3	CHEMBL3130	Homo sapiens	INH	%	87.3
	22852542	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1C1CC1		CHEMBL4751779	=	Inhibition	%	93.1	CHEMBL3130	Homo sapiens	INH	%	93.1
	22852543	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c([C@H](C)Nc2nc(N)nc(N)c2C#N)c(-c2ccccc2)c(=O)n2cc(F)ccc12		CHEMBL4791717	=	Inhibition	%	92.2	CHEMBL3130	Homo sapiens	INH	%	92.2
	22852544	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4778687	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852545	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4748330	=	Inhibition	%	94.8	CHEMBL3130	Homo sapiens	INH	%	94.8
	22852546	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c([C@H](C)Nc2ncnc(N)c2C#N)c(-c2ccc(F)cc2)c2ccc(F)cn2c1=O		CHEMBL4797361	=	Inhibition	%	42.0	CHEMBL3130	Homo sapiens	INH	%	42.0
	22852547	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4755417	=	Inhibition	%	58.2	CHEMBL3130	Homo sapiens	INH	%	58.2
	22852548	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4749578	=	Inhibition	%	81.9	CHEMBL3130	Homo sapiens	INH	%	81.9
	22852549	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4777036	=	Inhibition	%	39.94	CHEMBL3130	Homo sapiens	INH	%	39.94
	22852550	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cccc(F)c1		CHEMBL4792005	=	Inhibition	%	63.0	CHEMBL3130	Homo sapiens	INH	%	63.0
	22852551	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4748043	=	Inhibition	%	73.6	CHEMBL3130	Homo sapiens	INH	%	73.6
	22852552	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4742693	=	Inhibition	%	48.5	CHEMBL3130	Homo sapiens	INH	%	48.5
	22852553	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1cc(F)cc(F)c1		CHEMBL4752055	=	Inhibition	%	93.1	CHEMBL3130	Homo sapiens	INH	%	93.1
	22852554	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cc(F)cc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4750109	=	Inhibition	%	96.9	CHEMBL3130	Homo sapiens	INH	%	96.9
	22852555	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccc(F)cc1		CHEMBL4784696	=	Inhibition	%	61.0	CHEMBL3130	Homo sapiens	INH	%	61.0
	22852556	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4754291	=	Inhibition	%	91.9	CHEMBL3130	Homo sapiens	INH	%	91.9
	22852557	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)c1C#N		CHEMBL4787382	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852558	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)c(C#N)c(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)n1		CHEMBL4747142	=	Inhibition	%	29.4	CHEMBL3130	Homo sapiens	INH	%	29.4
	22852559	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ccnc(N)n1)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4746288	=	Inhibition	%	5.2	CHEMBL3130	Homo sapiens	INH	%	5.2
	22852560	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)ncc1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4742973	=	Inhibition	%	71.2	CHEMBL3130	Homo sapiens	INH	%	71.2
	22852561	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4794328	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852562	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4749877	=	Inhibition	%	40.5	CHEMBL3130	Homo sapiens	INH	%	40.5
	22852563	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c(F)ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4783353	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852564	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n2c1		CHEMBL4750875	=	Inhibition	%	1.2	CHEMBL3130	Homo sapiens	INH	%	1.2
	22852565	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1ccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n2c1		CHEMBL4777399	=	Inhibition	%	0.7	CHEMBL3130	Homo sapiens	INH	%	0.7
	22852566	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4787659	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852567	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n12		CHEMBL4782337	=	Inhibition	%	76.5	CHEMBL3130	Homo sapiens	INH	%	76.5
	22852568	CHEMBL4724039	Inhibition of PI3Kdelta (unknown origin) at 100 nM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccccn2c(=O)c1-c1ccccc1		CHEMBL4755607	=	Inhibition	%	17.7	CHEMBL3130	Homo sapiens	INH	%	17.7
	22852569	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2-c2ccc(F)cc2)c1C#N		CHEMBL4463183	=	Inhibition	%	81.9	CHEMBL3130	Homo sapiens	INH	%	81.9
	22852570	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2C)c1C#N		CHEMBL4784743	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852571	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852572	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	COc1ccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)c(-c3ccccc3)c(=O)n3cc(F)ccc23)cc1		CHEMBL4795389	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852573	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(C(N)=O)cc1		CHEMBL4750646	=	Inhibition	%	91.0	CHEMBL3130	Homo sapiens	INH	%	91.0
	22852574	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4749521	=	Inhibition	%	81.8	CHEMBL3130	Homo sapiens	INH	%	81.8
	22852575	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1C1CC1		CHEMBL4751779	=	Inhibition	%	98.8	CHEMBL3130	Homo sapiens	INH	%	98.8
	22852576	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c([C@H](C)Nc2nc(N)nc(N)c2C#N)c(-c2ccccc2)c(=O)n2cc(F)ccc12		CHEMBL4791717	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852577	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4778687	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852578	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4748330	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852579	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c([C@H](C)Nc2ncnc(N)c2C#N)c(-c2ccc(F)cc2)c2ccc(F)cn2c1=O		CHEMBL4797361	=	Inhibition	%	92.19	CHEMBL3130	Homo sapiens	INH	%	92.19
	22852580	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4755417	=	Inhibition	%	95.4	CHEMBL3130	Homo sapiens	INH	%	95.4
	22852581	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4749578	=	Inhibition	%	85.9	CHEMBL3130	Homo sapiens	INH	%	85.9
	22852582	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4777036	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852583	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cccc(F)c1		CHEMBL4792005	=	Inhibition	%	90.9	CHEMBL3130	Homo sapiens	INH	%	90.9
	22852584	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4748043	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852585	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4742693	=	Inhibition	%	82.9	CHEMBL3130	Homo sapiens	INH	%	82.9
	22852586	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1cc(F)cc(F)c1		CHEMBL4752055	=	Inhibition	%	96.4	CHEMBL3130	Homo sapiens	INH	%	96.4
	22852587	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cc(F)cc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4750109	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852588	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccc(F)cc1		CHEMBL4784696	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852589	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4754291	=	Inhibition	%	98.6	CHEMBL3130	Homo sapiens	INH	%	98.6
	22852590	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)nc(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)c1C#N		CHEMBL4787382	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852591	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1nc(N)c(C#N)c(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)n1		CHEMBL4747142	=	Inhibition	%	63.6	CHEMBL3130	Homo sapiens	INH	%	63.6
	22852592	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ccnc(N)n1)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4746288	=	Inhibition	%	4.8	CHEMBL3130	Homo sapiens	INH	%	4.8
	22852593	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)ncc1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4742973	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852594	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4794328	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852595	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4749877	=	Inhibition	%	93.8	CHEMBL3130	Homo sapiens	INH	%	93.8
	22852596	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1c(F)ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4783353	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852597	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n2c1		CHEMBL4750875	=	Inhibition	%	11.1	CHEMBL3130	Homo sapiens	INH	%	11.1
	22852598	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1ccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n2c1		CHEMBL4777399	=	Inhibition	%	6.5	CHEMBL3130	Homo sapiens	INH	%	6.5
	22852599	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4787659	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852600	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	Cc1cccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n12		CHEMBL4782337	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	22852601	CHEMBL4724040	Inhibition of PI3Kdelta (unknown origin) at 1 uM using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccccn2c(=O)c1-c1ccccc1		CHEMBL4755607	=	Inhibition	%	65.2	CHEMBL3130	Homo sapiens	INH	%	65.2
	22852713	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
	22852714	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2-c2ccc(F)cc2)c1C#N		CHEMBL4463183	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	22852715	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2c(-c3ccccc3)c(=O)n3cc(F)ccc3c2C)c1C#N		CHEMBL4784743	=	IC50	nM	54.0	CHEMBL3130	Homo sapiens	IC50	nM	54.0
	22852716	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC90	nM	37.6	CHEMBL3130	Homo sapiens	IC90	nM	37.6
	22852717	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC50	nM	9.5	CHEMBL3130	Homo sapiens	IC50	nM	9.5
	22852718	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	COc1ccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)c(-c3ccccc3)c(=O)n3cc(F)ccc23)cc1		CHEMBL4795389	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	22852719	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(C(N)=O)cc1		CHEMBL4750646	=	IC50	nM	7.6	CHEMBL3130	Homo sapiens	IC50	nM	7.6
	22852720	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4749521	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	22852721	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1C1CC1		CHEMBL4751779	=	IC50	nM	5.9	CHEMBL3130	Homo sapiens	IC50	nM	5.9
	22852722	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1c([C@H](C)Nc2nc(N)nc(N)c2C#N)c(-c2ccccc2)c(=O)n2cc(F)ccc12		CHEMBL4791717	=	IC50	nM	5.6	CHEMBL3130	Homo sapiens	IC50	nM	5.6
	22852723	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4778687	=	IC50	nM	3.39	CHEMBL3130	Homo sapiens	IC50	nM	3.39
	22852724	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1c(C2CC2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4748330	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	22852725	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1c([C@H](C)Nc2ncnc(N)c2C#N)c(-c2ccc(F)cc2)c2ccc(F)cn2c1=O		CHEMBL4797361	=	IC50	nM	114.0	CHEMBL3130	Homo sapiens	IC50	nM	114.0
	22852726	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4755417	=	IC50	nM	9.42	CHEMBL3130	Homo sapiens	IC50	nM	9.42
	22852727	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cc(F)cc(F)c1		CHEMBL4749578	=	IC50	nM	19.0	CHEMBL3130	Homo sapiens	IC50	nM	19.0
Not Determined	22852728	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4777036		IC50			CHEMBL3130	Homo sapiens	IC50		
	22852729	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1cccc(F)c1		CHEMBL4792005	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	22852730	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4748043	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	22852731	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc(=O)n2cc(F)ccc2c1-c1ccccc1		CHEMBL4742693	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	22852732	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1cc(F)cc(F)c1		CHEMBL4752055	=	IC50	nM	3.36	CHEMBL3130	Homo sapiens	IC50	nM	3.36
	22852733	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1cc(F)cc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4750109	=	IC50	nM	5.0	CHEMBL3130	Homo sapiens	IC50	nM	5.0
Not Determined	22852734	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccc(F)cc1		CHEMBL4784696		IC50			CHEMBL3130	Homo sapiens	IC50		
	22852735	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1cccc(-c2c([C@H](C)Nc3nc(N)nc(N)c3C#N)cc3ccc(F)cn3c2=O)c1		CHEMBL4754291	=	IC50	nM	1.28	CHEMBL3130	Homo sapiens	IC50	nM	1.28
	22852736	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1nc(N)nc(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)c1C#N		CHEMBL4787382	=	IC50	nM	0.89	CHEMBL3130	Homo sapiens	IC50	nM	0.89
Not Determined	22852737	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1nc(N)c(C#N)c(N[C@@H](C)c2cc3ccc(F)cn3c(=O)c2-c2ccccc2)n1		CHEMBL4747142		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	22852738	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ccnc(N)n1)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4746288		IC50			CHEMBL3130	Homo sapiens	IC50		
	22852739	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)ncc1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4742973	=	IC50	nM	7.0	CHEMBL3130	Homo sapiens	IC50	nM	7.0
	22852740	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4794328	=	IC50	nM	1.49	CHEMBL3130	Homo sapiens	IC50	nM	1.49
	22852741	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccc(F)cn2c(=O)c1-c1ccccc1		CHEMBL4749877	=	IC50	nM	9.8	CHEMBL3130	Homo sapiens	IC50	nM	9.8
	22852742	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1c(F)ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4783353	=	IC50	nM	2.28	CHEMBL3130	Homo sapiens	IC50	nM	2.28
Not Determined	22852743	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1ccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n2c1		CHEMBL4750875		IC50			CHEMBL3130	Homo sapiens	IC50		
Not Determined	22852744	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1ccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n2c1		CHEMBL4777399		IC50			CHEMBL3130	Homo sapiens	IC50		
	22852745	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1cccc2cc([C@H](C)Nc3ncnc(N)c3C#N)c(-c3ccccc3)c(=O)n12		CHEMBL4787659	=	IC50	nM	1.7	CHEMBL3130	Homo sapiens	IC50	nM	1.7
	22852746	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	Cc1cccc2cc([C@H](C)Nc3ncnc4[nH]cnc34)c(-c3ccccc3)c(=O)n12		CHEMBL4782337	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	nM	3.6
Not Determined	22852747	CHEMBL4724045	Inhibition of PI3Kdelta in human Raji cells assessed as reduction in phosphorylation of AKT at 473 measured after 2 hr by alpha screen assay	B	C[C@H](Nc1ncnc2[nH]cnc12)c1cc2ccccn2c(=O)c1-c1ccccc1		CHEMBL4755607		IC50			CHEMBL3130	Homo sapiens	IC50		
	22852966	CHEMBL4724092	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805348	=	IC50	nM	0.9	CHEMBL3130	Homo sapiens	IC50	nM	0.9
	22852967	CHEMBL4724092	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC90	nM	28.1	CHEMBL3130	Homo sapiens	IC90	nM	28.1
	22852968	CHEMBL4724092	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 45 mins by HTRF assay relative to control	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1c(-c2ccccc2)c(=O)n2cc(F)ccc2c1-c1ccc(F)cc1		CHEMBL4756563	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	22885745	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCNC(=O)C3)cc2n1		CHEMBL4758487	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	22885746	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C)C(=O)C3)cc2n1		CHEMBL4792029	=	IC50	nM	4.9	CHEMBL3130	Homo sapiens	IC50	nM	4.9
	22885747	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC)C(=O)C3)cc2n1		CHEMBL4747763	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	22885748	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC(O)CC4)C(=O)C3)cc2n1		CHEMBL4791401	=	IC50	nM	5.7	CHEMBL3130	Homo sapiens	IC50	nM	5.7
	22885749	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC4CC4)C(=O)C3)cc2n1		CHEMBL4786126	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	22885750	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCC4)C(=O)C3)cc2n1		CHEMBL4750636	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	22885751	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN([C@H]4CC[C@H](O)CC4)C(=O)C3)cc2n1		CHEMBL4796048	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	22885752	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC(N)=O)C(=O)C3)cc2n1		CHEMBL4797140	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	22885753	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC(=O)N4CCOCC4)C(=O)C3)cc2n1		CHEMBL4743956	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	22885754	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(c4cnn(C)c4)C(=O)C3)cc2n1		CHEMBL4761003	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	22885755	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(c4nccs4)C(=O)C3)cc2n1		CHEMBL4741654	=	IC50	nM	2.1	CHEMBL3130	Homo sapiens	IC50	nM	2.1
	22885756	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(c4cccnc4)C(=O)C3)cc2n1		CHEMBL4799262	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
	22885757	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C)CC3=O)cc2n1		CHEMBL4753485	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	nM	82.0
	22885758	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC(F)(F)F)CC3=O)cc2n1		CHEMBL4764816	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	22885759	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(C)C)CC3=O)cc2n1		CHEMBL4759104	=	IC50	nM	4.5	CHEMBL3130	Homo sapiens	IC50	nM	4.5
	22885760	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC4CC4)CC3=O)cc2n1		CHEMBL4755371	=	IC50	nM	6.3	CHEMBL3130	Homo sapiens	IC50	nM	6.3
	22885761	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCC4)CC3=O)cc2n1		CHEMBL4753342	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
	22885762	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCCC4)CC3=O)cc2n1		CHEMBL4761223	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	22885763	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCN(C)CC4)CC3=O)cc2n1		CHEMBL4789467	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	22885764	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCOCC4)CC3=O)cc2n1		CHEMBL4743060	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
	22885765	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCSCC4)CC3=O)cc2n1		CHEMBL4798399	=	IC50	nM	4.8	CHEMBL3130	Homo sapiens	IC50	nM	4.8
	22885766	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC(F)(F)CC4)CC3=O)cc2n1		CHEMBL4764632	=	IC50	nM	3.8	CHEMBL3130	Homo sapiens	IC50	nM	3.8
	22885767	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC5(CC4)OCCO5)CC3=O)cc2n1		CHEMBL4762501	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
	22885768	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	C=CCN1CCN(Cc2cc3nc(-n4c(CC)nc5ccccc54)nc(N4CCOCC4)c3s2)C(=O)C1		CHEMBL4788725	=	IC50	nM	1.6	CHEMBL3130	Homo sapiens	IC50	nM	1.6
	22885769	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC(=O)CC4)CC3=O)cc2n1		CHEMBL4743492	=	IC50	nM	1.6	CHEMBL3130	Homo sapiens	IC50	nM	1.6
	22885770	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC(N(C)C)CC4)CC3=O)cc2n1		CHEMBL4781154	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	22885771	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCC(N5CCCC5)CC4)CC3=O)cc2n1		CHEMBL4761579	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	22885772	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(CC(N)=O)CC3=O)cc2n1		CHEMBL4761019	=	IC50	nM	6.2	CHEMBL3130	Homo sapiens	IC50	nM	6.2
	22885773	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)[C@H](C)O)CC3=O)cc2n1		CHEMBL4791430	=	IC50	nM	3.6	CHEMBL3130	Homo sapiens	IC50	nM	3.6
	22885774	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(C)=O)CC3=O)cc2n1		CHEMBL4783142	=	IC50	nM	3.2	CHEMBL3130	Homo sapiens	IC50	nM	3.2
	22885775	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CC4)CC3=O)cc2n1		CHEMBL4788952	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	22885776	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CCC4)CC3=O)cc2n1		CHEMBL4752490	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	22885777	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CCCC4)CC3=O)cc2n1		CHEMBL4762689	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	22885778	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)C4CCCCC4)CC3=O)cc2n1		CHEMBL4797595	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
	22885779	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	C=CC(=O)N1CCN(Cc2cc3nc(-n4c(CC)nc5ccccc54)nc(N4CCOCC4)c3s2)C(=O)C1		CHEMBL4753343	=	IC50	nM	7.9	CHEMBL3130	Homo sapiens	IC50	nM	7.9
	22885780	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C(=O)OC(C)(C)C)CC3=O)cc2n1		CHEMBL4764431	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	22885781	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3=O)cc2n1		CHEMBL4783917	=	IC50	nM	2.2	CHEMBL3130	Homo sapiens	IC50	nM	2.2
	22885782	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(=O)(=O)CC)CC3=O)cc2n1		CHEMBL4800610	=	IC50	nM	4.4	CHEMBL3130	Homo sapiens	IC50	nM	4.4
	22885783	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCCS(=O)(=O)N1CCN(Cc2cc3nc(-n4c(CC)nc5ccccc54)nc(N4CCOCC4)c3s2)C(=O)C1		CHEMBL4764973	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
	22885784	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(=O)(=O)C4CC4)CC3=O)cc2n1		CHEMBL4787716	=	IC50	nM	1.2	CHEMBL3130	Homo sapiens	IC50	nM	1.2
	22885785	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(C)(=O)=O)CC3)cc2n1		CHEMBL2165500	=	IC50	nM	4.1	CHEMBL3130	Homo sapiens	IC50	nM	4.1
	22885786	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(S(=O)(=O)C4CC4)CC3)cc2n1		CHEMBL4784160	=	IC50	nM	4.8	CHEMBL3130	Homo sapiens	IC50	nM	4.8
	22885787	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CCc1nc2ccccc2n1-c1nc(N2CCOCC2)c2sc(CN3CCN(C4CCCC4)CC3)cc2n1		CHEMBL4755435	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	22885788	CHEMBL4728121	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	4.7	CHEMBL3130	Homo sapiens	IC50	nM	4.7
	22885893	CHEMBL4728133	Inhibition of recombinant human His-tagged PI3Kdelta expressed in baculovirus expression system using PIP2:PS as substrate incubated for 1 hr by invitrogen adapta assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
Active	22909107	CHEMBL4733884	Inhibition of PI3Kdelta (unknown origin) transfected in human Rh30 cells assessed as reduction in AKT phosphorylation at Ser473 residue at 10XIC50 by western blot analysis	B	COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1		CHEMBL4800252		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	22909108	CHEMBL4733885	Inhibition of PI3Kdelta (unknown origin) transfected in human Rh30 cells assessed as reduction in AKT phosphorylation at Thr308 residue at 10XIC50 by western blot analysis	B	COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1		CHEMBL4800252		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	22915913	CHEMBL4735508	Inhibition of PI3Kdelta (unknown origin)	B	NC(=O)c1cccc2cc(C(=O)N3CCN(c4nc(-c5cnc(NC(=O)CN6CCOCC6)cc5C(F)(F)F)nc(N5CCOCC5)n4)CC3)oc12		CHEMBL4761383	=	IC50	nM	197.2	CHEMBL3130	Homo sapiens	IC50	nM	197.2
	22926326	CHEMBL4737606	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo assay	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	IC50	nM	1.3	CHEMBL3130	Homo sapiens	IC50	nM	1.3
	22926327	CHEMBL4737606	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr by ADP-glo assay	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	IC50	nM	0.78	CHEMBL3130	Homo sapiens	IC50	nM	0.78
	22926364	CHEMBL4737643	Inhibition of human partial length PIK3CD (R108 to Q1044 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	0.0	CHEMBL3130	Homo sapiens	Activity	%	0.0
	22949822	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1ccccc1		CHEMBL3805430	=	EC50	nM	0.3	CHEMBL3130	Homo sapiens	EC50	nM	0.3
	22949823	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3928926	=	EC50	nM	0.9	CHEMBL3130	Homo sapiens	EC50	nM	0.9
	22949824	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3982635	=	EC50	nM	1.2	CHEMBL3130	Homo sapiens	EC50	nM	1.2
	22949825	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(Cl)c1		CHEMBL3912748	=	EC50	nM	4.0	CHEMBL3130	Homo sapiens	EC50	nM	4.0
	22949826	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	COc1cncc(-n2c([C@H](C)Nc3nc(N)nc(N)c3C#N)nc3cccc(Cl)c3c2=O)c1		CHEMBL3919440	=	EC50	nM	3.0	CHEMBL3130	Homo sapiens	EC50	nM	3.0
	22949827	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C2CC2)c1		CHEMBL3956715	=	EC50	nM	7.0	CHEMBL3130	Homo sapiens	EC50	nM	7.0
	22949828	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C(F)(F)F)c1		CHEMBL3985378	=	EC50	nM	21.0	CHEMBL3130	Homo sapiens	EC50	nM	21.0
	22949829	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2cccc(Cl)c2c(=O)n1-c1cncc(C#N)c1		CHEMBL4800080	=	EC50	nM	4.0	CHEMBL3130	Homo sapiens	EC50	nM	4.0
	22949830	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)cccc2c(=O)n1-c1cccnc1		CHEMBL3972344	=	EC50	nM	5.0	CHEMBL3130	Homo sapiens	EC50	nM	5.0
	22949831	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(Cl)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3942725	=	EC50	nM	0.9	CHEMBL3130	Homo sapiens	EC50	nM	0.9
	22949832	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(F)c2c(=O)n1-c1cccnc1		CHEMBL3933760	=	EC50	nM	11.0	CHEMBL3130	Homo sapiens	EC50	nM	11.0
	22949833	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3915848	=	EC50	nM	0.4	CHEMBL3130	Homo sapiens	EC50	nM	0.4
	22949834	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	C[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cncc(F)c1		CHEMBL3917562	=	EC50	nM	0.5	CHEMBL3130	Homo sapiens	EC50	nM	0.5
	22949835	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	CC[C@H](Nc1nc(N)nc(N)c1C#N)c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1		CHEMBL3900451	=	EC50	nM	2.0	CHEMBL3130	Homo sapiens	EC50	nM	2.0
	22949836	CHEMBL4765887	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC50	nM	1.0	CHEMBL3130	Homo sapiens	EC50	nM	1.0
	22949905	CHEMBL4765900	Inhibition of PI3K p110delta in human basophil assessed as reduction in anti-FCepsilonR1 mAb-stimulated basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins by flow cytometry analysis	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC50	nM	0.31	CHEMBL3130	Homo sapiens	EC50	nM	0.31
	22949909	CHEMBL4765904	Inhibition of PI3K p110delta in human basophil assessed as reduction in anti-FCepsilonR1 mAb-induced basophil activation preincubated for 60 mins followed by anti-FCepsilonR1 mAb stimulation and measured after 25 mins in presence of 25% serum by flow cytometry analysis	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC50	nM	1.3	CHEMBL3130	Homo sapiens	EC50	nM	1.3
	22949935	CHEMBL4765930	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of BCR-induced B-cell activation	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC50	nM	2.4	CHEMBL3130	Homo sapiens	EC50	nM	2.4
	22949936	CHEMBL4765930	Inhibition of PI3Kdelta in human whole blood assessed as inhibition of BCR-induced B-cell activation	B	N#Cc1c(N)nc(N)nc1N[C@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1		CHEMBL3928407	=	EC90	nM	21.0	CHEMBL3130	Homo sapiens	EC90	nM	21.0
	22980793	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	NC(=O)[C@H]1CCCN1C(=O)c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1		CHEMBL4790315	=	IC50	nM	5100.0	CHEMBL3130	Homo sapiens	IC50	uM	5.1
	22980794	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	NC(=O)C1CCN(C(=O)c2ccc3nc(Nc4ccc(-c5nc(N6CCOCC6)nc(N6CCOCC6)n5)cc4)[nH]c3c2)CC1		CHEMBL4787035	=	IC50	nM	2300.0	CHEMBL3130	Homo sapiens	IC50	uM	2.3
	22980795	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	C[C@H](NC(=O)c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1)C(N)=O		CHEMBL4794018	=	IC50	nM	5000.0	CHEMBL3130	Homo sapiens	IC50	uM	5.0
	22980796	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	O=C(c1ccc2nc(Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)[nH]c2c1)N1CCOCC1		CHEMBL4778112	=	IC50	nM	44000.0	CHEMBL3130	Homo sapiens	IC50	uM	44.0
	22980797	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	CN1CCN(C(=O)c2ccc3nc(Nc4ccc(-c5nc(N6CCOCC6)nc(N6CCOCC6)n5)cc4)[nH]c3c2)CC1		CHEMBL4788677	=	IC50	nM	13000.0	CHEMBL3130	Homo sapiens	IC50	uM	13.0
	22980798	CHEMBL4772818	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 1 hr in presence of ATP by ADP-Glo reagent based assay	B	CN(C)C1CCN(C(=O)c2cccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)c2)CC1	Outside typical range	CHEMBL4778200	=	IC50	nM	156000.0	CHEMBL3130	Homo sapiens	IC50	uM	156.0
	22990749	CHEMBL4775169	Inhibition of PI3K delta (unknown origin)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	570.0	CHEMBL3130	Homo sapiens	IC50	uM	0.57
	23122748	CHEMBL4805099	Inhibition of human PIK3CD assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	61.0	CHEMBL3130	Homo sapiens	Activity	%	61.0
	23123443	CHEMBL4805687	Inhibition of human PIK3CD assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	74.0	CHEMBL3130	Homo sapiens	Activity	%	74.0
	23123899	CHEMBL4806143	Inhibition of DNA-tagged human PIK3CD assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	95.0	CHEMBL3130	Homo sapiens	Activity	%	95.0
	23124976	CHEMBL4806704	Inhibition of human PIK3CD assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL3130	Homo sapiens	Activity	%	94.0
	23124977	CHEMBL4806704	Inhibition of human PIK3CD assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	71.0	CHEMBL3130	Homo sapiens	Activity	%	71.0
	23127306	CHEMBL4807579	Inhibition of PI3Kdelta (unknown origin)	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	23127307	CHEMBL4807579	Inhibition of PI3Kdelta (unknown origin)	B	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21		CHEMBL1684984	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	23183474	CHEMBL4817108	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	Cc1c(CN2CCN(C(=O)c3cc4cccc(C(N)=O)c4o3)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL4865059	=	IC50	nM	2.7	CHEMBL3130	Homo sapiens	IC50	nM	2.7
	23183475	CHEMBL4817108	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5s4)CC3)oc12		CHEMBL4871210	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	23183476	CHEMBL4817108	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5o4)CC3)oc12		CHEMBL4868231	=	IC50	nM	4.3	CHEMBL3130	Homo sapiens	IC50	nM	4.3
	23183477	CHEMBL4817108	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate measured after 2 hrs by ADP-glo plus luminescence assay	B	Cc1c(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL4858564	=	IC50	nM	6.8	CHEMBL3130	Homo sapiens	IC50	nM	6.8
	23193730	CHEMBL4819301	Inhibition of human PI3K delta by ADP-Glo luminescent kinase assay	B	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1		CHEMBL3622533	=	IC50	nM	39.0	CHEMBL3130	Homo sapiens	IC50	nM	39.0
	23195903	CHEMBL4819718	Binding affinity to wild-type human partial length PIK3CD (R108 to Q1044 residues) expressed in HEK293 cells by active site-directed competition binding based Kinomescan method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	>	Kd	nM	1000.0	CHEMBL3130	Homo sapiens	Kd	nM	1000.0
	23195908	CHEMBL4819723	Inhibition of human PIK3CD at 100 nM by scintillation counting based direct-filter Binding radiometric assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	100.0	CHEMBL3130	Homo sapiens	INH	%	100.0
	23207237	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Oc1cccc(-c2cc(C3=CCNCC3)c3cn[nH]c3c2)c1		CHEMBL4868842	=	IC50	nM	453.0	CHEMBL3130	Homo sapiens	IC50	nM	453.0
	23207238	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Oc1cccc(-c2cc(O)c(O)c3ncccc23)c1		CHEMBL4864026	=	IC50	nM	3260.0	CHEMBL3130	Homo sapiens	IC50	nM	3260.0
	23207239	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Oc1ccc(CNc2ccnc3c2C(c2ccc4c(c2)OCO4)NN3)cc1		CHEMBL4855807	=	IC50	nM	2410.0	CHEMBL3130	Homo sapiens	IC50	nM	2410.0
	23207240	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=c1[nH][nH]c2ccc(NCCCc3ccccc3)cc12		CHEMBL4847234	=	IC50	nM	3550.0	CHEMBL3130	Homo sapiens	IC50	nM	3550.0
	23207241	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCc1ccccc1)cc2-c1cccc(O)c1		CHEMBL4857908	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	23207242	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCN1CCOCC1)cc2-c1cccc(O)c1		CHEMBL4860874	=	IC50	nM	352.0	CHEMBL3130	Homo sapiens	IC50	nM	352.0
	23207243	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(NCCCc1ccccc1)cc2-c1cc(O)cc(F)c1		CHEMBL4855277	=	IC50	nM	20.3	CHEMBL3130	Homo sapiens	IC50	nM	20.3
	23207244	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cccc2-c1cc(O)cc(F)c1		CHEMBL4848881	=	IC50	nM	705.0	CHEMBL3130	Homo sapiens	IC50	nM	705.0
	23207245	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(-c1cccc(F)c1)cc2-c1cc(O)cc(F)c1		CHEMBL4855554	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	23207246	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	C[C@H]1CN(c2cc(-c3cc4c(c(-c5cc(O)cc(F)c5)c3)CNC4=O)ccn2)C[C@@H](C)O1		CHEMBL4856718	=	IC50	nM	3.5	CHEMBL3130	Homo sapiens	IC50	nM	3.5
	23207247	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	C[C@H]1CN(Cc2nnc(-c3cc4c(c(-c5cc(O)cc(F)c5)c3)CNC4=O)o2)C[C@@H](C)O1		CHEMBL4868375	=	IC50	nM	20.7	CHEMBL3130	Homo sapiens	IC50	nM	20.7
	23207248	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CCOCC3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4878320	=	IC50	nM	0.74	CHEMBL3130	Homo sapiens	IC50	nM	0.74
	23207249	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC(F)(F)C3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4873442	=	IC50	nM	0.51	CHEMBL3130	Homo sapiens	IC50	nM	0.51
	23207250	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cc(O)cc(F)c1		CHEMBL4852413	=	IC50	nM	1.8	CHEMBL3130	Homo sapiens	IC50	nM	1.8
	23207251	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ccc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cn1		CHEMBL4859469	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	23207252	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cncc(O)c1		CHEMBL4848004	=	IC50	nM	2.9	CHEMBL3130	Homo sapiens	IC50	nM	2.9
	23207253	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(O[C@@H]1CCN(C(=O)C3CC3)C1)cc2-c1cnc(F)c(O)c1		CHEMBL4877330	=	IC50	nM	0.7	CHEMBL3130	Homo sapiens	IC50	nM	0.7
	23207254	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Cc1ncc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4852562	=	IC50	nM	0.94	CHEMBL3130	Homo sapiens	IC50	nM	0.94
	23207255	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(O[C@@H]3CCN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4847971	=	IC50	nM	0.54	CHEMBL3130	Homo sapiens	IC50	nM	0.54
	23207256	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cccc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4878413	=	IC50	nM	70.0	CHEMBL3130	Homo sapiens	IC50	nM	70.0
	23207257	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1cc2c(c(-c3cnc(OC)c(NS(C)(=O)=O)c3)c1)CNC2=O		CHEMBL4846554	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	23207258	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC(C)C)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4867589	=	IC50	nM	29.0	CHEMBL3130	Homo sapiens	IC50	nM	29.0
	23207259	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	CCOc1cc2c(c(-c3cnc(OC)c(NS(C)(=O)=O)c3)c1)CNC2=O		CHEMBL4863164	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	23207260	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC3CCC3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4849053	=	IC50	nM	4.8	CHEMBL3130	Homo sapiens	IC50	nM	4.8
	23207261	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OCC3CCC3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4850175	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	23207262	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(OC3CN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4874239	=	IC50	nM	6.7	CHEMBL3130	Homo sapiens	IC50	nM	6.7
	23207263	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	C#Cc1ccc(-c2cc3c(c(-c4cnc(OC)c(NS(C)(=O)=O)c4)c2)CNC3=O)cn1		CHEMBL4867101	=	IC50	nM	3.4	CHEMBL3130	Homo sapiens	IC50	nM	3.4
	23207264	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	COc1ncc(-c2cc(-c3ccnc(N4C[C@H](C)O[C@H](C)C4)c3)cc3c2CNC3=O)cc1NS(C)(=O)=O		CHEMBL4863978	=	IC50	nM	1.4	CHEMBL3130	Homo sapiens	IC50	nM	1.4
	23207265	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Cn1ncc2cc(-c3cc(OC4CN(C(=O)C5CC5)C4)cc4c3CNC4=O)cnc21		CHEMBL4851164	=	IC50	nM	23.0	CHEMBL3130	Homo sapiens	IC50	nM	23.0
	23207266	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(OC1CN(C(=O)C3CC3)C1)cc2-c1cnc(Cl)c(OC(F)F)c1		CHEMBL4858005	=	IC50	nM	60.0	CHEMBL3130	Homo sapiens	IC50	nM	60.0
	23207267	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Nc1ncc(-c2cc(OC3CN(C(=O)C4CC4)C3)cc3c2CNC3=O)cc1C(F)(F)F		CHEMBL4861797	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	23207268	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	O=C1NCc2c1cc(OC1CN(C(=O)C3CC3)C1)cc2-c1ccc(OC(F)F)nc1		CHEMBL4861306	=	IC50	nM	166.0	CHEMBL3130	Homo sapiens	IC50	nM	166.0
	23207269	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	CNc1ncc(-c2cc(OC3CN(C(=O)C4C[C@H]4C)C3)cc3c2CNC3=O)cc1C(F)(F)F		CHEMBL4860971	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	23207270	CHEMBL4821970	Inhibition of PI3Kdelta (unknown origin) by HTRF assay	B	Cc1ncc(-c2cc(-c3ccnc(N4C[C@H](C)O[C@H](C)C4)c3)cc3c2CNC3=O)cn1		CHEMBL4852744	=	IC50	nM	207.0	CHEMBL3130	Homo sapiens	IC50	nM	207.0
	23222845	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCOCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4850400	=	IC50	nM	0.85	CHEMBL3130	Homo sapiens	IC50	nM	0.85
	23222846	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2ccc3nncc(N4CCOCC4)c3c2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4867375	=	IC50	nM	4.08	CHEMBL3130	Homo sapiens	IC50	nM	4.08
	23222847	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(Nc4ccccc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4867433	=	IC50	nM	4.47	CHEMBL3130	Homo sapiens	IC50	nM	4.47
	23222848	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2ccc3nncc(Nc4ccccc4)c3c2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4856418	=	IC50	nM	30.31	CHEMBL3130	Homo sapiens	IC50	nM	30.31
	23222849	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	CC(=O)Nc1ccc(Nc2cnnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccccc5)c4)cc23)cc1		CHEMBL4852849	=	IC50	nM	3.3	CHEMBL3130	Homo sapiens	IC50	nM	3.3
	23222850	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2ccc3nncc(Nc4ccc(NC(C)=O)cc4)c3c2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4859868	=	IC50	nM	8.57	CHEMBL3130	Homo sapiens	IC50	nM	8.57
	23222851	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(Cl)c3c2)cnc1Cl)c1ccccc1		CHEMBL4861043	=	IC50	nM	0.55	CHEMBL3130	Homo sapiens	IC50	nM	0.55
	23222852	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1ncc(-c2ccc3nncc(Cl)c3c2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4846081	=	IC50	nM	4.42	CHEMBL3130	Homo sapiens	IC50	nM	4.42
	23222853	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	6.53	CHEMBL3130	Homo sapiens	IC50	nM	6.53
	23222854	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nnccc3c2)cnc1Cl)c1ccccc1		CHEMBL4870212	=	IC50	nM	19.37	CHEMBL3130	Homo sapiens	IC50	nM	19.37
	23222855	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1ccc(CNc2cnnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccccc5)c4)cc23)cc1		CHEMBL4865798	=	IC50	nM	1.02	CHEMBL3130	Homo sapiens	IC50	nM	1.02
	23222856	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	C[C@@H](Nc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12)c1ccccc1		CHEMBL4851945	=	IC50	nM	5.46	CHEMBL3130	Homo sapiens	IC50	nM	5.46
	23222857	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	C[C@H](Nc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12)c1ccccc1		CHEMBL4855754	=	IC50	nM	27.05	CHEMBL3130	Homo sapiens	IC50	nM	27.05
	23222858	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4845684	=	IC50	nM	0.87	CHEMBL3130	Homo sapiens	IC50	nM	0.87
	23222859	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCCCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4876806	=	IC50	nM	0.67	CHEMBL3130	Homo sapiens	IC50	nM	0.67
	23222860	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	CC1CCN(c2cnnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccccc5)c4)cc23)CC1		CHEMBL4878126	=	IC50	nM	0.32	CHEMBL3130	Homo sapiens	IC50	nM	0.32
	23222861	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCNCC4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4865341	=	IC50	nM	1.58	CHEMBL3130	Homo sapiens	IC50	nM	1.58
	23222862	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	COc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12		CHEMBL4846935	=	IC50	nM	1.1	CHEMBL3130	Homo sapiens	IC50	nM	1.1
	23222863	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	CCOc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12		CHEMBL4860613	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
	23222864	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	CCCCCCOc1cnnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccccc4)c3)cc12		CHEMBL4878359	=	IC50	nM	215.28	CHEMBL3130	Homo sapiens	IC50	nM	215.28
	23222865	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(O)c3c2)cnc1Cl)c1ccccc1		CHEMBL4876461	=	IC50	nM	833.09	CHEMBL3130	Homo sapiens	IC50	nM	833.09
	23222866	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-n4ccnc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4871213	=	IC50	nM	0.21	CHEMBL3130	Homo sapiens	IC50	nM	0.21
	23222867	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccncc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4864419	=	IC50	nM	0.36	CHEMBL3130	Homo sapiens	IC50	nM	0.36
	23222868	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccccc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4872806	=	IC50	nM	2.91	CHEMBL3130	Homo sapiens	IC50	nM	2.91
	23222869	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccc(N5CCOCC5)cc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4853440	=	IC50	nM	0.4	CHEMBL3130	Homo sapiens	IC50	nM	0.4
	23222870	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4cnc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4871838	=	IC50	nM	0.65	CHEMBL3130	Homo sapiens	IC50	nM	0.65
	23222871	CHEMBL4824997	Inhibition of PI3Kdelta (unknown origin)	B	O=S(=O)(Nc1cc(-c2ccc3nncc(-c4ccc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1		CHEMBL4872728	=	IC50	nM	0.28	CHEMBL3130	Homo sapiens	IC50	nM	0.28
	23236459	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1ccccc1		CHEMBL4849115	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	23236460	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4469876	=	IC50	nM	3162.28	CHEMBL3130	Homo sapiens	pIC50		5.5
	23236461	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1ccnc(C)c1		CHEMBL4876289	=	IC50	nM	316.23	CHEMBL3130	Homo sapiens	pIC50		6.5
	23236462	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C)c1		CHEMBL4859024	=	IC50	nM	3981.07	CHEMBL3130	Homo sapiens	pIC50		5.4
	23236463	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C2CC2CN(C)C)c1	Outside typical range	CHEMBL4877995	=	IC50	nM	62.0	CHEMBL3130	Homo sapiens	pIC50		62.0
Not Determined	23236464	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C2=CCN(C)CC2)c1		CHEMBL4852717		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	23236465	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C#CCN2CCN(C(C)C)CC2)c1		CHEMBL4872328	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
Not Determined	23236466	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C#CCN2C[C@H](C)O[C@H](C)C2)c1		CHEMBL4878870		pIC50			CHEMBL3130	Homo sapiens	pIC50		
	23236467	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCN(C(C)C)CC3)cc2)c1		CHEMBL4850297	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	23236468	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCN(C)CC3)cc2)c1		CHEMBL4869356	=	IC50	nM	39.81	CHEMBL3130	Homo sapiens	pIC50		7.4
	23236469	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCNCC3)cc2)c1		CHEMBL4867203	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	23236470	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCC3)cc2)c1		CHEMBL4868553	=	IC50	nM	31.62	CHEMBL3130	Homo sapiens	pIC50		7.5
	23236471	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2cccc(CN3CCCCC3)c2)c1		CHEMBL4863100	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	23236472	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2cccc(CN3CCCC3)c2)c1		CHEMBL4872822	=	IC50	nM	199.53	CHEMBL3130	Homo sapiens	pIC50		6.7
	23236473	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCCC3)s2)c1		CHEMBL4870020	=	IC50	nM	31.62	CHEMBL3130	Homo sapiens	pIC50		7.5
	23236474	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCN(C(C)C)CC3)nc2)c1		CHEMBL4873390	=	IC50	nM	31.62	CHEMBL3130	Homo sapiens	pIC50		7.5
	23236475	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN(C)C)cc2)c1		CHEMBL4846241	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	23236476	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)c1		CHEMBL4869783	=	IC50	nM	25.12	CHEMBL3130	Homo sapiens	pIC50		7.6
	23236477	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3C[C@H](C)N(C)[C@H](C)C3)cc2)c1		CHEMBL4858875	=	IC50	nM	1.259	CHEMBL3130	Homo sapiens	pIC50		8.9
	23236478	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(N3CCN(C(C)C)CC3)cc2)c1		CHEMBL4845674	=	IC50	nM	50.12	CHEMBL3130	Homo sapiens	pIC50		7.3
	23236479	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(C#CCN2CCN(C(C)C)CC2)c1		CHEMBL4857056	=	IC50	nM	158.49	CHEMBL3130	Homo sapiens	pIC50		6.8
	23236480	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCN(C(C)C)CC3)cc2)c1		CHEMBL4855234	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	23236481	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCC3)cc2)c1		CHEMBL4869306	=	IC50	nM	79.43	CHEMBL3130	Homo sapiens	pIC50		7.1
	23236482	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCC3)c(F)c2)c1		CHEMBL4870356	=	IC50	nM	63.1	CHEMBL3130	Homo sapiens	pIC50		7.2
	23236483	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCCC3)cc2F)c1		CHEMBL4870970	=	IC50	nM	19.95	CHEMBL3130	Homo sapiens	pIC50		7.7
	23236484	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2)c1		CHEMBL4169192	=	IC50	nM	12.59	CHEMBL3130	Homo sapiens	pIC50		7.9
	23236485	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2)c1		CHEMBL4173087	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	23236486	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1		CHEMBL4167702	=	IC50	nM	6.31	CHEMBL3130	Homo sapiens	pIC50		8.2
	23236487	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)C)CC3)c(F)c2F)c1		CHEMBL4170075	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	23236488	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCC(C(C)(C)O)CC3)cc2F)c1		CHEMBL4174874	=	IC50	nM	10.0	CHEMBL3130	Homo sapiens	pIC50		8.0
	23236489	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2F)c1		CHEMBL4175737	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	23236490	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2)c1		CHEMBL4165185	=	IC50	nM	7.943	CHEMBL3130	Homo sapiens	pIC50		8.1
	23236491	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1ccnc(-c2ccc(CN3CCN(C(C)(C)C)CC3)cc2F)c1		CHEMBL4175571	=	IC50	nM	2.512	CHEMBL3130	Homo sapiens	pIC50		8.6
	23236492	CHEMBL4828192	Inhibition of PI3Kdelta in human whole blood assessed as reduction in cytostim-stimulated IFNgamma production preincubated for 1 hr followed by cytostim stimulation and measured after 20 hrs by electrochemiluminescence assay	B	COc1ncc(N2CCOCC2)cc1S(=O)(=O)Nc1cncc(-c2ccc(CN3CCN(C(C)C)CC3)cc2F)c1.O=CO		CHEMBL4878638	=	IC50	nM	3.162	CHEMBL3130	Homo sapiens	pIC50		8.5
	23236504	CHEMBL4828198	Inhibition of PI3Kdelta in human HL-60 cell extract measured after 2 hrs by kinobeads based chemoproteomic competition binding assay	B	COc1ncc(C2=CCOCC2)cc1S(=O)(=O)Nc1cncc(C#CCN2CCN(C(C)C)CC2)c1		CHEMBL4872328	=	IC50	nM	1.585	CHEMBL3130	Homo sapiens	pIC50		8.8
	23258666	CHEMBL4832741	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by TR-FRET based Adapta assay	B	Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](O)CC2)cc1-c1cnc(N)c(C(=O)C2CC2)n1		CHEMBL4859017	=	IC50	nM	120.0	CHEMBL3130	Homo sapiens	IC50	nM	120.0
	23258667	CHEMBL4832741	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by TR-FRET based Adapta assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	IC50	nM	960.0	CHEMBL3130	Homo sapiens	IC50	nM	960.0
	23258668	CHEMBL4832741	Inhibition of PI3Kdelta (unknown origin) using phosphatidylinositol as substrate incubated for 30 to 60 mins in presence of ATP by TR-FRET based Adapta assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)c(F)c3)c2)cnc1N		CHEMBL4857001	=	IC50	nM	1400.0	CHEMBL3130	Homo sapiens	IC50	nM	1400.0
	23258672	CHEMBL4832745	Inhibition of recombinant human PI3Kdelta assessed as reduction in PIP3 formation by AlphaScreen assay	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	=	IC50	nM	1090.0	CHEMBL3130	Homo sapiens	IC50	nM	1090.0
	23258676	CHEMBL4832749	Inhibition of PI3Kdelta (unknown origin) by Selectscreen kinase assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.5	CHEMBL3130	Homo sapiens	IC50	nM	2.5
	23258680	CHEMBL4832751	Inhibition of human PI3Kdelta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](O)CC2)cc1-c1cnc(N)c(C(=O)C2CC2)n1		CHEMBL4859017	=	IC50	nM	680.0	CHEMBL3130	Homo sapiens	IC50	nM	680.0
	23258681	CHEMBL4832751	Inhibition of human PI3Kdelta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	IC50	nM	4030.0	CHEMBL3130	Homo sapiens	IC50	nM	4030.0
	23258682	CHEMBL4832751	Inhibition of human PI3Kdelta expressed in rat fibroblast cells assessed as reduction in AKT phosphorylation at Ser473 residue incubated for 1 hr by AlphaScreen assay	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3ccc(F)c(F)c3)c2)cnc1N		CHEMBL4857001	=	IC50	nM	2879.0	CHEMBL3130	Homo sapiens	IC50	nM	2879.0
	23271973	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3[nH]c(-c4cnn(CC)c4C)nc23)C1		CHEMBL4860877	=	IC50	nM	875.0	CHEMBL3130	Homo sapiens	IC50	nM	875.0
	23271974	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C)C1		CHEMBL4441262	=	IC50	nM	24.0	CHEMBL3130	Homo sapiens	IC50	nM	24.0
	23271975	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3CC)C1		CHEMBL4849371	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	23271976	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCCn1c(-c2cnn(CC)c2C)nc2c(N[C@H]3CCN(C(=O)CC)C3)ncnc21		CHEMBL4850649	=	IC50	nM	198.0	CHEMBL3130	Homo sapiens	IC50	nM	198.0
	23271977	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3CC(F)F)C1		CHEMBL4853400	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	23271978	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3CC(F)(F)F)C1		CHEMBL4865558	=	IC50	nM	330.0	CHEMBL3130	Homo sapiens	IC50	nM	330.0
	23271979	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3C2CC2)C1		CHEMBL4872657	=	IC50	nM	720.0	CHEMBL3130	Homo sapiens	IC50	nM	720.0
	23271980	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnn(CC)c2C)n3CC2CC2)C1		CHEMBL4846624	=	IC50	nM	1350.0	CHEMBL3130	Homo sapiens	IC50	nM	1350.0
	23271981	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2ccn(CC)c2C)n3C)C1		CHEMBL4877831	=	IC50	nM	125.0	CHEMBL3130	Homo sapiens	IC50	nM	125.0
	23271982	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnc(C(C)(C)C)s2)n3C)C1		CHEMBL4852541	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	23271983	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnc(C)nc2)n3C)C1		CHEMBL4848249	=	IC50	nM	71.0	CHEMBL3130	Homo sapiens	IC50	nM	71.0
	23271984	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnc(C)nc2)n3CC)C1		CHEMBL4866823	=	IC50	nM	42.0	CHEMBL3130	Homo sapiens	IC50	nM	42.0
	23271985	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)CC)C3)ncnc21		CHEMBL4863544	=	IC50	nM	455.0	CHEMBL3130	Homo sapiens	IC50	nM	455.0
	23271986	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2ccc(C)nc2)n3C)C1		CHEMBL4847549	=	IC50	nM	160.0	CHEMBL3130	Homo sapiens	IC50	nM	160.0
	23271987	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2ccc(C(F)(F)F)nc2)n3C)C1		CHEMBL4866553	=	IC50	nM	66.0	CHEMBL3130	Homo sapiens	IC50	nM	66.0
	23271988	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2ccc(OC)nc2)n3C)C1		CHEMBL4873332	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	nM	67.0
	23271989	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnc(OC)c(F)c2)n3C)C1		CHEMBL4860474	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	23271990	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCC(=O)N1CC[C@H](Nc2ncnc3c2nc(-c2cnc(OC)c(C)c2)n3C)C1		CHEMBL4868988	=	IC50	nM	6.0	CHEMBL3130	Homo sapiens	IC50	nM	6.0
	23271991	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4853960	=	IC50	nM	20.0	CHEMBL3130	Homo sapiens	IC50	nM	20.0
	23271992	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4868053	=	IC50	nM	80.0	CHEMBL3130	Homo sapiens	IC50	nM	80.0
	23271993	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCC4)C3)ncnc21		CHEMBL4878995	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	23271994	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CCC4)C3)ncnc21		CHEMBL4873843	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	23271995	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4858121	=	IC50	nM	34.0	CHEMBL3130	Homo sapiens	IC50	nM	34.0
	23271996	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4870367	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	23271997	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC(F)(F)C4)C3)ncnc21		CHEMBL4858978	=	IC50	nM	13.0	CHEMBL3130	Homo sapiens	IC50	nM	13.0
	23271998	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CC(F)(F)C4)C3)ncnc21		CHEMBL4860194	=	IC50	nM	32.0	CHEMBL3130	Homo sapiens	IC50	nM	32.0
	23271999	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21		CHEMBL4878004	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	nM	67.0
	23272000	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21		CHEMBL4869250	=	IC50	nM	63.0	CHEMBL3130	Homo sapiens	IC50	nM	63.0
	23272001	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCOCC4)C3)ncnc21		CHEMBL4846361	=	IC50	nM	33.0	CHEMBL3130	Homo sapiens	IC50	nM	33.0
	23272002	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CCOCC4)C3)ncnc21		CHEMBL4848340	=	IC50	nM	390.0	CHEMBL3130	Homo sapiens	IC50	nM	390.0
	23272003	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)c4cocn4)C3)ncnc21		CHEMBL4869910	=	IC50	nM	82.0	CHEMBL3130	Homo sapiens	IC50	nM	82.0
	23272004	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)c4cocn4)C3)ncnc21		CHEMBL4873642	=	IC50	nM	94.0	CHEMBL3130	Homo sapiens	IC50	nM	94.0
	23272005	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4847079	=	IC50	nM	12.0	CHEMBL3130	Homo sapiens	IC50	nM	12.0
	23272006	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4874957	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	23272007	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4859422	=	IC50	nM	67.0	CHEMBL3130	Homo sapiens	IC50	nM	67.0
	23272008	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21		CHEMBL4868295	=	IC50	nM	43.0	CHEMBL3130	Homo sapiens	IC50	nM	43.0
	23272009	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)C4CCOC4)C3)ncnc21		CHEMBL4848054	=	IC50	nM	110.0	CHEMBL3130	Homo sapiens	IC50	nM	110.0
	23272010	CHEMBL4835452	Inhibition of PI3Kdelta in human Ramos cells assessed as reduction in anti-IgM-antibody-induced phosphorylation of AKT at Ser473 residue preincubated for 20 mins followed by anti-IgM antibody stimulation and measured after 30 mins by alphascreen assay	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)c4cocn4)C3)ncnc21		CHEMBL4858747	=	IC50	nM	300.0	CHEMBL3130	Homo sapiens	IC50	nM	300.0
	23272047	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4853960	=	IC50	nM	65.0	CHEMBL3130	Homo sapiens	IC50	nM	65.0
	23272048	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4868053	=	IC50	nM	270.0	CHEMBL3130	Homo sapiens	IC50	nM	270.0
	23272049	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CCC4)C3)ncnc21		CHEMBL4878995	=	IC50	nM	14.0	CHEMBL3130	Homo sapiens	IC50	nM	14.0
	23272050	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4858121	=	IC50	nM	26.0	CHEMBL3130	Homo sapiens	IC50	nM	26.0
	23272051	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4870367	=	IC50	nM	75.0	CHEMBL3130	Homo sapiens	IC50	nM	75.0
	23272052	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)C4CC(F)(F)C4)C3)ncnc21		CHEMBL4860194	=	IC50	nM	84.0	CHEMBL3130	Homo sapiens	IC50	nM	84.0
	23272053	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21		CHEMBL4878004	=	IC50	nM	9.0	CHEMBL3130	Homo sapiens	IC50	nM	9.0
	23272054	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(O[C@H]3CCN(C(=O)c4cocn4)C3)ncnc21		CHEMBL4873642	=	IC50	nM	600.0	CHEMBL3130	Homo sapiens	IC50	nM	600.0
	23272055	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)[C@H]4C[C@@H](OC)C4)C3)ncnc21		CHEMBL4859422	=	IC50	nM	73.0	CHEMBL3130	Homo sapiens	IC50	nM	73.0
	23272056	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)N4CC(OC)C4)C3)ncnc21		CHEMBL4868295	=	IC50	nM	68.0	CHEMBL3130	Homo sapiens	IC50	nM	68.0
	23272057	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)C4CCOC4)C3)ncnc21		CHEMBL4848054	=	IC50	nM	100.0	CHEMBL3130	Homo sapiens	IC50	nM	100.0
	23272058	CHEMBL4835454	Inhibition of PI3Kdelta in human whole blood assessed as reduction in anti-CD79b antibody-induced CD69 expression preincubated for 60 mins followed by anti-CD79b antibody stimulation and measured after 3 hrs by FACS analysis	B	CCn1c(-c2ccc(C(F)(F)F)nc2)nc2c(O[C@H]3CCN(C(=O)c4cocn4)C3)ncnc21		CHEMBL4858747	=	IC50	nM	380.0	CHEMBL3130	Homo sapiens	IC50	nM	380.0
	23272323	CHEMBL4835473	Inhibition of PI3Kdelta in human whole blood assessed as reduction in antihuman IgE antibody-stimulated CD63 expression preincubated for 30 mins followed by antihuman IgE antibody stimulation and measured after 20 mins by FACS analysis	B	CCn1c(-c2cnc(C)nc2)nc2c(N[C@H]3CCN(C(=O)C4CC4)C3)ncnc21		CHEMBL4853960	=	IC50	nM	50.0	CHEMBL3130	Homo sapiens	IC50	nM	50.0
Active	23280021	CHEMBL4836863	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280022	CHEMBL4836863	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280023	CHEMBL4836863	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280024	CHEMBL4836864	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280025	CHEMBL4836864	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280026	CHEMBL4836864	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280027	CHEMBL4836865	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of S6 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280028	CHEMBL4836865	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of S6 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280029	CHEMBL4836866	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of S6 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280030	CHEMBL4836866	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of S6 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280031	CHEMBL4836867	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of 4EBP1 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280032	CHEMBL4836867	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of 4EBP1 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280033	CHEMBL4836868	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of 4EBP1 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280034	CHEMBL4836868	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of 4EBP1 phosphorylation at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280083	CHEMBL4836885	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280084	CHEMBL4836885	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280085	CHEMBL4836885	Inhibition of PI3Kdelta in human SU-DHL-5 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280086	CHEMBL4836886	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280087	CHEMBL4836886	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	O=c1c2c(F)cccc2nc([C@@H](Nc2ncnc3nc[nH]c23)C2CC2)n1-c1ccccc1		CHEMBL4852166		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23280088	CHEMBL4836886	Inhibition of PI3Kdelta in human MOLT-4 cells assessed as inhibition of AKT phosphorylation at Thr308 residue at 1 to 5 uM measured after 3 hrs by western blot assay	B	Cc1cccc2nc([C@@H](Nc3ncnc4nc[nH]c34)C3CC3)n(-c3ccccc3)c(=O)c12		CHEMBL4868117		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
	23296114	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	=	IC50	nM	2.0	CHEMBL3130	Homo sapiens	IC50	nM	2.0
	23296115	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	IC50	nM	4.0	CHEMBL3130	Homo sapiens	IC50	nM	4.0
	23296116	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]ccc3c2)cnc1Cl)c1ccccc1		CHEMBL4867687	=	IC50	nM	334.0	CHEMBL3130	Homo sapiens	IC50	nM	334.0
	23296117	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4878009	=	IC50	nM	36.0	CHEMBL3130	Homo sapiens	IC50	nM	36.0
	23296118	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]cnc3c2)cnc1Cl)c1ccccc1		CHEMBL4868150	=	IC50	nM	28.0	CHEMBL3130	Homo sapiens	IC50	nM	28.0
	23296119	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]ccc3n2)cnc1Cl)c1ccccc1		CHEMBL4858344	=	IC50	nM	3057.0	CHEMBL3130	Homo sapiens	IC50	nM	3057.0
	23296120	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cc3cc[nH]c3cn2)cnc1Cl)c1ccccc1		CHEMBL4855354	=	IC50	nM	1307.0	CHEMBL3130	Homo sapiens	IC50	nM	1307.0
	23296121	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ccc3c2)cnc1Cl)c1ccccc1		CHEMBL4214320	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	23296122	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3c(c2)CCN3)cnc1Cl)c1ccccc1		CHEMBL4866066	=	IC50	nM	123.0	CHEMBL3130	Homo sapiens	IC50	nM	123.0
	23296123	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3c(c2)CCN3)cnc1Cl)c1ccccc1		CHEMBL4867262	=	IC50	nM	492.0	CHEMBL3130	Homo sapiens	IC50	nM	492.0
	23296124	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4204119	=	IC50	nM	1.0	CHEMBL3130	Homo sapiens	IC50	nM	1.0
	23296125	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]cnc3c2)cnc1Cl)c1ccccc1		CHEMBL4861979	=	IC50	nM	16.0	CHEMBL3130	Homo sapiens	IC50	nM	16.0
	23296126	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ccc3n2)cnc1Cl)c1ccccc1		CHEMBL4867808	=	IC50	nM	49.0	CHEMBL3130	Homo sapiens	IC50	nM	49.0
	23296127	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]nnc3c2)cnc1Cl)c1ccccc1		CHEMBL4877628	=	IC50	nM	15.0	CHEMBL3130	Homo sapiens	IC50	nM	15.0
	23296128	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3[nH]ncc3n2)cnc1Cl)c1ccccc1		CHEMBL4857283	=	IC50	nM	294.0	CHEMBL3130	Homo sapiens	IC50	nM	294.0
	23296129	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cc3cn[nH]c3cn2)cnc1Cl)c1ccccc1		CHEMBL4871016	=	IC50	nM	527.0	CHEMBL3130	Homo sapiens	IC50	nM	527.0
	23296130	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3occc3c2)cnc1Cl)c1ccccc1		CHEMBL4853357	=	IC50	nM	17.0	CHEMBL3130	Homo sapiens	IC50	nM	17.0
	23296131	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3sccc3c2)cnc1Cl)c1ccccc1		CHEMBL4877501	=	IC50	nM	859.0	CHEMBL3130	Homo sapiens	IC50	nM	859.0
	23296132	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3ocnc3c2)cnc1Cl)c1ccccc1		CHEMBL4878688	=	IC50	nM	37.0	CHEMBL3130	Homo sapiens	IC50	nM	37.0
	23296133	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3occc3c2)cnc1Cl)c1ccccc1		CHEMBL4851286	=	IC50	nM	209.0	CHEMBL3130	Homo sapiens	IC50	nM	209.0
	23296134	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2ccc3scnc3c2)cnc1Cl)c1ccccc1		CHEMBL4850951	=	IC50	nM	604.0	CHEMBL3130	Homo sapiens	IC50	nM	604.0
	23296135	CHEMBL4840758	Inhibition of PI3Kdelta (unknown origin) using PIP2 as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	O=S(=O)(Nc1cc(-c2cnc3scnc3c2)cnc1Cl)c1ccccc1		CHEMBL4858830	=	IC50	nM	204.0	CHEMBL3130	Homo sapiens	IC50	nM	204.0
Dose-Dependent Effect	23296151	CHEMBL4840768	Inhibition of PI3Kdelta in human MOLM16 cells assessed as reduction in Akt phosphorylation at Ser473 measured after 16 hrs by Western blot analysis	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4204119		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Active	23296152	CHEMBL4840769	Inhibition of PI3Kdelta in human MOLM16 cells assessed as reduction in Akt phosphorylation at Ser473 measured at 5 uM after 16 hrs by Western blot analysis	B	O=S(=O)(Nc1cc(-c2cnc3[nH]ncc3c2)cnc1Cl)c1ccccc1		CHEMBL4204119		Inhibition	%		CHEMBL3130	Homo sapiens	INH		
Not Active	23317584	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	72.0	CHEMBL3130	Homo sapiens	% Control	%	72.0
Not Active	23318052	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23318718	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	79.0	CHEMBL3130	Homo sapiens	% Control	%	79.0
Not Active	23319202	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	84.0	CHEMBL3130	Homo sapiens	% Control	%	84.0
Not Active	23319839	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23320314	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	87.0	CHEMBL3130	Homo sapiens	% Control	%	87.0
Not Active	23320992	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	69.0	CHEMBL3130	Homo sapiens	% Control	%	69.0
Not Active	23321460	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23322090	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	75.0	CHEMBL3130	Homo sapiens	% Control	%	75.0
Not Active	23322558	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	90.0	CHEMBL3130	Homo sapiens	% Control	%	90.0
Not Active	23323247	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	97.0	CHEMBL3130	Homo sapiens	% Control	%	97.0
Not Active	23323715	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	85.0	CHEMBL3130	Homo sapiens	% Control	%	85.0
Not Active	23324569	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23325204	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL3130	Homo sapiens	% Control	%	89.0
Not Active	23325672	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	99.0	CHEMBL3130	Homo sapiens	% Control	%	99.0
Not Active	23326319	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL3130	Homo sapiens	% Control	%	93.0
Not Active	23326787	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	99.0	CHEMBL3130	Homo sapiens	% Control	%	99.0
Not Active	23327487	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	67.0	CHEMBL3130	Homo sapiens	% Control	%	67.0
Not Active	23327955	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	67.0	CHEMBL3130	Homo sapiens	% Control	%	67.0
Not Active	23328542	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	66.0	CHEMBL3130	Homo sapiens	% Control	%	66.0
Not Active	23329010	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23329956	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	86.0	CHEMBL3130	Homo sapiens	% Control	%	86.0
Not Active	23330424	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	78.0	CHEMBL3130	Homo sapiens	% Control	%	78.0
Not Active	23331180	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	97.0	CHEMBL3130	Homo sapiens	% Control	%	97.0
Not Active	23331648	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23332235	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	76.9	CHEMBL3130	Homo sapiens	% Control	%	76.9
Not Active	23332701	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23333419	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	89.8	CHEMBL3130	Homo sapiens	% Control	%	89.8
Not Active	23334058	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	75.0	CHEMBL3130	Homo sapiens	% Control	%	75.0
Not Active	23334526	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23335505	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	51.0	CHEMBL3130	Homo sapiens	% Control	%	51.0
Not Active	23335973	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	51.0	CHEMBL3130	Homo sapiens	% Control	%	51.0
Not Active	23336600	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	75.0	CHEMBL3130	Homo sapiens	% Control	%	75.0
Not Active	23337068	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	85.0	CHEMBL3130	Homo sapiens	% Control	%	85.0
Not Active	23338149	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL3130	Homo sapiens	% Control	%	93.0
Not Active	23338617	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23339229	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	89.0	CHEMBL3130	Homo sapiens	% Control	%	89.0
Not Active	23339697	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	90.0	CHEMBL3130	Homo sapiens	% Control	%	90.0
Not Active	23340334	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23340802	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Slightly Active	23341459	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	34.0	CHEMBL3130	Homo sapiens	% Control	%	34.0
Not Active	23341927	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23342543	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23343011	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23343641	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	65.0	CHEMBL3130	Homo sapiens	% Control	%	65.0
Not Active	23344109	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	97.0	CHEMBL3130	Homo sapiens	% Control	%	97.0
Not Active	23344747	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23345320	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23345788	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL3130	Homo sapiens	% Control	%	92.0
Not Active	23346365	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23346833	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	98.8	CHEMBL3130	Homo sapiens	% Control	%	98.8
Not Active	23347435	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	81.9	CHEMBL3130	Homo sapiens	% Control	%	81.9
Not Active	23347925	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23348504	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23348972	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23349559	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23350177	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23350645	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23351250	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL3130	Homo sapiens	% Control	%	95.0
Not Active	23351718	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23352742	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	68.0	CHEMBL3130	Homo sapiens	% Control	%	68.0
Not Active	23353210	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	97.0	CHEMBL3130	Homo sapiens	% Control	%	97.0
Not Active	23354092	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	98.0	CHEMBL3130	Homo sapiens	% Control	%	98.0
Not Active	23354560	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23355292	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	94.0	CHEMBL3130	Homo sapiens	% Control	%	94.0
Not Active	23355760	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	82.0	CHEMBL3130	Homo sapiens	% Control	%	82.0
Not Active	23356396	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23356864	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	81.0	CHEMBL3130	Homo sapiens	% Control	%	81.0
Not Active	23357473	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23358120	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	81.0	CHEMBL3130	Homo sapiens	% Control	%	81.0
Not Active	23358588	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	64.0	CHEMBL3130	Homo sapiens	% Control	%	64.0
Not Active	23359174	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	85.7	CHEMBL3130	Homo sapiens	% Control	%	85.7
Not Active	23359772	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	99.0	CHEMBL3130	Homo sapiens	% Control	%	99.0
Not Active	23360240	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23360825	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	84.0	CHEMBL3130	Homo sapiens	% Control	%	84.0
Not Active	23361293	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	88.0	CHEMBL3130	Homo sapiens	% Control	%	88.0
Not Active	23361866	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	72.0	CHEMBL3130	Homo sapiens	% Control	%	72.0
Not Active	23362402	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	52.0	CHEMBL3130	Homo sapiens	% Control	%	52.0
Not Active	23362870	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23364512	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	75.0	CHEMBL3130	Homo sapiens	% Control	%	75.0
Not Active	23364980	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	60.0	CHEMBL3130	Homo sapiens	% Control	%	60.0
Not Active	23365719	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23366262	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	74.0	CHEMBL3130	Homo sapiens	% Control	%	74.0
Not Active	23366852	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	94.0	CHEMBL3130	Homo sapiens	% Control	%	94.0
Not Active	23367320	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23368198	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23368666	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL3130	Homo sapiens	% Control	%	93.0
Not Active	23369265	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23369733	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	67.0	CHEMBL3130	Homo sapiens	% Control	%	67.0
Not Active	23370701	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	90.0	CHEMBL3130	Homo sapiens	% Control	%	90.0
Not Active	23371169	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	71.0	CHEMBL3130	Homo sapiens	% Control	%	71.0
Not Active	23371978	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	67.0	CHEMBL3130	Homo sapiens	% Control	%	67.0
Not Active	23372446	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL3130	Homo sapiens	% Control	%	91.0
	23372938	CHEMBL4884903	PI3KCD(PI3DCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	23373347	CHEMBL4885194	PI3KCD(PI3DCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
	23373701	CHEMBL4885478	PI3KCD(PI3DCGRK) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3130	Homo sapiens	pIC50		6.0
Not Active	23375873	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	94.0	CHEMBL3130	Homo sapiens	% Control	%	94.0
Slightly Active	23376341	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	32.0	CHEMBL3130	Homo sapiens	% Control	%	32.0
Not Active	23376918	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	54.0	CHEMBL3130	Homo sapiens	% Control	%	54.0
Not Active	23377386	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	51.0	CHEMBL3130	Homo sapiens	% Control	%	51.0
Not Active	23378246	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	92.0	CHEMBL3130	Homo sapiens	% Control	%	92.0
Not Active	23378714	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23379881	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	91.0	CHEMBL3130	Homo sapiens	% Control	%	91.0
Not Active	23380349	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	61.0	CHEMBL3130	Homo sapiens	% Control	%	61.0
Not Active	23381043	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3130	Homo sapiens	% Control	%	100.0
Not Active	23381691	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	95.0	CHEMBL3130	Homo sapiens	% Control	%	95.0
Not Active	23382159	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	73.0	CHEMBL3130	Homo sapiens	% Control	%	73.0
Not Active	23382783	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	90.0	CHEMBL3130	Homo sapiens	% Control	%	90.0
Not Active	23383251	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	77.0	CHEMBL3130	Homo sapiens	% Control	%	77.0
Not Active	23385166	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	98.0	CHEMBL3130	Homo sapiens	% Control	%	98.0
Not Active	23385633	CHEMBL4879890	KinomeScan assay: inhibition of PIK3CD	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL3130	Homo sapiens	% Control	%	87.0
